1	Lung	NN	O	lung	nn	2	SENT_1	[p1l879t82r940b108],
2	Cancer	NN	O	cancer	_	0	SENT_1	[p1l948t82r1034b103],
3	77	CD	NUMBER	77	number	4	SENT_1	[p1l1042t82r1071b102],
4	(	CD	NUMBER	(	dep	2	SENT_1	[p1l1081t81r1163b108],
5	2012	CD	DATE	2012	dep	4	SENT_1	[p1l1081t81r1163b108],
6	)	CD	NUMBER	)	num	7	SENT_1	[p1l1081t81r1163b108],
7	438-442	CD	NUMBER	438-442	dep	2	SENT_1	[p1l1171t82r1281b103],

1	Contents	NNS	O	contents	_	0	SENT_2	[p1l708t188r844b214],
2	lists	NNS	O	list	dep	1	SENT_2	[p1l857t189r915b213],
3	available	JJ	O	available	amod	2	SENT_2	[p1l927t189r1063b214],
4	at	IN	O	at	_	0	SENT_2	[p1l1075t192r1102b214],
5	SciVerse	NNP	O	SciVerse	nn	6	SENT_2	[p1l1113t188r1243b214],
6	ScienceDirect	NNP	O	ScienceDirect	prep_at	3	SENT_2	[p1l1255t188r1463b214],

1	Lung	NN	O	lung	nn	2	SENT_3	[p1l926t289r1057b344],
2	Cancer	NN	O	cancer	_	0	SENT_3	[p1l1075t289r1260b333],

1	.	.	O	.	_	0	SENT_4	[p1l36t375r68b397],

1	_	NN	O	_	nn	2	SENT_5	[p1l36t375r68b397],
2	gar	NN	O	gar	_	0	SENT_5	[p1l201t375r252b398],
3	,	,	O	,	_	0	SENT_5	[p1l201t375r252b398],
4	ELSEVIER	NN	ORGANIZATION	elsevier	nn	6	SENT_5	[p1l12t421r248b456],
5	journal	NN	O	journal	nn	6	SENT_5	[p1l576t418r708b449],
6	homepage	NN	O	homepage	appos	2	SENT_5	[p1l730t418r933b449],
7	:	:	O	:	_	0	SENT_5	[p1l730t418r933b449],
8	www	NN	O	www	dep	2	SENT_5	[p1l949t418r1593b449],
9	.	.	O	.	_	0	SENT_5	[p1l949t418r1593b449],

1	e	LS	O	e	dep	3	SENT_6	[p1l949t418r1593b449],
2	|	SYM	O	|	dep	3	SENT_6	[p1l949t418r1593b449],
3	sevier.com/Iocate/lungcan	NN	O	sevier.com/iocate/lungcan	_	0	SENT_6	[p1l949t418r1593b449],

1	Prediction	NN	O	prediction	dep	8	SENT_7	[p1l6t565r277b611],
2	of	IN	O	of	_	0	SENT_7	[p1l295t565r350b611],
3	copper	NN	O	copper	nn	4	SENT_7	[p1l362t578r545b622],
4	transport	NN	O	transport	prep_of	1	SENT_7	[p1l562t572r810b622],
5	protein	NN	O	protein	dep	8	SENT_7	[p1l828t566r1021b622],
6	1	CD	NUMBER	1	num	5	SENT_7	[p1l1042t568r1062b610],
7	(	CD	NUMBER	(	num	8	SENT_7	[p1l1087t565r1263b622],
8	CTR1	NN	O	ctr1	dep	14	SENT_7	[p1l1087t565r1263b622],
9	)	CD	NUMBER	)	num	10	SENT_7	[p1l1087t565r1263b622],
10	genotype	NN	O	genotype	dep	8	SENT_7	[p1l1281t572r1528b622],
11	on	IN	O	on	_	0	SENT_7	[p1l1547t578r1611b611],
12	severe	JJ	O	severe	amod	13	SENT_7	[p1l1630t578r1799b611],
13	cisplatin	NN	O	cisplatin	prep_on	10	SENT_7	[p1l1818t565r2042b622],
14	induced	VBD	O	induce	_	0	SENT_7	[p1l6t637r217b682],
15	toxicity	NN	O	toxicity	dobj	14	SENT_7	[p1l235t638r437b693],
16	in	IN	O	in	_	0	SENT_7	[p1l454t638r503b682],
17	non-small	JJ	O	non-small	amod	20	SENT_7	[p1l522t637r790b682],
18	cell	NN	O	cell	nn	20	SENT_7	[p1l809t637r898b682],
19	lung	NN	O	lung	nn	20	SENT_7	[p1l917t637r1033b693],
20	cancer	NN	O	cancer	prep_in	14	SENT_7	[p1l1051t650r1224b682],
21	(	CD	NUMBER	(	num	24	SENT_7	[p1l1241t637r1453b693],
22	NSCLC	NN	O	nsclc	nn	24	SENT_7	[p1l1241t637r1453b693],
23	)	CD	NUMBER	)	num	24	SENT_7	[p1l1241t637r1453b693],
24	patients	NNS	O	patient	dep	20	SENT_7	[p1l1472t634r1718b693],
25	‘	CD	NUMBER	‘	dep	24	SENT_7	[p1l1472t634r1718b693],
26	?	.	O	?	_	0	SENT_7	[p1l1472t634r1718b693],

1	Xiaojing	VBG	PERSON	xiaoj	dep	130	SENT_8	[p1l6t740r180b784],
2	Xua	NN	PERSON	xua	dep	130	SENT_8	[p1l192t741r283b781],
3	,	,	O	,	_	0	SENT_8	[p1l192t741r283b781],
4	Huayi	NNP	PERSON	Huayi	dep	130	SENT_8	[p1l298t740r418b784],
5	Renb	NNP	PERSON	Renb	dep	130	SENT_8	[p1l434t734r547b781],
6	,	,	O	,	_	0	SENT_8	[p1l434t734r547b781],
7	Boting	NNP	PERSON	Boting	dep	130	SENT_8	[p1l563t740r697b784],
8	Zhou	NNP	PERSON	Zhou	dep	130	SENT_8	[p1l710t740r848b781],
9	°	NNP	O	°	dep	130	SENT_8	[p1l710t740r848b781],
10	,	,	O	,	_	0	SENT_8	[p1l710t740r848b781],
11	Yingchun	NNP	PERSON	Yingchun	dep	130	SENT_8	[p1l861t740r1060b784],
12	Zhaod	NNP	PERSON	Zhaod	dep	130	SENT_8	[p1l1073t734r1211b781],
13	,	,	O	,	_	0	SENT_8	[p1l1073t734r1211b781],
14	Ruixia	NNP	PERSON	Ruixia	dep	130	SENT_8	[p1l1227t740r1356b775],
15	Yuane	NNP	PERSON	Yuane	dep	130	SENT_8	[p1l1369t741r1509b781],
16	,	,	O	,	_	0	SENT_8	[p1l1369t741r1509b781],
17	Rui	NNP	PERSON	Rui	dep	130	SENT_8	[p1l1525t740r1590b775],
18	Mal	NNP	PERSON	Mal	dep	130	SENT_8	[p1l1606t734r1697b781],
19	,	,	O	,	_	0	SENT_8	[p1l1606t734r1697b781],
20	Honghao	NNP	PERSON	Honghao	dep	130	SENT_8	[p1l1713t740r1899b784],
21	Zhoua	NNP	PERSON	Zhoua	dep	130	SENT_8	[p1l1913t740r2053b781],
22	,	,	O	,	_	0	SENT_8	[p1l1913t740r2053b781],
23	Zhaoqian	NNP	PERSON	Zhaoqian	dep	130	SENT_8	[p1l7t793r200b838],
24	Liu	NNP	PERSON	Liu	dep	130	SENT_8	[p1l215t794r275b829],
25	av	IN	O	av	dep	130	SENT_8	[p1l283t795r325b818],
26	*	CD	NUMBER	*	dep	130	SENT_8	[p1l283t795r325b818],
27	3	CD	NUMBER	3	dep	130	SENT_8	[p1l6t871r15b882],
28	Institute	NNP	ORGANIZATION	Institute	dep	130	SENT_8	[p1l22t870r123b892],
29	of	IN	ORGANIZATION	of	dep	130	SENT_8	[p1l132t870r158b897],
30	Clinical	JJ	ORGANIZATION	clinical	dep	130	SENT_8	[p1l162t870r250b892],
31	Pharmacology	NN	ORGANIZATION	pharmacology	dep	130	SENT_8	[p1l258t870r435b897],
32	,	,	O	,	_	0	SENT_8	[p1l258t870r435b897],
33	Hunan	NNP	ORGANIZATION	Hunan	dep	130	SENT_8	[p1l444t871r525b892],
34	Key	NNP	ORGANIZATION	Key	dep	130	SENT_8	[p1l533t871r577b897],
35	Laboratory	NNP	ORGANIZATION	Laboratory	dep	130	SENT_8	[p1l585t870r717b897],
36	of	IN	ORGANIZATION	of	dep	130	SENT_8	[p1l726t870r752b897],
37	Pharmacogenetics	NNPS	ORGANIZATION	Pharmacogenetics	dep	130	SENT_8	[p1l755t870r979b897],
38	,	,	O	,	_	0	SENT_8	[p1l755t870r979b897],
39	Central	NNP	ORGANIZATION	Central	dep	130	SENT_8	[p1l989t870r1076b892],
40	South	NNP	ORGANIZATION	South	dep	130	SENT_8	[p1l1083t870r1151b892],
41	University	NNP	ORGANIZATION	University	dep	130	SENT_8	[p1l1161t870r1288b897],
42	,	,	O	,	_	0	SENT_8	[p1l1161t870r1288b897],
43	Changsha	NNP	LOCATION	Changsha	dep	130	SENT_8	[p1l1299t870r1420b897],
44	,	,	O	,	_	0	SENT_8	[p1l1299t870r1420b897],
45	Hunan	NNP	LOCATION	Hunan	dep	130	SENT_8	[p1l1429t871r1510b892],
46	Province	NNP	LOCATION	Province	dep	130	SENT_8	[p1l1518t870r1627b895],
47	,	,	O	,	_	0	SENT_8	[p1l1518t870r1627b895],
48	410078	CD	NUMBER	410078	dep	130	SENT_8	[p1l1635t871r1731b895],
49	,	,	O	,	_	0	SENT_8	[p1l1635t871r1731b895],
50	China	NNP	LOCATION	China	dep	130	SENT_8	[p1l1741t870r1809b892],
51	‘’	NNP	O	‘’	dep	130	SENT_8	[p1l6t902r16b917],
52	Department	NNP	ORGANIZATION	Department	dep	130	SENT_8	[p1l23t907r170b932],
53	of	IN	ORGANIZATION	of	dep	130	SENT_8	[p1l177t905r203b932],
54	Pharmacy	NNP	ORGANIZATION	Pharmacy	dep	130	SENT_8	[p1l206t905r332b932],
55	,	,	O	,	_	0	SENT_8	[p1l206t905r332b932],
56	Tumor	NN	ORGANIZATION	tumor	dep	130	SENT_8	[p1l342t907r422b927],
57	Hospital	NN	ORGANIZATION	hospital	dep	130	SENT_8	[p1l428t905r528b932],
58	of	IN	ORGANIZATION	of	dep	130	SENT_8	[p1l537t905r563b932],
59	Hunan	NNP	ORGANIZATION	Hunan	dep	130	SENT_8	[p1l566t907r647b927],
60	Province	NNP	ORGANIZATION	Province	dep	130	SENT_8	[p1l655t906r763b930],
61	,	,	O	,	_	0	SENT_8	[p1l655t906r763b930],
62	Hunan	NNP	LOCATION	Hunan	dep	130	SENT_8	[p1l773t907r854b927],
63	410013	CD	NUMBER	410013	dep	130	SENT_8	[p1l862t906r958b930],
64	,	,	O	,	_	0	SENT_8	[p1l862t906r958b930],
65	China	NNP	LOCATION	China	dep	130	SENT_8	[p1l968t905r1036b927],
66	5	CD	NUMBER	5	dep	130	SENT_8	[p1l6t942r14b953],
67	Department	NNP	ORGANIZATION	Department	dep	130	SENT_8	[p1l21t942r168b968],
68	of	IN	ORGANIZATION	of	dep	130	SENT_8	[p1l175t941r201b968],
69	Pharmacy	NNP	ORGANIZATION	Pharmacy	dep	130	SENT_8	[p1l204t941r330b968],
70	,	,	O	,	_	0	SENT_8	[p1l204t941r330b968],
71	Xiangya	NNP	LOCATION	Xiangya	dep	130	SENT_8	[p1l338t941r437b968],
72	Hospital	NNP	LOCATION	Hospital	dep	130	SENT_8	[p1l445t941r550b968],
73	,	,	O	,	_	0	SENT_8	[p1l445t941r550b968],
74	Central	NNP	ORGANIZATION	Central	dep	130	SENT_8	[p1l560t941r647b963],
75	South	NNP	ORGANIZATION	South	dep	130	SENT_8	[p1l654t941r722b963],
76	University	NNP	ORGANIZATION	University	dep	130	SENT_8	[p1l732t941r859b968],
77	,	,	O	,	_	0	SENT_8	[p1l732t941r859b968],
78	Hunan	NNP	PERSON	Hunan	dep	130	SENT_8	[p1l869t942r950b963],
79	410078	CD	NUMBER	410078	dep	130	SENT_8	[p1l958t942r1054b966],
80	,	,	O	,	_	0	SENT_8	[p1l958t942r1054b966],
81	China	NNP	LOCATION	China	dep	130	SENT_8	[p1l1064t941r1132b963],
82	‘‘	CD	NUMBER	‘‘	dep	130	SENT_8	[p1l6t973r16b988],
83	Oseotoprosis	NNP	ORGANIZATION	Oseotoprosis	dep	130	SENT_8	[p1l25t977r177b1003],
84	Research	NNP	ORGANIZATION	Research	dep	130	SENT_8	[p1l185t976r291b998],
85	Center	NNP	ORGANIZATION	Center	dep	130	SENT_8	[p1l300t977r382b1001],
86	,	,	O	,	_	0	SENT_8	[p1l300t977r382b1001],
87	Creighton	NNP	ORGANIZATION	Creighton	dep	130	SENT_8	[p1l392t976r508b1003],
88	University	NNP	ORGANIZATION	University	dep	130	SENT_8	[p1l518t977r645b1003],
89	,	,	O	,	_	0	SENT_8	[p1l518t977r645b1003],
90	Omaha	NNP	LOCATION	Omaha	dep	130	SENT_8	[p1l656t976r746b1001],
91	,	,	O	,	_	0	SENT_8	[p1l656t976r746b1001],
92	NE	NN	O	ne	dep	130	SENT_8	[p1l755t977r790b997],
93	68131	CD	NUMBER	68131	dep	130	SENT_8	[p1l798t977r877b1001],
94	,	,	O	,	_	0	SENT_8	[p1l798t977r877b1001],
95	USA	NNP	LOCATION	USA	dep	130	SENT_8	[p1l888t977r934b998],
96	9	CD	NUMBER	9	dep	130	SENT_8	[p1l6t1013r15b1024],
97	Xiehe	NNP	ORGANIZATION	Xiehe	dep	130	SENT_8	[p1l21t1012r88b1034],
98	Hospital	NNP	ORGANIZATION	Hospital	dep	130	SENT_8	[p1l96t1012r201b1039],
99	,	,	O	,	_	0	SENT_8	[p1l96t1012r201b1039],
100	Huazhong	NNP	ORGANIZATION	Huazhong	dep	130	SENT_8	[p1l210t1012r334b1039],
101	University	NNP	ORGANIZATION	University	dep	130	SENT_8	[p1l342t1012r464b1039],
102	of	IN	ORGANIZATION	of	dep	130	SENT_8	[p1l473t1012r499b1039],
103	Science	NNP	ORGANIZATION	Science	dep	130	SENT_8	[p1l502t1012r590b1034],
104	and	CC	ORGANIZATION	and	dep	130	SENT_8	[p1l598t1012r643b1034],
105	Technology	NNP	ORGANIZATION	Technology	dep	130	SENT_8	[p1l651t1012r792b1039],
106	,	,	O	,	_	0	SENT_8	[p1l651t1012r792b1039],
107	Wuhan	NNP	LOCATION	Wuhan	dep	130	SENT_8	[p1l802t1012r894b1037],
108	,	,	O	,	_	0	SENT_8	[p1l802t1012r894b1037],
109	Hubei	NNP	LOCATION	Hubei	dep	130	SENT_8	[p1l903t1012r975b1034],
110	Province	NNP	LOCATION	Province	dep	130	SENT_8	[p1l982t1012r1091b1037],
111	,	,	O	,	_	0	SENT_8	[p1l982t1012r1091b1037],
112	430071	CD	NUMBER	430071	dep	130	SENT_8	[p1l1099t1013r1196b1037],
113	,	,	O	,	_	0	SENT_8	[p1l1099t1013r1196b1037],
114	China	NNP	ORGANIZATION	China	dep	130	SENT_8	[p1l1206t1012r1274b1034],
115	f	FW	ORGANIZATION	f	dep	130	SENT_8	[p1l6t1044r13b1059],
116	Department	NNP	ORGANIZATION	Department	dep	130	SENT_8	[p1l20t1049r167b1075],
117	of	IN	ORGANIZATION	of	dep	130	SENT_8	[p1l174t1047r200b1075],
118	Oncology	NNP	ORGANIZATION	Oncology	dep	130	SENT_8	[p1l204t1048r321b1075],
119	,	,	O	,	_	0	SENT_8	[p1l204t1048r321b1075],
120	Xijing	NNP	LOCATION	Xijing	dep	130	SENT_8	[p1l328t1048r401b1075],
121	Hospital	NNP	LOCATION	Hospital	dep	130	SENT_8	[p1l407t1048r512b1075],
122	,	,	O	,	_	0	SENT_8	[p1l407t1048r512b1075],
123	Xi'an	NNP	LOCATION	Xi'an	dep	130	SENT_8	[p1l520t1048r587b1073],
124	,	,	O	,	_	0	SENT_8	[p1l520t1048r587b1073],
125	Shanxi	NNP	LOCATION	Shanxi	dep	130	SENT_8	[p1l596t1048r677b1069],
126	Province	NNP	LOCATION	Province	dep	130	SENT_8	[p1l684t1048r793b1073],
127	,	,	O	,	_	0	SENT_8	[p1l684t1048r793b1073],
128	710061	CD	NUMBER	710061	dep	130	SENT_8	[p1l804t1049r898b1073],
129	,	,	O	,	_	0	SENT_8	[p1l804t1049r898b1073],
130	China	NNP	LOCATION	China	_	0	SENT_8	[p1l908t1048r976b1069],

1	ARTICLE	NN	O	article	_	0	SENT_9	[p1l6t1184r232b1207],
2	INFO	NN	O	info	nn	3	SENT_9	[p1l277t1184r401b1207],
3	ABSTRACT	NN	O	abstract	dep	1	SENT_9	[p1l701t1184r972b1207],

1	Article	NNP	O	Article	nn	5	SENT_10	[p1l6t1263r85b1285],
2	history	NN	O	history	nn	5	SENT_10	[p1l97t1263r188b1290],
3	-	:	O	-	_	0	SENT_10	[p1l97t1263r188b1290],
4	'	''	O	'	_	0	SENT_10	[p1l97t1263r188b1290],
5	Background	NNP	O	Background	_	0	SENT_10	[p1l709t1265r879b1295],
6	:	:	O	:	_	0	SENT_10	[p1l709t1265r879b1295],
7	Cisplatin	NN	O	cisplatin	nn	8	SENT_10	[p1l895t1265r1019b1295],
8	toxicity	NN	O	toxicity	dep	5	SENT_10	[p1l1033t1265r1141b1295],
9	severely	RB	O	severely	advmod	10	SENT_10	[p1l1155t1265r1273b1295],
10	obstacles	NNS	O	obstacle	rcmod	8	SENT_10	[p1l1287t1265r1416b1289],
11	successful	JJ	O	successful	amod	12	SENT_10	[p1l1431t1265r1573b1289],
12	chemotherapy	NN	O	chemotherapy	dep	10	SENT_10	[p1l1588t1265r1795b1295],
13	in	IN	O	in	_	0	SENT_10	[p1l1809t1265r1835b1289],
14	lung	NN	O	lung	nn	16	SENT_10	[p1l1850t1265r1912b1295],
15	cancer	NN	O	cancer	nn	16	SENT_10	[p1l1926t1272r2019b1289],
16	patients	NNS	O	patient	prep_in	12	SENT_10	[p1l2033t1265r2154b1295],
17	.	.	O	.	_	0	SENT_10	[p1l2033t1265r2154b1295],

1	CisReceived	VBN	O	cisreceive	_	0	SENT_11	[p1l6t1304r58b1328, p1l7t1332r118b1353],
2	11	CD	DATE	11	num	3	SENT_11	[p1l129t1333r154b1353],
3	September	NNP	DATE	September	dobj	1	SENT_11	[p1l166t1332r304b1359],
4	2011	CD	DATE	2011	num	3	SENT_11	[p1l311t1333r370b1353],
5	Received	VBN	O	receive	partmod	3	SENT_11	[p1l7t1368r119b1389],
6	in	IN	O	in	_	0	SENT_11	[p1l128t1368r151b1389],
7	revised	JJ	O	revised	amod	8	SENT_11	[p1l160t1368r250b1389],
8	form	NN	O	form	prep_in	5	SENT_11	[p1l259t1367r319b1389],
9	3	CD	DATE	3	num	8	SENT_11	[p1l327t1369r341b1389],
10	January	NNP	DATE	January	tmod	8	SENT_11	[p1l347t1369r447b1394],
11	2012	CD	DATE	2012	num	10	SENT_11	[p1l455t1369r516b1389],
12	Accepted	JJ	O	accepted	amod	13	SENT_11	[p1l6t1403r122b1430],
13	25	CD	DATE	25	tmod	5	SENT_11	[p1l131t1404r160b1425],
14	March	NNP	DATE	March	dep	13	SENT_11	[p1l170t1403r249b1425],
15	2012	CD	DATE	2012	num	14	SENT_11	[p1l258t1404r319b1425],

1	platin	NN	O	platin	nn	2	SENT_12	[p1l7t1478r88b1508],
2	uptake	NN	O	uptake	nsubjpass	4	SENT_12	[p1l96t1478r193b1508],
3	is	VBZ	O	be	auxpass	4	SENT_12	[p1l201t1478r222b1502],
4	considered	VBN	O	consider	_	0	SENT_12	[p1l230t1478r385b1502],
5	as	IN	O	as	_	0	SENT_12	[p1l393t1485r421b1502],
6	one	CD	NUMBER	one	prep_as	4	SENT_12	[p1l429t1485r480b1502],
7	of	IN	O	of	_	0	SENT_12	[p1l488t1477r517b1502],
8	the	DT	O	the	det	10	SENT_12	[p1l522t1478r567b1502],
9	major	JJ	O	major	amod	10	SENT_12	[p1l575t1478r659b1508],
10	factors	NNS	O	factor	prep_of	6	SENT_12	[p1l666t1477r760b1502],
11	contributing	VBG	O	contribute	partmod	10	SENT_12	[p1l769t1478r946b1508],
12	to	TO	O	to	_	0	SENT_12	[p1l953t1481r980b1502],
13	the	DT	O	the	det	15	SENT_12	[p1l988t1478r1033b1502],
14	side	JJ	O	side	amod	15	SENT_12	[p1l1041t1478r1097b1502],
15	effects	NNS	O	effect	prep_to	11	SENT_12	[p1l1105t1477r1196b1502],
16	of	IN	O	of	_	0	SENT_12	[p1l1205t1477r1234b1502],
17	cisplatin	NN	O	cisplatin	prep_of	15	SENT_12	[p1l1239t1478r1366b1508],
18	.	.	O	.	_	0	SENT_12	[p1l1239t1478r1366b1508],

1	Genetic	JJ	O	genetic	amod	2	SENT_13	[p1l1374t1478r1482b1502],
2	Keywords	NNS	O	keyword	_	0	SENT_13	[p1l1599t1466r1725b1493],
3	:	:	O	:	_	0	SENT_13	[p1l1599t1466r1725b1493],
4	4	CD	NUMBER	4	dep	2	SENT_13	[p1l1893t1502r1897b1505],

1	Copper	NN	O	copper	nn	3	SENT_14	[p1l1600t1503r1690b1529],
2	transport	NN	O	transport	nn	3	SENT_14	[p1l1698t1505r1816b1529],
3	protein	NN	O	protein	_	0	SENT_14	[p1l1824t1505r1915b1529],
4	1	CD	NUMBER	1	number	5	SENT_14	[p1l1925t1503r1935b1523],
5	(	CD	NUMBER	(	dep	3	SENT_14	[p1l1947t1502r2030b1529],
6	CTR1	NN	O	ctr1	nn	7	SENT_14	[p1l1947t1502r2030b1529],
7	)	NN	O	)	dep	5	SENT_14	[p1l1947t1502r2030b1529],

1	variances	NNS	O	variance	nsubj	6	SENT_15	[p1l6t1518r139b1542],
2	of	IN	O	of	_	0	SENT_15	[p1l150t1517r179b1542],
3	core	NN	O	core	nn	4	SENT_15	[p1l185t1525r245b1542],
4	genes	NNS	O	gene	prep_of	1	SENT_15	[p1l254t1525r335b1548],
5	also	RB	O	also	advmod	6	SENT_15	[p1l345t1518r399b1542],
6	affect	VBP	O	affect	_	0	SENT_15	[p1l409t1517r488b1542],
7	cisplatin	NN	O	cisplatin	nn	8	SENT_15	[p1l497t1518r617b1548],
8	toxicity	NN	O	toxicity	dobj	6	SENT_15	[p1l626t1518r740b1548],
9	.	.	O	.	_	0	SENT_15	[p1l626t1518r740b1548],

1	It	PRP	O	it	nsubjpass	4	SENT_16	[p1l751t1519r770b1542],
2	has	VBZ	O	have	aux	4	SENT_16	[p1l780t1518r826b1542],
3	been	VBN	O	be	auxpass	4	SENT_16	[p1l836t1518r904b1542],
4	identiﬁed	VBN	O	identiﬁed	_	0	SENT_16	[p1l914t1517r1049b1542],
5	that	IN	O	that	complm	6	SENT_16	[p1l1059t1518r1116b1542],
6	CTR1	NN	O	ctr1	dep	4	SENT_16	[p1l1126t1519r1204b1545],
7	.	.	O	.	_	0	SENT_16	[p1l1126t1519r1204b1545],

1	copper	NN	O	copper	nn	2	SENT_17	[p1l1214t1525r1312b1548],
2	transporter	NN	O	transporter	_	0	SENT_17	[p1l1320t1521r1482b1548],
3	. . . .	CD	NUMBER	. . . .	dep	2	SENT_17	[p1l1824t1538r1828b1541],[p1l1618t1538r1621b1541],
4	,	,	O	,	_	0	SENT_17	[p1l85t1558r89b1562],
5	,	,	O	,	_	0	SENT_17	[p1l372t1558r376b1562],
6	,	,	O	,	_	0	SENT_17	[p1l479t1558r483b1562],
7	,	,	O	,	_	0	SENT_17	[p1l530t1558r534b1562],
8	,	,	O	,	_	0	SENT_17	[p1l609t1558r613b1562],
9	,	,	O	,	_	0	SENT_17	[p1l1011t1558r1015b1562],
10	,	,	O	,	_	0	SENT_17	[p1l1130t1558r1134b1562],
11	,	,	O	,	_	0	SENT_17	[p1l1198t1558r1202b1562],
12	,	,	O	,	_	0	SENT_17	[p1l1285t1558r1289b1562],
13	ClS	NN	O	cl	dep	14	SENT_17	[p1l1600t1538r1710b1565],
14	]	CD	NUMBER	]	dep	2	SENT_17	[p1l1600t1538r1710b1565],
15	)	CD	NUMBER	)	advmod	14	SENT_17	[p1l1600t1538r1710b1565],
16	laIlI1	NN	O	laili1	dep	17	SENT_17	[p1l1600t1538r1710b1565],
17	olIolIOXlClty	NN	O	oliolioxlclty	dep	14	SENT_17	[p1l1718t1541r1855b1565],
18	protein	NN	O	protein	dep	2	SENT_17	[p1l7t1561r110b1588],
19	1	CD	NUMBER	1	dep	18	SENT_17	[p1l121t1559r143b1585],
20	.	.	O	.	_	0	SENT_17	[p1l121t1559r143b1585],

1	plays	VBZ	O	play	_	0	SENT_18	[p1l153t1558r226b1588],
2	an	DT	O	a	det	4	SENT_18	[p1l236t1565r269b1582],
3	essential	JJ	O	essential	amod	4	SENT_18	[p1l279t1558r402b1582],
4	role	NN	O	role	dobj	1	SENT_18	[p1l413t1558r467b1582],
5	in	IN	O	in	_	0	SENT_18	[p1l477t1565r503b1582],
6	cisplatin	NN	O	cisplatin	nn	7	SENT_18	[p1l513t1558r633b1588],
7	uptake	NN	O	uptake	prep_in	4	SENT_18	[p1l643t1558r747b1588],
8	.	.	O	.	_	0	SENT_18	[p1l643t1558r747b1588],

1	The	DT	O	the	det	2	SENT_19	[p1l756t1558r808b1582],
2	purpose	NN	O	purpose	_	0	SENT_19	[p1l818t1565r932b1588],
3	of	IN	O	of	_	0	SENT_19	[p1l942t1557r972b1582],
4	this	DT	O	this	det	6	SENT_19	[p1l978t1558r1030b1582],
5	study	NN	O	study	nn	6	SENT_19	[p1l1041t1558r1119b1588],
6	1S	NN	O	1	prep_of	2	SENT_19	[p1l1128t1565r1149b1582],
7	to	TO	O	to	aux	8	SENT_19	[p1l1159t1561r1186b1582],
8	investigate	VB	O	investigate	infmod	6	SENT_19	[p1l1197t1561r1352b1588],
9	whether	IN	O	whether	complm	16	SENT_19	[p1l1361t1558r1482b1582],
10	Nomsman	NNP	MISC	Nomsman	nn	13	SENT_19	[p1l1600t1573r1730b1595],
11	cell	NN	O	cell	nn	13	SENT_19	[p1l1740t1573r1782b1595],
12	lung	NN	O	lung	nn	13	SENT_19	[p1l1791t1573r1846b1600],
13	Cancer	NN	O	cancer	dep	16	SENT_19	[p1l1854t1580r1937b1595],
14	(	CD	NUMBER	(	num	16	SENT_19	[p1l1945t1573r2045b1600],
15	NSCLC	NN	O	nsclc	nn	16	SENT_19	[p1l1945t1573r2045b1600],
16	)	NN	O	)	dep	8	SENT_19	[p1l1945t1573r2045b1600],

1	Polymorphism	NN	O	polymorphism	_	0	SENT_20	[p1l1600t1609r1785b1636],

1	CT	NN	O	ct	nn	3	SENT_21	[p1l7t1712r42b1735],
2	R1	NN	O	r1	nn	3	SENT_21	[p1l40t1712r71b1735],
3	polymorphism	NN	O	polymorphism	nsubjpass	5	SENT_21	[p1l84t1711r293b1741],
4	is	VBZ	O	be	auxpass	5	SENT_21	[p1l303t1711r324b1735],
5	associated	VBN	O	associate	_	0	SENT_21	[p1l334t1711r480b1735],
6	with	IN	O	with	_	0	SENT_21	[p1l489t1711r554b1735],
7	platinum	NN	O	platinum	nn	8	SENT_21	[p1l564t1711r693b1741],
8	toxicity	NN	O	toxicity	prep_with	5	SENT_21	[p1l702t1711r809b1741],
9	in	IN	O	in	_	0	SENT_21	[p1l819t1711r845b1735],
10	non-small	JJ	O	non-small	amod	13	SENT_21	[p1l854t1711r997b1735],
11	cell	NN	O	cell	nn	13	SENT_21	[p1l1007t1711r1055b1735],
12	lung	NN	O	lung	nn	13	SENT_21	[p1l1065t1711r1127b1741],
13	cancer	NN	O	cancer	prep_in	8	SENT_21	[p1l1136t1718r1229b1735],
14	(	CD	NUMBER	(	num	15	SENT_21	[p1l1237t1711r1350b1741],
15	NSCLC	NN	O	nsclc	tmod	5	SENT_21	[p1l1237t1711r1350b1741],
16	)	CD	NUMBER	)	num	17	SENT_21	[p1l1237t1711r1350b1741],
17	patients	NNS	O	patient	dep	15	SENT_21	[p1l1360t1711r1481b1741],
18	.	.	O	.	_	0	SENT_21	[p1l1360t1711r1481b1741],

1	Method	NN	O	method	_	0	SENT_22	[p1l6t1751r119b1775],
2	:	:	O	:	_	0	SENT_22	[p1l6t1751r119b1775],
3	204	CD	NUMBER	204	num	6	SENT_22	[p1l132t1752r184b1775],
4	incident	NN	O	incident	nn	6	SENT_22	[p1l196t1751r312b1775],
5	NSCLC	NN	O	nsclc	nn	6	SENT_22	[p1l324t1752r415b1775],
6	patients	NNS	O	patient	nsubjpass	12	SENT_22	[p1l427t1751r540b1781],
7	from	IN	O	from	_	0	SENT_22	[p1l553t1751r620b1775],
8	three	CD	NUMBER	three	num	10	SENT_22	[p1l632t1751r706b1775],
9	different	JJ	O	different	amod	10	SENT_22	[p1l719t1751r842b1775],
10	institutions	NNS	O	institution	prep_from	6	SENT_22	[p1l853t1751r1015b1775],
11	were	VBD	O	be	auxpass	12	SENT_22	[p1l1027t1758r1098b1775],
12	enrolled	VBN	O	enrol	dep	1	SENT_22	[p1l1110t1751r1227b1775],
13	and	CC	O	and	_	0	SENT_22	[p1l1239t1751r1291b1775],
14	followed	VBN	O	follow	conj_and	12	SENT_22	[p1l1303t1751r1426b1775],
15	up	RP	O	up	prt	14	SENT_22	[p1l1439t1758r1481b1781],
16	.	.	O	.	_	0	SENT_22	[p1l1439t1758r1481b1781],

1	These	DT	O	these	det	2	SENT_23	[p1l6t1791r88b1815],
2	patients	NNS	O	patient	nsubjpass	5	SENT_23	[p1l97t1791r210b1821],
3	were	VBD	O	be	auxpass	5	SENT_23	[p1l219t1798r290b1815],
4	histologically	RB	O	histologically	advmod	5	SENT_23	[p1l299t1791r489b1821],
5	conﬁrmed	VBN	O	conﬁrmed	_	0	SENT_23	[p1l497t1791r642b1815],
6	with	IN	O	with	_	0	SENT_23	[p1l650t1791r715b1815],
7	non-small	JJ	O	non-small	amod	10	SENT_23	[p1l725t1791r867b1815],
8	cell	NN	O	cell	nn	10	SENT_23	[p1l877t1791r924b1815],
9	lung	NN	O	lung	nn	10	SENT_23	[p1l934t1791r996b1821],
10	cancer	NN	O	cancer	prep_with	5	SENT_23	[p1l1004t1798r1103b1816],
11	.	.	O	.	_	0	SENT_23	[p1l1004t1798r1103b1816],

1	All	DT	O	all	det	2	SENT_24	[p1l1111t1791r1149b1815],
2	patients	NNS	O	patient	nsubj	4	SENT_24	[p1l1158t1791r1272b1821],
3	have	VBP	O	have	aux	4	SENT_24	[p1l1281t1791r1347b1815],
4	accepted	VBN	O	accept	_	0	SENT_24	[p1l1356t1791r1481b1821],
5	cisplatin-based	JJ	O	cisplatin-based	amod	6	SENT_24	[p1l7t1831r222b1861],
6	chemotherapy	NN	O	chemotherapy	dobj	4	SENT_24	[p1l238t1831r444b1861],
7	for	IN	O	for	_	0	SENT_24	[p1l459t1831r499b1855],
8	at	IN	O	at	quantmod	10	SENT_24	[p1l513t1835r540b1855],
9	least	JJS	O	least	mwe	8	SENT_24	[p1l555t1831r620b1855],
10	two	CD	NUMBER	two	num	11	SENT_24	[p1l635t1835r689b1855],
11	cycles	NNS	O	cycle	prep_for	6	SENT_24	[p1l705t1831r796b1861],
12	.	.	O	.	_	0	SENT_24	[p1l705t1831r796b1861],

1	Twenty	CD	NUMBER	twenty	num	2	SENT_25	[p1l811t1832r918b1861],
2	SNPS	NNS	O	snp	nsubjpass	6	SENT_25	[p1l933t1832r1001b1855],
3	of	IN	O	of	_	0	SENT_25	[p1l1017t1831r1047b1855],
4	CTR1	NN	O	ctr1	prep_of	2	SENT_25	[p1l1059t1832r1123b1855],
5	were	VBD	O	be	auxpass	6	SENT_25	[p1l1141t1838r1212b1855],
6	detected	VBN	O	detect	_	0	SENT_25	[p1l1227t1831r1349b1855],
7	in	IN	O	in	_	0	SENT_25	[p1l1365t1831r1391b1855],
8	these	DT	O	these	det	9	SENT_25	[p1l1406t1831r1481b1855],
9	patients	NNS	O	patient	prep_in	6	SENT_25	[p1l7t1871r128b1901],
10	.	.	O	.	_	0	SENT_25	[p1l7t1871r128b1901],

1	Phal-macogeneﬁcs	NNS	O	phal-macogeneﬁcs	nn	2	SENT_26	[p1l6t1909r235b1936],
2	Result	NN	O	result	_	0	SENT_26	[p1l705t1902r797b1926],
3	:	:	O	:	_	0	SENT_26	[p1l705t1902r797b1926],
4	CTR1	NN	O	ctr1	nn	6	SENT_26	[p1l812t1903r876b1926],
5	rs10981594	NN	O	rs10981594	nn	6	SENT_26	[p1l893t1903r1062b1926],
6	A	NN	O	a	dep	2	SENT_26	[p1l1075t1903r1130b1926],
7	>	JJR	O	>	amod	9	SENT_26	[p1l1075t1903r1130b1926],
8	C	NN	O	c	nn	9	SENT_26	[p1l1075t1903r1130b1926],
9	polymorphism	NN	O	polymorphism	nsubj	14	SENT_26	[p1l1144t1902r1353b1932],
10	is	VBZ	O	be	auxpass	11	SENT_26	[p1l1368t1902r1388b1926],
11	associated	VBN	O	associate	rcmod	9	SENT_26	[p1l1402t1902r1548b1926],
12	with	IN	O	with	_	0	SENT_26	[p1l1562t1902r1627b1926],
13	cisplatin	NN	O	cisplatin	prep_with	11	SENT_26	[p1l1641t1902r1761b1932],
14	induced	VBD	O	induce	rcmod	6	SENT_26	[p1l1776t1902r1888b1926],
15	severe	JJ	O	severe	amod	16	SENT_26	[p1l1903t1909r1993b1926],
16	toxicity	NN	O	toxicity	dobj	14	SENT_26	[p1l2007t1902r2115b1932],
17	in	IN	O	in	_	0	SENT_26	[p1l2128t1902r2154b1926],
18	NSCLC	NNP	MISC	NSCLC	nn	20	SENT_26	[p1l6t1947r96b1970],
19	Biomarker	NN	MISC	biomarker	nn	20	SENT_26	[p1l108t1949r240b1971],
20	patients	NNS	O	patient	prep_in	14	SENT_26	[p1l803t1946r924b1976],
21	.	.	O	.	_	0	SENT_26	[p1l803t1946r924b1976],

1	C-carrier	JJ	O	c-carrier	amod	2	SENT_27	[p1l939t1946r1064b1970],
2	subjects	NNS	O	subject	nsubj	3	SENT_27	[p1l1079t1946r1193b1976],
3	presented	VBD	O	present	_	0	SENT_27	[p1l1208t1946r1349b1976],
4	poorer	JJR	O	poorer	amod	5	SENT_27	[p1l1363t1953r1458b1976],
5	tolerance	NN	O	tolerance	dobj	3	SENT_27	[p1l1471t1946r1603b1970],
6	to	TO	O	to	_	0	SENT_27	[p1l1618t1949r1645b1970],
7	ototoxicity	NN	O	ototoxicity	nn	9	SENT_27	[p1l1660t1946r1814b1976],
8	(	NN	O	(	nn	9	SENT_27	[p1l1828t1946r1962b1976],
9	p	NN	O	p	prep_to	3	SENT_27	[p1l1828t1946r1962b1976],
10	<	JJR	O	<	dep	9	SENT_27	[p1l1828t1946r1962b1976],
11	0.05	CD	NUMBER	0.05	num	12	SENT_27	[p1l1828t1946r1962b1976],
12	)	NN	O	)	dep	10	SENT_27	[p1l1828t1946r1962b1976],
13	.	.	O	.	_	0	SENT_27	[p1l1828t1946r1962b1976],

1	The	DT	O	the	det	3	SENT_28	[p1l1976t1946r2027b1970],
2	survival	NN	O	survival	nn	3	SENT_28	[p1l2043t1946r2154b1970],
3	times	NNS	O	time	nsubj	14	SENT_28	[p1l6t1986r84b2010],
4	of	IN	O	of	_	0	SENT_28	[p1l98t1985r128b2010],
5	patients	NNS	O	patient	prep_of	3	SENT_28	[p1l867t2025r980b2055],
6	with	IN	O	with	_	0	SENT_28	[p1l990t2025r1055b2049],
7	different	JJ	O	different	amod	10	SENT_28	[p1l1065t2025r1188b2049],
8	rs10981694	NN	O	rs10981694	nn	10	SENT_28	[p1l1197t2026r1366b2049],
9	genetic	JJ	O	genetic	amod	10	SENT_28	[p1l1375t2025r1478b2055],
10	polymorphism	NN	O	polymorphism	prep_with	5	SENT_28	[p1l1487t2025r1696b2055],
11	were	VBD	O	be	cop	14	SENT_28	[p1l1705t2032r1776b2049],
12	not	RB	O	not	neg	14	SENT_28	[p1l1786t2029r1833b2049],
13	signiﬁcantly	RB	O	signiﬁcantly	advmod	14	SENT_28	[p1l1842t2025r2016b2055],
14	different	JJ	O	different	_	0	SENT_28	[p1l2025t2025r2154b2049],
15	.	.	O	.	_	0	SENT_28	[p1l2025t2025r2154b2049],

1	Conclusion	NN	O	conclusion	nsubj	11	SENT_29	[p1l6t2064r162b2089],
2	:	:	O	:	_	0	SENT_29	[p1l6t2064r162b2089],
3	NSCLC	NN	ORGANIZATION	nsclc	nn	4	SENT_29	[p1l176t2066r266b2089],
4	patients	NNS	O	patient	dep	1	SENT_29	[p1l279t2065r393b2095],
5	carrying	VBG	O	carry	partmod	4	SENT_29	[p1l407t2065r524b2095],
6	C	NN	O	c	nn	7	SENT_29	[p1l537t2066r554b2089],
7	allele	NN	O	allele	dobj	5	SENT_29	[p1l567t2064r641b2089],
8	of	IN	O	of	_	0	SENT_29	[p1l655t2064r684b2089],
9	CTR1	NN	O	ctr1	nn	10	SENT_29	[p1l689t2066r753b2089],
10	rs10981694	NN	O	rs10981694	prep_of	7	SENT_29	[p1l770t2066r938b2089],
11	presented	VBD	O	present	_	0	SENT_29	[p1l951t2064r1092b2095],
12	more	RBR	O	more	advmod	11	SENT_29	[p1l1106t2071r1179b2089],
13	sensitivity	NN	O	sensitivity	dobj	11	SENT_29	[p1l1193t2065r1339b2095],
14	to	TO	O	to	_	0	SENT_29	[p1l1352t2068r1379b2089],
15	ototoxicity	NN	O	ototoxicity	prep_to	11	SENT_29	[p1l1393t2065r1547b2095],
16	after	IN	O	after	_	0	SENT_29	[p1l1563t2064r1629b2089],
17	cisplatin	NN	O	cisplatin	nn	18	SENT_29	[p1l1645t2064r1765b2095],
18	treatment	NN	O	treatment	prep_after	11	SENT_29	[p1l1781t2068r1930b2089],
19	.	.	O	.	_	0	SENT_29	[p1l1781t2068r1930b2089],

1	CTR1	NN	O	ctr1	nsubj	2	SENT_30	[p1l1948t2065r2012b2089],
2	plays	VBZ	O	play	_	0	SENT_30	[p1l2032t2064r2104b2095],
3	an	DT	O	a	det	5	SENT_30	[p1l2121t2071r2154b2089],
4	essential	JJ	O	essential	amod	5	SENT_30	[p1l1254t2104r1377b2128],
5	role	NN	O	role	dobj	2	SENT_30	[p1l1389t2104r1442b2128],
6	in	IN	O	in	_	0	SENT_30	[p1l1454t2104r1480b2128],
7	cisplatin	NN	O	cisplatin	nn	8	SENT_30	[p1l1491t2104r1611b2134],
8	toxicity	NN	O	toxicity	prep_in	2	SENT_30	[p1l1622t2104r1730b2134],
9	and	CC	O	and	_	0	SENT_30	[p1l1740t2104r1791b2128],
10	could	MD	O	could	aux	12	SENT_30	[p1l1803t2104r1880b2128],
11	be	VB	O	be	auxpass	12	SENT_30	[p1l1891t2104r1923b2128],
12	considered	VBN	O	consider	conj_and	2	SENT_30	[p1l1935t2104r2089b2128],
13	as	IN	O	as	_	0	SENT_30	[p1l2101t2111r2128b2128],
14	a	DT	O	a	det	15	SENT_30	[p1l2140t2111r2154b2128],
15	predictor	NN	O	predictor	prep_as	12	SENT_30	[p1l642t2143r773b2173],
16	for	IN	O	for	_	0	SENT_30	[p1l782t2143r821b2167],
17	pretreatment	NN	O	pretreatment	nn	18	SENT_30	[p1l830t2147r1020b2173],
18	evaluation	NN	O	evaluation	prep_for	15	SENT_30	[p1l1030t2143r1178b2167],
19	in	IN	O	in	_	0	SENT_30	[p1l1188t2143r1214b2167],
20	lung	NN	O	lung	nn	22	SENT_30	[p1l1224t2143r1286b2173],
21	cancer	NN	O	cancer	nn	22	SENT_30	[p1l1296t2150r1388b2167],
22	patients	NNS	O	patient	prep_in	12	SENT_30	[p1l1397t2143r1518b2173],
23	.	.	O	.	_	0	SENT_30	[p1l1397t2143r1518b2173],

1	1	LS	NUMBER	1	_	0	SENT_31	[p1l9t2451r60b2500],
2	.	.	O	.	_	0	SENT_31	[p1l9t2451r60b2500],

1	Introduction	NN	O	introduction	_	0	SENT_32	[p1l104t2448r519b2500],

1	Platinum	NN	O	platinum	nsubj	4	SENT_33	[p1l106t2617r383b2669],
2	is	VBZ	O	be	cop	4	SENT_33	[p1l438t2618r482b2669],
3	one	CD	NUMBER	one	num	4	SENT_33	[p1l539t2632r648b2669],
4	kind	NN	O	kind	_	0	SENT_33	[p1l704t2617r837b2669],
5	of	IN	O	of	_	0	SENT_33	[p1l892t2617r956b2669],
6	pharmaceutical	JJ	O	pharmaceutical	amod	8	SENT_33	[p1l1003t2617r1479b2682],
7	chemotherapeutic	JJ	O	chemotherapeutic	amod	8	SENT_33	[p1l1535t2617r2047b2682, p1l8t2701r82b2752],
8	drug	NN	O	drug	prep_of	4	SENT_33	[p1l123t2700r278b2765],
9	,	,	O	,	_	0	SENT_33	[p1l123t2700r278b2765],
10	which	WDT	O	which	nsubjpass	13	SENT_33	[p1l319t2700r508b2752],
11	is	VBZ	O	be	auxpass	13	SENT_33	[p1l550t2701r594b2752],
12	widely	RB	O	widely	advmod	13	SENT_33	[p1l635t2700r845b2765],
13	used	VBN	O	use	rcmod	8	SENT_33	[p1l885t2700r1025b2752],
14	for	IN	O	for	_	0	SENT_33	[p1l1068t2700r1154b2752],
15	different	JJ	O	different	amod	17	SENT_33	[p1l1193t2700r1459b2752],
16	cancer	NN	O	cancer	nn	17	SENT_33	[p1l1500t2715r1701b2752],
17	treatment	NN	O	treatment	prep_for	13	SENT_33	[p1l1739t2708r2049b2752],
18	including	VBG	O	include	_	0	SENT_33	[p1l9t2783r297b2848],
19	testicular	JJ	O	testicular	amod	20	SENT_33	[p1l342t2783r631b2835],
20	cancer	NN	O	cancer	prep_including	17	SENT_33	[p1l676t2798r889b2843],
21	,	,	O	,	_	0	SENT_33	[p1l676t2798r889b2843],
22	germ	NN	O	germ	nn	24	SENT_33	[p1l936t2798r1095b2848],
23	cell	NN	O	cell	nn	24	SENT_33	[p1l1142t2783r1244b2835],
24	cancer	NN	O	cancer	appos	20	SENT_33	[p1l1292t2798r1505b2843],
25	,	,	O	,	_	0	SENT_33	[p1l1292t2798r1505b2843],
26	bladder	NN	O	bladder	nn	27	SENT_33	[p1l1553t2783r1788b2835],
27	cancer	NN	O	cancer	appos	20	SENT_33	[p1l1833t2798r2047b2843],
28	,	,	O	,	_	0	SENT_33	[p1l1833t2798r2047b2843],
29	ovarian	JJ	O	ovarian	amod	30	SENT_33	[p1l8t2867r237b2918],
30	cancer	NN	O	cancer	appos	20	SENT_33	[p1l285t2881r498b2926],
31	,	,	O	,	_	0	SENT_33	[p1l285t2881r498b2926],
32	as	RB	O	as	_	0	SENT_33	[p1l547t2881r606b2918],
33	well	RB	O	well	_	0	SENT_33	[p1l653t2866r783b2918],
34	as	IN	O	as	_	0	SENT_33	[p1l832t2881r891b2918],
35	lung	NN	O	lung	nn	36	SENT_33	[p1l940t2866r1075b2931],
36	cancer	NN	O	cancer	conj_and	20	SENT_33	[p1l1121t2881r1334b2919],
37	.	.	O	.	_	0	SENT_33	[p1l1121t2881r1334b2919],

1	As	IN	O	as	_	0	SENT_34	[p1l1381t2869r1452b2918],
2	the	DT	O	the	det	4	SENT_34	[p1l1501t2866r1597b2918],
3	ﬁrst	NN	O	ﬁrst	nn	4	SENT_34	[p1l1646t2866r1767b2918],
4	generation	NN	O	generation	prep_as	12	SENT_34	[p1l1813t2881r2047b2931, p1l8t2950r128b3001],
5	of	IN	O	of	_	0	SENT_34	[p1l173t2949r236b3001],
6	platinum	NN	O	platinum	nn	8	SENT_34	[p1l274t2950r554b3014],
7	anti-tumor	JJ	O	anti-tumor	amod	8	SENT_34	[p1l598t2950r938b3001],
8	drugs	NNS	O	drug	prep_of	4	SENT_34	[p1l981t2950r1166b3014],
9	,	,	O	,	_	0	SENT_34	[p1l981t2950r1166b3014],
10	cisplatin	NN	O	cisplatin	nsubjpass	12	SENT_34	[p1l1212t2950r1472b3014],
11	is	VBZ	O	be	auxpass	12	SENT_34	[p1l1517t2950r1561b3001],
12	considered	VBN	O	consider	_	0	SENT_34	[p1l1607t2950r1942b3001],
13	as	IN	O	as	_	0	SENT_34	[p1l1987t2965r2046b3001],
14	the	DT	O	the	det	18	SENT_34	[p1l8t3033r105b3085],
15	ﬁrst	JJ	O	ﬁrst	amod	18	SENT_34	[p1l146t3033r409b3085],
16	—	NN	O	—	nn	18	SENT_34	[p1l146t3033r409b3085],
17	1ine	NN	O	1ine	nn	18	SENT_34	[p1l146t3033r409b3085],
18	treatment	NN	O	treatment	prep_as	12	SENT_34	[p1l450t3041r759b3085],
19	in	IN	O	in	_	0	SENT_34	[p1l799t3034r855b3084],
20	non-small	JJ	O	non-small	amod	23	SENT_34	[p1l895t3033r1205b3085],
21	cell	NN	O	cell	nn	23	SENT_34	[p1l1246t3033r1349b3085],
22	lung	NN	O	lung	nn	23	SENT_34	[p1l1390t3033r1524b3097],
23	cancer	NN	O	cancer	prep_in	18	SENT_34	[p1l1564t3048r1764b3085],
24	(	CD	NUMBER	(	num	27	SENT_34	[p1l1803t3033r2047b3097],
25	NSCLC	NN	O	nsclc	nn	27	SENT_34	[p1l1803t3033r2047b3097],
26	)	CD	NUMBER	)	num	27	SENT_34	[p1l1803t3033r2047b3097],
27	patients	NNS	O	patient	dep	23	SENT_34	[p1l9t3116r254b3180],
28	[	CD	NUMBER	[	number	29	SENT_34	[p1l294t3115r388b3180],
29	1	CD	NUMBER	1	num	30	SENT_34	[p1l294t3115r388b3180],
30	]	NN	O	]	dep	27	SENT_34	[p1l294t3115r388b3180],
31	.	.	O	.	_	0	SENT_34	[p1l294t3115r388b3180],

1	In	IN	O	in	_	0	SENT_35	[p1l425t3118r482b3166],
2	general	JJ	O	general	prep_in	5	SENT_35	[p1l516t3115r758b3180],
3	,	,	O	,	_	0	SENT_35	[p1l516t3115r758b3180],
4	NSCLC	JJ	ORGANIZATION	nsclc	nsubj	5	SENT_35	[p1l794t3118r990b3167],
5	contributes	VBZ	O	contribute	_	0	SENT_35	[p1l1024t3115r1372b3167],
6	about	IN	O	about	advmod	12	SENT_35	[p1l1409t3115r1583b3167],
7	80	CD	PERCENT	80	num	8	SENT_35	[p1l1617t3118r1732b3167],
8	%	NN	PERCENT	%	pobj	6	SENT_35	[p1l1617t3118r1732b3167],
9	to	TO	O	to	prep	6	SENT_35	[p1l1767t3123r1825b3167],
10	newly	RB	O	newly	advmod	11	SENT_35	[p1l1861t3115r2049b3180],
11	histologically	RB	O	histologically	pobj	9	SENT_35	[p1l9t3198r419b3263],
12	diagnosed	VBN	O	diagnose	dep	5	SENT_35	[p1l472t3198r782b3263],
13	lung	NN	O	lung	nn	15	SENT_35	[p1l837t3198r972b3263],
14	cancer	NN	O	cancer	nn	15	SENT_35	[p1l1025t3213r1225b3250],
15	patients	NNS	O	patient	dobj	12	SENT_35	[p1l1277t3199r1539b3263],
16	.	.	O	.	_	0	SENT_35	[p1l1277t3199r1539b3263],

1	Most	JJS	O	most	amod	2	SENT_36	[p1l1595t3202r1748b3250],
2	patients	NNS	O	patient	nsubj	3	SENT_36	[p1l1801t3199r2046b3263],
3	were	VBD	O	be	_	0	SENT_36	[p1l7t3296r159b3333],
4	during	IN	O	during	_	0	SENT_36	[p1l200t3281r402b3346],
5	stage	NN	O	stage	prep_during	3	SENT_36	[p1l442t3289r598b3346],
6	III	CD	NUMBER	iii	advmod	5	SENT_36	[p1l639t3284r695b3333],
7	or	CC	O	or	_	0	SENT_36	[p1l736t3296r799b3333],
8	IV	CD	NUMBER	iv	advmod	5	SENT_36	[p1l837t3284r900b3333],
9	(	NN	O	(	nn	11	SENT_36	[p1l938t3281r1212b3345],
10	advance	NN	O	advance	nn	11	SENT_36	[p1l938t3281r1212b3345],
11	stages	NNS	O	stage	nsubj	12	SENT_36	[p1l1254t3281r1480b3346],
12	)	VBP	O	)	rcmod	5	SENT_36	[p1l1254t3281r1480b3346],
13	,	,	O	,	_	0	SENT_36	[p1l1254t3281r1480b3346],
14	when	WRB	O	when	advmod	18	SENT_36	[p1l1519t3281r1691b3333],
15	they	PRP	O	they	nsubjpass	18	SENT_36	[p1l1730t3281r1866b3346],
16	have	VBP	O	have	aux	18	SENT_36	[p1l1905t3281r2047b3333],
17	been	VBN	O	be	auxpass	18	SENT_36	[p1l8t3364r154b3416],
18	conﬁrmed	VBN	O	conﬁrmed	advcl	3	SENT_36	[p1l201t3364r514b3416],
19	with	IN	O	with	_	0	SENT_36	[p1l560t3364r700b3416],
20	lung	NN	O	lung	nn	21	SENT_36	[p1l747t3364r881b3429],
21	cancer	NN	O	cancer	prep_with	18	SENT_36	[p1l926t3379r1140b3424],
22	,	,	O	,	_	0	SENT_36	[p1l926t3379r1140b3424],
23	and	CC	O	and	_	0	SENT_36	[p1l1187t3364r1297b3416],
24	the	DT	O	the	det	26	SENT_36	[p1l1344t3364r1441b3416],
25	ﬁve-year	JJ	O	ﬁve-year	amod	26	SENT_36	[p1l1488t3364r1761b3429],
26	survival	NN	O	survival	conj_and	21	SENT_36	[p1l1807t3364r2047b3416],

1	‘	RB	O	‘	advmod	4	SENT_37	[p2l34t17r71b54],
2	ii	LS	O	ii	dep	3	SENT_37	[p2l34t17r71b54],
3	IRB	NN	ORGANIZATION	irb	nsubj	4	SENT_37	[p2l116t31r194b69],
4	approved	VBD	O	approve	_	0	SENT_37	[p2l226t28r472b80],
5	:	:	O	:	_	0	SENT_37	[p2l226t28r472b80],
6	ICPXL	NN	O	icpxl	num	13	SENT_37	[p2l507t30r853b70],
7	—	CD	NUMBER	—	number	6	SENT_37	[p2l507t30r853b70],
8	080015	CD	NUMBER	080015	number	6	SENT_37	[p2l507t30r853b70],
9	(	CD	NUMBER	(	number	6	SENT_37	[p2l886t28r1096b80],
10	Chinese	JJ	MISC	chinese	amod	13	SENT_37	[p2l886t28r1096b80],
11	Clinical	JJ	O	clinical	amod	13	SENT_37	[p2l1128t28r1307b70],
12	Trial	NN	O	trial	nn	13	SENT_37	[p2l1337t28r1447b70],
13	Registry	NN	O	registry	dobj	4	SENT_37	[p2l1479t29r1693b80],
14	:	:	O	:	_	0	SENT_37	[p2l1479t29r1693b80],
15	ChiCTR	NN	O	chictr	dep	13	SENT_37	[p2l1728t28r2047b70],
16	.	.	O	.	_	0	SENT_37	[p2l1728t28r2047b70],

1	—	NN	O	—	_	0	SENT_38	[p2l1728t28r2047b70],
2	.	.	O	.	_	0	SENT_38	[p2l1728t28r2047b70],

1	TNC	NN	O	tnc	_	0	SENT_39	[p2l1728t28r2047b70],
2	10000895	CD	NUMBER	10000895	num	1	SENT_39	[p2l10t99r285b151],
3	)	CD	NUMBER	)	number	4	SENT_39	[p2l10t99r285b151],
4	*	CD	NUMBER	*	dep	1	SENT_39	[p2l54t171r76b195],
5	Corresponding	VBG	O	correspond	partmod	1	SENT_39	[p2l105t170r467b222],
6	author	NN	O	author	dobj	5	SENT_39	[p2l483t170r657b212],
7	.	.	O	.	_	0	SENT_39	[p2l483t170r657b212],

1	Tel.	NNP	O	Tel.	_	0	SENT_40	[p2l673t170r774b212],
2	:	:	O	:	_	0	SENT_40	[p2l673t170r774b212],
3	+86 731 84805380	CD	NUMBER	+86 731 84805380	dep	1	SENT_40	[p2l1007t172r1268b218],[p2l795t172r883b212],
4	;	:	O	;	_	0	SENT_40	[p2l1007t172r1268b218],
5	fax	NN	O	fax	dep	1	SENT_40	[p2l1289t170r1376b212],
6	:	:	O	:	_	0	SENT_40	[p2l1289t170r1376b212],
7	+86 731 82354476	CD	NUMBER	+86 731 82354476	dep	5	SENT_40	[p2l1610t172r1867b212],[p2l1397t172r1485b212],
8	.	.	O	.	_	0	SENT_40	[p2l1610t172r1867b212],

1	E-mail	NN	O	e-mail	nn	2	SENT_41	[p2l105t241r261b283],
2	address	NN	O	address	_	0	SENT_41	[p2l277t241r469b283],
3	:	:	O	:	_	0	SENT_41	[p2l277t241r469b283],
4	liuzhaoqian@csu.edu.cn	NN	O	liuzhaoqian@csu.edu.cn	nn	8	SENT_41	[p2l488t241r1076b294],
5	(	CD	NUMBER	(	num	8	SENT_41	[p2l1093t241r1151b293],
6	Z.	NNP	PERSON	Z.	nn	8	SENT_41	[p2l1093t241r1151b293],
7	Liu	NNP	PERSON	Liu	nn	8	SENT_41	[p2l1170t241r1273b293],
8	)	NNP	O	)	dep	2	SENT_41	[p2l1170t241r1273b293],
9	.	.	O	.	_	0	SENT_41	[p2l1170t241r1273b293],

1	0169-5002	CD	DURATION	0169-5002	_	0	SENT_42	[p2l8t387r322b440],
2	/	:	O	/	punct	1	SENT_42	[p2l8t387r322b440],
3	$	$	MONEY	$	nsubj	5	SENT_42	[p2l8t387r322b440],
4	—	CD	MONEY	—	num	3	SENT_42	[p2l340t413r366b417],
5	see	VBP	O	see	dep	1	SENT_42	[p2l385t400r461b429],
6	front	JJ	O	front	amod	7	SENT_42	[p2l479t388r599b429],
7	matter	NN	O	matter	dobj	5	SENT_42	[p2l616t394r782b429],
8	©	CD	NUMBER	©	num	12	SENT_42	[p2l797t391r836b429],
9	2012	CD	DATE	2012	num	12	SENT_42	[p2l853t390r972b429],
10	Elsevier	NNP	ORGANIZATION	Elsevier	nn	12	SENT_42	[p2l992t388r1184b429],
11	Ireland	NNP	ORGANIZATION	Ireland	nn	12	SENT_42	[p2l1200t388r1371b429],
12	Ltd.	NNP	ORGANIZATION	Ltd.	dep	7	SENT_42	[p2l1389t388r1476b430],
13	.	.	O	.	_	0	SENT_42	[p2l1389t388r1476b430],

1	All	DT	O	all	det	2	SENT_43	[p2l1492t388r1557b429],
2	rights	NNS	O	rights	nsubj	3	SENT_43	[p2l1576t388r1715b440],
3	reserved	VBN	O	reserve	_	0	SENT_43	[p2l1734t388r1956b430],
4	.	.	O	.	_	0	SENT_43	[p2l1734t388r1956b430],

1	http://dx.doi.org/10.1016/j.lungcan.2012.03.023	NN	O	http://dx.doi.org/10.1016/j.lungcan.2012.03.023	_	0	SENT_44	[p2l8t457r1193b509],

1	©	RB	O	©	advmod	2	SENT_45	[p2l807t541r852b586],
2	2012	CD	DATE	2012	_	0	SENT_45	[p2l872t541r1010b586],
3	Elsevier	NNP	ORGANIZATION	Elsevier	nn	5	SENT_45	[p2l1032t538r1254b586],
4	Ireland	NNP	ORGANIZATION	Ireland	nn	5	SENT_45	[p2l1272t538r1470b586],
5	Ltd.	NNP	ORGANIZATION	Ltd.	dep	2	SENT_45	[p2l1490t538r1590b587],
6	.	.	O	.	_	0	SENT_45	[p2l1490t538r1590b587],

1	All	DT	O	all	det	2	SENT_46	[p2l1609t538r1685b586],
2	rights	NNS	O	rights	nsubj	3	SENT_46	[p2l1706t538r1866b598],
3	reserved	VBN	O	reserve	_	0	SENT_46	[p2l1887t538r2144b587],
4	.	.	O	.	_	0	SENT_46	[p2l1887t538r2144b587],

1	rate	NN	O	rate	nsubj	5	SENT_47	[p2l54t810r174b855],
2	of	IN	O	of	_	0	SENT_47	[p2l220t801r284b855],
3	these	DT	O	these	det	4	SENT_47	[p2l321t802r487b855],
4	patients	NNS	O	patient	prep_of	1	SENT_47	[p2l533t802r785b868],
5	were	VBD	O	be	_	0	SENT_47	[p2l830t817r986b855],
6	at	IN	O	at	_	0	SENT_47	[p2l1032t810r1090b855],
7	about	RB	O	about	quantmod	8	SENT_47	[p2l1133t802r1312b855],
8	15	CD	PERCENT	15	num	9	SENT_47	[p2l1359t804r1474b855],
9	%	NN	PERCENT	%	prep_at	5	SENT_47	[p2l1359t804r1474b855],
10	[	CD	NUMBER	[	number	11	SENT_47	[p2l1522t801r1675b868],
11	2,3	CD	NUMBER	2,3	num	12	SENT_47	[p2l1522t801r1675b868],
12	]	NN	O	]	dep	9	SENT_47	[p2l1522t801r1675b868],
13	.	.	O	.	_	0	SENT_47	[p2l1522t801r1675b868],

1	Nevertheless	RB	O	nevertheless	advmod	17	SENT_48	[p2l1722t802r2143b863],
2	,	,	O	,	_	0	SENT_48	[p2l1722t802r2143b863],
3	individual	JJ	O	individual	amod	4	SENT_48	[p2l54t888r369b941],
4	variations	NNS	O	variation	nsubjpass	17	SENT_48	[p2l385t889r697b941],
5	to	TO	O	to	_	0	SENT_48	[p2l714t896r774b941],
6	cisplatin	NN	O	cisplatin	nn	7	SENT_48	[p2l792t888r1058b954],
7	chemotherapy	NN	O	chemotherapy	prep_to	4	SENT_48	[p2l1074t888r1546b954],
8	,	,	O	,	_	0	SENT_48	[p2l1074t888r1546b954],
9	like	IN	O	like	_	0	SENT_48	[p2l1564t888r1674b941],
10	cisplatin	NN	O	cisplatin	nn	11	SENT_48	[p2l1692t888r1958b954],
11	resistance	NN	O	resistance	prep_like	4	SENT_48	[p2l1974t889r2144b941, p2l53t981r221b1026],
12	and	CC	O	and	_	0	SENT_48	[p2l249t973r362b1026],
13	toxicity	NN	O	toxicity	conj_and	11	SENT_48	[p2l391t974r643b1040],
14	,	,	O	,	_	0	SENT_48	[p2l391t974r643b1040],
15	are	VBP	O	be	auxpass	17	SENT_48	[p2l672t989r767b1026],
16	widely	RB	O	widely	advmod	17	SENT_48	[p2l794t973r1009b1040],
17	documented	VBN	O	document	_	0	SENT_48	[p2l1035t973r1430b1026],
18	as	IN	O	as	_	0	SENT_48	[p2l1459t989r1519b1026],
19	the	DT	O	the	det	21	SENT_48	[p2l1548t973r1647b1026],
20	major	JJ	O	major	amod	21	SENT_48	[p2l1676t974r1862b1040],
21	obstacle	NN	O	obstacle	prep_as	17	SENT_48	[p2l1888t973r2144b1026],
22	to	TO	O	to	_	0	SENT_48	[p2l52t1067r113b1112],
23	successful	JJ	O	successful	amod	27	SENT_48	[p2l148t1059r463b1112],
24	treatment	NN	O	treatment	nn	27	SENT_48	[p2l496t1067r813b1112],
25	[	NN	O	[	nn	27	SENT_48	[p2l849t1059r945b1126],
26	4	CD	NUMBER	4	num	27	SENT_48	[p2l849t1059r945b1126],
27	]	NN	O	]	prep_to	21	SENT_48	[p2l849t1059r945b1126],
28	.	.	O	.	_	0	SENT_48	[p2l849t1059r945b1126],

1	The	DT	O	the	det	5	SENT_49	[p2l977t1059r1091b1112],
2	most	RBS	O	most	advmod	3	SENT_49	[p2l1126t1067r1282b1112],
3	common	JJ	O	common	amod	5	SENT_49	[p2l1314t1075r1591b1112],
4	severe	JJ	O	severe	amod	5	SENT_49	[p2l1625t1075r1824b1112],
5	toxicities	NNS	O	toxicity	nsubj	9	SENT_49	[p2l1857t1060r2143b1112],
6	during	IN	O	during	_	0	SENT_49	[p2l53t1145r260b1212],
7	cisplatin	NN	O	cisplatin	nn	8	SENT_49	[p2l290t1145r556b1212],
8	therapy	NN	O	therapy	prep_during	5	SENT_49	[p2l587t1145r831b1212],
9	include	VBP	O	include	_	0	SENT_49	[p2l861t1145r1090b1198],
10	nephrotoxicity	NN	O	nephrotoxicity	nn	24	SENT_49	[p2l1122t1145r1602b1212],
11	,	,	O	,	_	0	SENT_49	[p2l1122t1145r1602b1212],
12	ototoxicty	NN	O	ototoxicty	dep	24	SENT_49	[p2l1634t1146r1969b1212],
13	,	,	O	,	_	0	SENT_49	[p2l1634t1146r1969b1212],
14	neurotoxicity	NN	O	neurotoxicity	dep	24	SENT_49	[p2l2002t1161r2144b1198, p2l54t1232r372b1298],
15	,	,	O	,	_	0	SENT_49	[p2l2002t1161r2144b1198, p2l54t1232r372b1298],
16	myelosuppression	NN	O	myelosuppression	dep	24	SENT_49	[p2l393t1231r983b1298],
17	,	,	O	,	_	0	SENT_49	[p2l393t1231r983b1298],
18	electrolyte	NN	O	electrolyte	dep	24	SENT_49	[p2l1004t1231r1338b1298],
19	disturbances	NNS	O	disturbance	nn	21	SENT_49	[p2l1358t1231r1774b1293],
20	,	,	O	,	_	0	SENT_49	[p2l1358t1231r1774b1293],
21	nausea	NN	O	nausea	nn	24	SENT_49	[p2l1795t1247r2012b1285],
22	and	CC	O	and	_	0	SENT_49	[p2l2030t1231r2144b1285],
23	anaphylactic	JJ	O	anaphylactic	nn	24	SENT_49	[p2l53t1317r452b1384],
24	reactions	NNS	O	reaction	nsubj	25	SENT_49	[p2l469t1318r754b1371],
25	[	VBP	O	[	ccomp	9	SENT_49	[p2l775t1317r872b1384],
26	5	CD	NUMBER	5	number	27	SENT_49	[p2l775t1317r872b1384],
27	]	CD	NUMBER	]	dobj	25	SENT_49	[p2l775t1317r872b1384],
28	.	.	O	.	_	0	SENT_49	[p2l775t1317r872b1384],

1	It	PRP	O	it	nsubj	4	SENT_50	[p2l890t1321r933b1371],
2	will	MD	O	will	aux	4	SENT_50	[p2l947t1318r1065b1370],
3	greatly	RB	O	greatly	advmod	4	SENT_50	[p2l1081t1318r1301b1384],
4	improve	VB	O	improve	_	0	SENT_50	[p2l1316t1318r1578b1384],
5	clinical	JJ	O	clinical	amod	6	SENT_50	[p2l1595t1317r1816b1371],
6	efﬁcacy	NN	O	efﬁcacy	dobj	4	SENT_50	[p2l1833t1317r2072b1384],
7	of	IN	O	of	_	0	SENT_50	[p2l2087t1317r2152b1371],
8	cisplatin	NN	O	cisplatin	nn	9	SENT_50	[p2l53t1404r319b1470],
9	chemotherapy	NN	O	chemotherapy	prep_of	6	SENT_50	[p2l338t1404r809b1470],
10	,	,	O	,	_	0	SENT_50	[p2l338t1404r809b1470],
11	if	IN	O	if	mark	17	SENT_50	[p2l830t1404r876b1456],
12	some	DT	O	some	det	14	SENT_50	[p2l887t1419r1052b1457],
13	efﬁcient	JJ	O	efﬁcient	amod	14	SENT_50	[p2l1071t1404r1327b1457],
14	biomarkers	NNS	O	biomarker	nsubjpass	17	SENT_50	[p2l1344t1404r1700b1457],
15	could	MD	O	could	aux	17	SENT_50	[p2l1720t1404r1890b1457],
16	be	VB	O	be	auxpass	17	SENT_50	[p2l1909t1404r1980b1457],
17	used	VBN	O	use	advcl	4	SENT_50	[p2l1999t1404r2144b1457],
18	to	TO	O	to	aux	19	SENT_50	[p2l53t1497r113b1542],
19	identify	VB	O	identify	xcomp	17	SENT_50	[p2l131t1489r375b1556],
20	individuals	NNS	O	individual	nsubj	22	SENT_50	[p2l391t1489r753b1542],
21	’	CD	NUMBER	’	num	22	SENT_50	[p2l391t1489r753b1542],
22	susceptibility	NN	O	susceptibility	xcomp	19	SENT_50	[p2l773t1489r1195b1556],
23	to	TO	O	to	_	0	SENT_50	[p2l1210t1497r1270b1542],
24	severe	JJ	O	severe	amod	26	SENT_50	[p2l1289t1505r1488b1542],
25	cisplatin	NN	O	cisplatin	nn	26	SENT_50	[p2l1506t1489r1772b1556],
26	toxicity	NN	O	toxicity	prep_to	22	SENT_50	[p2l1789t1490r2028b1556],
27	[	CD	NUMBER	[	number	28	SENT_50	[p2l2047t1489r2143b1556],
28	6	CD	NUMBER	6	num	29	SENT_50	[p2l2047t1489r2143b1556],
29	]	NN	O	]	dep	26	SENT_50	[p2l2047t1489r2143b1556],
30	.	.	O	.	_	0	SENT_50	[p2l2047t1489r2143b1556],

1	Recently	RB	DATE	recently	advmod	7	SENT_51	[p2l153t1575r437b1642],
2	,	,	O	,	_	0	SENT_51	[p2l153t1575r437b1642],
3	an	DT	O	a	det	5	SENT_51	[p2l474t1591r548b1628],
4	interesting	JJ	O	interesting	amod	5	SENT_51	[p2l584t1576r925b1642],
5	possibility	NN	O	possibility	nsubj	7	SENT_51	[p2l960t1575r1285b1642],
6	has	VBZ	O	have	aux	7	SENT_51	[p2l1320t1575r1422b1628],
7	emerged	VBN	O	emerge	_	0	SENT_51	[p2l1459t1575r1733b1642],
8	that	IN	O	that	complm	12	SENT_51	[p2l1769t1575r1895b1628],
9	copper	NN	O	copper	nn	11	SENT_51	[p2l1930t1591r2147b1642],
10	transporter	NN	O	transporter	nn	11	SENT_51	[p2l53t1669r412b1728],
11	family	NN	O	family	nsubj	12	SENT_51	[p2l428t1661r626b1728],
12	performs	VBZ	O	perform	ccomp	7	SENT_51	[p2l642t1661r927b1728],
13	as	IN	O	as	_	0	SENT_51	[p2l946t1677r1006b1714],
14	the	DT	O	the	det	19	SENT_51	[p2l1024t1661r1123b1714],
15	major	JJ	O	major	amod	19	SENT_51	[p2l1142t1662r1327b1728],
16	plasma	NN	O	plasma	nn	19	SENT_51	[p2l1343t1661r1940b1728],
17	—	NN	O	—	nn	19	SENT_51	[p2l1343t1661r1940b1728],
18	membrane	NN	O	membrane	nn	19	SENT_51	[p2l1343t1661r1940b1728],
19	transporter	NN	O	transporter	prep_as	12	SENT_51	[p2l1958t1669r2144b1714, p2l53t1755r250b1814],
20	in	IN	O	in	_	0	SENT_51	[p2l294t1748r351b1800],
21	cisplatin	NN	O	cisplatin	nn	22	SENT_51	[p2l397t1747r663b1814],
22	uptake	NN	O	uptake	prep_in	19	SENT_51	[p2l708t1747r922b1814],
23	as	RB	O	as	_	0	SENT_51	[p2l968t1763r1029b1801],
24	well	RB	O	well	_	0	SENT_51	[p2l1074t1747r1207b1801],
25	as	IN	O	as	_	0	SENT_51	[p2l1253t1763r1314b1801],
26	exportation	NN	O	exportation	nn	27	SENT_51	[p2l1361t1748r1729b1814],
27	[	NN	O	[	prep_as	12	SENT_51	[p2l1778t1747r1874b1814],
28	7	CD	NUMBER	7	num	29	SENT_51	[p2l1778t1747r1874b1814],
29	]	NN	O	]	dep	27	SENT_51	[p2l1778t1747r1874b1814],
30	.	.	O	.	_	0	SENT_51	[p2l1778t1747r1874b1814],

1	Copper	NN	O	copper	nn	3	SENT_52	[p2l1922t1750r2147b1814],
2	transporter	NN	O	transporter	nn	3	SENT_52	[p2l53t1842r412b1900],
3	family	NN	O	family	nsubjpass	5	SENT_52	[p2l441t1833r639b1900],
4	is	VBZ	O	be	auxpass	5	SENT_52	[p2l668t1834r713b1887],
5	comprised	VBN	O	comprise	_	0	SENT_52	[p2l744t1834r1074b1900],
6	ofCTR1	NN	O	ofctr1	nn	10	SENT_52	[p2l1105t1833r1316b1887],
7	(	NN	O	(	nn	10	SENT_52	[p2l1355t1834r1597b1900],
8	copper	NN	O	copper	nn	10	SENT_52	[p2l1355t1834r1597b1900],
9	transporter	NN	O	transporter	nn	10	SENT_52	[p2l1625t1842r1984b1900],
10	proteins	NNS	O	protein	dobj	5	SENT_52	[p2l2012t1849r2144b1900, p2l53t1921r202b1973],
11	1	CD	NUMBER	1	num	12	SENT_52	[p2l230t1920r287b1986],
12	)	NN	O	)	nsubj	14	SENT_52	[p2l230t1920r287b1986],
13	also	RB	O	also	advmod	14	SENT_52	[p2l311t1920r432b1973],
14	known	VBN	O	know	dep	5	SENT_52	[p2l457t1920r672b1973],
15	as	IN	O	as	_	0	SENT_52	[p2l695t1935r756b1973],
16	SLC31A1	NN	O	slc31a1	nn	20	SENT_52	[p2l781t1922r1046b1973],
17	(	CD	NUMBER	(	num	20	SENT_52	[p2l1077t1920r1292b1986],
18	solute	JJ	O	solute	amod	20	SENT_52	[p2l1077t1920r1292b1986],
19	carrier	NN	O	carrier	nn	20	SENT_52	[p2l1316t1921r1524b1973],
20	family	NN	O	family	prep_as	14	SENT_52	[p2l1546t1920r1744b1986],
21	31	CD	NUMBER	31	dobj	14	SENT_52	[p2l1765t1923r1856b1981],
22	,	,	O	,	_	0	SENT_52	[p2l1765t1923r1856b1981],
23	member	NN	O	member	nn	25	SENT_52	[p2l1881t1920r2147b1973],
24	1	CD	NUMBER	1	num	25	SENT_52	[p2l56t2005r129b2071],
25	)	NN	O	)	appos	21	SENT_52	[p2l56t2005r129b2071],
26	,	,	O	,	_	0	SENT_52	[p2l56t2005r129b2071],
27	ATP7A	NN	O	atp7a	nn	29	SENT_52	[p2l143t2007r352b2058],
28	(	NN	O	(	nn	29	SENT_52	[p2l366t2005r1033b2072],
29	copper	NN	O	copper	appos	21	SENT_52	[p2l366t2005r1033b2072],
30	—	CD	NUMBER	—	dep	29	SENT_52	[p2l366t2005r1033b2072],
31	transporting	VBG	O	transport	xcomp	14	SENT_52	[p2l366t2005r1033b2072],
32	ATPase	NN	O	atpase	nn	34	SENT_52	[p2l1045t2007r1269b2058],
33	1	CD	NUMBER	1	num	34	SENT_52	[p2l1289t2008r1312b2058],
34	)	NN	O	)	dobj	31	SENT_52	[p2l1329t2005r1361b2071],
35	,	,	O	,	_	0	SENT_52	[p2l1329t2005r1361b2071],
36	and	CC	O	and	_	0	SENT_52	[p2l1378t2005r1491b2058],
37	ATP7B	NN	O	atp7b	dep	48	SENT_52	[p2l1506t2007r1707b2058],
38	(	CD	NUMBER	(	num	37	SENT_52	[p2l1725t2005r1986b2071],
39	ATPase	NN	O	atpase	dep	37	SENT_52	[p2l1725t2005r1986b2071],
40	,	,	O	,	_	0	SENT_52	[p2l1725t2005r1986b2071],
41	Cu2	NN	O	cu2	dep	37	SENT_52	[p2l2004t1996r2141b2058],
42	+	CC	O	+	_	0	SENT_52	[p2l2004t1996r2141b2058],
43	transporting	NN	O	transporting	conj_+	39	SENT_52	[p2l53t2092r460b2158],
44	,	,	O	,	_	0	SENT_52	[p2l53t2092r460b2158],
45	beta	NN	O	beta	appos	39	SENT_52	[p2l484t2091r618b2144],
46	polypeptide	NN	O	polypeptide	dep	48	SENT_52	[p2l642t2091r1043b2158],
47	)	CD	NUMBER	)	num	46	SENT_52	[p2l642t2091r1043b2158],
48	[	CD	NUMBER	[	dep	52	SENT_52	[p2l1071t2091r1287b2158],
49	8	CD	NUMBER	8	num	50	SENT_52	[p2l1071t2091r1287b2158],
50	—	NN	O	—	dep	48	SENT_52	[p2l1071t2091r1287b2158],
51	10	CD	NUMBER	10	num	52	SENT_52	[p2l1071t2091r1287b2158],
52	]	NN	O	]	conj_and	5	SENT_52	[p2l1071t2091r1287b2158],
53	.	.	O	.	_	0	SENT_52	[p2l1071t2091r1287b2158],

1	It	PRP	O	it	nsubjpass	5	SENT_53	[p2l1312t2095r1355b2144],
2	has	VBZ	O	have	aux	5	SENT_53	[p2l1378t2091r1480b2144],
3	also	RB	O	also	advmod	5	SENT_53	[p2l1504t2091r1625b2144],
4	been	VBN	O	be	auxpass	5	SENT_53	[p2l1649t2091r1799b2144],
5	conﬁrmed	VBN	O	conﬁrmed	_	0	SENT_53	[p2l1822t2091r2144b2144],
6	that	IN	O	that	complm	8	SENT_53	[p2l53t2177r179b2231],
7	CTR1	NN	O	ctr1	nsubj	8	SENT_53	[p2l207t2180r357b2231],
8	plays	VBZ	O	play	ccomp	5	SENT_53	[p2l395t2177r555b2244],
9	an	DT	O	a	det	11	SENT_53	[p2l586t2193r659b2231],
10	essential	JJ	O	essential	amod	11	SENT_53	[p2l689t2177r962b2231],
11	role	NN	O	role	dobj	8	SENT_53	[p2l993t2177r1112b2231],
12	in	IN	O	in	_	0	SENT_53	[p2l1142t2178r1200b2230],
13	cisplatin	NN	O	cisplatin	nn	14	SENT_53	[p2l1230t2177r1496b2244],
14	inﬂux	NN	O	inﬂux	prep_in	11	SENT_53	[p2l1526t2177r1707b2231],
15	among	IN	O	among	_	0	SENT_53	[p2l1735t2193r1950b2244],
16	these	DT	O	these	det	18	SENT_53	[p2l1978t2177r2144b2231],
17	three	CD	NUMBER	three	num	18	SENT_53	[p2l53t2263r216b2317],
18	components	NNS	O	component	prep_among	8	SENT_53	[p2l254t2272r641b2330],
19	[	CD	NUMBER	[	number	20	SENT_53	[p2l682t2263r874b2330],
20	7,11	CD	NUMBER	7,11	num	21	SENT_53	[p2l682t2263r874b2330],
21	]	NN	O	]	dep	8	SENT_53	[p2l682t2263r874b2330],
22	.	.	O	.	_	0	SENT_53	[p2l682t2263r874b2330],

1	Cellular	JJ	MISC	cellular	amod	2	SENT_54	[p2l913t2264r1155b2317],
2	uptake	NN	O	uptake	_	0	SENT_54	[p2l1189t2263r1403b2330],
3	of	IN	O	of	_	0	SENT_54	[p2l1440t2263r1505b2317],
4	cisplatin	NN	O	cisplatin	prep_of	2	SENT_54	[p2l1534t2264r1815b2330],
5	,	,	O	,	_	0	SENT_54	[p2l1534t2264r1815b2330],
6	and	CC	O	and	_	0	SENT_54	[p2l1853t2264r1966b2317],
7	DNA	NN	O	dna	conj_and	4	SENT_54	[p2l2004t2266r2147b2316],

1	X.	NNP	O	X.	nn	2	SENT_55	[p2l401t2406r423b2427],
2	Xu	NNP	O	Xu	_	0	SENT_55	[p2l431t2406r464b2427],
3	et	FW	O	et	nn	4	SENT_55	[p2l473t2408r496b2427],
4	al.	FW	O	al.	dep	2	SENT_55	[p2l503t2405r528b2427],
5	/	:	O	/	punct	2	SENT_55	[p2l535t2405r547b2432],
6	Lung	NN	O	lung	nn	7	SENT_55	[p2l553t2406r613b2432],
7	Cancer	NN	O	cancer	dep	2	SENT_55	[p2l620t2406r703b2427],
8	77	CD	NUMBER	77	number	9	SENT_55	[p2l712t2406r740b2427],
9	(	CD	NUMBER	(	num	10	SENT_55	[p2l747t2405r828b2432],
10	2012	CD	DATE	2012	dep	7	SENT_55	[p2l747t2405r828b2432],
11	)	CD	NUMBER	)	number	12	SENT_55	[p2l747t2405r828b2432],
12	438-442 439	CD	NUMBER	438-442 439	num	10	SENT_55	[p2l1712t2406r1759b2427],[p2l835t2406r942b2427],

1	repair	NN	O	repair	nn	2	SENT_56	[p2l11t2545r203b2612],
2	ability	NN	O	ability	nsubjpass	4	SENT_56	[p2l228t2545r431b2612],
3	are	VBP	O	be	auxpass	4	SENT_56	[p2l456t2560r554b2599],
4	suggested	VBN	O	suggest	_	0	SENT_56	[p2l582t2545r900b2612],
5	as	IN	O	as	_	0	SENT_56	[p2l928t2560r990b2599],
6	major	JJ	O	major	amod	7	SENT_56	[p2l1019t2545r1208b2612],
7	causes	NNS	O	cause	prep_as	4	SENT_56	[p2l1234t2560r1440b2599],
8	for	IN	O	for	_	0	SENT_56	[p2l1469t2544r1558b2599],
9	severe	JJ	O	severe	amod	10	SENT_56	[p2l1585t2560r1788b2599],
10	toxicity	NN	O	toxicity	prep_for	7	SENT_56	[p2l1815t2545r2059b2612],
11	in	IN	O	in	_	0	SENT_56	[p2l2086t2545r2145b2598],
12	cisplatin	NN	O	cisplatin	nn	13	SENT_56	[p2l11t2632r283b2699],
13	treatment	NN	O	treatment	prep_in	4	SENT_56	[p2l304t2640r627b2686],
14	in	FW	O	in	prep	13	SENT_56	[p2l649t2633r704b2686],
15	vivo	FW	O	vivo	nn	16	SENT_56	[p2l726t2633r852b2686],
16	[	FW	O	[	pobj	14	SENT_56	[p2l879t2632r1018b2699],
17	12	CD	NUMBER	12	num	18	SENT_56	[p2l879t2632r1018b2699],
18	]	NN	O	]	dep	16	SENT_56	[p2l879t2632r1018b2699],
19	.	.	O	.	_	0	SENT_56	[p2l879t2632r1018b2699],

1	It	PRP	O	it	nsubjpass	5	SENT_57	[p2l113t2721r157b2772],
2	has	VBZ	O	have	aux	5	SENT_57	[p2l194t2718r298b2772],
3	been	VBN	O	be	auxpass	5	SENT_57	[p2l336t2718r490b2772],
4	extensively	RB	O	extensively	advmod	5	SENT_57	[p2l528t2718r894b2786],
5	studied	VBN	O	study	_	0	SENT_57	[p2l931t2718r1167b2772],
6	that	IN	O	that	complm	15	SENT_57	[p2l1204t2718r1334b2772],
7	genetic	JJ	O	genetic	amod	8	SENT_57	[p2l1369t2719r1602b2786],
8	polymorphisms	NNS	O	polymorphism	nsubj	15	SENT_57	[p2l1639t2718r2143b2786],
9	of	IN	O	of	_	0	SENT_57	[p2l11t2805r77b2859],
10	DNA	NN	O	dna	nn	12	SENT_57	[p2l110t2808r256b2859],
11	repair	NN	O	repair	nn	12	SENT_57	[p2l294t2806r485b2873],
12	pathway	NN	O	pathway	prep_of	8	SENT_57	[p2l523t2805r803b2873],
13	are	VBP	O	be	cop	15	SENT_57	[p2l841t2821r938b2859],
14	closely	RB	O	closely	advmod	15	SENT_57	[p2l978t2805r1198b2873],
15	related	JJ	O	related	ccomp	5	SENT_57	[p2l1237t2805r1460b2859],
16	to	TO	O	to	_	0	SENT_57	[p2l1499t2813r1561b2859],
17	different	JJ	O	different	amod	19	SENT_57	[p2l1601t2805r1880b2859],
18	clinical	JJ	O	clinical	amod	19	SENT_57	[p2l1918t2805r2144b2859],
19	outcomes	NNS	O	outcome	prep_to	15	SENT_57	[p2l11t2900r321b2946],
20	in	IN	O	in	_	0	SENT_57	[p2l350t2893r408b2946],
21	NSCLC	NN	O	nsclc	nn	22	SENT_57	[p2l435t2895r640b2946],
22	patients	NNS	O	patient	prep_in	19	SENT_57	[p2l666t2893r923b2960],
23	treated	VBN	O	treat	partmod	22	SENT_57	[p2l951t2892r1180b2946],
24	with	IN	O	with	_	0	SENT_57	[p2l1205t2892r1354b2946],
25	cisplatin	NN	O	cisplatin	nn	26	SENT_57	[p2l1380t2892r1652b2960],
26	chemotherapy	NN	O	chemotherapy	prep_with	23	SENT_57	[p2l1678t2892r2146b2960],
27	[	CD	NUMBER	[	number	28	SENT_57	[p2l14t2979r276b3047],
28	13	CD	NUMBER	13	dep	26	SENT_57	[p2l14t2979r276b3047],
29	—	CD	NUMBER	—	num	31	SENT_57	[p2l14t2979r276b3047],
30	15	CD	NUMBER	15	num	31	SENT_57	[p2l14t2979r276b3047],
31	]	NN	O	]	dep	28	SENT_57	[p2l14t2979r276b3047],
32	.	.	O	.	_	0	SENT_57	[p2l14t2979r276b3047],

1	Current	JJ	DATE	current	nsubj	2	SENT_58	[p2l308t2982r552b3034],
2	researches	VBZ	O	research	_	0	SENT_58	[p2l581t2979r919b3034],
3	of	IN	O	of	_	0	SENT_58	[p2l950t2979r1017b3034],
4	clinical	JJ	O	clinical	amod	6	SENT_58	[p2l1039t2979r1264b3034],
5	individualized	JJ	O	individualized	amod	6	SENT_58	[p2l1295t2979r1753b3034],
6	medication	NN	O	medication	prep_of	2	SENT_58	[p2l1784t2979r2144b3033],
7	and	CC	O	and	_	0	SENT_58	[p2l11t3067r127b3121],
8	their	PRP$	O	they	poss	9	SENT_58	[p2l160t3067r314b3121],
9	evaluation	NN	O	evaluation	nsubj	10	SENT_58	[p2l345t3067r682b3121],
10	show	VBP	O	show	conj_and	2	SENT_58	[p2l716t3067r886b3121],
11	that	IN	O	that	complm	19	SENT_58	[p2l918t3067r1047b3121],
12	single	JJ	O	single	amod	14	SENT_58	[p2l1080t3067r1265b3134],
13	nucleotide	NN	O	nucleotide	nn	14	SENT_58	[p2l1299t3067r1637b3121],
14	polymorphism	NN	O	polymorphism	nsubj	19	SENT_58	[p2l1670t3066r2144b3134],
15	(	CD	NUMBER	(	num	17	SENT_58	[p2l11t3154r187b3221],
16	SNP	NN	O	snp	nn	17	SENT_58	[p2l11t3154r187b3221],
17	)	NN	O	)	dep	14	SENT_58	[p2l11t3154r187b3221],
18	can	MD	O	can	aux	19	SENT_58	[p2l234t3169r342b3208],
19	contribute	VB	O	contribute	ccomp	10	SENT_58	[p2l388t3154r722b3208],
20	to	TO	O	to	prep	19	SENT_58	[p2l769t3162r830b3208],
21	and	CC	O	and	_	0	SENT_58	[p2l877t3154r993b3208],
22	partially	RB	O	partially	advmod	19	SENT_58	[p2l1041t3154r1310b3221],
23	explain	VB	O	explain	ccomp	10	SENT_58	[p2l1354t3154r1590b3221],
24	inter	NN	O	inter	nn	25	SENT_58	[p2l1637t3154r2144b3208],
25	—	NN	O	—	dobj	23	SENT_58	[p2l1637t3154r2144b3208],
26	individual	JJ	O	individual	amod	27	SENT_58	[p2l1637t3154r2144b3208],
27	differences	NNS	O	difference	dobj	19	SENT_58	[p2l11t3240r363b3294],
28	in	IN	O	in	_	0	SENT_58	[p2l389t3241r448b3294],
29	chemotherapeutic	JJ	O	chemotherapeutic	amod	30	SENT_58	[p2l472t3240r1061b3308],
30	response	NN	O	response	prep_in	19	SENT_58	[p2l1086t3256r1370b3308],
31	and	CC	O	and	_	0	SENT_58	[p2l1395t3240r1512b3294],
32	toxicities	NNS	O	toxicity	prep_in	19	SENT_58	[p2l1536t3241r1844b3295],
33	.	.	O	.	_	0	SENT_58	[p2l1536t3241r1844b3295],

1	Pharmacogenomics	NN	MISC	pharmacogenomic	nn	2	SENT_59	[p2l1871t3240r2144b3294, p2l11t3328r388b3395],
2	studies	NNS	O	study	nsubj	9	SENT_59	[p2l411t3327r636b3381],
3	could	MD	O	could	aux	4	SENT_59	[p2l658t3327r832b3381],
4	elucidate	VB	O	elucidate	_	0	SENT_59	[p2l853t3327r1145b3381],
5	the	DT	O	the	det	7	SENT_59	[p2l1166t3327r1267b3381],
6	genetic	JJ	O	genetic	amod	7	SENT_59	[p2l1287t3328r1521b3395],
7	bases	NNS	O	basis	dobj	4	SENT_59	[p2l1540t3327r1712b3381],
8	and	CC	O	and	_	0	SENT_59	[p2l1734t3327r1850b3381],
9	use	VB	O	use	conj_and	4	SENT_59	[p2l1872t3343r1977b3381],
10	such	JJ	O	such	amod	11	SENT_59	[p2l2000t3327r2145b3381],
11	information	NN	O	information	dobj	9	SENT_59	[p2l11t3414r395b3469],
12	to	TO	O	to	aux	13	SENT_59	[p2l416t3422r477b3469],
13	predict	VB	O	predict	xcomp	9	SENT_59	[p2l501t3414r728b3482],
14	efﬁcacy	NN	O	efﬁcacy	dobj	13	SENT_59	[p2l749t3414r993b3482],
15	of	IN	O	of	_	0	SENT_59	[p2l1014t3414r1080b3469],
16	chemotherapy	NN	O	chemotherapy	prep_of	14	SENT_59	[p2l1095t3414r1563b3482],
17	[	CD	NUMBER	[	num	19	SENT_59	[p2l1587t3414r1726b3482],
18	16	CD	NUMBER	16	num	19	SENT_59	[p2l1587t3414r1726b3482],
19	]	NN	O	]	dobj	4	SENT_59	[p2l1587t3414r1726b3482],
20	.	.	O	.	_	0	SENT_59	[p2l1587t3414r1726b3482],

1	To	TO	O	to	_	0	SENT_60	[p2l110t3505r187b3556],
2	our	PRP$	O	we	poss	3	SENT_60	[p2l205t3517r313b3556],
3	knowledge	NN	O	knowledge	prep_to	6	SENT_60	[p2l329t3501r697b3569],
4	,	,	O	,	_	0	SENT_60	[p2l329t3501r697b3569],
5	there	EX	O	there	expl	6	SENT_60	[p2l715t3501r882b3556],
6	is	VBZ	O	be	_	0	SENT_60	[p2l901t3502r947b3556],
7	no	DT	O	no	nsubj	6	SENT_60	[p2l966t3517r1043b3556],
8	published	VBN	O	publish	dep	7	SENT_60	[p2l1062t3501r1376b3569],
9	or	CC	O	or	_	0	SENT_60	[p2l1395t3517r1461b3555],
10	report	NN	O	report	nsubj	11	SENT_60	[p2l1477t3509r1676b3569],
11	provided	VBD	O	provide	dep	7	SENT_60	[p2l1693t3501r1979b3569],
12	relationship	NN	O	relationship	dobj	11	SENT_60	[p2l1997t3501r2143b3556, p2l10t3589r273b3656],
13	between	IN	O	between	_	0	SENT_60	[p2l289t3589r567b3643],
14	CT	NN	O	ct	nn	17	SENT_60	[p2l583t3591r662b3643],
15	R1	NN	O	r1	nn	17	SENT_60	[p2l657t3592r728b3642],
16	genetic	JJ	O	genetic	amod	17	SENT_60	[p2l750t3589r983b3656],
17	polymorphisms	NNS	O	polymorphism	prep_between	12	SENT_60	[p2l998t3588r1502b3656],
18	and	CC	O	and	_	0	SENT_60	[p2l1519t3589r1635b3643],
19	severe	JJ	O	severe	amod	21	SENT_60	[p2l1653t3604r1856b3643],
20	cisplatin	NN	O	cisplatin	nn	21	SENT_60	[p2l1873t3589r2145b3656],
21	toxicity	NN	O	toxicity	conj_and	12	SENT_60	[p2l10t3677r254b3743],
22	in	IN	O	in	_	0	SENT_60	[p2l274t3677r333b3729],
23	cancer	NN	O	cancer	nn	24	SENT_60	[p2l355t3691r564b3730],
24	patients	NNS	O	patient	prep_in	21	SENT_60	[p2l584t3677r842b3743],
25	up	IN	O	up	advmod	11	SENT_60	[p2l864t3692r943b3743],
26	to	TO	O	to	prep	25	SENT_60	[p2l965t3684r1026b3730],
27	now	RB	DATE	now	pobj	26	SENT_60	[p2l1049t3691r1203b3730],
28	.	.	O	.	_	0	SENT_60	[p2l1049t3691r1203b3730],

1	In	IN	O	in	_	0	SENT_61	[p2l1226t3679r1285b3729],
2	our	PRP$	O	we	poss	3	SENT_61	[p2l1306t3692r1415b3730],
3	study	NN	O	study	prep_in	6	SENT_61	[p2l1435t3676r1626b3743],
4	,	,	O	,	_	0	SENT_61	[p2l1435t3676r1626b3743],
5	we	PRP	O	we	nsubj	6	SENT_61	[p2l1646t3692r1740b3730],
6	proposed	VBD	O	propose	_	0	SENT_61	[p2l1762t3676r2061b3743],
7	to	TO	O	to	aux	8	SENT_61	[p2l2082t3684r2144b3730],
8	test	VB	O	test	xcomp	6	SENT_61	[p2l10t3770r129b3816],
9	the	DT	O	the	det	11	SENT_61	[p2l154t3762r255b3816],
10	following	VBG	O	follow	amod	11	SENT_61	[p2l282t3762r587b3830],
11	hypothesis	NN	O	hypothesis	dobj	8	SENT_61	[p2l613t3762r960b3830],
12	for	IN	O	for	_	0	SENT_61	[p2l988t3762r1077b3816],
13	the	DT	O	the	det	15	SENT_61	[p2l1101t3762r1203b3816],
14	ﬁrst	JJ	O	ﬁrst	amod	15	SENT_61	[p2l1231t3762r1357b3816],
15	time	NN	O	time	prep_for	11	SENT_61	[p2l1382t3763r1547b3817],
16	:	:	O	:	_	0	SENT_61	[p2l1382t3763r1547b3817],
17	(	CD	NUMBER	(	number	18	SENT_61	[p2l1580t3762r1667b3829],
18	1	CD	NUMBER	1	num	19	SENT_61	[p2l1580t3762r1667b3829],
19	)	NN	O	)	dep	11	SENT_61	[p2l1580t3762r1667b3829],
20	whether	IN	O	whether	_	0	SENT_61	[p2l1693t3762r1967b3816],
21	CTR1	NN	O	ctr1	prep_whether	19	SENT_61	[p2l1993t3765r2137b3816],

1	genetic	JJ	O	genetic	amod	2	SENT_62	[p3l10t25r243b92],
2	polymorphism	NN	O	polymorphism	nsubj	3	SENT_62	[p3l275t24r749b92],
3	relates	VBZ	O	relate	_	0	SENT_62	[p3l781t24r993b78],
4	to	TO	O	to	_	0	SENT_62	[p3l1026t32r1087b78],
5	severe	JJ	O	severe	amod	10	SENT_62	[p3l1121t40r1324b78],
6	cisplatin	NN	O	cisplatin	nn	10	SENT_62	[p3l1357t24r1629b92],
7	toxicity	NN	O	toxicity	nn	10	SENT_62	[p3l1660t25r1904b92],
8	and/or	NN	O	and/or	nn	10	SENT_62	[p3l1934t24r2146b92],
9	clinical	JJ	O	clinical	amod	10	SENT_62	[p3l11t111r237b165],
10	outcomes	NNS	O	outcome	prep_to	3	SENT_62	[p3l267t119r577b166],
11	in	IN	O	in	_	0	SENT_62	[p3l608t112r667b165],
12	NSCLC	NN	ORGANIZATION	nsclc	nn	13	SENT_62	[p3l696t114r901b166],
13	patients	NNS	O	patient	prep_in	10	SENT_62	[p3l930t112r1187b179],
14	and	CC	O	and	_	0	SENT_62	[p3l1217t111r1333b166],
15	(	NN	O	(	conj_and	10	SENT_62	[p3l1363t111r1450b179],
16	2	CD	NUMBER	2	number	17	SENT_62	[p3l1363t111r1450b179],
17	)	CD	NUMBER	)	dep	15	SENT_62	[p3l1363t111r1450b179],
18	whether	IN	O	whether	complm	25	SENT_62	[p3l1479t111r1753b166],
19	CTR1	NN	O	ctr1	nn	20	SENT_62	[p3l1781t114r1926b166],
20	genotype	NN	O	genotype	nsubjpass	25	SENT_62	[p3l1961t127r2144b179, p3l10t207r150b266],
21	or	CC	O	or	_	0	SENT_62	[p3l172t214r238b253],
22	SNPs	NNS	O	snp	nsubjpass	25	SENT_62	[p3l257t201r411b253],
23	could	MD	O	could	aux	25	SENT_62	[p3l434t199r607b253],
24	be	VB	O	be	auxpass	25	SENT_62	[p3l628t199r702b253],
25	used	VBN	O	use	ccomp	3	SENT_62	[p3l723t199r871b253],
26	as	IN	O	as	_	0	SENT_62	[p3l892t214r955b253],
27	biomarkers	NNS	O	biomarker	prep_as	25	SENT_62	[p3l977t199r1340b253],
28	to	TO	O	to	aux	29	SENT_62	[p3l1362t207r1424b253],
29	identify	VB	O	identify	xcomp	25	SENT_62	[p3l1446t198r1695b266],
30	susceptibility	NN	O	susceptibility	dobj	29	SENT_62	[p3l1715t199r2146b266],
31	to	TO	O	to	aux	32	SENT_62	[p3l10t294r72b340],
32	predict	VB	O	predict	xcomp	29	SENT_62	[p3l95t286r322b353],
33	potential	JJ	O	potential	amod	35	SENT_62	[p3l344t286r631b353],
34	chemotherapeutic	JJ	O	chemotherapeutic	amod	35	SENT_62	[p3l654t286r1243b353],
35	toxicity	NN	O	toxicity	dobj	32	SENT_62	[p3l1264t287r1508b353],
36	in	IN	O	in	_	0	SENT_62	[p3l1529t287r1588b339],
37	NSCLC	NN	O	nsclc	nn	38	SENT_62	[p3l1610t289r1815b340],
38	patients	NNS	O	patient	prep_in	32	SENT_62	[p3l1837t287r2110b353],
39	.	.	O	.	_	0	SENT_62	[p3l1837t287r2110b353],

1	2	LS	NUMBER	2	_	0	SENT_63	[p3l10t509r65b561],
2	.	.	O	.	_	0	SENT_63	[p3l10t509r65b561],

1	Methods	NNS	O	method	_	0	SENT_64	[p3l111t506r404b560],

1	2.1	CD	NUMBER	2.1	_	0	SENT_65	[p3l7t686r113b738],
2	.	.	O	.	_	0	SENT_65	[p3l7t686r113b738],

1	Patients	NNS	O	patient	_	0	SENT_66	[p3l161t685r408b738],

1	The	DT	O	the	det	3	SENT_67	[p3l110t861r226b915],
2	study	NN	O	study	nn	3	SENT_67	[p3l247t861r423b929],
3	protocol	NN	O	protocol	nsubj	6	SENT_67	[p3l441t861r708b929],
4	has	VBZ	O	have	aux	6	SENT_67	[p3l728t861r832b915],
5	been	VBN	O	be	cop	6	SENT_67	[p3l851t861r1005b915],
6	IRB	NNP	ORGANIZATION	IRB	_	0	SENT_67	[p3l1025t864r1126b915],
7	approved	VBN	O	approve	partmod	6	SENT_67	[p3l1146t861r1448b929],
8	by	IN	O	by	_	0	SENT_67	[p3l1467t861r1544b929],
9	the	DT	O	the	det	10	SENT_67	[p3l1560t861r1662b915],
10	Committee	NNP	ORGANIZATION	Committee	agent	7	SENT_67	[p3l1682t862r2037b915],
11	for	IN	ORGANIZATION	for	_	0	SENT_67	[p3l2057t861r2146b915],
12	Medical	NNP	ORGANIZATION	Medical	nn	13	SENT_67	[p3l11t948r263b1002],
13	Ethics	NNP	ORGANIZATION	Ethics	prep_for	7	SENT_67	[p3l296t948r501b1010],
14	,	,	ORGANIZATION	,	_	0	SENT_67	[p3l296t948r501b1010],
15	Institute	NNP	ORGANIZATION	Institute	appos	13	SENT_67	[p3l534t949r804b1002],
16	of	IN	ORGANIZATION	of	_	0	SENT_67	[p3l836t948r903b1002],
17	Clinical	JJ	ORGANIZATION	clinical	amod	18	SENT_67	[p3l927t948r1161b1002],
18	Pharmacology	NN	ORGANIZATION	pharmacology	prep_of	15	SENT_67	[p3l1194t948r1666b1016],
19	,	,	O	,	_	0	SENT_67	[p3l1194t948r1666b1016],
20	Central	NNP	ORGANIZATION	Central	nn	22	SENT_67	[p3l1699t948r1928b1002],
21	South	NNP	ORGANIZATION	South	nn	22	SENT_67	[p3l1961t948r2145b1002],
22	University	NNP	ORGANIZATION	University	appos	13	SENT_67	[p3l10t1036r344b1103],
23	with	IN	O	with	_	0	SENT_67	[p3l376t1035r524b1089],
24	the	DT	O	the	det	26	SENT_67	[p3l559t1035r660b1089],
25	Registration	NNP	O	Registration	nn	26	SENT_67	[p3l696t1036r1084b1103],
26	Number	NNP	O	Number	prep_with	22	SENT_67	[p3l1120t1035r1383b1089],
27	of	IN	O	of	_	0	SENT_67	[p3l1417t1035r1483b1089],
28	ICPXL-080015	NN	O	icpxl-080015	prep_of	26	SENT_67	[p3l1511t1038r1981b1090],
29	.	.	O	.	_	0	SENT_67	[p3l1511t1038r1981b1090],

1	And	CC	O	and	_	0	SENT_68	[p3l2015t1035r2144b1089],
2	this	DT	O	this	det	3	SENT_68	[p3l10t1122r127b1177],
3	study	NN	O	study	nsubjpass	8	SENT_68	[p3l159t1122r336b1190],
4	has	VBZ	O	have	aux	6	SENT_68	[p3l365t1122r469b1177],
5	been	VBN	O	be	auxpass	6	SENT_68	[p3l500t1122r654b1177],
6	registered	VBN	O	register	_	0	SENT_68	[p3l684t1122r1006b1190],
7	and	CC	O	and	_	0	SENT_68	[p3l1037t1122r1153b1177],
8	received	VBN	O	receive	conj_and	6	SENT_68	[p3l1184t1122r1453b1177],
9	the	DT	O	the	det	12	SENT_68	[p3l1484t1122r1585b1177],
10	clinical	JJ	O	clinical	amod	12	SENT_68	[p3l1616t1122r1842b1177],
11	research	NN	O	research	nn	12	SENT_68	[p3l1873t1122r2144b1177],
12	admission	NN	O	admission	dobj	6	SENT_68	[p3l11t1210r338b1264],
13	from	IN	O	from	_	0	SENT_68	[p3l365t1209r518b1264],
14	Chinese	JJ	O	chinese	amod	17	SENT_68	[p3l545t1210r794b1264],
15	Clinical	JJ	O	clinical	amod	17	SENT_68	[p3l822t1209r1056b1264],
16	Trial	NN	O	trial	nn	17	SENT_68	[p3l1080t1210r1225b1264],
17	Registry	NN	O	registry	prep_from	6	SENT_68	[p3l1253t1210r1528b1277],
18	,	,	O	,	_	0	SENT_68	[p3l1253t1210r1528b1277],
19	with	IN	O	with	conj_and	6	SENT_68	[p3l1554t1210r1702b1264],
20	the	DT	O	the	det	22	SENT_68	[p3l1728t1210r1829b1264],
21	Registration	NNP	O	Registration	nn	22	SENT_68	[p3l1857t1210r2144b1277, p3l10t1298r137b1351],
22	Number	NN	O	number	pobj	19	SENT_68	[p3l152t1297r415b1351],
23	of	IN	O	of	_	0	SENT_68	[p3l429t1297r496b1351],
24	ChiCTR-TNC-1	NN	O	chictr-tnc-1	prep_of	22	SENT_68	[p3l504t1297r954b1351],
25	0000895	CD	NUMBER	0000895	num	24	SENT_68	[p3l967t1300r1263b1351],
26	.	.	O	.	_	0	SENT_68	[p3l967t1300r1263b1351],

1	In	IN	O	in	_	0	SENT_69	[p3l1280t1300r1339b1350],
2	total	NN	O	total	prep_in	7	SENT_69	[p3l1354t1297r1516b1359],
3	,	,	O	,	_	0	SENT_69	[p3l1354t1297r1516b1359],
4	204	CD	NUMBER	204	num	6	SENT_69	[p3l1533t1300r1650b1351],
5	NSCLC	NN	O	nsclc	nn	6	SENT_69	[p3l1666t1300r1871b1351],
6	patients	NNS	O	patient	nsubj	7	SENT_69	[p3l1886t1298r2143b1364],
7	enrolled	VBN	O	enrol	_	0	SENT_69	[p3l11t1383r275b1437],
8	in	IN	O	in	_	0	SENT_69	[p3l300t1384r359b1437],
9	our	PRP$	O	we	poss	10	SENT_69	[p3l382t1399r491b1437],
10	research	NN	O	research	prep_in	7	SENT_69	[p3l513t1383r799b1438],
11	.	.	O	.	_	0	SENT_69	[p3l513t1383r799b1438],

1	All	PDT	O	all	predet	4	SENT_70	[p3l821t1383r907b1437],
2	these	DT	O	these	det	4	SENT_70	[p3l931t1383r1100b1437],
3	cancer	NN	O	cancer	nn	4	SENT_70	[p3l1125t1399r1334b1437],
4	patients	NNS	O	patient	nsubj	6	SENT_70	[p3l1356t1384r1614b1451],
5	have	VBP	O	have	aux	6	SENT_70	[p3l1639t1383r1788b1437],
6	signed	VBN	O	sign	_	0	SENT_70	[p3l1813t1383r2019b1451],
7	the	DT	O	the	det	9	SENT_70	[p3l2043t1383r2144b1437],
8	written	VBN	O	write	amod	9	SENT_70	[p3l9t1471r249b1524],
9	consents	NNS	O	consent	dobj	6	SENT_70	[p3l278t1478r558b1524],
10	in	IN	O	in	_	0	SENT_70	[p3l588t1471r647b1524],
11	compliance	NN	O	compliance	prep_in	6	SENT_70	[p3l676t1470r1044b1538],
12	with	IN	O	with	_	0	SENT_70	[p3l1072t1470r1220b1524],
13	Declaration	NN	O	declaration	prep_with	6	SENT_70	[p3l1249t1470r1619b1524],
14	of	IN	O	of	_	0	SENT_70	[p3l1648t1470r1714b1524],
15	Helsinki	NNP	LOCATION	Helsinki	prep_of	13	SENT_70	[p3l1736t1470r2013b1533],
16	,	,	O	,	_	0	SENT_70	[p3l1736t1470r2013b1533],
17	the	DT	O	the	det	18	SENT_70	[p3l2043t1470r2144b1524],
18	Code	NNP	O	Code	appos	15	SENT_70	[p3l11t1557r167b1612],
19	of	IN	O	of	_	0	SENT_70	[p3l193t1557r259b1612],
20	Ethics	NNPS	O	Ethics	prep_of	18	SENT_70	[p3l277t1557r466b1612],
21	of	IN	O	of	_	0	SENT_70	[p3l493t1557r559b1611],
22	the	DT	O	the	det	25	SENT_70	[p3l576t1557r677b1612],
23	World	NNP	ORGANIZATION	World	nn	25	SENT_70	[p3l700t1557r903b1611],
24	Medical	NNP	ORGANIZATION	Medical	nn	25	SENT_70	[p3l930t1557r1181b1612],
25	Association	NNP	ORGANIZATION	Association	prep_of	20	SENT_70	[p3l1204t1558r1573b1612],
26	before	IN	O	before	mark	29	SENT_70	[p3l1598t1557r1800b1612],
27	this	DT	O	this	det	28	SENT_70	[p3l1826t1557r1942b1612],
28	study	NN	O	study	nsubj	29	SENT_70	[p3l1969t1557r2146b1625],
29	began	VBD	O	begin	advcl	6	SENT_70	[p3l10t1644r217b1712],
30	.	.	O	.	_	0	SENT_70	[p3l10t1644r217b1712],

1	All	DT	O	all	det	2	SENT_71	[p3l110t1732r196b1785],
2	patients	NNS	O	patient	nsubjpass	4	SENT_71	[p3l225t1732r482b1799],
3	were	VBD	O	be	auxpass	4	SENT_71	[p3l510t1747r670b1786],
4	collected	VBN	O	collect	_	0	SENT_71	[p3l699t1732r985b1786],
5	from	IN	O	from	_	0	SENT_71	[p3l1015t1731r1168b1786],
6	three	CD	NUMBER	three	num	9	SENT_71	[p3l1195t1732r1363b1786],
7	different	JJ	O	different	amod	9	SENT_71	[p3l1392t1731r1670b1786],
8	medical	JJ	O	medical	amod	9	SENT_71	[p3l1698t1732r1948b1786],
9	institutions	NNS	O	institution	prep_from	4	SENT_71	[p3l1978t1732r2144b1786, p3l10t1820r235b1873],
10	from	IN	O	from	_	0	SENT_71	[p3l265t1819r417b1873],
11	2005	CD	DATE	2005	num	13	SENT_71	[p3l444t1822r600b1873],
12	to	TO	DATE	to	dep	13	SENT_71	[p3l630t1827r691b1873],
13	2009	CD	DATE	2009	prep_from	4	SENT_71	[p3l720t1822r893b1881],
14	,	,	O	,	_	0	SENT_71	[p3l720t1822r893b1881],
15	including	VBG	O	include	_	0	SENT_71	[p3l923t1819r1224b1886],
16	Xiangya	NNP	ORGANIZATION	Xiangya	nn	17	SENT_71	[p3l1247t1820r1506b1886],
17	Hospital	NNP	ORGANIZATION	Hospital	prep_including	4	SENT_71	[p3l1534t1819r1799b1886],
18	of	IN	ORGANIZATION	of	_	0	SENT_71	[p3l1828t1819r1894b1873],
19	Central	NNP	ORGANIZATION	Central	nn	21	SENT_71	[p3l1914t1819r2144b1873],
20	South	NNP	ORGANIZATION	South	nn	21	SENT_71	[p3l11t1905r195b1959],
21	University	NNP	ORGANIZATION	University	prep_of	17	SENT_71	[p3l211t1906r559b1973],
22	,	,	O	,	_	0	SENT_71	[p3l211t1906r559b1973],
23	Changsha	NNP	LOCATION	Changsha	conj_and	21	SENT_71	[p3l578t1905r901b1973],
24	,	,	O	,	_	0	SENT_71	[p3l578t1905r901b1973],
25	Hunan	NNP	LOCATION	Hunan	nn	26	SENT_71	[p3l921t1908r1132b1959],
26	province	NN	O	province	conj_and	21	SENT_71	[p3l1150t1906r1444b1973],
27	,	,	O	,	_	0	SENT_71	[p3l1150t1906r1444b1973],
28	Zhongnan	NNP	ORGANIZATION	Zhongnan	nn	29	SENT_71	[p3l1462t1905r1784b1973],
29	Hospital	NNP	ORGANIZATION	Hospital	conj_and	21	SENT_71	[p3l1802t1905r2067b1973],
30	of	IN	ORGANIZATION	of	_	0	SENT_71	[p3l2086t1905r2152b1959],
31	Wuhan	NNP	ORGANIZATION	Wuhan	nn	32	SENT_71	[p3l8t1992r244b2046],
32	University	NNP	ORGANIZATION	University	prep_of	29	SENT_71	[p3l269t1993r616b2060],
33	,	,	O	,	_	0	SENT_71	[p3l269t1993r616b2060],
34	Wuhan	NNP	LOCATION	Wuhan	conj_and	21	SENT_71	[p3l640t1992r891b2055],
35	,	,	O	,	_	0	SENT_71	[p3l640t1992r891b2055],
36	Hubei	NNP	LOCATION	Hubei	nn	37	SENT_71	[p3l919t1992r1107b2046],
37	province	NN	O	province	conj_and	21	SENT_71	[p3l1133t1993r1412b2060],
38	and	CC	O	and	_	0	SENT_71	[p3l1438t1992r1554b2046],
39	Xijing	NNP	LOCATION	Xijing	nn	40	SENT_71	[p3l1578t1993r1769b2060],
40	Hospital	NNP	LOCATION	Hospital	prep_of	17	SENT_71	[p3l1794t1992r2059b2060],
41	in	IN	O	in	_	0	SENT_71	[p3l2086t1993r2145b2046],
42	Shanxi	NNP	LOCATION	Shanxi	nn	43	SENT_71	[p3l11t2079r224b2134],
43	Province	NNP	LOCATION	Province	prep_in	40	SENT_71	[p3l250t2080r542b2134],
44	.	.	O	.	_	0	SENT_71	[p3l250t2080r542b2134],

1	Generally	RB	O	generally	advmod	15	SENT_72	[p3l568t2079r890b2147],
2	,	,	O	,	_	0	SENT_72	[p3l568t2079r890b2147],
3	these	DT	O	these	det	6	SENT_72	[p3l915t2079r1085b2134],
4	three	CD	NUMBER	three	num	5	SENT_72	[p3l1109t2079r1277b2134],
5	institutions	NNS	O	institution	npadvmod	6	SENT_72	[p3l1302t2080r1668b2134],
6	located	JJ	O	located	nsubj	15	SENT_72	[p3l1695t2079r1925b2133],
7	in	IN	O	in	_	0	SENT_72	[p3l1951t2080r2009b2133],
8	different	JJ	O	different	amod	9	SENT_72	[p3l2034t2079r2143b2133, p3l11t2166r203b2221],
9	areas	NNS	O	area	prep_in	6	SENT_72	[p3l221t2182r386b2221],
10	of	IN	O	of	_	0	SENT_72	[p3l407t2166r473b2221],
11	China	NNP	LOCATION	China	prep_of	9	SENT_72	[p3l485t2167r666b2221],
12	and	CC	O	and	_	0	SENT_72	[p3l685t2167r801b2221],
13	these	DT	O	these	det	14	SENT_72	[p3l821t2167r990b2221],
14	patients	NNS	O	patient	conj_and	11	SENT_72	[p3l1010t2167r1268b2234],
15	were	VBD	O	be	_	0	SENT_72	[p3l1287t2182r1447b2221],
16	genetically	RB	O	genetically	advmod	17	SENT_72	[p3l1466t2167r1817b2234],
17	unrelated	JJ	O	unrelated	amod	20	SENT_72	[p3l1835t2167r2144b2221],
18	ethnic	JJ	O	ethnic	amod	20	SENT_72	[p3l11t2255r210b2309],
19	Han	NNP	MISC	Han	nn	20	SENT_72	[p3l232t2258r359b2309],
20	Chinese	NNPS	MISC	Chinese	dep	15	SENT_72	[p3l382t2255r647b2309],
21	.	.	O	.	_	0	SENT_72	[p3l382t2255r647b2309],

1	The	DT	O	the	dep	150	SENT_73	[p3l110t2342r226b2396],
2	inclusion	NN	O	inclusion	dep	150	SENT_73	[p3l285t2342r576b2396],
3	criteria	NNS	O	criterion	dep	150	SENT_73	[p3l635t2343r864b2396],
4	in	IN	O	in	dep	150	SENT_73	[p3l922t2343r981b2395],
5	our	PRP$	O	we	dep	150	SENT_73	[p3l1039t2358r1147b2396],
6	study	NN	O	study	dep	150	SENT_73	[p3l1204t2342r1381b2409],
7	was	VBD	O	be	dep	150	SENT_73	[p3l1436t2357r1560b2396],
8	as	IN	O	as	dep	150	SENT_73	[p3l1619t2357r1681b2396],
9	follows	VBZ	O	follow	dep	150	SENT_73	[p3l1741t2342r1993b2397],
10	:	:	O	:	_	0	SENT_73	[p3l1741t2342r1993b2397],
11	(	CD	NUMBER	(	dep	150	SENT_73	[p3l2056t2342r2144b2409],
12	1	CD	NUMBER	1	dep	150	SENT_73	[p3l2056t2342r2144b2409],
13	)	CD	NUMBER	)	dep	150	SENT_73	[p3l2056t2342r2144b2409],
14	all	DT	O	all	dep	150	SENT_73	[p3l11t2428r84b2482],
15	patients	NNS	O	patient	dep	150	SENT_73	[p3l127t2429r384b2496],
16	were	VBD	O	be	dep	150	SENT_73	[p3l425t2444r585b2482],
17	conﬁrmed	VBN	O	conﬁrmed	dep	150	SENT_73	[p3l627t2428r955b2482],
18	with	IN	O	with	dep	150	SENT_73	[p3l996t2428r1143b2482],
19	incident	NN	O	incident	dep	150	SENT_73	[p3l1185t2428r1448b2482],
20	non-small	JJ	O	non-small	dep	150	SENT_73	[p3l1489t2428r1813b2482],
21	cell	NN	O	cell	dep	150	SENT_73	[p3l1855t2428r1962b2482],
22	lung	NN	O	lung	dep	150	SENT_73	[p3l2005t2428r2146b2496],
23	cancer	NN	O	cancer	dep	150	SENT_73	[p3l11t2531r221b2569],
24	histologically	RB	O	histologically	dep	150	SENT_73	[p3l265t2515r694b2583],
25	or	CC	O	or	dep	150	SENT_73	[p3l738t2531r804b2569],
26	cytologically	RB	O	cytologically	dep	150	SENT_73	[p3l848t2515r1273b2583],
27	;	:	O	;	_	0	SENT_73	[p3l848t2515r1273b2583],
28	(	NN	O	(	dep	150	SENT_73	[p3l1324t2515r1411b2582],
29	2	CD	NUMBER	2	dep	150	SENT_73	[p3l1324t2515r1411b2582],
30	)	CD	NUMBER	)	dep	150	SENT_73	[p3l1324t2515r1411b2582],
31	all	DT	O	all	dep	150	SENT_73	[p3l1457t2515r1530b2569],
32	patients	NNS	O	patient	dep	150	SENT_73	[p3l1577t2516r1834b2583],
33	were	VBD	O	be	dep	150	SENT_73	[p3l1879t2531r2039b2569],
34	in	IN	O	in	dep	150	SENT_73	[p3l2086t2516r2145b2569],
35	advanced	JJ	O	advanced	dep	150	SENT_73	[p3l11t2602r314b2657],
36	stages	NNS	O	stage	dep	150	SENT_73	[p3l355t2610r549b2670],
37	of	IN	O	of	dep	150	SENT_73	[p3l590t2602r656b2656],
38	IIIA	NN	O	iium	dep	150	SENT_73	[p3l688t2605r810b2665],
39	,	,	O	,	_	0	SENT_73	[p3l688t2605r810b2665],
40	IIIB	NN	O	iiib	dep	150	SENT_73	[p3l851t2606r953b2656],
41	or	CC	O	or	dep	150	SENT_73	[p3l993t2618r1059b2656],
42	IV	CD	NUMBER	iv	dep	150	SENT_73	[p3l1097t2606r1176b2665],
43	,	,	O	,	_	0	SENT_73	[p3l1097t2606r1176b2665],
44	possessing	VBG	O	possess	dep	150	SENT_73	[p3l1216t2603r1560b2670],
45	a	DT	O	a	dep	150	SENT_73	[p3l1597t2618r1630b2657],
46	measurable	JJ	O	measurable	dep	150	SENT_73	[p3l1669t2602r2040b2657],
47	or	CC	O	or	dep	150	SENT_73	[p3l2080t2618r2146b2657],
48	assessable	JJ	O	assessable	dep	150	SENT_73	[p3l11t2689r340b2744],
49	tumor	NN	O	tumor	dep	150	SENT_73	[p3l390t2698r591b2744],
50	lesion	NN	O	lesion	dep	150	SENT_73	[p3l639t2690r848b2752],
51	;	:	O	;	_	0	SENT_73	[p3l639t2690r848b2752],
52	(	CD	NUMBER	(	dep	150	SENT_73	[p3l903t2690r990b2757],
53	3	CD	NUMBER	3	dep	150	SENT_73	[p3l903t2690r990b2757],
54	)	NN	O	)	dep	150	SENT_73	[p3l903t2690r990b2757],
55	all	DT	O	all	dep	150	SENT_73	[p3l1041t2690r1114b2744],
56	patients	NNS	O	patient	dep	150	SENT_73	[p3l1165t2690r1423b2757],
57	satisﬁed	VBD	O	satisﬁed	dep	150	SENT_73	[p3l1475t2689r1738b2744],
58	the	DT	O	the	dep	150	SENT_73	[p3l1789t2690r1890b2744],
59	conditions	NNS	O	condition	dep	150	SENT_73	[p3l1941t2690r2144b2744, p3l10t2778r166b2831],
60	for	IN	O	for	dep	150	SENT_73	[p3l194t2777r283b2831],
61	chemotherapy	NN	O	chemotherapy	dep	150	SENT_73	[p3l307t2777r774b2844],
62	according	VBG	O	accord	dep	150	SENT_73	[p3l798t2777r1112b2844],
63	to	TO	O	to	dep	150	SENT_73	[p3l1135t2785r1196b2831],
64	the	DT	O	the	dep	150	SENT_73	[p3l1223t2777r1324b2831],
65	adequate	JJ	O	adequate	dep	150	SENT_73	[p3l1350t2777r1643b2844],
66	organ	NN	O	organ	dep	150	SENT_73	[p3l1670t2792r1851b2844],
67	function	NN	O	function	dep	150	SENT_73	[p3l1877t2777r2145b2831],
68	test	NN	O	test	dep	150	SENT_73	[p3l10t2871r143b2925],
69	,	,	O	,	_	0	SENT_73	[p3l10t2871r143b2925],
70	routine	JJ	O	routine	dep	150	SENT_73	[p3l196t2864r428b2917],
71	blood	NN	O	blood	dep	150	SENT_73	[p3l480t2863r659b2917],
72	test	NN	O	test	dep	150	SENT_73	[p3l711t2871r829b2917],
73	(	CD	NUMBER	(	dep	150	SENT_73	[p3l879t2863r1289b2931],
74	hemoglobin	NN	O	hemoglobin	dep	150	SENT_73	[p3l879t2863r1289b2931],
75	level	NN	O	level	dep	150	SENT_73	[p3l1341t2863r1490b2917],
76	3	CD	NUMBER	3	dep	150	SENT_73	[p3l1509t2879r1550b2925],
77	8	CD	NUMBER	8	dep	150	SENT_73	[p3l1569t2866r1603b2917],
78	g/ml	NN	O	g/ml	dep	150	SENT_73	[p3l1620t2863r1781b2931],
79	,	,	O	,	_	0	SENT_73	[p3l1620t2863r1781b2931],
80	leukocyte	NN	O	leukocyte	dep	150	SENT_73	[p3l1834t2863r2144b2931],
81	count	NN	O	count	dep	150	SENT_73	[p3l11t2958r193b3005],
82	31.5	CD	NUMBER	31.5	dep	150	SENT_73	[p3l210t2953r360b3013],
83	x	CC	O	x	dep	150	SENT_73	[p3l385t2972r420b3004],
84	109/L	CD	NUMBER	109/l	dep	150	SENT_73	[p3l447t2941r630b3019],
85	,	,	O	,	_	0	SENT_73	[p3l447t2941r630b3019],
86	platelet	NN	O	platelet	dep	150	SENT_73	[p3l679t2950r923b3019],
87	count	NN	O	count	dep	150	SENT_73	[p3l970t2958r1151b3005],
88	3100	CD	NUMBER	3100	dep	150	SENT_73	[p3l1168t2953r1345b3013],
89	x	CC	O	x	dep	150	SENT_73	[p3l1368t2972r1403b3004],
90	109/L	CD	NUMBER	109/l	dep	150	SENT_73	[p3l1429t2941r1639b3019],
91	)	NN	O	)	dep	150	SENT_73	[p3l1429t2941r1639b3019],
92	,	,	O	,	_	0	SENT_73	[p3l1429t2941r1639b3019],
93	liver	NN	O	liver	dep	150	SENT_73	[p3l1688t2950r1831b3005],
94	function	NN	O	function	dep	150	SENT_73	[p3l1877t2950r2145b3005],
95	test	NN	O	test	dep	150	SENT_73	[p3l10t3046r129b3092],
96	(	CD	NUMBER	(	dep	150	SENT_73	[p3l166t3038r424b3105],
97	alanine	NN	O	alanine	dep	150	SENT_73	[p3l166t3038r424b3105],
98	transaminase51	NN	O	transaminase51	dep	150	SENT_73	[p3l463t3039r1064b3101],
99	.5	CD	NUMBER	.5	dep	150	SENT_73	[p3l463t3039r1064b3101],
100	x	CC	O	x	dep	150	SENT_73	[p3l1089t3060r1124b3091],
101	upper	JJ	O	upper	dep	150	SENT_73	[p3l1147t3054r1337b3106],
102	limit	NN	O	limit	dep	150	SENT_73	[p3l1374t3038r1525b3092],
103	normal	JJ	O	normal	dep	150	SENT_73	[p3l1563t3038r1807b3101],
104	,	,	O	,	_	0	SENT_73	[p3l1563t3038r1807b3101],
105	aspartate	JJ	O	aspartate	dep	150	SENT_73	[p3l1847t3046r2144b3106],
106	transaminase	NN	O	transaminase	dep	150	SENT_73	[p3l10t3126r442b3180],
107	3	CD	NUMBER	3	dep	150	SENT_73	[p3l461t3141r502b3188],
108	1.5	CD	NUMBER	1.5	dep	150	SENT_73	[p3l525t3128r612b3180],
109	x	NN	O	x	dep	150	SENT_73	[p3l637t3147r672b3178],
110	upper	JJ	O	upper	dep	150	SENT_73	[p3l695t3141r884b3193],
111	limit	NN	O	limit	dep	150	SENT_73	[p3l931t3125r1082b3179],
112	normal	JJ	O	normal	dep	150	SENT_73	[p3l1129t3125r1400b3193],
113	)	NN	O	)	dep	150	SENT_73	[p3l1129t3125r1400b3193],
114	,	,	O	,	_	0	SENT_73	[p3l1129t3125r1400b3193],
115	kidney	NN	O	kidney	dep	150	SENT_73	[p3l1449t3125r1666b3193],
116	function	NN	O	function	dep	150	SENT_73	[p3l1713t3125r1980b3180],
117	test	NN	O	test	dep	150	SENT_73	[p3l2027t3133r2145b3180],
118	(	CD	NUMBER	(	dep	150	SENT_73	[p3l11t3213r359b3280],
119	creatinine	NN	O	creatinine	dep	150	SENT_73	[p3l11t3213r359b3280],
120	clearance	NN	O	clearance	dep	150	SENT_73	[p3l391t3213r694b3267],
121	3	CD	NUMBER	3	dep	150	SENT_73	[p3l713t3229r753b3275],
122	60	CD	NUMBER	60	dep	150	SENT_73	[p3l773t3215r849b3267],
123	ml/min	NN	O	ml/min	dep	150	SENT_73	[p3l866t3212r1116b3280],
124	,	,	O	,	_	0	SENT_73	[p3l866t3212r1116b3280],
125	serum	NN	O	serum	dep	150	SENT_73	[p3l1150t3228r1350b3267],
126	creatinine	NN	O	creatinine	dep	150	SENT_73	[p3l1382t3213r1704b3267],
127	51.5	CD	NUMBER	51.5	dep	150	SENT_73	[p3l1723t3216r1874b3275],
128	X	NN	O	x	dep	150	SENT_73	[p3l1899t3234r1933b3265],
129	upper	JJ	O	upper	dep	150	SENT_73	[p3l1957t3228r2146b3280],
130	limit	NN	O	limit	dep	150	SENT_73	[p3l11t3300r162b3354],
131	normal	JJ	O	normal	dep	150	SENT_73	[p3l194t3300r469b3367],
132	)	NN	O	)	dep	150	SENT_73	[p3l194t3300r469b3367],
133	;	:	O	;	_	0	SENT_73	[p3l194t3300r469b3367],
134	(	CD	NUMBER	(	dep	150	SENT_73	[p3l507t3300r594b3367],
135	4	CD	NUMBER	4	dep	150	SENT_73	[p3l507t3300r594b3367],
136	)	CD	NUMBER	)	dep	150	SENT_73	[p3l507t3300r594b3367],
137	all	DT	O	all	dep	150	SENT_73	[p3l627t3300r701b3354],
138	patients	NNS	O	patient	dep	150	SENT_73	[p3l734t3301r991b3367],
139	were	VBD	O	be	dep	150	SENT_73	[p3l1023t3315r1183b3354],
140	treated	VBN	O	treat	dep	150	SENT_73	[p3l1215t3300r1445b3354],
141	with	IN	O	with	dep	150	SENT_73	[p3l1476t3300r1624b3354],
142	cisplatin	NN	O	cisplatin	dep	150	SENT_73	[p3l1656t3300r2144b3367],
143	—	NN	O	—	dep	150	SENT_73	[p3l1656t3300r2144b3367],
144	based	VBN	O	base	dep	150	SENT_73	[p3l1656t3300r2144b3367],
145	chemotherapy	NN	O	chemotherapy	dep	150	SENT_73	[p3l11t3386r479b3454],
146	for	IN	O	for	dep	150	SENT_73	[p3l501t3386r590b3440],
147	at	IN	O	at	dep	150	SENT_73	[p3l611t3394r670b3440],
148	least	JJS	O	least	dep	150	SENT_73	[p3l692t3386r841b3440],
149	two	CD	NUMBER	two	dep	150	SENT_73	[p3l863t3394r984b3440],
150	cycles	NNS	O	cycle	_	0	SENT_73	[p3l1008t3386r1215b3454],
151	.	.	O	.	_	0	SENT_73	[p3l1008t3386r1215b3454],

1	The	DT	O	the	det	3	SENT_74	[p3l1236t3386r1353b3440],
2	exclusion	NN	O	exclusion	nn	3	SENT_74	[p3l1377t3386r1681b3440],
3	criteria	NNS	O	criterion	nsubj	7	SENT_74	[p3l1703t3387r1933b3440],
4	in	IN	O	in	_	0	SENT_74	[p3l1956t3387r2015b3440],
5	our	PRP$	O	we	poss	6	SENT_74	[p3l2038t3402r2146b3440],
6	study	NN	O	study	prep_in	3	SENT_74	[p3l12t3473r189b3541],
7	was	VBD	O	be	_	0	SENT_74	[p3l211t3489r356b3528],
8	:	:	O	:	_	0	SENT_74	[p3l211t3489r356b3528],
9	(	CD	NUMBER	(	number	10	SENT_74	[p3l387t3473r474b3541],
10	1	CD	NUMBER	1	num	12	SENT_74	[p3l387t3473r474b3541],
11	)	NN	O	)	nn	12	SENT_74	[p3l387t3473r474b3541],
12	patients	NNS	O	patient	nsubj	13	SENT_74	[p3l501t3474r758b3541],
13	have	VBP	O	have	parataxis	7	SENT_74	[p3l786t3473r934b3527],
14	previous	JJ	O	previous	amod	16	SENT_74	[p3l961t3474r1236b3541],
15	cancer	NN	O	cancer	nn	16	SENT_74	[p3l1263t3489r1473b3527],
16	history	NN	O	history	dobj	13	SENT_74	[p3l1497t3473r1740b3541],
17	;	:	O	;	_	0	SENT_74	[p3l1497t3473r1740b3541],
18	(	NN	O	(	nsubj	23	SENT_74	[p3l1771t3473r1859b3541],
19	2	CD	NUMBER	2	num	18	SENT_74	[p3l1771t3473r1859b3541],
20	)	CD	NUMBER	)	num	21	SENT_74	[p3l1771t3473r1859b3541],
21	patients	NNS	O	patient	dep	18	SENT_74	[p3l1886t3474r2143b3541],
22	have	VBP	O	have	aux	23	SENT_74	[p3l11t3560r160b3614],
23	accepted	VBN	O	accept	parataxis	7	SENT_74	[p3l202t3560r485b3628],
24	surgery	NN	O	surgery	dobj	23	SENT_74	[p3l528t3576r770b3628],
25	or	CC	O	or	_	0	SENT_74	[p3l810t3576r876b3614],
26	radiation	NN	O	radiation	dobj	23	SENT_74	[p3l916t3560r1206b3614],
27	for	IN	O	for	_	0	SENT_74	[p3l1247t3560r1336b3614],
28	lung	NN	O	lung	nn	30	SENT_74	[p3l1376t3560r1517b3628],
29	cancer	NN	O	cancer	nn	30	SENT_74	[p3l1557t3576r1767b3614],
30	treatment	NN	O	treatment	prep_for	24	SENT_74	[p3l1806t3568r2143b3623],
31	,	,	O	,	_	0	SENT_74	[p3l1806t3568r2143b3623],
32	or	CC	O	or	_	0	SENT_74	[p3l11t3663r77b3701],
33	any	DT	O	any	det	34	SENT_74	[p3l105t3663r220b3715],
34	chemotherapy	NN	O	chemotherapy	dobj	23	SENT_74	[p3l249t3647r717b3715],
35	other	JJ	O	other	dep	34	SENT_74	[p3l745t3647r917b3702],
36	than	IN	O	than	_	0	SENT_74	[p3l945t3647r1089b3701],
37	platinum-contained	JJ	O	platinum-contained	amod	38	SENT_74	[p3l1120t3647r1763b3715],
38	agents	NNS	O	agent	prep_than	34	SENT_74	[p3l1794t3655r2021b3715],
39	;	:	O	;	_	0	SENT_74	[p3l1794t3655r2021b3715],
40	(	CD	NUMBER	(	number	41	SENT_74	[p3l2056t3648r2144b3715],
41	3	CD	NUMBER	3	num	43	SENT_74	[p3l2056t3648r2144b3715],
42	)	NN	O	)	nn	43	SENT_74	[p3l2056t3648r2144b3715],
43	patients	NNS	O	patient	nsubj	44	SENT_74	[p3l11t3735r268b3802],
44	have	VBP	O	have	parataxis	7	SENT_74	[p3l287t3735r436b3789],
45	serious	JJ	O	serious	amod	47	SENT_74	[p3l454t3735r679b3789],
46	concomitant	JJ	O	concomitant	amod	47	SENT_74	[p3l697t3735r1102b3789],
47	diseases	NNS	O	disease	dobj	44	SENT_74	[p3l1118t3735r1396b3797],
48	,	,	O	,	_	0	SENT_74	[p3l1118t3735r1396b3797],
49	including	VBG	O	include	_	0	SENT_74	[p3l1415t3735r1716b3802],
50	uncontrolled	JJ	O	uncontrolled	amod	51	SENT_74	[p3l1731t3735r2144b3789],
51	hypertension	NN	O	hypertension	prep_including	47	SENT_74	[p4l11t17r452b84],
52	,	,	O	,	_	0	SENT_74	[p4l11t17r452b84],
53	cardiac	JJ	O	cardiac	amod	54	SENT_74	[p4l496t17r724b71],
54	arrhythmia	NN	O	arrhythmium	appos	51	SENT_74	[p4l766t17r1129b84],
55	requiring	VBG	O	require	partmod	54	SENT_74	[p4l1172t18r1470b84],
56	medical	JJ	O	medical	amod	57	SENT_74	[p4l1512t17r1763b71],
57	treatment	NN	O	treatment	dobj	55	SENT_74	[p4l1806t25r2143b79],
58	,	,	O	,	_	0	SENT_74	[p4l1806t25r2143b79],
59	myocardial	JJ	O	myocardial	amod	60	SENT_74	[p4l11t103r369b171],
60	infarction	NN	O	infarction	conj_or	57	SENT_74	[p4l395t103r707b157],
61	or	CC	O	or	_	0	SENT_74	[p4l732t119r798b157],
62	active	JJ	O	active	amod	65	SENT_74	[p4l821t104r1009b157],
63	congestive	JJ	O	congestive	amod	65	SENT_74	[p4l1034t104r1375b171],
64	heart	NN	O	heart	nn	65	SENT_74	[p4l1401t103r1569b157],
65	failure	NN	O	failure	conj_or	57	SENT_74	[p4l1593t103r1797b157],
66	in	IN	O	in	_	0	SENT_74	[p4l1824t104r1883b157],
67	the	DT	DURATION	the	det	70	SENT_74	[p4l1907t103r2008b157],
68	last	JJ	DURATION	last	amod	70	SENT_74	[p4l2034t103r2146b157],
69	six	CD	DURATION	six	num	70	SENT_74	[p4l12t192r99b245],
70	months	NNS	NUMBER	month	prep_in	55	SENT_74	[p4l121t191r379b246],
71	.	.	O	.	_	0	SENT_74	[p4l121t191r379b246],

1	During	IN	O	during	_	0	SENT_75	[p4l113t279r333b346],
2	the	DT	O	the	det	3	SENT_75	[p4l352t278r453b333],
3	study	NN	O	study	prep_during	10	SENT_75	[p4l476t278r666b346],
4	,	,	O	,	_	0	SENT_75	[p4l476t278r666b346],
5	all	DT	O	all	det	6	SENT_75	[p4l688t278r761b332],
6	patients	NNS	O	patient	nsubjpass	10	SENT_75	[p4l783t279r1040b346],
7	enrolled	VBN	O	enrol	partmod	6	SENT_75	[p4l1063t278r1327b333],
8	have	VBP	O	have	aux	10	SENT_75	[p4l1349t278r1497b333],
9	been	VBN	O	be	auxpass	10	SENT_75	[p4l1518t278r1672b333],
10	recorded	VBN	O	record	_	0	SENT_75	[p4l1693t278r1977b333],
11	with	IN	O	with	_	0	SENT_75	[p4l1997t278r2144b332],
12	detailed	JJ	O	detailed	amod	15	SENT_75	[p4l11t365r268b420],
13	basic	JJ	O	basic	amod	15	SENT_75	[p4l286t365r446b420],
14	clinical	JJ	O	clinical	amod	15	SENT_75	[p4l463t365r688b420],
15	information	NN	O	information	prep_with	10	SENT_75	[p4l707t365r1105b428],
16	,	,	O	,	_	0	SENT_75	[p4l707t365r1105b428],
17	including	VBG	O	include	_	0	SENT_75	[p4l1124t365r1425b433],
18	age	NN	O	age	prep_including	10	SENT_75	[p4l1440t381r1547b433],
19	of	IN	O	of	_	0	SENT_75	[p4l1565t365r1631b419],
20	diagnose	VB	O	diagnose	prep_of	18	SENT_75	[p4l1641t365r1940b433],
21	,	,	O	,	_	0	SENT_75	[p4l1641t365r1940b433],
22	histological	JJ	O	histological	amod	23	SENT_75	[p4l1959t365r2143b420, p4l11t452r217b520],
23	type	NN	O	type	ccomp	10	SENT_75	[p4l234t461r390b520],
24	,	,	O	,	_	0	SENT_75	[p4l234t461r390b520],
25	cancer	NN	O	cancer	nn	26	SENT_75	[p4l408t468r617b507],
26	stage	NN	O	stage	appos	23	SENT_75	[p4l633t461r813b520],
27	,	,	O	,	_	0	SENT_75	[p4l633t461r813b520],
28	family	NN	O	family	nn	30	SENT_75	[p4l831t452r1033b520],
29	cancer	NN	O	cancer	nn	30	SENT_75	[p4l1049t468r1259b507],
30	history	NN	O	history	appos	23	SENT_75	[p4l1274t452r1513b520],
31	,	,	O	,	_	0	SENT_75	[p4l1274t452r1513b520],
32	smoking	NN	O	smoking	nn	33	SENT_75	[p4l1532t453r1806b520],
33	status	NN	O	status	appos	23	SENT_75	[p4l1822t461r2010b507],
34	and	CC	O	and	_	0	SENT_75	[p4l2027t453r2144b507],
35	so	RB	O	so	conj_and	23	SENT_75	[p4l12t555r77b594],
36	on	IN	O	on	dep	35	SENT_75	[p4l101t555r194b594],
37	.	.	O	.	_	0	SENT_75	[p4l101t555r194b594],

1	For	IN	O	for	_	0	SENT_76	[p4l218t543r319b594],
2	present	JJ	DATE	present	amod	4	SENT_76	[p4l340t548r582b607],
3	smoking	NN	O	smoking	nn	4	SENT_76	[p4l605t540r878b607],
4	status	NN	O	status	prep_for	20	SENT_76	[p4l900t548r1105b602],
5	,	,	O	,	_	0	SENT_76	[p4l900t548r1105b602],
6	pack	NN	O	pack	nn	8	SENT_76	[p4l1129t540r1447b607],
7	—	CD	NUMBER	—	num	8	SENT_76	[p4l1129t540r1447b607],
8	year	NN	NUMBER	year	nsubj	20	SENT_76	[p4l1129t540r1447b607],
9	of	IN	O	of	_	0	SENT_76	[p4l1468t540r1534b594],
10	smoke	NN	O	smoke	nn	13	SENT_76	[p4l1550t540r1757b594],
11	(	CD	NUMBER	(	num	13	SENT_76	[p4l1780t540r2143b607],
12	(	NN	O	(	nn	13	SENT_76	[p4l1780t540r2143b607],
13	cigarettes	NNS	O	cigarette	prep_of	8	SENT_76	[p4l1780t540r2143b607],
14	per	IN	O	per	_	0	SENT_76	[p4l11t643r116b696],
15	day/20	NN	O	day/20	prep_per	8	SENT_76	[p4l132t627r377b696],
16	)	CD	NUMBER	)	num	15	SENT_76	[p4l132t627r377b696],
17	x	CC	O	x	_	0	SENT_76	[p4l400t650r435b681],
18	smoking	NN	O	smoking	nn	19	SENT_76	[p4l459t628r733b696],
19	years	NNS	DURATION	year	prep_per	8	SENT_76	[p4l748t628r943b696],
20	)	VBP	O	)	_	0	SENT_76	[p4l748t628r943b696],
21	was	VBD	O	be	auxpass	22	SENT_76	[p4l960t643r1084b683],
22	calculated	VBN	O	calculate	ccomp	20	SENT_76	[p4l1103t627r1445b691],
23	,	,	O	,	_	0	SENT_76	[p4l1103t627r1445b691],
24	and	CC	O	and	_	0	SENT_76	[p4l1463t628r1579b683],
25	the	DT	O	the	det	27	SENT_76	[p4l1597t628r1699b683],
26	median	JJ	O	median	amod	27	SENT_76	[p4l1717t628r1958b683],
27	pacl	NN	O	pacl	nsubj	35	SENT_76	[p4l1975t628r2150b696, p4l9t733r149b785],
28	<	JJR	O	<	amod	30	SENT_76	[p4l1975t628r2150b696, p4l9t733r149b785],
29	year	NN	DURATION	year	nn	30	SENT_76	[p4l1975t628r2150b696, p4l9t733r149b785],
30	value	NN	O	value	dep	27	SENT_76	[p4l178t717r350b772],
31	in	IN	O	in	_	0	SENT_76	[p4l383t718r442b771],
32	this	DT	O	this	det	33	SENT_76	[p4l473t717r590b772],
33	study	NN	O	study	prep_in	27	SENT_76	[p4l624t717r801b785],
34	was	VBD	O	be	cop	35	SENT_76	[p4l830t733r955b772],
35	25	CD	NUMBER	25	conj_and	20	SENT_76	[p4l988t720r1081b772],
36	.	.	O	.	_	0	SENT_76	[p4l988t720r1081b772],

1	We	PRP	O	we	nsubj	2	SENT_77	[p4l1111t720r1219b772],
2	used	VBD	O	use	_	0	SENT_77	[p4l1252t717r1400b772],
3	this	DT	O	this	det	4	SENT_77	[p4l1432t717r1549b772],
4	value	NN	O	value	dobj	2	SENT_77	[p4l1580t717r1753b772],
5	to	TO	O	to	aux	6	SENT_77	[p4l1784t725r1846b772],
6	separate	VB	O	separate	infmod	4	SENT_77	[p4l1880t725r2150b785],
7	all	DT	O	all	det	9	SENT_77	[p4l11t805r84b860],
8	smoking	NN	O	smoking	nn	9	SENT_77	[p4l121t805r395b874],
9	patients	NNS	O	patient	dobj	6	SENT_77	[p4l429t806r688b874],
10	into	IN	O	into	_	0	SENT_77	[p4l724t806r849b860],
11	light	JJ	O	light	amod	12	SENT_77	[p4l886t805r1032b874],
12	smokers	NNS	O	smoker	prep_into	6	SENT_77	[p4l1066t805r1333b860],
13	and	CC	O	and	_	0	SENT_77	[p4l1370t805r1486b860],
14	heavy	JJ	O	heavy	amod	15	SENT_77	[p4l1522t805r1712b874],
15	smokers	NNS	O	smoker	prep_into	6	SENT_77	[p4l1747t805r2030b861],
16	.	.	O	.	_	0	SENT_77	[p4l1747t805r2030b861],

1	All	DT	O	all	det	2	SENT_78	[p4l2064t805r2150b859],
2	patients	NNS	O	patient	nsubjpass	5	SENT_78	[p4l11t895r269b963],
3	have	VBP	O	have	aux	5	SENT_78	[p4l299t894r449b949],
4	been	VBN	O	be	auxpass	5	SENT_78	[p4l477t894r631b949],
5	followed	VBN	O	follow	dep	22	SENT_78	[p4l661t894r940b949],
6	up	RP	O	up	prt	5	SENT_78	[p4l970t910r1049b963],
7	for	IN	O	for	_	0	SENT_78	[p4l1079t894r1168b949],
8	survival	NN	O	survival	nn	9	SENT_78	[p4l1196t894r1448b949],
9	analysis	NN	O	analysis	prep_for	5	SENT_78	[p4l1477t894r1732b963],
10	as	RB	O	as	advmod	11	SENT_78	[p4l1762t910r1824b949],
11	well	RB	O	well	advmod	5	SENT_78	[p4l1852t894r2005b958],
12	,	,	O	,	_	0	SENT_78	[p4l1852t894r2005b958],
13	and	CC	O	and	_	0	SENT_78	[p4l2034t894r2150b949],
14	the	DT	O	the	det	15	SENT_78	[p4l10t983r112b1038],
15	median	NN	O	median	nsubj	16	SENT_78	[p4l135t983r376b1038],
16	follow	VB	O	follow	conj_and	5	SENT_78	[p4l398t983r713b1052],
17	—	RB	O	—	advmod	16	SENT_78	[p4l398t983r713b1052],
18	up	RP	O	up	prep	16	SENT_78	[p4l398t983r713b1052],
19	time	NN	O	time	dep	18	SENT_78	[p4l735t984r881b1038],
20	is	VBZ	O	be	cop	22	SENT_78	[p4l904t984r951b1038],
21	25	CD	DURATION	25	num	22	SENT_78	[p4l974t986r1049b1038],
22	months	NNS	NUMBER	month	_	0	SENT_78	[p4l1074t983r1317b1038],
23	(	JJ	O	(	amod	24	SENT_78	[p4l1341t983r1561b1052],
24	range	NN	O	range	nsubj	22	SENT_78	[p4l1341t983r1561b1052],
25	,	,	O	,	_	0	SENT_78	[p4l1341t983r1561b1052],
26	2-79	CD	NUMBER	2-79	num	28	SENT_78	[p4l1585t986r1743b1038],
27	month	NN	NUMBER	month	nn	28	SENT_78	[p4l1767t983r2020b1052],
28	)	NN	O	)	appos	24	SENT_78	[p4l1767t983r2020b1052],
29	.	.	O	.	_	0	SENT_78	[p4l1767t983r2020b1052],

1	2.2	CD	NUMBER	2.2	_	0	SENT_79	[p4l7t1164r113b1217],
2	.	.	O	.	_	0	SENT_79	[p4l7t1164r113b1217],

1	Chemotherapeutic	JJ	O	chemotherapeutic	amod	2	SENT_80	[p4l164t1162r731b1230],
2	treatment	NN	O	treatment	_	0	SENT_80	[p4l752t1170r1060b1217],

1	The	DT	O	the	det	2	SENT_81	[p4l110t1340r227b1395],
2	chemotherapy	NN	O	chemotherapy	nsubj	4	SENT_81	[p4l272t1340r741b1409],
3	was	VBD	O	be	cop	4	SENT_81	[p4l782t1356r907b1395],
4	cisplatin	NN	O	cisplatin	_	0	SENT_81	[p4l952t1340r1224b1409],
5	based	VBN	O	base	partmod	4	SENT_81	[p4l1268t1340r1451b1395],
6	regiments	NNS	O	regiment	dobj	5	SENT_81	[p4l1497t1341r1836b1409],
7	.	.	O	.	_	0	SENT_81	[p4l1497t1341r1836b1409],

1	Twentyone	NNP	O	Twentyone	nn	2	SENT_82	[p4l1879t1343r2150b1409, p4l11t1445r126b1484],
2	days	NNS	DURATION	day	nsubjpass	8	SENT_82	[p4l174t1429r317b1498],
3	(	RB	O	(	advmod	8	SENT_82	[p4l366t1429r560b1497],
4	three	CD	DURATION	three	num	5	SENT_82	[p4l366t1429r560b1497],
5	weeks	NNS	NUMBER	week	dep	3	SENT_82	[p4l606t1429r835b1497],
6	)	CD	NUMBER	)	dep	3	SENT_82	[p4l606t1429r835b1497],
7	were	VBD	O	be	auxpass	8	SENT_82	[p4l881t1445r1042b1484],
8	considered	VBN	O	consider	_	0	SENT_82	[p4l1090t1429r1442b1484],
9	as	IN	O	as	_	0	SENT_82	[p4l1490t1445r1552b1484],
10	one	CD	NUMBER	one	num	11	SENT_82	[p4l1601t1445r1716b1484],
11	cycle	NN	O	cycle	prep_as	8	SENT_82	[p4l1765t1429r1940b1498],
12	.	.	O	.	_	0	SENT_82	[p4l1765t1429r1940b1498],

1	Main	NNP	O	Main	nn	3	SENT_83	[p4l1990t1430r2151b1484],
2	chemotherapeutic	JJ	O	chemotherapeutic	amod	3	SENT_83	[p4l11t1518r602b1587],
3	regimens	NNS	O	regimen	nsubj	4	SENT_83	[p4l636t1519r932b1587],
4	included	VBD	O	include	_	0	SENT_83	[p4l969t1518r1245b1573],
5	cisplatin	NN	O	cisplatin	dobj	4	SENT_83	[p4l1281t1518r1553b1587],
6	plus	CC	O	plus	prep	5	SENT_83	[p4l1588t1518r1719b1587],
7	gemcitabine	NN	O	gemcitabine	nn	10	SENT_83	[p4l1754t1518r2150b1587],
8	(	CD	NUMBER	(	num	10	SENT_83	[p4l11t1607r163b1676],
9	GP	NN	O	gp	nn	10	SENT_83	[p4l11t1607r163b1676],
10	)	NN	O	)	dep	6	SENT_83	[p4l11t1607r163b1676],
11	,	,	O	,	_	0	SENT_83	[p4l11t1607r163b1676],
12	cisplatin	NN	O	cisplatin	appos	5	SENT_83	[p4l196t1607r469b1676],
13	plus	CC	O	plus	prep	12	SENT_83	[p4l501t1607r632b1676],
14	etoposide	NN	O	etoposide	nn	17	SENT_83	[p4l666t1607r978b1676],
15	(	CD	NUMBER	(	num	17	SENT_83	[p4l1011t1608r1153b1676],
16	EP	NN	O	ep	nn	17	SENT_83	[p4l1011t1608r1153b1676],
17	)	NN	O	)	dep	13	SENT_83	[p4l1011t1608r1153b1676],
18	,	,	O	,	_	0	SENT_83	[p4l1011t1608r1153b1676],
19	cisplatin	NN	O	cisplatin	appos	5	SENT_83	[p4l1187t1607r1459b1676],
20	plus	CC	O	plus	prep	19	SENT_83	[p4l1491t1607r1622b1676],
21	docetaxel	NN	O	docetaxel	nn	24	SENT_83	[p4l1655t1607r1964b1662],
22	(	CD	NUMBER	(	num	24	SENT_83	[p4l1996t1607r2150b1676],
23	DP	NN	O	dp	nn	24	SENT_83	[p4l1996t1607r2150b1676],
24	)	NN	O	)	dep	20	SENT_83	[p4l1996t1607r2150b1676],
25	,	,	O	,	_	0	SENT_83	[p4l1996t1607r2150b1676],
26	cisplatin	NN	O	cisplatin	appos	5	SENT_83	[p4l11t1696r283b1764],
27	plus	CC	O	plus	prep	26	SENT_83	[p4l318t1696r449b1764],
28	vindesine	NN	O	vindesine	nn	31	SENT_83	[p4l483t1696r794b1751],
29	(	CD	NUMBER	(	num	31	SENT_83	[p4l829t1696r979b1764],
30	VP	NN	O	vp	nn	31	SENT_83	[p4l829t1696r979b1764],
31	)	NN	O	)	dep	27	SENT_83	[p4l829t1696r979b1764],
32	.	.	O	.	_	0	SENT_83	[p4l829t1696r979b1764],

1	Intravenous	JJ	O	intravenous	amod	3	SENT_84	[p4l1015t1699r1398b1751],
2	cisplatin	NN	O	cisplatin	nn	3	SENT_84	[p4l1434t1696r1706b1764],
3	(	NN	O	(	nsubjpass	8	SENT_84	[p4l1740t1696r1884b1764],
4	100	CD	NUMBER	100	num	6	SENT_84	[p4l1740t1696r1884b1764],
5	mg/m2	NN	O	mg/m2	nn	6	SENT_84	[p4l1901t1687r2150b1764],
6	)	NN	O	)	dep	3	SENT_84	[p4l1901t1687r2150b1764],
7	was	VBD	O	be	auxpass	8	SENT_84	[p4l9t1801r133b1840],
8	given	VBN	O	give	_	0	SENT_84	[p4l157t1786r332b1853],
9	to	TO	O	to	_	0	SENT_84	[p4l356t1793r417b1840],
10	all	PDT	O	all	predet	12	SENT_84	[p4l442t1785r516b1840],
11	the	DT	O	the	det	12	SENT_84	[p4l540t1785r641b1840],
12	patients	NNS	O	patient	prep_to	8	SENT_84	[p4l666t1786r924b1853],
13	on	IN	O	on	_	0	SENT_84	[p4l950t1801r1028b1840],
14	day	NN	DURATION	day	prep_on	12	SENT_84	[p4l1052t1785r1167b1853],
15	1	CD	NUMBER	1	num	14	SENT_84	[p4l1193t1788r1240b1840],
16	.	.	O	.	_	0	SENT_84	[p4l1193t1788r1240b1840],

1	According	VBG	O	accord	_	0	SENT_85	[p4l1263t1785r1590b1853],
2	to	TO	O	to	prepc_according_to	63	SENT_85	[p4l1612t1793r1674b1840],
3	different	JJ	O	different	amod	4	SENT_85	[p4l1699t1785r1978b1840],
4	regiments	NNS	O	regiment	pobj	63	SENT_85	[p4l2002t1786r2150b1853, p4l11t1880r225b1936],
5	,	,	O	,	_	0	SENT_85	[p4l2002t1786r2150b1853, p4l11t1880r225b1936],
6	gemcitabine	NN	O	gemcitabine	nsubjpass	63	SENT_85	[p4l246t1872r643b1941],
7	(	CD	NUMBER	(	num	6	SENT_85	[p4l665t1872r849b1940],
8	1000	CD	DATE	1000	num	10	SENT_85	[p4l665t1872r849b1940],
9	mg/m2	NN	O	mg/m2	nn	10	SENT_85	[p4l866t1863r1115b1941],
10	)	NN	O	)	nsubjpass	12	SENT_85	[p4l866t1863r1115b1941],
11	was	VBD	O	be	auxpass	12	SENT_85	[p4l1135t1888r1260b1927],
12	given	VBN	O	give	rcmod	6	SENT_85	[p4l1281t1873r1456b1941],
13	as	IN	O	as	_	0	SENT_85	[p4l1476t1888r1539b1927],
14	an	DT	O	a	det	15	SENT_85	[p4l1561t1888r1636b1927],
15	infusion	NN	O	infusion	prep_as	12	SENT_85	[p4l1658t1872r1918b1927],
16	on	IN	O	on	_	0	SENT_85	[p4l1939t1888r2018b1927],
17	day	NN	DURATION	day	prep_on	15	SENT_85	[p4l2038t1872r2153b1941],
18	1	CD	NUMBER	1	num	17	SENT_85	[p4l14t1963r39b2015],
19	and	CC	O	and	_	0	SENT_85	[p4l67t1960r183b2015],
20	day	NN	DURATION	day	nsubjpass	29	SENT_85	[p4l204t1960r318b2029],
21	8	CD	NUMBER	8	num	20	SENT_85	[p4l337t1963r389b2024],
22	,	,	O	,	_	0	SENT_85	[p4l337t1963r389b2024],
23	etoposide	NN	O	etoposide	appos	20	SENT_85	[p4l410t1960r723b2029],
24	(	CD	NUMBER	(	number	25	SENT_85	[p4l744t1960r846b2028],
25	80	CD	NUMBER	80	num	27	SENT_85	[p4l744t1960r846b2028],
26	mg/m2	NN	O	mg/m2	nn	27	SENT_85	[p4l863t1951r1112b2029],
27	)	NN	O	)	dep	23	SENT_85	[p4l863t1951r1112b2029],
28	was	VBD	O	be	auxpass	29	SENT_85	[p4l1132t1976r1256b2015],
29	given	VBN	O	give	conj_and	12	SENT_85	[p4l1277t1961r1451b2029],
30	by	IN	O	by	_	0	SENT_85	[p4l1470t1960r1548b2029],
31	intravenous	JJ	O	intravenous	amod	32	SENT_85	[p4l1567t1961r1949b2015],
32	injection	NN	O	injection	agent	29	SENT_85	[p4l1971t1961r2150b2029, p4l10t2049r137b2103],
33	from	IN	O	from	_	0	SENT_85	[p4l167t2048r320b2103],
34	day	NN	DURATION	day	prep_from	29	SENT_85	[p4l350t2048r464b2117],
35	1	CD	NUMBER	1	num	34	SENT_85	[p4l496t2051r520b2103],
36	to	TO	O	to	_	0	SENT_85	[p4l557t2057r619b2103],
37	day	NN	DURATION	day	prep_to	29	SENT_85	[p4l650t2048r764b2117],
38	5	CD	NUMBER	5	num	37	SENT_85	[p4l793t2052r844b2112],
39	,	,	O	,	_	0	SENT_85	[p4l793t2052r844b2112],
40	intravenous	JJ	O	intravenous	amod	42	SENT_85	[p4l875t2049r1257b2103],
41	docetaxel	NN	O	docetaxel	nn	42	SENT_85	[p4l1288t2048r1596b2103],
42	(	NN	O	(	conj_and	6	SENT_85	[p4l1627t2049r1728b2117],
43	75	CD	NUMBER	75	num	45	SENT_85	[p4l1627t2049r1728b2117],
44	mg/m2	NN	O	mg/m2	nn	45	SENT_85	[p4l1747t2039r1997b2117],
45	)	NN	O	)	nsubjpass	47	SENT_85	[p4l1747t2039r1997b2117],
46	was	VBD	O	be	auxpass	47	SENT_85	[p4l2025t2065r2150b2103],
47	given	VBN	O	give	rcmod	42	SENT_85	[p4l9t2138r184b2205],
48	on	IN	O	on	_	0	SENT_85	[p4l216t2153r294b2192],
49	day	NN	DURATION	day	prep_on	47	SENT_85	[p4l326t2137r440b2205],
50	1	CD	NUMBER	1	num	49	SENT_85	[p4l474t2140r498b2191],
51	and	CC	O	and	_	0	SENT_85	[p4l538t2137r655b2192],
52	day	NN	DURATION	day	prep_on	47	SENT_85	[p4l687t2137r802b2205],
53	8	CD	NUMBER	8	num	52	SENT_85	[p4l832t2140r883b2200],
54	,	,	O	,	_	0	SENT_85	[p4l832t2140r883b2200],
55	and	CC	O	and	_	0	SENT_85	[p4l916t2137r1032b2192],
56	intravenous	JJ	O	intravenous	amod	61	SENT_85	[p4l1066t2138r1447b2192],
57	vindesine	NN	O	vindesine	nn	61	SENT_85	[p4l1479t2137r1790b2192],
58	(	NN	O	(	nn	61	SENT_85	[p4l1822t2137r1881b2205],
59	3	CD	NUMBER	3	num	61	SENT_85	[p4l1822t2137r1881b2205],
60	mg/m2	NN	O	mg/m2	nn	61	SENT_85	[p4l1901t2128r2151b2205],
61	)	NN	O	)	nsubjpass	63	SENT_85	[p4l1901t2128r2151b2205],
62	was	VBD	O	be	auxpass	63	SENT_85	[p4l9t2242r133b2281],
63	given	VBN	O	give	_	0	SENT_85	[p4l164t2227r338b2294],
64	on	IN	O	on	_	0	SENT_85	[p4l369t2242r447b2281],
65	day	NN	DURATION	day	prep_on	63	SENT_85	[p4l477t2226r591b2294],
66	1	CD	NUMBER	1	num	65	SENT_85	[p4l624t2229r648b2280],
67	and	CC	O	and	_	0	SENT_85	[p4l686t2226r803b2281],
68	day	NN	DURATION	day	conj_and	65	SENT_85	[p4l834t2226r948b2294],
69	8	CD	NUMBER	8	num	68	SENT_85	[p4l977t2229r1028b2281],
70	.	.	O	.	_	0	SENT_85	[p4l977t2229r1028b2281],

1	After	IN	O	after	_	0	SENT_86	[p4l1057t2226r1220b2281],
2	one	CD	DURATION	one	prep_after	15	SENT_86	[p4l1248t2242r1363b2281],
3	week	NN	NUMBER	week	tmod	15	SENT_86	[p4l1392t2226r1565b2281],
4	(	IN	O	(	_	0	SENT_86	[p4l1594t2226r1721b2294],
5	the	DT	O	the	det	7	SENT_86	[p4l1594t2226r1721b2294],
6	rest	NN	O	rest	nn	7	SENT_86	[p4l1753t2234r1873b2281],
7	period	NN	O	period	prep_(	15	SENT_86	[p4l1902t2226r2150b2294],
8	)	CD	NUMBER	)	dep	7	SENT_86	[p4l1902t2226r2150b2294],
9	,	,	O	,	_	0	SENT_86	[p4l1902t2226r2150b2294],
10	these	DT	O	these	nsubjpass	15	SENT_86	[p4l10t2315r180b2370],
11	above	IN	O	above	_	0	SENT_86	[p4l202t2315r390b2370],
12	treatments	NNS	O	treatment	prep_above	10	SENT_86	[p4l411t2323r765b2370],
13	will	MD	O	will	aux	15	SENT_86	[p4l786t2315r906b2369],
14	be	VB	O	be	auxpass	15	SENT_86	[p4l927t2315r1001b2370],
15	repeated	VBN	O	repeat	_	0	SENT_86	[p4l1023t2315r1321b2383],
16	.	.	O	.	_	0	SENT_86	[p4l1023t2315r1321b2383],

1	For	IN	O	for	_	0	SENT_87	[p4l1344t2318r1446b2370],
2	all	DT	O	all	det	3	SENT_87	[p4l1465t2315r1538b2370],
3	patients	NNS	O	patient	prep_for	8	SENT_87	[p4l1560t2316r1819b2383],
4	recruited	VBN	O	recruit	partmod	3	SENT_87	[p4l1842t2315r2150b2378],
5	,	,	O	,	_	0	SENT_87	[p4l1842t2315r2150b2378],
6	the	DT	O	the	det	7	SENT_87	[p4l10t2403r112b2458],
7	treatment	NN	O	treatment	nsubj	8	SENT_87	[p4l136t2411r460b2458],
8	lasted	VBD	O	last	_	0	SENT_87	[p4l484t2403r672b2458],
9	for	IN	O	for	_	0	SENT_87	[p4l698t2403r787b2458],
10	at	IN	O	at	quantmod	12	SENT_87	[p4l809t2411r869b2458],
11	least	JJS	O	least	mwe	10	SENT_87	[p4l892t2403r1041b2458],
12	two	CD	NUMBER	two	num	13	SENT_87	[p4l1063t2411r1185b2458],
13	cycles	NNS	O	cycle	prep_for	8	SENT_87	[p4l1210t2403r1400b2472],
14	and	CC	O	and	_	0	SENT_87	[p4l1426t2403r1542b2458],
15	at	IN	O	at	quantmod	17	SENT_87	[p4l1566t2411r1626b2458],
16	most	JJS	O	most	mwe	15	SENT_87	[p4l1649t2411r1809b2458],
17	six	CD	NUMBER	six	num	18	SENT_87	[p4l1833t2404r1921b2458],
18	cycles	NNS	O	cycle	prep_for	8	SENT_87	[p4l1943t2403r2150b2472],
19	.	.	O	.	_	0	SENT_87	[p4l1943t2403r2150b2472],

1	At	IN	O	at	_	0	SENT_88	[p4l8t2495r80b2547],
2	the	DT	DURATION	the	det	3	SENT_88	[p4l109t2492r211b2547],
3	end	NN	DURATION	end	prep_at	16	SENT_88	[p4l242t2492r358b2547],
4	of	IN	DURATION	of	_	0	SENT_88	[p4l390t2492r457b2547],
5	second	JJ	DURATION	second	amod	6	SENT_88	[p4l481t2492r702b2547],
6	cycle	NN	O	cycle	prep_of	3	SENT_88	[p4l733t2492r909b2561],
7	,	,	O	,	_	0	SENT_88	[p4l733t2492r909b2561],
8	an	DT	O	a	det	14	SENT_88	[p4l940t2508r1015b2547],
9	approximately	RB	O	approximately	quantmod	10	SENT_88	[p4l1046t2492r1519b2561],
10	5	CD	NUMBER	5	num	11	SENT_88	[p4l1549t2496r1582b2547],
11	ml	NN	O	ml	npadvmod	12	SENT_88	[p4l1601t2492r1681b2547],
12	venous	JJ	O	venous	amod	14	SENT_88	[p4l1711t2508r1939b2547],
13	blood	NN	O	blood	nn	14	SENT_88	[p4l1971t2492r2150b2547],
14	sample	NN	O	sample	nsubjpass	16	SENT_88	[p4l12t2581r240b2650],
15	was	VBD	O	be	auxpass	16	SENT_88	[p4l257t2597r382b2636],
16	collected	VBN	O	collect	_	0	SENT_88	[p4l402t2581r689b2636],
17	from	IN	O	from	_	0	SENT_88	[p4l709t2581r862b2636],
18	each	DT	O	each	det	19	SENT_88	[p4l881t2581r1027b2636],
19	patient	NN	O	patient	prep_from	16	SENT_88	[p4l1046t2582r1275b2650],
20	for	IN	O	for	_	0	SENT_88	[p4l1292t2581r1382b2636],
21	genetic	JJ	O	genetic	amod	22	SENT_88	[p4l1397t2582r1631b2650],
22	studies	NNS	O	study	prep_for	19	SENT_88	[p4l1650t2581r1893b2637],
23	.	.	O	.	_	0	SENT_88	[p4l1650t2581r1893b2637],

1	And	CC	O	and	cc	3	SENT_89	[p4l1910t2581r2038b2636],
2	we	PRP	O	we	nsubj	3	SENT_89	[p4l2056t2597r2150b2636],
3	extracted	VBD	O	extract	_	0	SENT_89	[p4l11t2670r313b2726],
4	genomic	JJ	O	genomic	amod	5	SENT_89	[p4l344t2671r620b2739],
5	DNA	NN	O	dna	dobj	3	SENT_89	[p4l651t2673r797b2725],
6	from	IN	O	from	_	0	SENT_89	[p4l827t2670r979b2726],
7	whole	JJ	O	whole	amod	9	SENT_89	[p4l1009t2671r1207b2726],
8	human	JJ	O	human	amod	9	SENT_89	[p4l1239t2671r1465b2726],
9	blood	NN	O	blood	prep_from	3	SENT_89	[p4l1495t2671r1674b2726],
10	using	VBG	O	use	xcomp	3	SENT_89	[p4l1706t2671r1879b2739],
11	DNeasy	NNP	O	DNeasy	nn	12	SENT_89	[p4l1909t2674r2153b2739],
12	Blood	NNP	O	Blood	dobj	10	SENT_89	[p4l11t2760r191b2815],
13	82	CD	NUMBER	82	num	14	SENT_89	[p4l208t2763r254b2815],
14	Tissue	NN	O	tissue	amod	12	SENT_89	[p4l268t2761r469b2815],
15	Kit	NN	O	kit	nn	18	SENT_89	[p4l487t2761r576b2815],
16	(	CD	NUMBER	(	num	18	SENT_89	[p4l592t2760r874b2828],
17	QIAGEN	NNP	ORGANIZATION	QIAGEN	nn	18	SENT_89	[p4l592t2760r874b2828],
18	Inc.	NNP	ORGANIZATION	Inc.	dep	14	SENT_89	[p4l891t2763r1017b2823],
19	,	,	O	,	_	0	SENT_89	[p4l891t2763r1017b2823],
20	Maryland	NNP	LOCATION	Maryland	appos	18	SENT_89	[p4l1035t2760r1359b2828],
21	,	,	O	,	_	0	SENT_89	[p4l1035t2760r1359b2828],
22	USA	NNP	LOCATION	USA	appos	18	SENT_89	[p4l1376t2760r1532b2828],
23	)	CD	NUMBER	)	num	22	SENT_89	[p4l1376t2760r1532b2828],
24	following	VBG	O	follow	_	0	SENT_89	[p4l1550t2760r1855b2828],
25	the	DT	O	the	det	27	SENT_89	[p4l1870t2760r1972b2815],
26	standard	JJ	O	standard	amod	27	SENT_89	[p4l1990t2768r2150b2815, p4l11t2848r155b2903],
27	protocols	NNS	O	protocol	prep_following	22	SENT_89	[p4l179t2848r493b2917],
28	.	.	O	.	_	0	SENT_89	[p4l179t2848r493b2917],

1	Chemotherapy	NN	O	chemotherapy	nn	2	SENT_90	[p4l113t2937r591b3006],
2	response	NN	O	response	nsubjpass	4	SENT_90	[p4l620t2953r906b3006],
3	was	VBD	O	be	auxpass	4	SENT_90	[p4l935t2953r1060b2992],
4	assessed	VBN	O	assess	_	0	SENT_90	[p4l1092t2937r1382b3000],
5	,	,	O	,	_	0	SENT_90	[p4l1092t2937r1382b3000],
6	according	VBG	O	accord	_	0	SENT_90	[p4l1413t2937r1728b3006],
7	to	TO	O	to	prepc_according_to	4	SENT_90	[p4l1757t2945r1818b2992],
8	Response	NN	O	response	nn	10	SENT_90	[p4l1850t2940r2150b3006],
9	Evaluation	NN	O	evaluation	nn	10	SENT_90	[p4l11t3026r352b3081],
10	Criteria	NNS	O	criterion	pobj	4	SENT_90	[p4l417t3027r655b3081],
11	in	IN	O	in	_	0	SENT_90	[p4l721t3027r780b3081],
12	Solid	JJ	O	solid	amod	16	SENT_90	[p4l845t3026r1001b3081],
13	Tumor	NN	O	tumor	nn	16	SENT_90	[p4l1064t3030r1281b3081],
14	Group	NNP	O	Group	nn	16	SENT_90	[p4l1344t3029r1542b3095],
15	(	CD	NUMBER	(	num	16	SENT_90	[p4l1608t3026r1880b3094],
16	RECIST	NNP	O	RECIST	prep_in	10	SENT_90	[p4l1608t3026r1880b3094],
17	)	CD	NUMBER	)	num	18	SENT_90	[p4l1608t3026r1880b3094],
18	guidelines	NNS	O	guideline	dep	16	SENT_90	[p4l1944t3026r2150b3095, p4l11t3115r175b3179],
19	,	,	O	,	_	0	SENT_90	[p4l1944t3026r2150b3095, p4l11t3115r175b3179],
20	including	VBG	O	include	_	0	SENT_90	[p4l238t3115r540b3184],
21	complete	JJ	O	complete	amod	22	SENT_90	[p4l601t3115r899b3184],
22	response	NN	O	response	prep_including	4	SENT_90	[p4l962t3131r1264b3184],
23	,	,	O	,	_	0	SENT_90	[p4l962t3131r1264b3184],
24	partial	JJ	O	partial	amod	25	SENT_90	[p4l1327t3115r1535b3184],
25	response	NN	O	response	conj_and	22	SENT_90	[p4l1597t3131r1899b3184],
26	,	,	O	,	_	0	SENT_90	[p4l1597t3131r1899b3184],
27	stable	JJ	O	stable	amod	28	SENT_90	[p4l1963t3115r2150b3170],
28	disease	NN	O	disease	conj_and	22	SENT_90	[p4l11t3205r243b3260],
29	and	CC	O	and	_	0	SENT_90	[p4l299t3205r415b3260],
30	progressive	JJ	O	progressive	amod	32	SENT_90	[p4l471t3205r841b3273],
31	disease	NN	O	disease	nn	32	SENT_90	[p4l898t3204r1130b3260],
32	[	NN	O	[	conj_and	22	SENT_90	[p4l1189t3204r1329b3273],
33	17	CD	NUMBER	17	num	34	SENT_90	[p4l1189t3204r1329b3273],
34	]	NN	O	]	dep	32	SENT_90	[p4l1189t3204r1329b3273],
35	.	.	O	.	_	0	SENT_90	[p4l1189t3204r1329b3273],

1	Toxicity	NN	O	toxicity	nsubjpass	3	SENT_91	[p4l1383t3205r1643b3273],
2	was	VBD	O	be	auxpass	3	SENT_91	[p4l1695t3220r1820b3260],
3	assessed	VBN	O	assess	_	0	SENT_91	[p4l1877t3205r2150b3260],
4	according	VBG	O	accord	_	0	SENT_91	[p4l11t3294r325b3362],
5	to	TO	O	to	prepc_according_to	3	SENT_91	[p4l369t3302r431b3349],
6	standard	JJ	O	standard	amod	10	SENT_91	[p4l479t3294r759b3349],
7	National	NNP	O	National	nn	10	SENT_91	[p4l807t3294r1078b3349],
8	Cancer	NNP	O	Cancer	nn	10	SENT_91	[p4l1125t3297r1344b3349],
9	Institution	NNP	O	Institution	nn	10	SENT_91	[p4l1389t3295r1727b3349],
10	Criteria	NNP	O	Criteria	pobj	3	SENT_91	[p4l1773t3295r2012b3349],
11	3.0	CD	NUMBER	3.0	num	10	SENT_91	[p4l2057t3297r2151b3349],
12	(	CD	NUMBER	(	num	14	SENT_91	[p4l11t3382r789b3451],
13	http://ctep.cancer.gov	NN	O	http://ctep.cancer.gov	nn	14	SENT_91	[p4l11t3382r789b3451],
14	)	NN	O	)	dep	10	SENT_91	[p4l11t3382r789b3451],
15	.	.	O	.	_	0	SENT_91	[p4l11t3382r789b3451],

1	Severe	JJ	O	severe	amod	2	SENT_92	[p4l819t3385r1030b3437],
2	toxicity	NN	O	toxicity	nsubj	3	SENT_92	[p4l1059t3383r1303b3451],
3	consisted	VBD	O	consist	_	0	SENT_92	[p4l1331t3382r1632b3437],
4	of	IN	O	of	_	0	SENT_92	[p4l1662t3382r1728b3437],
5	grade	NN	O	grade	prep_of	3	SENT_92	[p4l1748t3382r1927b3451],
6	3	CD	NUMBER	3	num	5	SENT_92	[p4l1955t3385r1989b3437],
7	or	CC	O	or	_	0	SENT_92	[p4l2022t3398r2088b3437],
8	4	CD	NUMBER	4	num	10	SENT_92	[p4l2113t3385r2151b3436],
9	hematologic	JJ	O	hematologic	amod	10	SENT_92	[p4l11t3471r410b3540],
10	toxicity	NN	O	toxicity	prep_of	3	SENT_92	[p4l443t3472r701b3540],
11	,	,	O	,	_	0	SENT_92	[p4l443t3472r701b3540],
12	grade	NN	O	grade	conj_or	5	SENT_92	[p4l734t3471r914b3540],
13	3	CD	NUMBER	3	dep	12	SENT_92	[p4l946t3474r980b3526],
14	or	CC	O	or	_	0	SENT_92	[p4l1018t3487r1084b3526],
15	4	CD	NUMBER	4	dep	12	SENT_92	[p4l1114t3474r1152b3526],
16	of	IN	O	of	_	0	SENT_92	[p4l1186t3471r1252b3526],
17	emesis	NN	O	emesis	prep_of	13	SENT_92	[p4l1278t3472r1513b3535],
18	,	,	O	,	_	0	SENT_92	[p4l1278t3472r1513b3535],
19	grade	NN	O	grade	conj_or	5	SENT_92	[p4l1547t3471r1726b3540],
20	1-4	CD	NUMBER	1-4	num	19	SENT_92	[p4l1764t3474r1879b3526],
21	of	IN	O	of	_	0	SENT_92	[p4l1912t3471r1978b3526],
22	neuropathy	NN	O	neuropathy	prep_of	19	SENT_92	[p4l2005t3487r2150b3526, p4l11t3560r277b3629],
23	,	,	O	,	_	0	SENT_92	[p4l2005t3487r2150b3526, p4l11t3560r277b3629],
24	grade	NN	O	grade	conj_or	5	SENT_92	[p4l307t3560r486b3629],
25	1-4	CD	NUMBER	1-4	num	24	SENT_92	[p4l519t3563r634b3615],
26	of	IN	O	of	_	0	SENT_92	[p4l663t3560r730b3615],
27	neuropathy	NN	O	neuropathy	prep_of	24	SENT_92	[p4l752t3560r1140b3629],
28	,	,	O	,	_	0	SENT_92	[p4l752t3560r1140b3629],
29	and	CC	O	and	_	0	SENT_92	[p4l1171t3560r1287b3615],
30	grade	NN	O	grade	prep_of	3	SENT_92	[p4l1316t3560r1495b3629],
31	2-3	CD	NUMBER	2-3	num	30	SENT_92	[p4l1525t3563r1640b3615],
32	of	IN	O	of	_	0	SENT_92	[p4l1673t3560r1739b3615],
33	neuropathy	NN	O	neuropathy	prep_of	30	SENT_92	[p4l1761t3560r2150b3629],
34	.	.	O	.	_	0	SENT_92	[p4l1761t3560r2150b3629],

1	During	IN	O	during	_	0	SENT_93	[p4l11t3650r232b3718],
2	the	DT	O	the	det	3	SENT_93	[p4l257t3649r359b3704],
3	treatment	NN	O	treatment	prep_during	7	SENT_93	[p4l386t3657r725b3713],
4	,	,	O	,	_	0	SENT_93	[p4l386t3657r725b3713],
5	all	DT	O	all	det	6	SENT_93	[p4l753t3649r827b3704],
6	patients	NNS	O	patient	nsubj	7	SENT_93	[p4l855t3650r1113b3718],
7	accepted	VBD	O	accept	_	0	SENT_93	[p4l1142t3649r1426b3718],
8	regulate	VBP	O	regulate	ccomp	7	SENT_93	[p4l1455t3649r1717b3718],
9	tests	NNS	O	test	nsubj	11	SENT_93	[p4l1745t3657r1892b3704],
10	to	TO	O	to	aux	11	SENT_93	[p4l1920t3658r1982b3704],
11	conﬁrm	VB	O	conﬁrm	xcomp	8	SENT_93	[p4l2010t3665r2150b3704, p4l11t3738r145b3793],
12	good	JJ	O	good	amod	14	SENT_93	[p4l160t3739r316b3807],
13	chemotherapy	NN	O	chemotherapy	nn	14	SENT_93	[p4l334t3739r804b3807],
14	tolerances	NNS	O	tolerance	dobj	11	SENT_93	[p4l818t3739r1148b3794],
15	concerning	VBG	O	concern	partmod	14	SENT_93	[p4l1167t3739r1526b3807],
16	regulate	VBP	O	regulate	dep	15	SENT_93	[p4l1541t3739r1804b3807],
17	blood	NN	O	blood	nn	18	SENT_93	[p4l1821t3739r2000b3794],
18	test	NN	O	test	dobj	16	SENT_93	[p4l2017t3747r2150b3802],
19	,	,	O	,	_	0	SENT_93	[p4l2017t3747r2150b3802],

1	liver	NN	O	liver	nn	3	SENT_94	[p5l11t17r155b72],
2	function	NN	O	function	nn	3	SENT_94	[p5l173t17r441b72],
3	test	NN	O	test	_	0	SENT_94	[p5l459t25r592b80],
4	,	,	O	,	_	0	SENT_94	[p5l459t25r592b80],
5	kidney	NN	O	kidney	nn	7	SENT_94	[p5l613t17r831b85],
6	function	NN	O	function	nn	7	SENT_94	[p5l849t17r1117b72],
7	test	NN	O	test	conj_and	3	SENT_94	[p5l1136t25r1268b80],
8	,	,	O	,	_	0	SENT_94	[p5l1136t25r1268b80],
9	chest	NN	O	chest	nn	10	SENT_94	[p5l1289t17r1457b72],
10	X	NN	O	x	conj_and	3	SENT_94	[p5l1473t20r1666b85],
11	—	CD	NUMBER	—	num	12	SENT_94	[p5l1473t20r1666b85],
12	ray	NN	O	ray	dep	10	SENT_94	[p5l1473t20r1666b85],
13	,	,	O	,	_	0	SENT_94	[p5l1473t20r1666b85],
14	ECG	NN	O	ecg	conj_and	3	SENT_94	[p5l1688t20r1814b72],
15	and	CC	O	and	_	0	SENT_94	[p5l1834t17r1950b72],
16	so	RB	O	so	advmod	3	SENT_94	[p5l1971t33r2036b72],
17	on	IN	O	on	dep	3	SENT_94	[p5l2057t33r2150b72],
18	.	.	O	.	_	0	SENT_94	[p5l2057t33r2150b72],

1	The	DT	O	the	det	2	SENT_95	[p5l8t105r125b160],
2	chemotherapy	NN	O	chemotherapy	nsubjpass	7	SENT_95	[p5l149t105r619b174],
3	would	MD	O	would	aux	5	SENT_95	[p5l639t105r842b160],
4	be	VB	O	be	auxpass	5	SENT_95	[p5l866t105r939b160],
5	discontinued	VBN	O	discontinue	_	0	SENT_95	[p5l964t105r1398b168],
6	,	,	O	,	_	0	SENT_95	[p5l964t105r1398b168],
7	postponed	VBN	O	postpone	conj_or	5	SENT_95	[p5l1423t105r1779b174],
8	,	,	O	,	_	0	SENT_95	[p5l1423t105r1779b174],
9	or	CC	O	or	_	0	SENT_95	[p5l1804t121r1870b160],
10	reduced	VBN	O	reduce	conj_or	5	SENT_95	[p5l1893t105r2150b160],
11	in	IN	O	in	_	0	SENT_95	[p5l11t195r70b249],
12	case	NN	O	case	_	0	SENT_95	[p5l93t210r226b249],
13	of	IN	O	of	_	0	SENT_95	[p5l249t194r316b249],
14	disease	NN	O	disease	nn	15	SENT_95	[p5l331t194r563b249],
15	progression	NN	O	progression	nn	18	SENT_95	[p5l586t195r964b263],
16	or	CC	O	or	_	0	SENT_95	[p5l986t210r1052b249],
17	unacceptable	JJ	O	unacceptable	conj_or	15	SENT_95	[p5l1073t194r1499b263],
18	toxicity	NN	O	toxicity	prep_in_case_of	10	SENT_95	[p5l1521t195r1780b263],
19	.	.	O	.	_	0	SENT_95	[p5l1521t195r1780b263],

1	2.3	CD	NUMBER	2.3	_	0	SENT_96	[p5l7t375r113b427],
2	.	.	O	.	_	0	SENT_96	[p5l7t375r113b427],

1	SNP	NN	O	snp	nn	2	SENT_97	[p5l161t375r286b427],
2	selection	NN	O	selection	_	0	SENT_97	[p5l301t373r569b427],
3	and	CC	O	and	_	0	SENT_97	[p5l593t373r707b427],
4	detection	NN	O	detection	conj_and	2	SENT_97	[p5l728t373r1010b427],

1	In	IN	O	in	_	0	SENT_98	[p5l113t553r173b604],
2	total	NN	O	total	prep_in	9	SENT_98	[p5l188t550r349b613],
3	,	,	O	,	_	0	SENT_98	[p5l188t550r349b613],
4	20	CD	NUMBER	20	num	5	SENT_98	[p5l366t553r442b605],
5	SNPs	NNS	O	snp	nsubjpass	11	SENT_98	[p5l459t553r613b605],
6	of	IN	O	of	_	0	SENT_98	[p5l630t550r697b605],
7	CTR1	NN	O	ctr1	prep_of	5	SENT_98	[p5l705t553r850b605],
8	were	VBD	O	be	auxpass	9	SENT_98	[p5l872t566r1032b605],
9	selected	VBN	O	select	_	0	SENT_98	[p5l1049t550r1309b605],
10	and	CC	O	and	_	0	SENT_98	[p5l1325t550r1441b605],
11	detected	VBN	O	detect	conj_and	9	SENT_98	[p5l1458t550r1735b605],
12	in	IN	O	in	_	0	SENT_98	[p5l1751t551r1810b604],
13	this	DT	O	this	det	14	SENT_98	[p5l1825t550r1941b605],
14	study	NN	O	study	prep_in	9	SENT_98	[p5l1959t550r2150b618],
15	.	.	O	.	_	0	SENT_98	[p5l1959t550r2150b618],

1	All	PDT	O	all	predet	4	SENT_99	[p5l8t638r94b692],
2	these	DT	O	these	det	4	SENT_99	[p5l122t638r292b693],
3	20	CD	NUMBER	20	num	4	SENT_99	[p5l320t641r397b693],
4	SNPs	NNS	O	snp	nsubj	20	SENT_99	[p5l425t641r579b693],
5	satisﬁed	VBD	O	satisﬁed	rcmod	4	SENT_99	[p5l609t638r873b693],
6	the	DT	O	the	det	8	SENT_99	[p5l901t638r1003b693],
7	following	VBG	O	follow	amod	8	SENT_99	[p5l1031t638r1336b707],
8	criteria	NNS	O	criterion	dobj	5	SENT_99	[p5l1363t639r1612b694],
9	:	:	O	:	_	0	SENT_99	[p5l1363t639r1612b694],
10	(	CD	NUMBER	(	number	11	SENT_99	[p5l1644t638r1732b706],
11	1	CD	NUMBER	1	num	12	SENT_99	[p5l1644t638r1732b706],
12	)	NN	O	)	dep	8	SENT_99	[p5l1644t638r1732b706],
13	minor	JJ	O	minor	amod	18	SENT_99	[p5l1761t639r1956b693],
14	allele	NN	O	allele	nn	18	SENT_99	[p5l1981t638r2150b693],
15	frequency	NN	O	frequency	nn	18	SENT_99	[p5l11t727r334b796],
16	(	CD	NUMBER	(	num	18	SENT_99	[p5l363t727r558b795],
17	MAF	NN	O	maf	nn	18	SENT_99	[p5l363t727r558b795],
18	)	NN	O	)	dep	12	SENT_99	[p5l363t727r558b795],
19	was	VBD	O	be	cop	20	SENT_99	[p5l587t743r712b782],
20	larger	JJR	O	larger	_	0	SENT_99	[p5l744t727r932b796],
21	than	IN	O	than	_	0	SENT_99	[p5l960t727r1104b782],
22	10	CD	PERCENT	10	num	23	SENT_99	[p5l1138t730r1256b782],
23	%	NN	PERCENT	%	prep_than	20	SENT_99	[p5l1138t730r1256b782],
24	in	IN	O	in	_	0	SENT_99	[p5l1286t728r1346b782],
25	Chinese	JJ	MISC	chinese	amod	26	SENT_99	[p5l1376t727r1626b782],
26	population	NN	O	population	prep_in	23	SENT_99	[p5l1657t727r2027b796],
27	;	:	O	;	_	0	SENT_99	[p5l1657t727r2027b796],
28	(	NN	O	(	nn	30	SENT_99	[p5l2063t727r2150b796],
29	2	CD	NUMBER	2	num	30	SENT_99	[p5l2063t727r2150b796],
30	)	NN	O	)	dep	23	SENT_99	[p5l2063t727r2150b796],
31	they	PRP	O	they	nsubj	35	SENT_99	[p5l10t816r153b885],
32	were	VBD	O	be	cop	35	SENT_99	[p5l166t832r327b871],
33	haplotype	NN	O	haplotype	nn	35	SENT_99	[p5l344t816r666b885],
34	tagger	NN	O	tagger	nn	35	SENT_99	[p5l683t825r887b885],
35	SNPs	NNS	O	snp	rcmod	30	SENT_99	[p5l902t819r1056b871],
36	along	IN	O	along	_	0	SENT_99	[p5l1074t816r1250b885],
37	CTR1	NN	O	ctr1	nn	39	SENT_99	[p5l1266t819r1411b871],
38	gene	NN	O	gene	nn	39	SENT_99	[p5l1434t832r1585b885],
39	region	NN	O	region	prep_along	35	SENT_99	[p5l1603t817r1827b885],
40	;	:	O	;	_	0	SENT_99	[p5l1603t817r1827b885],
41	(	CD	NUMBER	(	number	42	SENT_99	[p5l1849t817r1936b885],
42	3	CD	NUMBER	3	num	43	SENT_99	[p5l1849t817r1936b885],
43	)	NN	O	)	dep	49	SENT_99	[p5l1849t817r1936b885],
44	if	IN	O	if	dep	49	SENT_99	[p5l1954t816r2002b871],
45	they	PRP	O	they	nsubj	49	SENT_99	[p5l2010t816r2153b885],
46	were	VBD	O	be	cop	49	SENT_99	[p5l9t921r170b961],
47	not	RB	O	not	neg	49	SENT_99	[p5l194t914r299b961],
48	tagger	NN	O	tagger	nn	49	SENT_99	[p5l320t914r524b974],
49	SNPs	NNS	O	snp	advcl	53	SENT_99	[p5l545t908r716b969],
50	,	,	O	,	_	0	SENT_99	[p5l545t908r716b969],
51	they	PRP	O	they	nsubj	53	SENT_99	[p5l740t906r882b974],
52	were	VBD	O	be	cop	53	SENT_99	[p5l902t921r1062b961],
53	SNPs	NNS	O	snp	parataxis	35	SENT_99	[p5l1086t908r1241b961],
54	located	VBN	O	locate	partmod	53	SENT_99	[p5l1265t906r1497b961],
55	in	IN	O	in	_	0	SENT_99	[p5l1521t906r1580b960],
56	promoter	NN	O	promoter	nn	57	SENT_99	[p5l1603t914r1910b974],
57	region	NN	O	region	prep_in	54	SENT_99	[p5l1931t906r2150b974],
58	,	,	O	,	_	0	SENT_99	[p5l1931t906r2150b974],
59	3	CD	NUMBER	3	num	61	SENT_99	[p5l10t997r214b1058],
60	’	NN	O	’	nn	61	SENT_99	[p5l10t997r214b1058],
61	UTR	NN	O	utr	conj_or	57	SENT_99	[p5l10t997r214b1058],
62	,	,	O	,	_	0	SENT_99	[p5l10t997r214b1058],
63	or	CC	O	or	_	0	SENT_99	[p5l233t1011r299b1050],
64	exon	NN	O	exon	nn	65	SENT_99	[p5l314t1011r469b1050],
65	region	NN	O	region	conj_or	57	SENT_99	[p5l487t996r705b1063],
66	,	,	O	,	_	0	SENT_99	[p5l487t996r705b1063],
67	either	CC	O	either	preconj	23	SENT_99	[p5l724t995r915b1050],
68	missense	NN	O	missense	nn	69	SENT_99	[p5l931t996r1224b1050],
69	mutation	NN	O	mutation	conj	23	SENT_99	[p5l1242t996r1538b1050],
70	or	CC	O	or	_	0	SENT_99	[p5l1556t1011r1622b1050],
71	nonsense	NN	O	nonsense	nn	72	SENT_99	[p5l1638t1011r1938b1050],
72	mutation	NN	O	mutation	conj	23	SENT_99	[p5l1956t1003r2150b1050, p5l10t1084r152b1139],
73	.	.	O	.	_	0	SENT_99	[p5l1956t1003r2150b1050, p5l10t1084r152b1139],

1	Haplotype	NN	O	haplotype	nn	3	SENT_100	[p5l170t1083r502b1152],
2	tagger	NN	O	tagger	nn	3	SENT_100	[p5l518t1091r722b1152],
3	SNPs	NNS	O	snp	nsubjpass	5	SENT_100	[p5l737t1086r891b1138],
4	were	VBD	O	be	auxpass	5	SENT_100	[p5l907t1099r1067b1138],
5	selected	VBN	O	select	dep	9	SENT_100	[p5l1086t1083r1346b1138],
6	using	VBG	O	use	xcomp	5	SENT_100	[p5l1363t1084r1536b1152],
7	pair	NN	O	pair	nn	8	SENT_100	[p5l1551t1083r1896b1152],
8	—	NN	O	—	dobj	6	SENT_100	[p5l1551t1083r1896b1152],
9	wised	VBD	O	wise	_	0	SENT_100	[p5l1551t1083r1896b1152],
10	tagging	VBG	O	tag	ccomp	9	SENT_100	[p5l1913t1084r2152b1152],
11	with	IN	O	with	_	0	SENT_100	[p5l9t1171r157b1226],
12	default	NN	O	default	nn	13	SENT_100	[p5l180t1171r406b1226],
13	setting	NN	O	setting	prep_with	10	SENT_100	[p5l429t1172r649b1240],
14	(	CD	NUMBER	(	num	16	SENT_100	[p5l670t1171r1000b1240],
15	pair	NN	O	pair	nn	16	SENT_100	[p5l670t1171r1000b1240],
16	—	NN	O	—	dep	10	SENT_100	[p5l670t1171r1000b1240],
17	wise	JJ	O	wise	amod	19	SENT_100	[p5l670t1171r1000b1240],
18	r2	NN	O	r2	nn	19	SENT_100	[p5l1024t1162r1077b1225],
19	threshold	NN	O	threshold	dep	16	SENT_100	[p5l1105t1171r1413b1226],
20	0.8	CD	NUMBER	0.8	num	21	SENT_100	[p5l1437t1171r1572b1239],
21	)	NN	O	)	nsubj	9	SENT_100	[p5l1437t1171r1572b1239],
22	.	.	O	.	_	0	SENT_100	[p5l1437t1171r1572b1239],

1	It	PRP	O	it	nsubjpass	3	SENT_101	[p5l1596t1174r1641b1226],
2	was	VBD	O	be	auxpass	3	SENT_101	[p5l1661t1187r1786b1226],
3	performed	VBN	O	perform	_	0	SENT_101	[p5l1810t1171r2150b1240],
4	by	IN	O	by	_	0	SENT_101	[p5l10t1260r87b1329],
5	Haploview	NNP	O	Haploview	agent	3	SENT_101	[p5l108t1260r455b1329],
6	4.2	CD	NUMBER	4.2	number	7	SENT_101	[p5l474t1263r567b1316],
7	(	CD	NUMBER	(	dep	5	SENT_101	[p5l592t1260r982b1329],
8	Cambridge	NNP	LOCATION	Cambridge	nn	12	SENT_101	[p5l592t1260r982b1329],
9	,	,	O	,	_	0	SENT_101	[p5l592t1260r982b1329],
10	MA	NNP	O	MA	appos	12	SENT_101	[p5l1006t1262r1129b1324],
11	,	,	O	,	_	0	SENT_101	[p5l1006t1262r1129b1324],
12	USA	NNP	LOCATION	USA	dep	7	SENT_101	[p5l1152t1260r1324b1328],
13	)	CD	NUMBER	)	num	12	SENT_101	[p5l1152t1260r1324b1328],
14	.	.	O	.	_	0	SENT_101	[p5l1152t1260r1324b1328],

1	In	IN	O	in	_	0	SENT_102	[p5l113t1353r173b1404],
2	our	PRP$	O	we	poss	3	SENT_102	[p5l189t1365r298b1404],
3	study	NN	O	study	prep_in	6	SENT_102	[p5l313t1349r503b1418],
4	,	,	O	,	_	0	SENT_102	[p5l313t1349r503b1418],
5	we	PRP	O	we	nsubj	6	SENT_102	[p5l519t1365r613b1404],
6	used	VBD	O	use	_	0	SENT_102	[p5l630t1349r778b1404],
7	restriction	NN	O	restriction	nn	10	SENT_102	[p5l795t1350r1129b1404],
8	fragment	NN	O	fragment	nn	10	SENT_102	[p5l1145t1349r1441b1418],
9	length	NN	O	length	nn	10	SENT_102	[p5l1456t1349r1660b1418],
10	polymorphism	NN	O	polymorphism	dobj	6	SENT_102	[p5l1676t1349r2151b1418],
11	based	VBN	O	base	partmod	10	SENT_102	[p5l10t1439r194b1494],
12	sequencing	NN	O	sequencing	dobj	11	SENT_102	[p5l225t1439r589b1507],
13	to	TO	O	to	aux	14	SENT_102	[p5l616t1447r678b1494],
14	do	VB	O	do	xcomp	11	SENT_102	[p5l708t1439r784b1494],
15	SNP	NN	O	snp	nn	16	SENT_102	[p5l814t1441r940b1494],
16	detection	NN	O	detection	dobj	14	SENT_102	[p5l968t1439r1285b1494],
17	.	.	O	.	_	0	SENT_102	[p5l968t1439r1285b1494],

1	And	CC	O	and	cc	4	SENT_103	[p5l1313t1439r1442b1494],
2	sequencing	NN	O	sequencing	nsubjpass	4	SENT_103	[p5l1473t1439r1837b1507],
3	was	VBD	O	be	auxpass	4	SENT_103	[p5l1863t1454r1988b1494],
4	performed	VBN	O	perform	_	0	SENT_103	[p5l2019t1454r2150b1507, p5l11t1528r243b1583],
5	by	IN	O	by	_	0	SENT_103	[p5l265t1528r342b1596],
6	Applied	NNP	O	Applied	nn	11	SENT_103	[p5l360t1528r610b1596],
7	Biosystems	NNP	O	Biosystems	nn	11	SENT_103	[p5l634t1529r994b1596],
8	ABI	NNP	O	ABI	nn	11	SENT_103	[p5l1015t1530r1123b1582],
9	3730	CD	NUMBER	3730	num	11	SENT_103	[p5l1145t1531r1305b1583],
10	genetic	JJ	O	genetic	amod	11	SENT_103	[p5l1326t1529r1560b1596],
11	analyzer	NN	O	analyzer	agent	4	SENT_103	[p5l1582t1528r1857b1596],
12	(	CD	NUMBER	(	num	11	SENT_103	[p5l1877t1528r2150b1596],
13	Applied	NNP	O	Applied	nn	14	SENT_103	[p5l1877t1528r2150b1596],
14	Biosystems	NNP	O	Biosystems	dep	11	SENT_103	[p5l11t1617r388b1685],
15	,	,	O	,	_	0	SENT_103	[p5l11t1617r388b1685],
16	Foster	NNP	LOCATION	Foster	nn	17	SENT_103	[p5l412t1619r609b1671],
17	City	NNP	LOCATION	City	appos	11	SENT_103	[p5l629t1617r769b1685],
18	,	,	O	,	_	0	SENT_103	[p5l629t1617r769b1685],
19	USA	NNP	LOCATION	USA	appos	17	SENT_103	[p5l791t1616r963b1684],
20	)	CD	NUMBER	)	num	19	SENT_103	[p5l791t1616r963b1684],
21	.	.	O	.	_	0	SENT_103	[p5l791t1616r963b1684],

1	2.4	CD	NUMBER	2.4	_	0	SENT_104	[p5l7t1797r113b1850],
2	.	.	O	.	_	0	SENT_104	[p5l7t1797r113b1850],

1	Statistical	JJ	O	statistical	amod	2	SENT_105	[p5l161t1794r466b1849],
2	analysis	NN	O	analysis	_	0	SENT_105	[p5l487t1794r733b1863],

1	All	DT	O	all	det	2	SENT_106	[p5l110t1973r196b2027],
2	SNPs	NNS	MISC	snp	nsubjpass	5	SENT_106	[p5l227t1975r381b2028],
3	have	VBP	O	have	aux	5	SENT_106	[p5l412t1973r561b2028],
4	been	VBN	O	be	auxpass	5	SENT_106	[p5l591t1973r745b2028],
5	tested	VBN	O	test	_	0	SENT_106	[p5l774t1973r970b2028],
6	and	CC	O	and	_	0	SENT_106	[p5l1000t1973r1116b2028],
7	obey	VB	O	obey	conj_and	5	SENT_106	[p5l1147t1973r1300b2041],
8	Hardy-Weinberg	JJ	O	hardy-weinberg	amod	9	SENT_106	[p5l1329t1973r1873b2041],
9	equilibrium	NN	O	equilibrium	dobj	7	SENT_106	[p5l1901t1973r2150b2041, p5l11t2063r179b2117],
10	.	.	O	.	_	0	SENT_106	[p5l1901t1973r2150b2041, p5l11t2063r179b2117],

1	For	IN	O	for	_	0	SENT_107	[p5l202t2065r304b2117],
2	allele	NN	O	allele	nn	3	SENT_107	[p5l323t2062r492b2117],
3	analysis	NN	O	analysis	prep_for	8	SENT_107	[p5l513t2062r784b2130],
4	,	,	O	,	_	0	SENT_107	[p5l513t2062r784b2130],
5	Bonferroni	NNP	PERSON	Bonferroni	nn	6	SENT_107	[p5l807t2062r1149b2117],
6	Correction	NNP	PERSON	Correction	nsubjpass	8	SENT_107	[p5l1171t2063r1508b2117],
7	was	VBD	O	be	auxpass	8	SENT_107	[p5l1528t2078r1652b2117],
8	used	VBN	O	use	_	0	SENT_107	[p5l1675t2062r1822b2117],
9	to	TO	O	to	aux	10	SENT_107	[p5l1843t2070r1905b2117],
10	correct	VB	O	correct	xcomp	8	SENT_107	[p5l1927t2070r2152b2117],
11	unadjusted	JJ	O	unadjusted	amod	13	SENT_107	[p5l11t2150r370b2219],
12	p	NN	O	p	nn	13	SENT_107	[p5l394t2166r432b2219],
13	value	NN	O	value	dobj	10	SENT_107	[p5l459t2150r631b2205],
14	and	CC	O	and	_	0	SENT_107	[p5l659t2150r775b2205],
15	max	NN	O	max	nn	17	SENT_107	[p5l804t2166r941b2205],
16	(	CD	NUMBER	(	num	17	SENT_107	[p5l967t2150r1054b2218],
17	T	NN	O	t	dobj	10	SENT_107	[p5l967t2150r1054b2218],
18	)	CD	NUMBER	)	num	20	SENT_107	[p5l967t2150r1054b2218],
19	permutation	NN	O	permutation	nn	20	SENT_107	[p5l1082t2151r1487b2219],
20	test	NN	O	test	nsubjpass	22	SENT_107	[p5l1514t2158r1632b2205],
21	was	VBD	O	be	auxpass	22	SENT_107	[p5l1657t2166r1782b2205],
22	performed	VBN	O	perform	dep	10	SENT_107	[p5l1810t2150r2150b2219],
23	to	TO	O	to	aux	24	SENT_107	[p5l10t2247r72b2294],
24	get	VB	O	get	xcomp	22	SENT_107	[p5l90t2247r190b2308],
25	empirical	JJ	O	empirical	amod	28	SENT_107	[p5l208t2239r510b2308],
26	p	NN	O	p	nn	28	SENT_107	[p5l526t2239r785b2308],
27	—	NN	O	—	nn	28	SENT_107	[p5l526t2239r785b2308],
28	value	NN	O	value	dobj	24	SENT_107	[p5l526t2239r785b2308],
29	.	.	O	.	_	0	SENT_107	[p5l526t2239r785b2308],

1	For	IN	O	for	dep	6	SENT_108	[p5l806t2243r908b2294],
2	genotype	NN	O	genotype	nn	3	SENT_108	[p5l924t2247r1223b2308],
3	analysis	NN	O	analysis	pobj	1	SENT_108	[p5l1242t2239r1513b2308],
4	,	,	O	,	_	0	SENT_108	[p5l1242t2239r1513b2308],
5	genotypic	JJ	O	genotypic	amod	6	SENT_108	[p5l1532t2240r1850b2308],
6	test	NN	O	test	_	0	SENT_108	[p5l1868t2247r1987b2294],
7	with	IN	O	with	_	0	SENT_108	[p5l2003t2239r2151b2294],
8	2df	NN	O	2df	prep_with	6	SENT_108	[p5l11t2328r120b2383],
9	and	CC	O	and	_	0	SENT_108	[p5l134t2328r250b2383],
10	Cochran	NNP	PERSON	Cochran	conj_and	8	SENT_108	[p5l272t2328r876b2397],
11	.	.	O	.	_	0	SENT_108	[p5l272t2328r876b2397],

1	—	NN	O	—	_	0	SENT_109	[p5l272t2328r876b2397],
2	.	.	O	.	_	0	SENT_109	[p5l272t2328r876b2397],

1	Armitage	NN	PERSON	armitage	nn	3	SENT_110	[p5l272t2328r876b2397],
2	trend	NN	O	trend	nn	3	SENT_110	[p5l897t2328r1070b2383],
3	test	NN	O	test	nsubjpass	5	SENT_110	[p5l1092t2336r1210b2383],
4	was	VBD	O	be	auxpass	5	SENT_110	[p5l1229t2344r1353b2383],
5	used	VBN	O	use	_	0	SENT_110	[p5l1376t2328r1523b2383],
6	to	TO	O	to	aux	7	SENT_110	[p5l1545t2336r1607b2383],
7	provide	VB	O	provide	xcomp	5	SENT_110	[p5l1629t2328r1873b2397],
8	association	NN	O	association	dobj	7	SENT_110	[p5l1895t2329r2150b2383, p5l10t2418r137b2472],
9	between	IN	O	between	_	0	SENT_110	[p5l152t2417r431b2472],
10	CTR1	NN	O	ctr1	nn	11	SENT_110	[p5l447t2420r592b2472],
11	polymorphisms	NNS	O	polymorphism	prep_between	8	SENT_110	[p5l616t2417r1122b2486],
12	and	CC	O	and	_	0	SENT_110	[p5l1139t2417r1255b2472],
13	cisplatin	NN	O	cisplatin	nsubj	14	SENT_110	[p5l1272t2417r1544b2486],
14	induced	VBD	O	induce	conj_and	5	SENT_110	[p5l1561t2417r1816b2472],
15	toxicity	NN	O	toxicity	dobj	14	SENT_110	[p5l1833t2418r2077b2486],
16	in	IN	O	in	_	0	SENT_110	[p5l2092t2418r2151b2472],
17	NSCLC	NN	O	nsclc	nn	18	SENT_110	[p5l11t2509r216b2562],
18	patients	NNS	O	patient	prep_in	14	SENT_110	[p5l239t2507r514b2575],
19	.	.	O	.	_	0	SENT_110	[p5l239t2507r514b2575],

1	All	PDT	O	all	predet	2	SENT_111	[p5l535t2506r621b2561],
2	these	DT	O	these	nsubjpass	5	SENT_111	[p5l644t2507r815b2562],
3	above	IN	O	above	advmod	2	SENT_111	[p5l838t2507r1026b2562],
4	were	VBD	O	be	auxpass	5	SENT_111	[p5l1048t2522r1208b2562],
5	performed	VBN	O	perform	_	0	SENT_111	[p5l1232t2506r1572b2575],
6	by	IN	O	by	_	0	SENT_111	[p5l1595t2507r1672b2575],
7	PLINK	NNP	O	PLINK	nn	8	SENT_111	[p5l1694t2510r1886b2561],
8	Version	NNP	O	Version	agent	5	SENT_111	[p5l1904t2507r2151b2562],
9	1.07	CD	NUMBER	1.07	number	10	SENT_111	[p5l14t2598r143b2650],
10	(	CD	NUMBER	(	dep	8	SENT_111	[p5l166t2595r556b2663],
11	Cambridge	NNP	LOCATION	Cambridge	nn	15	SENT_111	[p5l166t2595r556b2663],
12	,	,	O	,	_	0	SENT_111	[p5l166t2595r556b2663],
13	MA	NNP	O	MA	appos	15	SENT_111	[p5l579t2597r701b2658],
14	,	,	O	,	_	0	SENT_111	[p5l579t2597r701b2658],
15	USA	NNP	LOCATION	USA	dep	10	SENT_111	[p5l722t2595r894b2663],
16	)	CD	NUMBER	)	num	15	SENT_111	[p5l722t2595r894b2663],
17	.	.	O	.	_	0	SENT_111	[p5l722t2595r894b2663],

1	D’	NN	O	d’	nsubjpass	5	SENT_112	[p5l917t2597r977b2649],
2	and	CC	O	and	_	0	SENT_112	[p5l1001t2595r1117b2650],
3	r2	NN	O	r2	nsubjpass	5	SENT_112	[p5l1139t2586r1191b2649],
4	was	VBD	O	be	auxpass	5	SENT_112	[p5l1216t2611r1340b2650],
5	calculated	VBN	O	calculate	_	0	SENT_112	[p5l1363t2595r1688b2650],
6	by	IN	O	by	_	0	SENT_112	[p5l1709t2595r1787b2663],
7	Haploview	NN	PERSON	haploview	agent	5	SENT_112	[p5l1806t2595r2153b2663],

1	440	CD	NUMBER	440	num	3	SENT_113	[p5l402t2739r449b2760],
2	X.	NNP	O	X.	nn	3	SENT_113	[p5l1216t2739r1238b2760],
3	Xu	NNP	O	Xu	_	0	SENT_113	[p5l1246t2739r1279b2760],
4	et	FW	O	et	nn	5	SENT_113	[p5l1288t2741r1311b2760],
5	al.	FW	O	al.	dep	3	SENT_113	[p5l1318t2738r1343b2760],
6	/	:	O	/	punct	3	SENT_113	[p5l1350t2738r1362b2765],
7	Lung	NN	O	lung	nn	8	SENT_113	[p5l1368t2739r1428b2765],
8	Cancer	NN	O	cancer	dep	3	SENT_113	[p5l1435t2739r1518b2760],
9	77	CD	NUMBER	77	number	10	SENT_113	[p5l1527t2739r1555b2760],
10	(	CD	NUMBER	(	num	11	SENT_113	[p5l1562t2738r1643b2765],
11	2012	CD	DATE	2012	dep	8	SENT_113	[p5l1562t2738r1643b2765],
12	)	CD	NUMBER	)	number	13	SENT_113	[p5l1562t2738r1643b2765],
13	438-442	CD	NUMBER	438-442	num	11	SENT_113	[p5l1650t2739r1757b2760],

1	4.2	CD	NUMBER	4.2	_	0	SENT_114	[p5l7t2880r118b2940],
2	,	,	O	,	_	0	SENT_114	[p5l7t2880r118b2940],
3	to	TO	O	to	dep	1	SENT_114	[p5l148t2886r209b2932],
4	analyze	VB	O	analyze	dep	3	SENT_114	[p5l239t2878r481b2945],
5	pairwise	JJ	O	pairwise	amod	10	SENT_114	[p5l511t2878r785b2945],
6	linkage	NN	O	linkage	nn	10	SENT_114	[p5l815t2878r1045b2945],
7	dis-equilibrium	NN	O	dis-equilibrium	nn	10	SENT_114	[p5l1075t2878r1577b2945],
8	(	CD	NUMBER	(	num	10	SENT_114	[p5l1606t2878r1754b2945],
9	LD	NN	O	ld	nn	10	SENT_114	[p5l1606t2878r1754b2945],
10	)	NN	O	)	dobj	4	SENT_114	[p5l1606t2878r1754b2945],
11	.	.	O	.	_	0	SENT_114	[p5l1606t2878r1754b2945],

1	And	CC	O	and	cc	5	SENT_115	[p5l1782t2878r1910b2932],
2	haplotype	NN	O	haplotype	nn	3	SENT_115	[p5l1940t2878r2146b2945, p5l9t2973r148b3032],
3	blocks	NNS	O	block	nsubjpass	5	SENT_115	[p5l174t2965r376b3019],
4	were	VBD	O	be	auxpass	5	SENT_115	[p5l402t2980r562b3019],
5	deﬁned	VBN	O	deﬁned	_	0	SENT_115	[p5l589t2965r829b3019],
6	by	IN	O	by	_	0	SENT_115	[p5l855t2965r932b3032],
7	the	DT	O	the	det	10	SENT_115	[p5l956t2965r1058b3019],
8	standard	JJ	O	standard	amod	10	SENT_115	[p5l1085t2965r1366b3019],
9	Haploview	NN	O	haploview	nn	10	SENT_115	[p5l1393t2965r1739b3032],
10	parameters	NNS	O	parameter	agent	5	SENT_115	[p5l1764t2973r2145b3032],
11	.	.	O	.	_	0	SENT_115	[p5l1764t2973r2145b3032],

1	Individual	JJ	O	individual	amod	3	SENT_116	[p5l10t3051r333b3105],
2	haplotype	NN	O	haplotype	nn	3	SENT_116	[p5l365t3051r687b3119],
3	frequencies	NNS	O	frequency	nsubjpass	5	SENT_116	[p5l719t3051r1089b3119],
4	were	VBD	O	be	auxpass	5	SENT_116	[p5l1120t3067r1280b3105],
5	estimated	VBN	O	estimate	_	0	SENT_116	[p5l1312t3051r1630b3105],
6	by	IN	O	by	_	0	SENT_116	[p5l1660t3051r1738b3119],
7	PHASE	NNP	O	PHASE	nn	8	SENT_116	[p5l1768t3053r1979b3105],
8	Version	NNP	O	Version	agent	5	SENT_116	[p5l2007t3054r2146b3105, p5l10t3139r140b3192],
9	2.1.1	CD	NUMBER	2.1.1	number	10	SENT_116	[p5l166t3141r309b3193],
10	(	CD	NUMBER	(	dep	8	SENT_116	[p5l344t3138r602b3205],
11	Seattle	NNP	LOCATION	Seattle	nn	15	SENT_116	[p5l344t3138r602b3205],
12	,	,	O	,	_	0	SENT_116	[p5l344t3138r602b3205],
13	WA	NNP	LOCATION	WA	appos	15	SENT_116	[p5l627t3141r760b3201],
14	,	,	O	,	_	0	SENT_116	[p5l627t3141r760b3201],
15	USA	NNP	LOCATION	USA	dep	10	SENT_116	[p5l787t3138r943b3206],
16	)	CD	NUMBER	)	num	15	SENT_116	[p5l787t3138r943b3206],
17	[	CD	NUMBER	[	number	18	SENT_116	[p5l973t3138r1211b3206],
18	18,19	CD	NUMBER	18,19	num	19	SENT_116	[p5l973t3138r1211b3206],
19	]	NN	O	]	dep	10	SENT_116	[p5l973t3138r1211b3206],
20	.	.	O	.	_	0	SENT_116	[p5l973t3138r1211b3206],

1	I	PRP	O	I	nsubj	2	SENT_117	[p5l1239t3138r1705b3206],
2	(	VBP	O	(	_	0	SENT_117	[p5l1239t3138r1705b3206],
3	aplan	NN	O	aplan	dobj	2	SENT_117	[p5l1239t3138r1705b3206],
4	.	.	O	.	_	0	SENT_117	[p5l1239t3138r1705b3206],

1	—	NN	O	—	_	0	SENT_118	[p5l1239t3138r1705b3206],
2	.	.	O	.	_	0	SENT_118	[p5l1239t3138r1705b3206],

1	Meier	NNP	PERSON	Meier	nsubjpass	12	SENT_119	[p5l1239t3138r1705b3206],
2	,	,	O	,	_	0	SENT_119	[p5l1239t3138r1705b3206],
3	log	NN	O	log	nn	5	SENT_119	[p5l1733t3138r2006b3206],
4	—	CD	NUMBER	—	num	5	SENT_119	[p5l1733t3138r2006b3206],
5	ranl	NN	O	ranl	appos	1	SENT_119	[p5l1733t3138r2006b3206],
6	<	JJR	O	<	amod	7	SENT_119	[p5l1733t3138r2006b3206],
7	test	NN	O	test	dep	5	SENT_119	[p5l2029t3146r2148b3192],
8	and	CC	O	and	_	0	SENT_119	[p5l9t3225r126b3279],
9	Cox	NN	PERSON	cox	nn	10	SENT_119	[p5l152t3228r270b3279],
10	regression	NN	O	regression	conj_and	7	SENT_119	[p5l294t3226r627b3293],
11	were	VBD	O	be	auxpass	12	SENT_119	[p5l650t3241r810b3279],
12	conducted	VBN	O	conduct	_	0	SENT_119	[p5l836t3225r1171b3279],
13	to	TO	O	to	aux	14	SENT_119	[p5l1196t3233r1258b3279],
14	evaluate	VB	O	evaluate	xcomp	12	SENT_119	[p5l1284t3225r1554b3279],
15	the	DT	O	the	det	16	SENT_119	[p5l1580t3225r1681b3279],
16	effect	NN	O	effect	dobj	14	SENT_119	[p5l1707t3225r1885b3279],
17	of	IN	O	of	_	0	SENT_119	[p5l1910t3225r1976b3279],
18	CTR1	NN	O	ctr1	nn	19	SENT_119	[p5l1994t3228r2139b3279],
19	genotypes	NNS	O	genotype	prep_of	16	SENT_119	[p5l8t3320r337b3380],
20	on	IN	O	on	_	0	SENT_119	[p5l358t3328r436b3366],
21	the	DT	O	the	det	24	SENT_119	[p5l454t3312r556b3367],
22	overall	JJ	O	overall	amod	24	SENT_119	[p5l576t3312r793b3367],
23	survival	NN	O	survival	nn	24	SENT_119	[p5l814t3312r1066b3367],
24	rate	NN	O	rate	prep_on	14	SENT_119	[p5l1086t3320r1210b3367],
25	of	IN	O	of	_	0	SENT_119	[p5l1229t3312r1296b3366],
26	non-small	JJ	O	non-small	amod	30	SENT_119	[p5l1308t3312r1632b3367],
27	cell	NN	O	cell	nn	30	SENT_119	[p5l1652t3312r1760b3366],
28	lung	NN	O	lung	nn	30	SENT_119	[p5l1780t3312r1920b3380],
29	cancer	NN	O	cancer	nn	30	SENT_119	[p5l1938t3328r2149b3366],
30	patients	NNS	O	patient	prep_of	24	SENT_119	[p5l10t3400r284b3467],
31	.	.	O	.	_	0	SENT_119	[p5l10t3400r284b3467],

1	These	DT	O	these	det	3	SENT_120	[p5l305t3400r491b3454],
2	aforementioned	JJ	O	aforementioned	amod	3	SENT_120	[p5l514t3399r1030b3454],
3	statistics	NNS	O	statistics	nsubjpass	5	SENT_120	[p5l1054t3400r1333b3454],
4	were	VBD	O	be	auxpass	5	SENT_120	[p5l1356t3415r1516b3454],
5	performed	VBN	O	perform	_	0	SENT_120	[p5l1540t3399r1879b3467],
6	by	IN	O	by	_	0	SENT_120	[p5l1902t3400r1979b3467],
7	SPSS	NNP	ORGANIZATION	SPSS	nn	11	SENT_120	[p5l2001t3402r2146b3454],
8	15.0	CD	NUMBER	15.0	num	11	SENT_120	[p5l13t3490r143b3542],
9	(	CD	NUMBER	(	num	11	SENT_120	[p5l166t3487r338b3554],
10	SPSS	NNP	ORGANIZATION	SPSS	nn	11	SENT_120	[p5l166t3487r338b3554],
11	Inc.	NNP	ORGANIZATION	Inc.	agent	5	SENT_120	[p5l361t3490r486b3549],
12	,	,	O	,	_	0	SENT_120	[p5l361t3490r486b3549],
13	Chicago	NNP	LOCATION	Chicago	nn	15	SENT_120	[p5l510t3487r776b3554],
14	,	,	O	,	_	0	SENT_120	[p5l510t3487r776b3554],
15	USA	NNP	LOCATION	USA	appos	11	SENT_120	[p5l799t3487r970b3554],
16	)	CD	NUMBER	)	num	15	SENT_120	[p5l799t3487r970b3554],
17	.	.	O	.	_	0	SENT_120	[p5l799t3487r970b3554],

1	3	LS	NUMBER	3	_	0	SENT_121	[p5l7t3707r64b3758],
2	.	.	O	.	_	0	SENT_121	[p5l7t3707r64b3758],

1	Results	NNS	O	result	_	0	SENT_122	[p5l110t3704r352b3758],

1	3.1	CD	NUMBER	3.1	_	0	SENT_123	[p6l6t95r111b147],
2	.	.	O	.	_	0	SENT_123	[p6l6t95r111b147],

1	Clinical	JJ	O	clinical	amod	2	SENT_124	[p6l163t92r388b146],
2	characteristics	NNS	O	characteristic	_	0	SENT_124	[p6l410t92r853b146],
3	of	IN	O	of	_	0	SENT_124	[p6l875t92r942b160],
4	NSCLC	NN	O	nsclc	nn	5	SENT_124	[p6l949t95r1151b146],
5	patients	NNS	O	patient	prep_of	2	SENT_124	[p6l1164t93r1414b160],

1	Two	CD	NUMBER	two	num	2	SENT_125	[p6l108t273r246b324],
2	hundred	CD	NUMBER	hundred	nsubj	11	SENT_125	[p6l287t269r559b324],
3	and	CC	NUMBER	and	_	0	SENT_125	[p6l599t269r715b324],
4	four	CD	NUMBER	four	num	6	SENT_125	[p6l756t269r888b324],
5	NSCLC	NN	O	nsclc	nn	6	SENT_125	[p6l926t272r1131b324],
6	patients	NNS	O	patient	conj_and	2	SENT_125	[p6l1170t270r1428b337],
7	from	IN	O	from	_	0	SENT_125	[p6l1469t269r1622b324],
8	three	CD	NUMBER	three	num	10	SENT_125	[p6l1661t269r1829b324],
9	different	JJ	O	different	amod	10	SENT_125	[p6l1869t269r2148b324],
10	institutions	NNS	O	institution	prep_from	2	SENT_125	[p6l10t357r377b411],
11	enrolled	VBN	O	enrol	_	0	SENT_125	[p6l407t357r672b411],
12	in	IN	O	in	_	0	SENT_125	[p6l702t357r761b410],
13	our	PRP$	O	we	poss	14	SENT_125	[p6l790t372r898b411],
14	study	NN	O	study	prep_in	11	SENT_125	[p6l926t357r1117b424],
15	,	,	O	,	_	0	SENT_125	[p6l926t357r1117b424],
16	and	CC	O	and	_	0	SENT_125	[p6l1147t357r1263b411],
17	all	DT	O	all	det	18	SENT_125	[p6l1292t357r1365b411],
18	patients	NNS	O	patient	nsubj	20	SENT_125	[p6l1396t357r1653b424],
19	have	VBP	O	have	aux	20	SENT_125	[p6l1684t357r1833b411],
20	accepted	VBN	O	accept	conj_and	11	SENT_125	[p6l1862t357r2146b424],
21	cisplatin	NN	O	cisplatin	nn	22	SENT_125	[p6l9t444r498b511],
22	—	NN	O	—	dobj	20	SENT_125	[p6l9t444r498b511],
23	based	VBN	O	base	partmod	22	SENT_125	[p6l9t444r498b511],
24	chemotherapy	NN	O	chemotherapy	dobj	23	SENT_125	[p6l524t444r992b511],
25	for	IN	O	for	_	0	SENT_125	[p6l1016t444r1106b498],
26	at	IN	O	at	quantmod	28	SENT_125	[p6l1129t452r1189b498],
27	least	JJS	O	least	mwe	26	SENT_125	[p6l1213t444r1362b498],
28	two	CD	NUMBER	two	num	29	SENT_125	[p6l1385t452r1507b498],
29	cycles	NNS	O	cycle	prep_for	24	SENT_125	[p6l1534t444r1740b511],
30	.	.	O	.	_	0	SENT_125	[p6l1534t444r1740b511],

1	The	DT	O	the	det	3	SENT_126	[p6l1764t444r1880b498],
2	median	JJ	O	median	amod	3	SENT_126	[p6l1907t444r2147b498],
3	age	NN	O	age	nsubj	7	SENT_126	[p6l9t546r116b598],
4	of	IN	O	of	_	0	SENT_126	[p6l146t530r212b584],
5	them	PRP	O	they	prep_of	3	SENT_126	[p6l233t530r401b584],
6	was	VBD	O	be	cop	7	SENT_126	[p6l428t546r553b584],
7	55	CD	NUMBER	55	_	0	SENT_126	[p6l584t533r675b593],
8	,	,	O	,	_	0	SENT_126	[p6l584t533r675b593],
9	ranging	VBG	O	range	partmod	7	SENT_126	[p6l706t531r951b598],
10	from	IN	O	from	_	0	SENT_126	[p6l979t530r1132b584],
11	33	CD	DURATION	33	number	13	SENT_126	[p6l1160t533r1235b584],
12	to	TO	DURATION	to	dep	13	SENT_126	[p6l1266t538r1328b584],
13	77	CD	DURATION	77	num	14	SENT_126	[p6l1359t533r1433b584],
14	years	NNS	NUMBER	year	prep_from	9	SENT_126	[p6l1462t546r1631b598],
15	old	JJ	DURATION	old	amod	14	SENT_126	[p6l1661t530r1775b585],
16	.	.	O	.	_	0	SENT_126	[p6l1661t530r1775b585],

1	They	PRP	O	they	nsubjpass	3	SENT_127	[p6l1802t530r1960b598],
2	were	VBD	O	be	auxpass	3	SENT_127	[p6l1986t546r2146b584],
3	divided	VBN	O	divide	ccomp	18	SENT_127	[p6l9t617r248b671],
4	into	IN	O	into	_	0	SENT_127	[p6l275t618r399b671],
5	three	CD	NUMBER	three	num	6	SENT_127	[p6l425t617r593b671],
6	groups	NNS	O	group	prep_into	3	SENT_127	[p6l618t633r837b685],
7	according	VBG	O	accord	_	0	SENT_127	[p6l864t617r1178b685],
8	to	TO	O	to	prepc_according_to	3	SENT_127	[p6l1202t625r1264b671],
9	the	DT	O	the	det	11	SENT_127	[p6l1290t617r1392b671],
10	median	JJ	O	median	amod	11	SENT_127	[p6l1419t617r1659b671],
11	age	NN	O	age	pobj	3	SENT_127	[p6l1685t633r1807b685],
12	,	,	O	,	_	0	SENT_127	[p6l1685t633r1807b685],
13	67	CD	PERCENT	67	nsubj	18	SENT_127	[p6l1835t617r2146b685],
14	(	CD	PERCENT	(	number	15	SENT_127	[p6l1835t617r2146b685],
15	32.8	CD	PERCENT	32.8	dep	16	SENT_127	[p6l1835t617r2146b685],
16	%	NN	PERCENT	%	dep	13	SENT_127	[p6l1835t617r2146b685],
17	)	CD	NUMBER	)	num	18	SENT_127	[p6l1835t617r2146b685],
18	subjects	NNS	O	subject	_	0	SENT_127	[p6l10t704r268b772],
19	younger	JJR	O	younger	dobj	18	SENT_127	[p6l295t720r562b772],
20	than	IN	O	than	_	0	SENT_127	[p6l587t704r732b759],
21	50	CD	DURATION	50	num	22	SENT_127	[p6l760t707r836b759],
22	years	NNS	NUMBER	year	prep_than	19	SENT_127	[p6l861t720r1047b772],
23	,	,	O	,	_	0	SENT_127	[p6l861t720r1047b772],
24	and	CC	O	and	_	0	SENT_127	[p6l1075t704r1191b759],
25	77	CD	PERCENT	77	conj_and	19	SENT_127	[p6l1221t708r1295b758],
26	(	CD	PERCENT	(	number	27	SENT_127	[p6l1324t705r1553b772],
27	37.7	CD	PERCENT	37.7	num	28	SENT_127	[p6l1324t705r1553b772],
28	%	NN	PERCENT	%	dep	25	SENT_127	[p6l1324t705r1553b772],
29	)	CD	NUMBER	)	num	30	SENT_127	[p6l1324t705r1553b772],
30	subjects	NNS	O	subject	npadvmod	45	SENT_127	[p6l1583t704r1841b772],
31	between	IN	O	between	quantmod	32	SENT_127	[p6l1869t704r2147b759],
32	50	CD	NUMBER	50	num	35	SENT_127	[p6l10t794r86b846],
33	and	CC	O	and	_	0	SENT_127	[p6l128t791r244b846],
34	60	CD	DURATION	60	num	35	SENT_127	[p6l287t794r363b846],
35	years	NNS	NUMBER	year	npadvmod	36	SENT_127	[p6l403t807r572b859],
36	old	JJ	DURATION	old	amod	30	SENT_127	[p6l616t791r730b854],
37	,	,	O	,	_	0	SENT_127	[p6l616t791r730b854],
38	other	JJ	O	other	dep	36	SENT_127	[p6l773t792r945b846],
39	60	CD	PERCENT	60	number	40	SENT_127	[p6l986t794r1061b846],
40	(	CD	PERCENT	(	prep	38	SENT_127	[p6l1104t792r1334b859],
41	29.4	CD	PERCENT	29.4	num	42	SENT_127	[p6l1104t792r1334b859],
42	%	NN	PERCENT	%	dep	40	SENT_127	[p6l1104t792r1334b859],
43	)	CD	NUMBER	)	num	44	SENT_127	[p6l1104t792r1334b859],
44	patients	NNS	O	patient	dep	36	SENT_127	[p6l1376t792r1634b859],
45	older	JJR	O	older	dep	18	SENT_127	[p6l1678t792r1844b846],
46	than	IN	O	than	_	0	SENT_127	[p6l1884t791r2028b846],
47	60	CD	DURATION	60	num	48	SENT_127	[p6l2070t794r2146b846],
48	years	NNS	NUMBER	year	prep_than	18	SENT_127	[p6l7t894r193b946],
49	.	.	O	.	_	0	SENT_127	[p6l7t894r193b946],

1	Sixty-one	CD	NUMBER	sixty-one	num	3	SENT_128	[p6l213t879r519b946],
2	female	JJ	O	female	amod	3	SENT_128	[p6l538t878r753b933],
3	patients	NNS	O	patient	nsubj	4	SENT_128	[p6l773t879r1031b946],
4	accounted	VBD	O	account	_	0	SENT_128	[p6l1050t879r1380b933],
5	for	IN	O	for	_	0	SENT_128	[p6l1400t878r1489b933],
6	29.9	CD	PERCENT	29.9	num	7	SENT_128	[p6l1506t881r1700b941],
7	%	NN	PERCENT	%	prep_for	4	SENT_128	[p6l1506t881r1700b941],
8	,	,	O	,	_	0	SENT_128	[p6l1506t881r1700b941],
9	and	CC	O	and	_	0	SENT_128	[p6l1719t879r1835b933],
10	143	CD	NUMBER	143	num	12	SENT_128	[p6l1858t881r1969b933],
11	male	JJ	O	male	amod	12	SENT_128	[p6l1991t879r2146b933],
12	patients	NNS	O	patient	nsubj	13	SENT_128	[p6l10t967r267b1033],
13	accounted	VBD	O	account	conj_and	4	SENT_128	[p6l298t966r628b1020],
14	for	IN	O	for	_	0	SENT_128	[p6l659t966r748b1020],
15	70.1	CD	PERCENT	70.1	num	16	SENT_128	[p6l776t969r954b1020],
16	%	NN	PERCENT	%	prep_for	13	SENT_128	[p6l776t969r954b1020],
17	as	IN	O	as	_	0	SENT_128	[p6l983t981r1045b1020],
18	the	DT	O	the	det	21	SENT_128	[p6l1075t966r1177b1020],
19	major	JJ	O	major	amod	21	SENT_128	[p6l1208t967r1397b1033],
20	gender	NN	O	gender	nn	21	SENT_128	[p6l1423t966r1648b1033],
21	groups	NNS	O	group	prep_as	13	SENT_128	[p6l1674t981r1909b1033],
22	.	.	O	.	_	0	SENT_128	[p6l1674t981r1909b1033],

1	In	IN	O	in	_	0	SENT_129	[p6l1941t969r2000b1019],
2	this	DT	O	this	det	3	SENT_129	[p6l2029t966r2145b1020],
3	study	NN	O	study	prep_in	8	SENT_129	[p6l10t1052r201b1120],
4	,	,	O	,	_	0	SENT_129	[p6l10t1052r201b1120],
5	pack-year-smoke	JJ	O	pack-year-smoke	amod	6	SENT_129	[p6l235t1052r793b1120],
6	value	NN	O	value	nsubjpass	8	SENT_129	[p6l824t1052r996b1106],
7	was	VBD	O	be	auxpass	8	SENT_129	[p6l1027t1068r1152b1106],
8	used	VBN	O	use	_	0	SENT_129	[p6l1185t1052r1333b1106],
9	to	TO	O	to	aux	10	SENT_129	[p6l1365t1060r1427b1106],
10	identify	VB	O	identify	xcomp	8	SENT_129	[p6l1460t1052r1709b1120],
11	the	DT	O	the	det	13	SENT_129	[p6l1739t1052r1840b1106],
12	smoking	NN	O	smoking	nn	13	SENT_129	[p6l1874t1052r2148b1120],
13	status	NN	O	status	dobj	10	SENT_129	[p6l10t1147r198b1193],
14	with	IN	O	with	_	0	SENT_129	[p6l229t1139r377b1193],
15	the	DT	O	the	det	17	SENT_129	[p6l407t1139r508b1193],
16	median	JJ	O	median	amod	17	SENT_129	[p6l540t1139r781b1193],
17	value	NN	O	value	prep_with	10	SENT_129	[p6l809t1139r981b1193],
18	of	IN	O	of	_	0	SENT_129	[p6l1013t1139r1079b1193],
19	twenty-ﬁve	NN	O	twenty-ﬁve	prep_of	17	SENT_129	[p6l1102t1139r1494b1207],
20	.	.	O	.	_	0	SENT_129	[p6l1102t1139r1494b1207],

1	Sixty-nine	CD	NUMBER	sixty-nine	num	2	SENT_130	[p6l1526t1140r1856b1207],
2	patients	NNS	O	patient	nsubj	7	SENT_130	[p6l1888t1140r2145b1207],
3	(	IN	O	(	_	0	SENT_130	[p6l9t1226r239b1294],
4	33.8	CD	PERCENT	33.8	num	5	SENT_130	[p6l9t1226r239b1294],
5	%	NN	PERCENT	%	prep_(	2	SENT_130	[p6l9t1226r239b1294],
6	)	CD	NUMBER	)	dep	5	SENT_130	[p6l9t1226r239b1294],
7	belonged	VBD	O	belong	_	0	SENT_130	[p6l265t1226r560b1294],
8	to	TO	O	to	_	0	SENT_130	[p6l586t1234r648b1281],
9	heavy	JJ	O	heavy	amod	11	SENT_130	[p6l675t1226r865b1294],
10	smoke	NN	O	smoke	nn	11	SENT_130	[p6l890t1226r1097b1281],
11	group	NN	O	group	prep_to	7	SENT_130	[p6l1123t1242r1326b1294],
12	,	,	O	,	_	0	SENT_130	[p6l1123t1242r1326b1294],
13	whose	WP$	O	whose	dep	19	SENT_130	[p6l1352t1226r1560b1281],
14	pack-year-smoke	JJ	O	pack-year-smoke	amod	15	SENT_130	[p6l1588t1226r2146b1294],
15	values	NNS	O	value	nsubj	19	SENT_130	[p6l7t1314r210b1368],
16	were	VBD	O	be	cop	19	SENT_130	[p6l232t1329r392b1368],
17	more	JJR	O	more	mwe	18	SENT_130	[p6l416t1329r582b1368],
18	than	IN	O	than	quantmod	19	SENT_130	[p6l604t1314r749b1368],
19	25	CD	NUMBER	25	dep	11	SENT_130	[p6l770t1316r863b1368],
20	.	.	O	.	_	0	SENT_130	[p6l770t1316r863b1368],

1	Seventy	CD	PERCENT	seventy	nsubj	9	SENT_131	[p6l887t1316r1295b1381],
2	—	CD	PERCENT	—	num	3	SENT_131	[p6l887t1316r1295b1381],
3	two	CD	PERCENT	two	dep	1	SENT_131	[p6l887t1316r1295b1381],
4	(	CD	PERCENT	(	number	5	SENT_131	[p6l1318t1314r1547b1381],
5	35.3	CD	PERCENT	35.3	num	6	SENT_131	[p6l1318t1314r1547b1381],
6	%	NN	PERCENT	%	dep	1	SENT_131	[p6l1318t1314r1547b1381],
7	)	CD	NUMBER	)	num	8	SENT_131	[p6l1318t1314r1547b1381],
8	patients	NNS	O	patient	dep	6	SENT_131	[p6l1571t1314r1828b1381],
9	belonged	VBD	O	belong	_	0	SENT_131	[p6l1851t1314r2146b1381],
10	to	TO	O	to	_	0	SENT_131	[p6l9t1409r70b1455],
11	light	JJ	O	light	amod	13	SENT_131	[p6l105t1401r251b1468],
12	smoke	NN	O	smoke	nn	13	SENT_131	[p6l285t1401r492b1455],
13	group	NN	O	group	prep_to	9	SENT_131	[p6l525t1416r712b1468],
14	with	IN	O	with	_	0	SENT_131	[p6l745t1401r893b1455],
15	pack-year-smoke	JJ	O	pack-year-smoke	amod	16	SENT_131	[p6l927t1401r1486b1468],
16	value	NN	O	value	prep_with	9	SENT_131	[p6l1519t1401r1691b1455],
17	less	JJR	O	less	mwe	18	SENT_131	[p6l1726t1401r1840b1455],
18	than	IN	O	than	quantmod	19	SENT_131	[p6l1875t1401r2019b1455],
19	25	CD	NUMBER	25	dep	16	SENT_131	[p6l2053t1404r2145b1455],
20	.	.	O	.	_	0	SENT_131	[p6l2053t1404r2145b1455],

1	There	EX	O	there	expl	2	SENT_132	[p6l7t1488r189b1542],
2	were	VBD	O	be	_	0	SENT_132	[p6l205t1503r365b1542],
3	still	RB	O	still	advmod	2	SENT_132	[p6l383t1488r498b1542],
4	63	CD	PERCENT	63	pobj	3	SENT_132	[p6l516t1488r827b1555],
5	(	CD	PERCENT	(	number	6	SENT_132	[p6l516t1488r827b1555],
6	30.9	CD	PERCENT	30.9	num	7	SENT_132	[p6l516t1488r827b1555],
7	%	NN	PERCENT	%	iobj	2	SENT_132	[p6l516t1488r827b1555],
8	)	CD	NUMBER	)	num	12	SENT_132	[p6l516t1488r827b1555],
9	non	JJ	O	non	amod	12	SENT_132	[p6l844t1488r1206b1542],
10	—	NN	O	—	nn	12	SENT_132	[p6l844t1488r1206b1542],
11	smoke	NN	O	smoke	nn	12	SENT_132	[p6l844t1488r1206b1542],
12	subjects	NNS	O	subject	dep	7	SENT_132	[p6l1224t1488r1482b1555],
13	in	IN	O	in	_	0	SENT_132	[p6l1501t1489r1559b1541],
14	this	DT	O	this	det	15	SENT_132	[p6l1575t1488r1691b1542],
15	study	NN	O	study	prep_in	12	SENT_132	[p6l1710t1488r1901b1555],
16	.	.	O	.	_	0	SENT_132	[p6l1710t1488r1901b1555],

1	Among	IN	O	among	_	0	SENT_133	[p6l1916t1490r2148b1555],
2	the	DT	O	the	det	3	SENT_133	[p6l9t1574r110b1628],
3	patients	NNS	O	patient	prep_among	8	SENT_133	[p6l136t1575r410b1642],
4	,	,	O	,	_	0	SENT_133	[p6l136t1575r410b1642],
5	only	RB	O	only	advmod	7	SENT_133	[p6l435t1574r575b1642],
6	two	CD	NUMBER	two	num	7	SENT_133	[p6l597t1582r719b1628],
7	people	NNS	O	people	nsubj	8	SENT_133	[p6l744t1574r959b1642],
8	(	VBP	O	(	_	0	SENT_133	[p6l984t1574r1172b1641],
9	1.0	CD	PERCENT	1.0	num	10	SENT_133	[p6l984t1574r1172b1641],
10	%	NN	PERCENT	%	dobj	8	SENT_133	[p6l984t1574r1172b1641],
11	)	CD	NUMBER	)	nsubj	12	SENT_133	[p6l984t1574r1172b1641],
12	had	VBD	O	have	rcmod	10	SENT_133	[p6l1198t1574r1313b1628],
13	family	NN	O	family	nn	15	SENT_133	[p6l1339t1574r1542b1642],
14	cancer	NN	O	cancer	nn	15	SENT_133	[p6l1565t1590r1775b1628],
15	history	NN	O	history	dobj	12	SENT_133	[p6l1797t1574r2037b1642],
16	.	.	O	.	_	0	SENT_133	[p6l1797t1574r2037b1642],

1	All	DT	O	all	det	2	SENT_134	[p6l2060t1574r2146b1628],
2	patients	NNS	O	patient	nsubj	12	SENT_134	[p6l10t1662r267b1729],
3	were	VBD	O	be	cop	12	SENT_134	[p6l283t1677r443b1715],
4	in	IN	O	in	_	0	SENT_134	[p6l461t1662r520b1715],
5	advanced	JJ	O	advanced	amod	6	SENT_134	[p6l535t1661r839b1715],
6	stages	NNS	O	stage	prep_in	12	SENT_134	[p6l857t1669r1068b1729],
7	,	,	O	,	_	0	SENT_134	[p6l857t1669r1068b1729],
8	71	CD	PERCENT	71	number	9	SENT_134	[p6l1087t1664r1154b1715],
9	(	CD	PERCENT	(	appos	6	SENT_134	[p6l1179t1661r1409b1729],
10	34.8	CD	PERCENT	34.8	num	11	SENT_134	[p6l1179t1661r1409b1729],
11	%	NN	PERCENT	%	dep	9	SENT_134	[p6l1179t1661r1409b1729],
12	)	CD	NUMBER	)	_	0	SENT_134	[p6l1179t1661r1409b1729],
13	in	IN	O	in	_	0	SENT_134	[p6l1426t1662r1485b1715],
14	stage	NN	O	stage	nn	15	SENT_134	[p6l1502t1669r1666b1729],
15	111A	NN	O	111a	prep_in	12	SENT_134	[p6l1683t1664r1805b1724],
16	,	,	O	,	_	0	SENT_134	[p6l1683t1664r1805b1724],
17	75	CD	PERCENT	75	number	18	SENT_134	[p6l1824t1665r1897b1715],
18	(	CD	PERCENT	(	conj_and	12	SENT_134	[p6l1916t1661r2146b1729],
19	36.8	CD	PERCENT	36.8	num	20	SENT_134	[p6l1916t1661r2146b1729],
20	%	NN	PERCENT	%	dep	18	SENT_134	[p6l1916t1661r2146b1729],
21	)	CD	NUMBER	)	dep	18	SENT_134	[p6l1916t1661r2146b1729],
22	in	IN	O	in	_	0	SENT_134	[p6l10t1749r69b1802],
23	stage	NN	O	stage	nn	24	SENT_134	[p6l98t1756r262b1816],
24	IIIB	NN	O	iiib	prep_in	21	SENT_134	[p6l291t1752r393b1802],
25	and	CC	O	and	_	0	SENT_134	[p6l422t1748r538b1802],
26	58	CD	PERCENT	58	conj_and	12	SENT_134	[p6l568t1751r642b1803],
27	(	CD	PERCENT	(	number	28	SENT_134	[p6l673t1749r903b1816],
28	28.4	CD	PERCENT	28.4	num	29	SENT_134	[p6l673t1749r903b1816],
29	%	NN	PERCENT	%	dep	26	SENT_134	[p6l673t1749r903b1816],
30	)	CD	NUMBER	)	dep	26	SENT_134	[p6l673t1749r903b1816],
31	in	IN	O	in	_	0	SENT_134	[p6l932t1749r991b1802],
32	stage	NN	O	stage	prep_in	30	SENT_134	[p6l1020t1756r1184b1816],
33	IV	CD	NUMBER	iv	num	32	SENT_134	[p6l1213t1752r1292b1803],
34	.	.	O	.	_	0	SENT_134	[p6l1213t1752r1292b1803],

1	After	IN	O	after	_	0	SENT_135	[p6l1319t1748r1482b1803],
2	cisplatin	NN	O	cisplatin	nn	3	SENT_135	[p6l1508t1748r1780b1816],
3	treatment	NN	O	treatment	prep_after	8	SENT_135	[p6l1807t1756r2146b1811],
4	,	,	O	,	_	0	SENT_135	[p6l1807t1756r2146b1811],
5	severe	JJ	O	severe	amod	7	SENT_135	[p6l10t1851r214b1890],
6	neutropenia	NN	O	neutropenia	nn	7	SENT_135	[p6l230t1836r622b1903],
7	toxicity	NN	O	toxicity	nsubj	8	SENT_135	[p6l637t1836r881b1903],
8	occurred	VBD	O	occur	_	0	SENT_135	[p6l895t1836r1176b1890],
9	in	IN	O	in	_	0	SENT_135	[p6l1192t1836r1251b1889],
10	121	CD	PERCENT	121	number	11	SENT_135	[p6l1270t1838r1376b1889],
11	(	CD	PERCENT	(	prep_in	8	SENT_135	[p6l1399t1836r1629b1903],
12	59.3	CD	PERCENT	59.3	number	13	SENT_135	[p6l1399t1836r1629b1903],
13	%	NN	PERCENT	%	amod	11	SENT_135	[p6l1399t1836r1629b1903],
14	)	CD	NUMBER	)	num	15	SENT_135	[p6l1399t1836r1629b1903],
15	patients	NNS	O	patient	dobj	8	SENT_135	[p6l1645t1836r1919b1903],
16	.	.	O	.	_	0	SENT_135	[p6l1645t1836r1919b1903],

1	Severe	JJ	O	severe	amod	2	SENT_136	[p6l1936t1838r2146b1890],
2	anemia	NN	O	anemia	nsubj	3	SENT_136	[p6l9t1924r244b1977],
3	happened	VBD	O	happen	_	0	SENT_136	[p6l269t1923r586b1990],
4	in	IN	O	in	_	0	SENT_136	[p6l612t1924r671b1976],
5	137	CD	PERCENT	137	number	6	SENT_136	[p6l699t1926r811b1977],
6	(	CD	PERCENT	(	prep_in	3	SENT_136	[p6l838t1923r1068b1990],
7	67.2	CD	PERCENT	67.2	num	8	SENT_136	[p6l838t1923r1068b1990],
8	%	NN	PERCENT	%	tmod	3	SENT_136	[p6l838t1923r1068b1990],
9	)	CD	NUMBER	)	num	10	SENT_136	[p6l838t1923r1068b1990],
10	patients	NNS	O	patient	dep	8	SENT_136	[p6l1094t1924r1368b1990],
11	.	.	O	.	_	0	SENT_136	[p6l1094t1924r1368b1990],

1	Thrombocytopenia	NN	O	thrombocytopenia	nsubj	6	SENT_137	[p6l1391t1923r2006b1990],
2	and	CC	O	and	_	0	SENT_137	[p6l2030t1923r2146b1977],
3	emesis	NN	O	emesis	nsubj	6	SENT_137	[p6l9t2010r227b2063],
4	were	VBD	O	be	cop	6	SENT_137	[p6l250t2025r411b2063],
5	more	RBR	O	more	advmod	6	SENT_137	[p6l436t2025r601b2063],
6	common	JJ	O	common	_	0	SENT_137	[p6l626t2025r924b2071],
7	,	,	O	,	_	0	SENT_137	[p6l626t2025r924b2071],
8	with	IN	O	with	_	0	SENT_137	[p6l947t2009r1095b2063],
9	the	DT	O	the	det	11	SENT_137	[p6l1118t2009r1219b2063],
10	occurring	VBG	O	occur	amod	11	SENT_137	[p6l1244t2010r1550b2077],
11	ratio	NN	O	ratio	prep_with	6	SENT_137	[p6l1574t2010r1721b2063],
12	of	IN	O	of	_	0	SENT_137	[p6l1745t2009r1812b2063],
13	86.3	CD	PERCENT	86.3	number	17	SENT_137	[p6l1828t2012r2006b2064],
14	%	NN	PERCENT	%	dep	17	SENT_137	[p6l1828t2012r2006b2064],
15	and	CC	O	and	_	0	SENT_137	[p6l2030t2009r2146b2063],
16	82.4	CD	PERCENT	82.4	prep_of	11	SENT_137	[p6l10t2099r188b2151],
17	%	NN	PERCENT	%	prep_of	11	SENT_137	[p6l10t2099r188b2151],
18	respectively	RB	O	respectively	advmod	17	SENT_137	[p6l225t2096r629b2164],
19	.	.	O	.	_	0	SENT_137	[p6l225t2096r629b2164],

1	One	CD	NUMBER	one	num	2	SENT_138	[p6l667t2099r792b2150],
2	hundred	CD	NUMBER	hundred	nsubj	10	SENT_138	[p6l830t2096r1103b2150],
3	and	CC	NUMBER	and	_	0	SENT_138	[p6l1140t2096r1256b2150],
4	four	CD	NUMBER	four	num	5	SENT_138	[p6l1294t2096r1426b2150],
5	patients	NNS	O	patient	nsubj	10	SENT_138	[p6l1461t2097r1719b2164],
6	(	IN	O	(	_	0	SENT_138	[p6l1757t2096r1987b2163],
7	51.0	CD	PERCENT	51.0	num	8	SENT_138	[p6l1757t2096r1987b2163],
8	%	NN	PERCENT	%	prep_(	2	SENT_138	[p6l1757t2096r1987b2163],
9	)	CD	NUMBER	)	dep	8	SENT_138	[p6l1757t2096r1987b2163],
10	suffered	VBD	O	suffer	_	0	SENT_138	[p6l2026t2096r2146b2150, p6l10t2183r173b2237],
11	severe	JJ	O	severe	amod	12	SENT_138	[p6l190t2199r394b2237],
12	nephrotoxicity	NN	O	nephrotoxicity	dobj	10	SENT_138	[p6l410t2183r901b2251],
13	,	,	O	,	_	0	SENT_138	[p6l410t2183r901b2251],
14	and	CC	O	and	_	0	SENT_138	[p6l918t2183r1034b2237],
15	88	CD	PERCENT	88	nsubj	21	SENT_138	[p6l1051t2186r1125b2237],
16	(	CD	PERCENT	(	number	17	SENT_138	[p6l1143t2183r1373b2251],
17	43.1	CD	PERCENT	43.1	num	18	SENT_138	[p6l1143t2183r1373b2251],
18	%	NN	PERCENT	%	dep	15	SENT_138	[p6l1143t2183r1373b2251],
19	)	CD	NUMBER	)	num	20	SENT_138	[p6l1143t2183r1373b2251],
20	patients	NNS	O	patient	dep	15	SENT_138	[p6l1390t2184r1647b2251],
21	suffered	VBD	O	suffer	conj_and	10	SENT_138	[p6l1665t2183r1925b2237],
22	severe	JJ	O	severe	amod	23	SENT_138	[p6l1942t2199r2146b2237],
23	ototoxicity	NN	O	ototoxicity	dobj	21	SENT_138	[p6l9t2271r373b2338],
24	.	.	O	.	_	0	SENT_138	[p6l9t2271r373b2338],

1	The	DT	O	the	det	4	SENT_139	[p6l404t2270r521b2324],
2	grade	NN	O	grade	nn	4	SENT_139	[p6l553t2270r732b2338],
3	1-3	CD	NUMBER	1-3	num	4	SENT_139	[p6l768t2273r879b2324],
4	neuropathy	NN	O	neuropathy	nsubj	5	SENT_139	[p6l915t2270r1290b2338],
5	happened	VBD	O	happen	_	0	SENT_139	[p6l1321t2270r1638b2338],
6	to	TO	O	to	_	0	SENT_139	[p6l1671t2278r1732b2324],
7	126	CD	PERCENT	126	num	8	SENT_139	[p6l1769t2273r1883b2325],
8	(	CD	PERCENT	(	prep_to	5	SENT_139	[p6l1916t2270r2146b2338],
9	61.8	CD	PERCENT	61.8	num	10	SENT_139	[p6l1916t2270r2146b2338],
10	%	NN	PERCENT	%	tmod	5	SENT_139	[p6l1916t2270r2146b2338],
11	)	CD	NUMBER	)	num	12	SENT_139	[p6l1916t2270r2146b2338],
12	patients	NNS	O	patient	dep	10	SENT_139	[p6l10t2358r284b2425],
13	.	.	O	.	_	0	SENT_139	[p6l10t2358r284b2425],

1	After	IN	O	after	_	0	SENT_140	[p6l317t2357r479b2412],
2	treatment	NN	O	treatment	prep_after	10	SENT_140	[p6l511t2366r835b2412],
3	of	IN	O	of	_	0	SENT_140	[p6l868t2357r934b2412],
4	two	CD	NUMBER	two	num	5	SENT_140	[p6l960t2366r1082b2412],
5	cycles	NNS	O	cycle	prep_of	2	SENT_140	[p6l1117t2358r1324b2425],
6	,	,	O	,	_	0	SENT_140	[p6l1117t2358r1324b2425],
7	chemotherapy	NN	O	chemotherapy	nn	8	SENT_140	[p6l1359t2358r1828b2425],
8	response	NN	O	response	nsubjpass	10	SENT_140	[p6l1861t2373r2146b2425],
9	was	VBD	O	be	auxpass	10	SENT_140	[p6l8t2462r132b2500],
10	assessed	VBN	O	assess	_	0	SENT_140	[p6l155t2446r445b2501],
11	.	.	O	.	_	0	SENT_140	[p6l155t2446r445b2501],

1	All	DT	O	all	det	4	SENT_141	[p6l466t2446r552b2499],
2	basic	JJ	O	basic	amod	4	SENT_141	[p6l574t2446r735b2500],
3	clinical	JJ	O	clinical	amod	4	SENT_141	[p6l757t2446r983b2500],
4	data	NNS	O	datum	nsubjpass	6	SENT_141	[p6l1006t2446r1143b2500],
5	was	VBD	O	be	auxpass	6	SENT_141	[p6l1163t2462r1288b2500],
6	shown	VBN	O	show	_	0	SENT_141	[p6l1312t2446r1525b2500],
7	in	IN	O	in	_	0	SENT_141	[p6l1547t2447r1606b2499],
8	Table	NNP	O	Table	prep_in	6	SENT_141	[p6l1625t2446r1798b2500],
9	1	CD	NUMBER	1	num	8	SENT_141	[p6l1824t2449r1872b2501],
10	.	.	O	.	_	0	SENT_141	[p6l1824t2449r1872b2501],

1	3.2	CD	NUMBER	3.2	_	0	SENT_142	[p6l6t2657r111b2709],
2	.	.	O	.	_	0	SENT_142	[p6l6t2657r111b2709],

1	Association	NNP	O	Association	_	0	SENT_143	[p6l156t2656r508b2709],
2	between	IN	O	between	_	0	SENT_143	[p6l531t2655r788b2709],
3	CTR1	NN	O	ctr1	nn	4	SENT_143	[p6l812t2657r957b2709],
4	rs10981694	NN	O	rs10981694	prep_between	1	SENT_143	[p6l987t2657r1350b2709],
5	polymorphism	NN	O	polymorphism	nn	9	SENT_143	[p6l1368t2654r1816b2722],
6	and	CC	O	and	_	0	SENT_143	[p6l1839t2655r1953b2709],
7	severe	JJ	O	severe	conj_and	5	SENT_143	[p6l6t2757r200b2796],
8	cisplatin	NN	O	cisplatin	nn	9	SENT_143	[p6l222t2742r479b2809],
9	toxicity	NN	O	toxicity	dep	1	SENT_143	[p6l504t2743r730b2809],
10	in	IN	O	in	_	0	SENT_143	[p6l752t2743r806b2796],
11	NSCLC	NN	O	nsclc	nn	12	SENT_143	[p6l827t2745r1029b2796],
12	patients	NNS	O	patient	prep_in	9	SENT_143	[p6l1041t2743r1293b2809],

1	In	IN	O	in	_	0	SENT_144	[p6l111t2923r171b2973],
2	general	JJ	O	general	prep_in	5	SENT_144	[p6l194t2919r448b2987],
3	,	,	O	,	_	0	SENT_144	[p6l194t2919r448b2987],
4	there	EX	O	there	expl	5	SENT_144	[p6l472t2919r640b2973],
5	were	VBD	O	be	_	0	SENT_144	[p6l662t2935r823b2973],
6	142	CD	PERCENT	142	dep	5	SENT_144	[p6l850t2922r963b2973],
7	(	CD	PERCENT	(	number	8	SENT_144	[p6l989t2919r1219b2986],
8	69.6	CD	PERCENT	69.6	num	9	SENT_144	[p6l989t2919r1219b2986],
9	%	NN	PERCENT	%	dobj	6	SENT_144	[p6l989t2919r1219b2986],
10	)	CD	NUMBER	)	num	11	SENT_144	[p6l989t2919r1219b2986],
11	AA	NN	O	aa	dep	9	SENT_144	[p6l1241t2921r1334b2973],
12	wide	JJ	O	wide	amod	14	SENT_144	[p6l1354t2919r1511b2973],
13	type	NN	O	type	nn	14	SENT_144	[p6l1535t2927r1675b2987],
14	homozygotes	NNS	O	homozygote	dep	9	SENT_144	[p6l1700t2919r2146b2987],
15	,	,	O	,	_	0	SENT_144	[p6l1700t2919r2146b2987],
16	61	CD	PERCENT	61	conj_and	9	SENT_144	[p6l10t3009r78b3060],
17	(	CD	PERCENT	(	number	18	SENT_144	[p6l103t3006r333b3073],
18	29.9	CD	PERCENT	29.9	num	19	SENT_144	[p6l103t3006r333b3073],
19	%	NN	PERCENT	%	dep	16	SENT_144	[p6l103t3006r333b3073],
20	)	CD	NUMBER	)	num	23	SENT_144	[p6l103t3006r333b3073],
21	AC	NN	ORGANIZATION	ac	nn	23	SENT_144	[p6l347t3008r435b3060],
22	wide	JJ	O	wide	amod	23	SENT_144	[p6l449t3006r606b3060],
23	heterozygotes	NNS	O	heterozygote	dep	16	SENT_144	[p6l623t3006r1076b3074],
24	and	CC	O	and	_	0	SENT_144	[p6l1094t3006r1210b3060],
25	only	RB	O	only	quantmod	27	SENT_144	[p6l1227t3006r1367b3074],
26	one	CD	PERCENT	one	number	27	SENT_144	[p6l1381t3022r1496b3060],
27	(	CD	PERCENT	(	conj_and	9	SENT_144	[p6l1513t3006r1702b3074],
28	0.5	CD	PERCENT	0.5	num	29	SENT_144	[p6l1513t3006r1702b3074],
29	%	NN	PERCENT	%	dep	27	SENT_144	[p6l1513t3006r1702b3074],
30	)	CD	NUMBER	)	xcomp	6	SENT_144	[p6l1513t3006r1702b3074],
31	mutated	VBN	O	mutate	partmod	30	SENT_144	[p6l1720t3006r1990b3060],
32	type	NN	O	type	nn	33	SENT_144	[p6l2007t3014r2146b3074],
33	heterozygote	NN	O	heterozygote	dobj	31	SENT_144	[p6l10t3093r432b3161],
34	found	VBN	O	find	partmod	33	SENT_144	[p6l467t3093r652b3148],
35	in	IN	O	in	_	0	SENT_144	[p6l686t3094r745b3147],
36	our	PRP$	O	we	poss	37	SENT_144	[p6l779t3109r887b3148],
37	study	NN	O	study	prep_in	34	SENT_144	[p6l920t3093r1111b3161],
38	.	.	O	.	_	0	SENT_144	[p6l920t3093r1111b3161],

1	Table	NNP	O	Table	nsubj	3	SENT_145	[p6l1143t3093r1315b3147],
2	1	CD	NUMBER	1	num	1	SENT_145	[p6l1353t3096r1377b3147],
3	shows	VBZ	O	show	_	0	SENT_145	[p6l1420t3093r1620b3148],
4	the	DT	O	the	det	5	SENT_145	[p6l1654t3093r1756b3148],
5	association	NN	O	association	dobj	3	SENT_145	[p6l1790t3094r2147b3148],
6	between	IN	O	between	_	0	SENT_145	[p6l9t3181r287b3235],
7	CTR1	NN	O	ctr1	nn	9	SENT_145	[p6l303t3183r457b3235],
8	rs10981694	NN	O	rs10981694	nn	9	SENT_145	[p6l482t3183r865b3235],
9	polymorphism	NN	O	polymorphism	prep_between	5	SENT_145	[p6l881t3181r1356b3248],
10	and	CC	O	and	_	0	SENT_145	[p6l1372t3181r1489b3235],
11	severe	JJ	O	severe	amod	13	SENT_145	[p6l1507t3196r1711b3235],
12	cisplatin	NN	O	cisplatin	nn	13	SENT_145	[p6l1728t3181r2000b3248],
13	toxicity	NN	O	toxicity	prep_between	5	SENT_145	[p6l2016t3189r2146b3235, p6l10t3269r147b3335],
14	in	IN	O	in	_	0	SENT_145	[p6l174t3269r233b3321],
15	NSCLC	NN	O	nsclc	nn	16	SENT_145	[p6l261t3271r466b3322],
16	patients	NNS	O	patient	prep_in	9	SENT_145	[p6l493t3269r768b3335],
17	.	.	O	.	_	0	SENT_145	[p6l493t3269r768b3335],

1	There	EX	O	there	expl	2	SENT_146	[p6l794t3268r977b3322],
2	was	VBD	O	be	_	0	SENT_146	[p6l1004t3283r1128b3322],
3	signiﬁcant	NN	O	signiﬁcant	nn	4	SENT_146	[p6l1159t3268r1493b3335],
4	difference	NN	O	difference	nsubj	2	SENT_146	[p6l1519t3268r1841b3322],
5	between	IN	O	between	_	0	SENT_146	[p6l1869t3268r2147b3322],
6	rs10981694	NN	O	rs10981694	nn	7	SENT_146	[p6l10t3357r392b3408],
7	polymorphisms	NNS	O	polymorphism	prep_between	4	SENT_146	[p6l434t3354r939b3422],
8	and	CC	O	and	_	0	SENT_146	[p6l983t3354r1098b3408],
9	severe	JJ	O	severe	amod	10	SENT_146	[p6l1142t3370r1346b3408],
10	ototoxicity	NN	O	ototoxicity	prep_between	4	SENT_146	[p6l1389t3355r1753b3422],
11	.	.	O	.	_	0	SENT_146	[p6l1389t3355r1753b3422],

1	The	DT	O	the	det	7	SENT_147	[p6l1793t3354r1910b3408],
2	minor	JJ	O	minor	amod	7	SENT_147	[p6l1954t3355r2149b3408],
3	allele	NN	O	allele	nn	7	SENT_147	[p6l9t3441r178b3495],
4	frequency	NN	O	frequency	nn	7	SENT_147	[p6l198t3441r520b3509],
5	(	CD	NUMBER	(	num	7	SENT_147	[p6l536t3441r732b3509],
6	MAF	NN	O	maf	nn	7	SENT_147	[p6l536t3441r732b3509],
7	)	NN	O	)	nsubj	15	SENT_147	[p6l536t3441r732b3509],
8	of	IN	O	of	_	0	SENT_147	[p6l751t3441r817b3495],
9	C	NN	O	c	nn	10	SENT_147	[p6l828t3444r866b3495],
10	allele	NN	O	allele	prep_of	7	SENT_147	[p6l884t3441r1053b3495],
11	in	IN	O	in	_	0	SENT_147	[p6l1072t3442r1131b3495],
12	tolerance	NN	O	tolerance	nn	13	SENT_147	[p6l1148t3441r1447b3495],
13	group	NN	O	group	prep_in	10	SENT_147	[p6l1465t3457r1653b3509],
14	was	VBD	O	be	cop	15	SENT_147	[p6l1670t3457r1794b3495],
15	0.11	CD	NUMBER	0.11	_	0	SENT_147	[p6l1814t3444r1964b3504],
16	,	,	O	,	_	0	SENT_147	[p6l1814t3444r1964b3504],
17	compared	VBN	O	compare	_	0	SENT_147	[p6l1983t3457r2146b3495, p6l10t3528r191b3596],
18	with	IN	O	with	prepc_compared_with	15	SENT_147	[p6l216t3528r365b3582],
19	0.21	CD	NUMBER	0.21	pobj	15	SENT_147	[p6l391t3531r517b3583],
20	in	IN	O	in	_	0	SENT_147	[p6l553t3529r612b3582],
21	severe	JJ	O	severe	amod	22	SENT_147	[p6l639t3544r843b3583],
22	group	NN	O	group	prep_in	19	SENT_147	[p6l869t3544r1073b3596],
23	.	.	O	.	_	0	SENT_147	[p6l869t3544r1073b3596],

1	This	DT	O	this	det	4	SENT_148	[p6l1098t3528r1230b3583],
2	minor	JJ	O	minor	amod	4	SENT_148	[p6l1259t3529r1454b3583],
3	allele	NN	O	allele	nn	4	SENT_148	[p6l1478t3528r1647b3583],
4	frequency	NN	O	frequency	nsubj	7	SENT_148	[p6l1676t3528r1998b3596],
5	was	VBD	O	be	cop	7	SENT_148	[p6l2021t3544r2145b3583],
6	signiﬁcance	NN	O	signiﬁcance	nn	7	SENT_148	[p6l10t3615r387b3683],
7	difference	NN	O	difference	_	0	SENT_148	[p6l408t3615r730b3670],
8	in	IN	O	in	_	0	SENT_148	[p6l751t3616r810b3669],
9	different	JJ	O	different	amod	10	SENT_148	[p6l830t3615r1109b3670],
10	groups	NNS	O	group	prep_in	7	SENT_148	[p6l1127t3631r1362b3683],
11	,	,	O	,	_	0	SENT_148	[p6l1127t3631r1362b3683],
12	with	IN	O	with	_	0	SENT_148	[p6l1382t3616r1530b3670],
13	p	NN	O	p	nsubj	16	SENT_148	[p6l1545t3631r1584b3683],
14	=	JJ	O	=	amod	13	SENT_148	[p6l1601t3638r1634b3655],
15	0.01	CD	NUMBER	0.01	tmod	14	SENT_148	[p6l1651t3618r1776b3670],
16	using	VBG	O	use	prepc_with	7	SENT_148	[p6l1805t3616r1978b3683],
17	Bonferroni	NNP	PERSON	Bonferroni	nn	18	SENT_148	[p6l1997t3619r2146b3670, p6l10t3702r226b3757],
18	correction	NN	O	correction	dobj	16	SENT_148	[p6l261t3703r605b3757],
19	.	.	O	.	_	0	SENT_148	[p6l261t3703r605b3757],

1	After	IN	O	after	_	0	SENT_149	[p6l638t3702r800b3757],
2	maximum	NN	O	maximum	nn	4	SENT_149	[p6l833t3703r1164b3757],
3	(	CD	NUMBER	(	num	4	SENT_149	[p6l1198t3703r1284b3770],
4	T	NN	O	t	prep_after	11	SENT_149	[p6l1198t3703r1284b3770],
5	)	CD	NUMBER	)	num	4	SENT_149	[p6l1198t3703r1284b3770],
6	permutation	NN	O	permutation	nn	9	SENT_149	[p6l1320t3703r1739b3770],
7	,	,	O	,	_	0	SENT_149	[p6l1320t3703r1739b3770],
8	empirical	JJ	O	empirical	amod	9	SENT_149	[p6l1775t3703r2077b3770],
9	p	NN	O	p	nsubjpass	15	SENT_149	[p6l2107t3718r2146b3770],
10	was	VBD	O	be	auxpass	11	SENT_149	[p7l8t32r132b71],
11	o.	VBN	O	o.	_	0	SENT_149	[p7l162t20r295b71],
12	oo	NN	O	oo	dobj	11	SENT_149	[p7l162t20r295b71],
13	and	CC	O	and	_	0	SENT_149	[p7l325t17r441b71],
14	still	RB	O	still	advmod	15	SENT_149	[p7l471t17r586b71],
15	having	VBG	O	have	conj_and	11	SENT_149	[p7l616t17r832b84],
16	statistical	JJ	O	statistical	amod	17	SENT_149	[p7l860t17r1166b71],
17	signiﬁcance	NN	O	signiﬁcance	dobj	15	SENT_149	[p7l1197t17r1589b84],
18	.	.	O	.	_	0	SENT_149	[p7l1197t17r1589b84],

1	The	DT	O	the	det	3	SENT_150	[p7l1616t17r1733b71],
2	odd	JJ	O	odd	amod	3	SENT_150	[p7l1763t17r1881b71],
3	ratio	NN	O	ratio	nsubj	8	SENT_150	[p7l1911t18r2058b71],
4	of	IN	O	of	_	0	SENT_150	[p7l2088t17r2154b71],
5	C	NN	O	c	nn	6	SENT_150	[p7l10t106r48b157],
6	allele	NN	O	allele	prep_of	3	SENT_150	[p7l72t103r241b157],
7	was	VBD	O	be	cop	8	SENT_150	[p7l265t119r390b157],
8	0.47	CD	NUMBER	0.47	_	0	SENT_150	[p7l417t106r549b158],
9	with	IN	O	with	_	0	SENT_150	[p7l575t103r723b157],
10	comparison	NN	O	comparison	prep_with	8	SENT_150	[p7l748t104r1126b171],
11	of	IN	O	of	_	0	SENT_150	[p7l1151t103r1218b157],
12	tolerant	JJ	O	tolerant	amod	15	SENT_150	[p7l1235t103r1491b157],
13	and	CC	O	and	_	0	SENT_150	[p7l1515t103r1631b157],
14	severe	JJ	O	severe	conj_and	12	SENT_150	[p7l1658t119r1862b157],
15	toxicity	NN	O	toxicity	prep_of	10	SENT_150	[p7l1887t104r2145b171],
16	.	.	O	.	_	0	SENT_150	[p7l1887t104r2145b171],

1	These	DT	O	these	det	2	SENT_151	[p7l7t190r192b244],
2	results	NNS	O	result	nsubjpass	6	SENT_151	[p7l214t190r427b244],
3	also	RB	O	also	advmod	6	SENT_151	[p7l450t190r573b244],
4	have	VBP	O	have	aux	6	SENT_151	[p7l596t190r745b244],
5	been	VBN	O	be	auxpass	6	SENT_151	[p7l767t190r921b244],
6	validated	VBN	O	validate	_	0	SENT_151	[p7l941t190r1238b244],
7	in	IN	O	in	_	0	SENT_151	[p7l1261t191r1320b244],
8	genotype	NN	O	genotype	nn	9	SENT_151	[p7l1340t198r1638b258],
9	analysis	NN	O	analysis	prep_in	6	SENT_151	[p7l1660t190r1931b258],
10	.	.	O	.	_	0	SENT_151	[p7l1660t190r1931b258],

1	Fisher	NNP	PERSON	Fisher	nn	3	SENT_152	[p7l1955t190r2149b244],
2	exact	JJ	O	exact	amod	3	SENT_152	[p7l9t285r179b332],
3	test	NN	O	test	nsubj	6	SENT_152	[p7l204t285r322b332],
4	with	IN	O	with	_	0	SENT_152	[p7l346t277r494b331],
5	2df	JJ	O	2df	prep_with	3	SENT_152	[p7l520t277r630b331],
6	showed	VBD	O	show	_	0	SENT_152	[p7l650t277r897b332],
7	p	NN	O	p	nn	8	SENT_152	[p7l920t293r958b345],
8	value	NN	O	value	dobj	6	SENT_152	[p7l984t277r1156b332],
9	as	IN	O	as	_	0	SENT_152	[p7l1183t293r1246b332],
10	0.01	CD	NUMBER	0.01	prep_as	6	SENT_152	[p7l1274t280r1399b332],
11	compared	VBN	O	compare	prep	6	SENT_152	[p7l1434t277r1755b345],
12	these	DT	O	these	det	14	SENT_152	[p7l1782t277r1952b332],
13	three	CD	NUMBER	three	num	14	SENT_152	[p7l1979t277r2146b332],
14	genotypes	NNS	O	genotype	dep	11	SENT_152	[p7l8t373r354b432],
15	.	.	O	.	_	0	SENT_152	[p7l8t373r354b432],

1	p	NN	O	p	nn	2	SENT_153	[p7l380t380r419b432],
2	Value	NN	O	value	_	0	SENT_153	[p7l446t365r628b419],
3	of	IN	O	of	_	0	SENT_153	[p7l658t364r725b419],
4	Cochran	NNP	PERSON	Cochran	prep_of	2	SENT_153	[p7l747t365r1350b432],
5	.	.	O	.	_	0	SENT_153	[p7l747t365r1350b432],

1	—	NN	O	—	_	0	SENT_154	[p7l747t365r1350b432],
2	.	.	O	.	_	0	SENT_154	[p7l747t365r1350b432],

1	Armitage	NN	PERSON	armitage	nn	3	SENT_155	[p7l747t365r1350b432],
2	trend	NN	O	trend	nn	3	SENT_155	[p7l1379t364r1552b419],
3	test	NN	O	test	nsubjpass	5	SENT_155	[p7l1582t373r1700b419],
4	was	VBD	O	be	auxpass	5	SENT_155	[p7l1727t380r1852b419],
5	o.	VBN	O	o.	_	0	SENT_155	[p7l1882t367r2032b419],
6	oo	NN	O	oo	dobj	5	SENT_155	[p7l1882t367r2032b419],
7	.	.	O	.	_	0	SENT_155	[p7l1882t367r2032b419],

1	All	PDT	O	all	predet	3	SENT_156	[p7l2060t365r2146b418],
2	these	DT	O	these	det	3	SENT_156	[p7l9t452r179b506],
3	results	NNS	O	result	nsubj	4	SENT_156	[p7l196t452r409b506],
4	indicated	VBD	O	indicate	_	0	SENT_156	[p7l427t452r724b506],
5	that	IN	O	that	complm	9	SENT_156	[p7l740t452r869b506],
6	C	NN	O	c	nn	8	SENT_156	[p7l884t455r923b506],
7	allele	NN	O	allele	nn	8	SENT_156	[p7l938t452r1107b506],
8	carrier	NN	O	carrier	nsubj	9	SENT_156	[p7l1124t453r1336b506],
9	had	VBD	O	have	ccomp	4	SENT_156	[p7l1351t452r1466b506],
10	greater	JJR	O	greater	amod	11	SENT_156	[p7l1482t460r1714b519],
11	risks	NNS	O	risk	dobj	9	SENT_156	[p7l1729t452r1874b506],
12	of	IN	O	of	_	0	SENT_156	[p7l1892t452r1958b506],
13	experiencing	VBG	O	experience	prepc_of	11	SENT_156	[p7l1967t467r2146b519, p7l10t540r272b606],
14	severe	JJ	O	severe	amod	15	SENT_156	[p7l303t554r507b593],
15	cisplatin	NN	O	cisplatin	nsubj	16	SENT_156	[p7l540t539r812b606],
16	induced	VBD	O	induce	ccomp	13	SENT_156	[p7l845t539r1101b593],
17	ototoxicity	NN	O	ototoxicity	dobj	16	SENT_156	[p7l1133t540r1497b606],
18	.	.	O	.	_	0	SENT_156	[p7l1133t540r1497b606],

1	We	PRP	O	we	nsubj	3	SENT_157	[p7l1527t542r1636b593],
2	also	RB	O	also	advmod	3	SENT_157	[p7l1668t539r1792b593],
3	compared	VBD	O	compare	_	0	SENT_157	[p7l1826t539r2146b606],
4	the	DT	O	the	det	7	SENT_157	[p7l9t625r110b679],
5	rs10981694	NN	O	rs10981694	nn	7	SENT_157	[p7l147t628r529b679],
6	allele	NN	O	allele	nn	7	SENT_157	[p7l564t625r733b679],
7	frequency	NN	O	frequency	dobj	3	SENT_157	[p7l769t625r1091b693],
8	as	RB	O	as	_	0	SENT_157	[p7l1125t641r1187b679],
9	well	RB	O	well	_	0	SENT_157	[p7l1222t625r1358b679],
10	as	IN	O	as	_	0	SENT_157	[p7l1394t641r1456b679],
11	genotype	NN	O	genotype	nn	12	SENT_157	[p7l1492t633r1790b693],
12	frequency	NN	O	frequency	dobj	3	SENT_157	[p7l1826t625r2148b693],
13	in	IN	O	in	_	0	SENT_157	[p7l10t713r69b766],
14	severe	JJ	O	severe	amod	25	SENT_157	[p7l107t728r311b766],
15	and	CC	O	and	_	0	SENT_157	[p7l349t712r465b766],
16	tolerant	JJ	O	tolerant	amod	25	SENT_157	[p7l503t712r759b766],
17	neutropenia	NN	O	neutropenia	nn	25	SENT_157	[p7l797t713r1204b780],
18	,	,	O	,	_	0	SENT_157	[p7l797t713r1204b780],
19	anemia	NN	O	anemia	dep	25	SENT_157	[p7l1242t713r1493b775],
20	,	,	O	,	_	0	SENT_157	[p7l1242t713r1493b775],
21	thrombocytopenia	NN	O	thrombocytopenia	dep	25	SENT_157	[p7l1531t712r2146b780],
22	,	,	O	,	_	0	SENT_157	[p7l1531t712r2146b780],
23	emesis	NN	O	emesis	dep	25	SENT_157	[p7l9t800r244b862],
24	,	,	O	,	_	0	SENT_157	[p7l9t800r244b862],
25	nephrotoxicity	NN	O	nephrotoxicity	prep_in	3	SENT_157	[p7l269t799r759b867],
26	,	,	O	,	_	0	SENT_157	[p7l269t799r759b867],
27	and	CC	O	and	_	0	SENT_157	[p7l784t799r900b854],
28	neuropathy	NN	O	neuropathy	nn	29	SENT_157	[p7l924t799r1299b867],
29	groups	NNS	O	group	conj_and	25	SENT_157	[p7l1319t815r1554b867],
30	.	.	O	.	_	0	SENT_157	[p7l1319t815r1554b867],

1	There	EX	O	there	expl	2	SENT_158	[p7l1576t799r1759b854],
2	was	VBD	O	be	dep	14	SENT_158	[p7l1781t815r1906b854],
3	no	DT	O	no	det	5	SENT_158	[p7l1930t815r2008b853],
4	signiﬁcant	JJ	O	signiﬁcant	amod	5	SENT_158	[p7l2032t800r2146b867, p7l10t886r253b941],
5	association	NN	O	association	nsubj	2	SENT_158	[p7l269t887r626b941],
6	found	VBD	O	find	rcmod	5	SENT_158	[p7l643t886r828b941],
7	between	IN	O	between	_	0	SENT_158	[p7l845t887r1123b941],
8	rs10981694	CD	NUMBER	rs10981694	num	9	SENT_158	[p7l1140t889r1522b941],
9	polymorphism	NN	O	polymorphism	prep_between	6	SENT_158	[p7l1539t887r2013b954],
10	and	CC	O	and	_	0	SENT_158	[p7l2030t887r2146b941],
11	aforementioned	JJ	O	aforementioned	amod	13	SENT_158	[p7l9t974r525b1028],
12	severe	JJ	O	severe	amod	13	SENT_158	[p7l549t989r752b1028],
13	toxicities	NNS	O	toxicity	prep_between	6	SENT_158	[p7l775t975r1068b1028],
14	(	VBP	O	(	_	0	SENT_158	[p7l1091t974r1287b1041],
15	Table	NNP	O	Table	dobj	14	SENT_158	[p7l1091t974r1287b1041],
16	2	CD	NUMBER	2	num	15	SENT_158	[p7l1310t974r1388b1041],
17	)	CD	NUMBER	)	nsubj	14	SENT_158	[p7l1310t974r1388b1041],
18	.	.	O	.	_	0	SENT_158	[p7l1310t974r1388b1041],

1	Tablel	NNP	O	Tablel	nn	4	SENT_159	[p7l9t1056r197b1099],
2	Basic	JJ	O	basic	amod	4	SENT_159	[p7l12t1128r141b1171],
3	clinical	JJ	O	clinical	amod	4	SENT_159	[p7l176t1127r356b1171],
4	characteristic	NN	O	characteristic	nsubj	11	SENT_159	[p7l392t1127r740b1171],
5	of	IN	O	of	_	0	SENT_159	[p7l775t1127r828b1171],
6	non-small	JJ	O	non-small	amod	10	SENT_159	[p7l858t1127r1117b1171],
7	cell	NN	O	cell	nn	10	SENT_159	[p7l1153t1127r1239b1171],
8	lung	NN	O	lung	nn	10	SENT_159	[p7l1276t1127r1388b1181],
9	cancer	NN	O	cancer	nn	10	SENT_159	[p7l1423t1140r1590b1171],
10	patients	NNS	O	patient	prep_of	4	SENT_159	[p7l1624t1128r1830b1181],
11	treated	VBN	O	treat	_	0	SENT_159	[p7l1866t1127r2050b1171],
12	by	IN	O	by	_	0	SENT_159	[p7l2085t1127r2147b1181],
13	cisplatin-based	JJ	O	cisplatin-based	amod	14	SENT_159	[p7l12t1197r402b1252],
14	chemotherapy	NN	O	chemotherapy	prep_by	11	SENT_159	[p7l420t1197r805b1252],
15	.	.	O	.	_	0	SENT_159	[p7l420t1197r805b1252],

1	Characteristic	JJ	O	characteristic	amod	2	SENT_160	[p7l63t1333r416b1377],
2	Patients	NNS	O	patient	dep	3	SENT_160	[p7l1211t1334r1415b1377],
3	(	VBP	O	(	_	0	SENT_160	[p7l1434t1334r1483b1388],
4	n	NN	O	n	nsubj	5	SENT_160	[p7l1434t1334r1483b1388],
5	=	JJ	O	=	xcomp	3	SENT_160	[p7l1497t1352r1523b1365],
6	204	CD	NUMBER	204	num	7	SENT_160	[p7l1536t1334r1651b1387],
7	)	NN	O	)	nsubj	3	SENT_160	[p7l1536t1334r1651b1387],

1	No.	NN	PERCENT	no.	nn	2	SENT_161	[p7l1211t1474r1293b1515],
2	%	NN	PERCENT	%	_	0	SENT_161	[p7l1983t1473r2015b1515],

1	Age	NNP	O	Age	_	0	SENT_162	[p7l60t1583r168b1635],
2	,	,	O	,	_	0	SENT_162	[p7l60t1583r168b1635],
3	years	NNS	DURATION	year	appos	1	SENT_162	[p7l185t1593r320b1635],
4	:50	CD	NUMBER	:50	number	5	SENT_162	[p7l64t1654r164b1702],
5	67	CD	NUMBER	67	dep	10	SENT_162	[p7l1244t1654r1304b1696],
6	32.8	CD	NUMBER	32.8	number	7	SENT_162	[p7l1982t1654r2089b1696],
7	60-50	CD	NUMBER	60-50	num	9	SENT_162	[p7l63t1727r221b1768],
8	77	CD	NUMBER	77	number	9	SENT_162	[p7l1244t1727r1304b1768],
9	37.7	CD	NUMBER	37.7	npadvmod	10	SENT_162	[p7l1982t1727r2089b1769],
10	>	JJR	O	>	amod	3	SENT_162	[p7l63t1798r154b1840],
11	60	CD	NUMBER	60	number	12	SENT_162	[p7l63t1798r154b1840],
12	60	CD	NUMBER	60	num	3	SENT_162	[p7l1244t1798r1305b1840],
13	29.4	CD	NUMBER	29.4	num	14	SENT_162	[p7l1983t1798r2091b1840],
14	Sex	NN	O	sex	npadvmod	15	SENT_162	[p7l63t1870r151b1911],
15	Female	JJ	O	female	amod	3	SENT_162	[p7l63t1940r245b1983],
16	61	CD	NUMBER	61	number	17	SENT_162	[p7l1244t1942r1298b1983],
17	29.9	CD	NUMBER	29.9	num	18	SENT_162	[p7l1983t1942r2090b1984],
18	Male	NN	O	male	nsubj	22	SENT_162	[p7l63t2012r187b2056],
19	143	CD	NUMBER	143	number	20	SENT_162	[p7l1214t2014r1302b2056],
20	70.1	CD	NUMBER	70.1	dep	21	SENT_162	[p7l1984t2014r2084b2056],
21	Smoking	NN	O	smoking	dep	18	SENT_162	[p7l63t2083r287b2137],
22	status	NN	O	status	rcmod	3	SENT_162	[p7l304t2089r454b2126],
23	Yes	UH	O	yes	dep	24	SENT_162	[p7l60t2158r147b2199],
24	1	CD	NUMBER	1	dobj	22	SENT_162	[p7l1213t2157r1233b2198],
25	41	CD	NUMBER	41	number	26	SENT_162	[p7l1242t2157r1299b2198],
26	69.1	CD	NUMBER	69.1	dep	22	SENT_162	[p7l1984t2157r2084b2199],
27	No	DT	O	no	det	30	SENT_162	[p7l63t2229r132b2270],
28	63	CD	NUMBER	63	number	29	SENT_162	[p7l1244t2229r1302b2270],
29	30.9	CD	NUMBER	30.9	num	30	SENT_162	[p7l1982t2229r2090b2270],
30	Pack	NN	O	pack	nsubj	33	SENT_162	[p7l63t2298r338b2352],
31	—	CD	NUMBER	—	num	32	SENT_162	[p7l63t2298r338b2352],
32	years	NNS	NUMBER	year	tmod	30	SENT_162	[p7l63t2298r338b2352],
33	smoked	VBN	O	smoke	rcmod	26	SENT_162	[p7l358t2298r557b2341],
34	525	CD	NUMBER	525	dobj	33	SENT_162	[p7l64t2371r162b2419],
35	72	CD	NUMBER	72	number	36	SENT_162	[p7l1244t2371r1303b2412],
36	35.3	CD	NUMBER	35.3	npadvmod	37	SENT_162	[p7l1982t2371r2088b2413],
37	>	JJR	O	>	amod	34	SENT_162	[p7l63t2443r153b2484],
38	25	CD	NUMBER	25	num	39	SENT_162	[p7l63t2443r153b2484],
39	69	CD	NUMBER	69	dep	70	SENT_162	[p7l1244t2443r1304b2484],
40	33.8	CD	NUMBER	33.8	num	42	SENT_162	[p7l1982t2443r2089b2485],
41	Family	NNP	O	Family	nn	42	SENT_162	[p7l63t2512r235b2566],
42	history	NN	O	history	dep	39	SENT_162	[p7l252t2512r432b2566],
43	of	IN	O	of	_	0	SENT_162	[p7l449t2512r502b2556],
44	cancer	NN	O	cancer	prep_of	42	SENT_162	[p7l514t2525r681b2556],
45	Yes	UH	O	yes	dep	44	SENT_162	[p7l60t2586r147b2627],
46	2	CD	NUMBER	2	num	47	SENT_162	[p7l1276t2586r1303b2627],
47	1.0	CD	NUMBER	1.0	dep	63	SENT_162	[p7l2018t2586r2090b2628],
48	No	DT	O	no	det	52	SENT_162	[p7l63t2659r132b2699],
49	202	NN	NUMBER	202	nn	52	SENT_162	[p7l1211t2658r1303b2699],
50	99.0	CD	NUMBER	99.0	num	52	SENT_162	[p7l1983t2658r2090b2700],
51	Stage	NN	O	stage	nn	52	SENT_162	[p7l63t2729r198b2782],
52	IIIA	NN	O	iium	dep	47	SENT_162	[p7l63t2801r150b2842],
53	71	CD	NUMBER	71	number	54	SENT_162	[p7l1244t2801r1298b2842],
54	34.8	CD	NUMBER	34.8	dep	52	SENT_162	[p7l1982t2801r2089b2843],
55	IIIB	NN	O	iiib	dep	63	SENT_162	[p7l63t2874r144b2914],
56	75	CD	NUMBER	75	num	55	SENT_162	[p7l1244t2874r1303b2915],
57	36.8	CD	NUMBER	36.8	number	58	SENT_162	[p7l1982t2873r2089b2915],
58	IV	CD	NUMBER	iv	num	60	SENT_162	[p7l63t2945r115b2986],
59	58	CD	NUMBER	58	number	60	SENT_162	[p7l1244t2945r1303b2986],
60	28.4	CD	NUMBER	28.4	npadvmod	61	SENT_162	[p7l1983t2945r2091b2986],
61	Severe	JJ	O	severe	amod	63	SENT_162	[p7l63t3016r230b3057],
62	toxicitya	NN	O	toxicitya	nn	63	SENT_162	[p7l248t3015r463b3068],
63	Neutropenia	NN	O	neutropenia	dep	42	SENT_162	[p7l63t3086r384b3140],
64	1	CD	NUMBER	1	dep	63	SENT_162	[p7l1213t3088r1233b3128],
65	21	CD	NUMBER	21	number	66	SENT_162	[p7l1243t3087r1298b3128],
66	59.3	CD	NUMBER	59.3	amod	42	SENT_162	[p7l1984t3087r2088b3129],
67	Anemia	NN	O	anemia	dep	70	SENT_162	[p7l60t3157r258b3200],
68	1	CD	NUMBER	1	num	67	SENT_162	[p7l1213t3159r1233b3200],
69	37	CD	NUMBER	37	num	70	SENT_162	[p7l1242t3159r1304b3200],
70	67.2	CD	NUMBER	67.2	dep	78	SENT_162	[p7l1984t3159r2089b3201],
71	Thrombocytopenia	NNP	O	Thrombocytopenia	dep	70	SENT_162	[p7l60t3228r551b3282],
72	1	CD	NUMBER	1	num	71	SENT_162	[p7l1213t3230r1233b3271],
73	76	CD	NUMBER	76	number	74	SENT_162	[p7l1244t3230r1305b3272],
74	86.3	CD	NUMBER	86.3	num	75	SENT_162	[p7l1984t3230r2088b3272],
75	Emesis	NN	O	emesis	dep	71	SENT_162	[p7l63t3300r239b3343],
76	168	CD	NUMBER	168	number	77	SENT_162	[p7l1214t3302r1303b3343],
77	82.4	CD	NUMBER	82.4	num	75	SENT_162	[p7l1984t3302r2091b3344],
78	Nephrotoxicity	NN	O	nephrotoxicity	dep	81	SENT_162	[p7l63t3371r451b3425],
79	104	CD	NUMBER	104	num	78	SENT_162	[p7l1214t3373r1305b3414],
80	51.0	CD	NUMBER	51.0	num	81	SENT_162	[p7l1984t3373r2090b3415],
81	Ototoxicity	NN	O	ototoxicity	dep	87	SENT_162	[p7l63t3443r350b3497],
82	88	CD	NUMBER	88	number	83	SENT_162	[p7l1244t3444r1303b3486],
83	43.1	CD	NUMBER	43.1	num	84	SENT_162	[p7l1982t3444r2084b3486],
84	Neuropathy	NN	O	neuropathy	dep	81	SENT_162	[p7l63t3513r369b3567],
85	1	CD	NUMBER	1	num	86	SENT_162	[p7l1213t3515r1233b3556],
86	26	CD	NUMBER	26	dep	84	SENT_162	[p7l1243t3515r1305b3556],
87	61.8	CD	NUMBER	61.8	dep	34	SENT_162	[p7l1984t3515r2089b3557],

1	a	DT	O	a	det	3	SENT_163	[p8l62t22r81b44],
2	Severe	JJ	O	severe	amod	3	SENT_163	[p8l113t23r281b64],
3	toxicity	NN	O	toxicity	_	0	SENT_163	[p8l307t21r516b75],
4	:	:	O	:	_	0	SENT_163	[p8l307t21r516b75],
5	grade	NN	O	grade	dep	3	SENT_163	[p8l545t20r688b75],
6	3-4	CD	NUMBER	3-4	num	5	SENT_163	[p8l714t23r809b64],
7	of	IN	O	of	_	0	SENT_163	[p8l835t20r888b64],
8	neutropenia	NN	O	neutropenia	prep_of	5	SENT_163	[p8l908t21r1233b75],
9	,	,	O	,	_	0	SENT_163	[p8l908t21r1233b75],
10	anemia	NN	O	anemia	appos	3	SENT_163	[p8l1260t21r1460b71],
11	,	,	O	,	_	0	SENT_163	[p8l1260t21r1460b71],
12	thrombocytopenia	NN	O	thrombocytopenia	appos	3	SENT_163	[p8l1486t20r1977b75],
13	,	,	O	,	_	0	SENT_163	[p8l1486t20r1977b75],
14	grade	NN	O	grade	appos	3	SENT_163	[p8l2003t20r2146b75],
15	3-4	CD	NUMBER	3-4	num	14	SENT_163	[p8l11t94r106b135],
16	of	IN	O	of	_	0	SENT_163	[p8l132t92r186b135],
17	emesis	NN	O	emesis	prep_of	14	SENT_163	[p8l206t93r393b142],
18	,	,	O	,	_	0	SENT_163	[p8l206t93r393b142],
19	grade	NN	O	grade	appos	3	SENT_163	[p8l419t92r562b146],
20	1-4	CD	NUMBER	1-4	num	19	SENT_163	[p8l591t94r683b135],
21	of	IN	O	of	_	0	SENT_163	[p8l710t92r763b135],
22	ototoxicity	NN	O	ototoxicity	nn	26	SENT_163	[p8l783t93r1073b146],
23	,	,	O	,	_	0	SENT_163	[p8l783t93r1073b146],
24	grade	NN	O	grade	dep	26	SENT_163	[p8l1099t92r1243b146],
25	1-4	CD	NUMBER	1-4	num	26	SENT_163	[p8l1272t94r1364b135],
26	nephrotoxicity	NN	O	nephrotoxicity	prep_of	19	SENT_163	[p8l1390t92r1782b146],
27	,	,	O	,	_	0	SENT_163	[p8l1390t92r1782b146],
28	grade	NN	O	grade	appos	3	SENT_163	[p8l1808t92r1951b146],
29	1-3	CD	NUMBER	1-3	num	28	SENT_163	[p8l1981t94r2070b135],
30	of	IN	O	of	_	0	SENT_163	[p8l2099t92r2152b135],
31	neuropathy	NN	O	neuropathy	prep_of	28	SENT_163	[p8l12t163r322b218],
32	.	.	O	.	_	0	SENT_163	[p8l12t163r322b218],

1	3.3	CD	NUMBER	3.3	_	0	SENT_164	[p8l9t374r114b426],
2	.	.	O	.	_	0	SENT_164	[p8l9t374r114b426],

1	Survival	NN	O	survival	nn	2	SENT_165	[p8l162t371r414b426],
2	analysis	NN	O	analysis	nsubj	9	SENT_165	[p8l435t371r680b439],
3	of	IN	O	of	_	0	SENT_165	[p8l702t371r769b439],
4	rs10981694	NN	O	rs10981694	nn	5	SENT_165	[p8l779t374r1142b426],
5	polymorphisms	NNS	O	polymorphism	prep_of	2	SENT_165	[p8l1159t371r1637b439],
6	in	IN	O	in	_	0	SENT_165	[p8l1659t372r1714b426],
7	NSCLC	NN	O	nsclc	nn	8	SENT_165	[p8l1735t374r1936b426],
8	patients	NNS	O	patient	prep_in	5	SENT_165	[p8l7t460r258b526],
9	accepted	VBD	O	accept	_	0	SENT_165	[p8l279t459r548b526],
10	cisplatin-based	JJ	O	cisplatin-based	amod	11	SENT_165	[p8l569t458r1033b526],
11	chemotherapy	NN	O	chemotherapy	dobj	9	SENT_165	[p8l1055t459r1495b526],

1	All	DT	O	all	det	2	SENT_166	[p8l111t636r197b690],
2	patients	NNS	O	patient	nsubjpass	4	SENT_166	[p8l217t637r474b704],
3	were	VBD	O	be	auxpass	4	SENT_166	[p8l493t652r654b690],
4	followed	VBN	O	follow	_	0	SENT_166	[p8l674t636r953b690],
5	up	RB	O	up	advmod	4	SENT_166	[p8l973t652r1052b704],
6	and	CC	O	and	_	0	SENT_166	[p8l1072t636r1188b690],
7	survival	NN	O	survival	nn	8	SENT_166	[p8l1209t636r1461b690],
8	information	NN	O	information	nsubjpass	10	SENT_166	[p8l1481t636r1864b690],
9	was	VBD	O	be	auxpass	10	SENT_166	[p8l1882t652r2006b690],
10	collected	VBN	O	collect	conj_and	4	SENT_166	[p8l2026t636r2145b690, p8l13t723r220b786],
11	,	,	O	,	_	0	SENT_166	[p8l2026t636r2145b690, p8l13t723r220b786],
12	with	IN	O	with	_	0	SENT_166	[p8l243t723r391b777],
13	median	JJ	O	median	amod	15	SENT_166	[p8l415t723r655b777],
14	follow-up	JJ	O	follow-up	amod	15	SENT_166	[p8l679t723r992b791],
15	time	NN	O	time	prep_with	10	SENT_166	[p8l1016t724r1161b777],
16	25	CD	DURATION	25	num	17	SENT_166	[p8l1186t726r1260b777],
17	months	NNS	NUMBER	month	tmod	15	SENT_166	[p8l1287t723r1529b777],
18	(	RB	O	(	advmod	19	SENT_166	[p8l1554t723r1825b791],
19	ranging	VBG	O	range	partmod	15	SENT_166	[p8l1554t723r1825b791],
20	from	IN	O	from	_	0	SENT_166	[p8l1848t723r2000b777],
21	2	CD	DURATION	2	number	23	SENT_166	[p8l2024t726r2058b777],
22	to	TO	DURATION	to	dep	23	SENT_166	[p8l2083t731r2145b777],
23	79	CD	DURATION	79	num	24	SENT_166	[p8l13t813r88b865],
24	months	NNS	NUMBER	month	prep_from	19	SENT_166	[p8l120t810r404b878],
25	)	RB	O	)	advmod	19	SENT_166	[p8l120t810r404b878],
26	.	.	O	.	_	0	SENT_166	[p8l120t810r404b878],

1	The	DT	O	the	det	2	SENT_167	[p8l433t810r549b865],
2	results	NNS	O	result	nsubj	5	SENT_167	[p8l581t810r793b865],
3	of	IN	O	of	_	0	SENT_167	[p8l825t810r891b865],
4	I	PRP	O	I	prep_of	2	SENT_167	[p8l914t810r1366b878],
5	(	VBP	O	(	_	0	SENT_167	[p8l914t810r1366b878],
6	aplan	NN	O	aplan	dobj	5	SENT_167	[p8l914t810r1366b878],
7	.	.	O	.	_	0	SENT_167	[p8l914t810r1366b878],

1	—	NN	O	—	_	0	SENT_168	[p8l914t810r1366b878],
2	.	.	O	.	_	0	SENT_168	[p8l914t810r1366b878],

1	Meier	JJR	PERSON	meier	amod	2	SENT_169	[p8l914t810r1366b878],
2	survival	NN	O	survival	nsubjpass	5	SENT_169	[p8l1395t810r1646b865],
3	test	NN	O	test	dep	2	SENT_169	[p8l1677t818r1795b865],
4	were	VBD	O	be	auxpass	5	SENT_169	[p8l1822t826r1982b865],
5	presented	VBN	O	present	_	0	SENT_169	[p8l2013t826r2145b878, p8l13t897r223b952],
6	in	IN	O	in	_	0	SENT_169	[p8l258t898r317b951],
7	Fig	NN	O	fig	prep_in	5	SENT_169	[p8l351t898r456b965],
8	.	.	O	.	_	0	SENT_169	[p8l351t898r456b965],

1	1	LS	NUMBER	1	_	0	SENT_170	[p8l494t901r543b952],
2	.	.	O	.	_	0	SENT_170	[p8l494t901r543b952],

1	Overall	JJ	O	overall	amod	4	SENT_171	[p8l578t897r806b952],
2	median	JJ	O	median	amod	4	SENT_171	[p8l840t898r1080b952],
3	survival	NN	O	survival	nn	4	SENT_171	[p8l1114t898r1366b952],
4	time	NN	O	time	nsubj	11	SENT_171	[p8l1400t898r1544b952],
5	in	IN	O	in	_	0	SENT_171	[p8l1580t898r1638b951],
6	our	PRP$	O	we	poss	7	SENT_171	[p8l1672t913r1780b952],
7	study	NN	O	study	prep_in	4	SENT_171	[p8l1813t898r1990b965],
8	was	VBD	O	be	cop	11	SENT_171	[p8l2020t913r2144b952],
9	rs1	CD	NUMBER	rs1	num	11	SENT_171	[p8l1535t1231r1593b1274],
10	121931594	CD	NUMBER	121931594	num	11	SENT_171	[p8l1602t1228r1801b1274],
11	genotype	NN	O	genotype	_	0	SENT_171	[p8l1562t1286r1774b1338],

1	.	.	O	.	_	0	SENT_172	[p8l1437t1366r1590b1406],

1	_	RB	O	_	dep	2	SENT_173	[p8l1437t1366r1590b1406],
2	Fl	NN	O	fl	dep	4	SENT_173	[p8l1437t1366r1590b1406],
3	=	JJ	O	=	amod	4	SENT_173	[p8l1437t1366r1590b1406],
4	AA	NN	O	aa	dep	7	SENT_173	[p8l1437t1366r1590b1406],
5	-	:	O	-	_	0	SENT_173	[p8l1440t1424r1553b1461],
6	WC	NN	PERSON	wc	nn	7	SENT_173	[p8l1440t1424r1553b1461],
7	Ganrieri	NN	PERSON	ganrierus	_	0	SENT_173	[p8l1566t1424r1697b1461],
8	!	.	O	!	_	0	SENT_173	[p8l1437t1473r1590b1516],

1	l	NN	O	l	_	0	SENT_174	[p8l1437t1473r1590b1516],
2	!	.	O	!	_	0	SENT_174	[p8l1437t1473r1590b1516],

1	AA	NN	O	aa	nsubj	2	SENT_175	[p8l1437t1473r1590b1516],
2	censured	VBD	O	censure	_	0	SENT_175	[p8l1602t1479r1789b1516],
3	+	CC	O	+	_	0	SENT_175	[p8l1440t1528r1516b1565],
4	-	:	O	-	_	0	SENT_175	[p8l1440t1528r1516b1565],
5	C	NN	O	c	dep	2	SENT_175	[p8l1526t1531r1553b1568],
6	aamrier	NN	O	aamrier	dep	5	SENT_175	[p8l1565t1531r1694b1568],
7	censored	VBD	O	censor	conj_+	2	SENT_175	[p8l1709t1531r1893b1568],

1	Cum	NNP	O	Cum	nn	2	SENT_176	[p8l160t2013r206b2139],
2	Survival	NNP	O	Survival	_	0	SENT_176	[p8l160t1757r206b1992],
3	no	DT	O	no	det	6	SENT_176	[p8l396t2817r454b2854],
4	man	NN	O	man	nn	6	SENT_176	[p8l741t2817r849b2854],
5	4U	NN	O	4u	nn	6	SENT_176	[p8l1109t2817r1220b2854],
6	*	NN	O	*	dep	2	SENT_176	[p8l1109t2817r1220b2854],
7	.	.	O	.	_	0	SENT_176	[p8l1109t2817r1220b2854],

1	.	.	O	.	_	0	SENT_177	[p8l1109t2817r1220b2854],

1	ﬂU	NN	O	ﬂu	_	0	SENT_178	[p8l1109t2817r1220b2854],
2	’	CD	NUMBER	’	num	4	SENT_178	[p8l1109t2817r1220b2854],
3	sultan	NN	O	sultan	nn	4	SENT_178	[p8l1483t2787r1590b2854],
4	ammo	NN	O	ammo	dep	1	SENT_178	[p8l1853t2817r1963b2854],

1	Survéival	JJ	O	survéival	amod	3	SENT_179	[p8l851t2903r1085b2952],
2	Tiime	NN	O	tiime	nn	3	SENT_179	[p8l1106t2903r1241b2952],
3	«	NN	O	«	_	0	SENT_179	[p8l1263t2903r1480b2964],
4	(	CD	NUMBER	(	num	6	SENT_179	[p8l1263t2903r1480b2964],
5	M-amh	JJ	O	m-amh	amod	6	SENT_179	[p8l1263t2903r1480b2964],
6	)	NN	O	)	dep	3	SENT_179	[p8l1263t2903r1480b2964],

1	Fig	NN	O	fig	_	0	SENT_180	[p8l11t3061r104b3116],
2	.	.	O	.	_	0	SENT_180	[p8l11t3061r104b3116],

1	1	LS	NUMBER	1	_	0	SENT_181	[p8l129t3064r172b3105],
2	.	.	O	.	_	0	SENT_181	[p8l129t3064r172b3105],

1	I	PRP	O	I	nsubj	2	SENT_182	[p8l205t3061r566b3116],
2	(	VBP	O	(	_	0	SENT_182	[p8l205t3061r566b3116],
3	aplan	NN	O	aplan	dobj	2	SENT_182	[p8l205t3061r566b3116],
4	.	.	O	.	_	0	SENT_182	[p8l205t3061r566b3116],

1	—	NN	O	—	_	0	SENT_183	[p8l205t3061r566b3116],
2	.	.	O	.	_	0	SENT_183	[p8l205t3061r566b3116],

1	Meier	JJR	PERSON	meier	amod	2	SENT_184	[p8l205t3061r566b3116],
2	analysis	NN	O	analysis	nsubj	19	SENT_184	[p8l589t3061r793b3116],
3	between	IN	O	between	_	0	SENT_184	[p8l818t3061r1040b3105],
4	CTR1	NN	O	ctr1	nn	6	SENT_184	[p8l1065t3063r1181b3105],
5	genetic	JJ	O	genetic	amod	6	SENT_184	[p8l1210t3062r1397b3116],
6	polymorphism	NN	O	polymorphism	prep_between	2	SENT_184	[p8l1422t3061r1801b3116],
7	and	CC	O	and	_	0	SENT_184	[p8l1825t3061r1918b3105],
8	survival	NN	O	survival	nn	9	SENT_184	[p8l1944t3061r2145b3105],
9	time	NN	O	time	prep_between	2	SENT_184	[p8l11t3133r127b3176],
10	in	IN	O	in	_	0	SENT_184	[p8l163t3133r210b3176],
11	non-small	JJ	O	non-small	amod	16	SENT_184	[p8l246t3133r505b3176],
12	cell	NN	O	cell	nn	16	SENT_184	[p8l540t3133r626b3176],
13	lung	NN	O	lung	nn	16	SENT_184	[p8l663t3133r775b3187],
14	cancer	NN	O	cancer	nn	16	SENT_184	[p8l809t3145r977b3176],
15	(	CD	NUMBER	(	num	16	SENT_184	[p8l1011t3133r1216b3187],
16	NSCLC	NN	O	nsclc	prep_in	9	SENT_184	[p8l1011t3133r1216b3187],
17	)	CD	NUMBER	)	num	18	SENT_184	[p8l1011t3133r1216b3187],
18	patients	NNS	O	patient	dep	9	SENT_184	[p8l1251t3133r1457b3187],
19	accepted	VBD	O	accept	_	0	SENT_184	[p8l1493t3133r1720b3187],
20	cisplatin-based	JJ	O	cisplatin-based	amod	21	SENT_184	[p8l1755t3133r2145b3187],
21	chemotherapy	NN	O	chemotherapy	dobj	19	SENT_184	[p8l12t3204r397b3258],
22	.	.	O	.	_	0	SENT_184	[p8l12t3204r397b3258],

1	X.	NNP	O	X.	nn	2	SENT_185	[p8l799t3334r821b3355],
2	Xu	NNP	O	Xu	_	0	SENT_185	[p8l829t3334r862b3355],
3	et	FW	O	et	nn	4	SENT_185	[p8l871t3336r894b3355],
4	al.	FW	O	al.	dep	2	SENT_185	[p8l901t3333r926b3355],
5	/	:	O	/	punct	2	SENT_185	[p8l933t3333r945b3360],
6	Lung	NN	O	lung	nn	7	SENT_185	[p8l951t3334r1011b3360],
7	Cancer	NN	O	cancer	dep	2	SENT_185	[p8l1018t3334r1101b3355],
8	77	CD	NUMBER	77	number	9	SENT_185	[p8l1109t3334r1138b3355],
9	(	CD	NUMBER	(	num	10	SENT_185	[p8l1145t3333r1226b3360],
10	2012	CD	DATE	2012	dep	7	SENT_185	[p8l1145t3333r1226b3360],
11	)	CD	NUMBER	)	number	12	SENT_185	[p8l1145t3333r1226b3360],
12	438-442 441	CD	NUMBER	438-442 441	num	10	SENT_185	[p8l2110t3334r2154b3355],[p8l1233t3334r1340b3355],

1	Table	NNP	O	Table	dep	11	SENT_186	[p8l6t3413r77b3434],
2	2	CD	NUMBER	2	num	1	SENT_186	[p8l85t3414r100b3434],
3	Association	NNP	O	Association	dep	1	SENT_186	[p8l6t3448r151b3470],
4	between	IN	O	between	_	0	SENT_186	[p8l159t3448r268b3470],
5	CTR1	NN	O	ctr1	nn	7	SENT_186	[p8l277t3449r334b3470],
6	rs10981694	NN	O	rs10981694	nn	7	SENT_186	[p8l346t3449r495b3470],
7	A	NN	O	a	prep_between	3	SENT_186	[p8l503t3449r552b3470],
8	>	JJR	O	>	amod	9	SENT_186	[p8l503t3449r552b3470],
9	C	NN	O	c	dep	11	SENT_186	[p8l503t3449r552b3470],
10	genetic	JJ	O	genetic	amod	11	SENT_186	[p8l560t3448r652b3475],
11	polymorphism	NN	O	polymorphism	dep	15	SENT_186	[p8l660t3448r846b3475],
12	and	CC	O	and	_	0	SENT_186	[p8l855t3448r900b3470],
13	severe	JJ	O	severe	amod	14	SENT_186	[p8l909t3454r989b3470],
14	cisplatin	NN	O	cisplatin	conj_and	11	SENT_186	[p8l998t3448r1105b3475],
15	induced	VBD	O	induce	_	0	SENT_186	[p8l1114t3448r1214b3470],
16	toxicity	NN	O	toxicity	dobj	15	SENT_186	[p8l1222t3448r1318b3475],
17	in	IN	O	in	_	0	SENT_186	[p8l1327t3448r1349b3470],
18	non-small	JJ	O	non-small	amod	22	SENT_186	[p8l1358t3448r1485b3470],
19	cell	NN	O	cell	nn	22	SENT_186	[p8l1494t3448r1536b3470],
20	lung	NN	O	lung	nn	22	SENT_186	[p8l1546t3448r1601b3475],
21	cancer	NN	O	cancer	nn	22	SENT_186	[p8l1609t3454r1691b3470],
22	patients	NNS	O	patient	prep_in	15	SENT_186	[p8l1699t3448r1807b3475],
23	.	.	O	.	_	0	SENT_186	[p8l1699t3448r1807b3475],

1	Side	NN	O	side	nn	2	SENT_187	[p8l32t3516r84b3538],
2	effects	NNS	O	effect	dep	9	SENT_187	[p8l93t3516r174b3538],
3	Minoral1ele	JJ	O	minoral1ele	amod	5	SENT_187	[p8l391t3516r749b3544],
4	(	NN	O	(	nn	5	SENT_187	[p8l391t3516r749b3544],
5	C	NN	O	c	dep	2	SENT_187	[p8l391t3516r749b3544],
6	)	JJ	O	)	amod	7	SENT_187	[p8l391t3516r749b3544],
7	frequency	NN	O	frequency	dep	9	SENT_187	[p8l391t3516r749b3544],
8	(	CD	PERCENT	(	num	9	SENT_187	[p8l391t3516r749b3544],
9	%	NN	PERCENT	%	dep	16	SENT_187	[p8l391t3516r749b3544],
10	)	CD	NUMBER	)	num	12	SENT_187	[p8l391t3516r749b3544],
11	pa	NN	O	pa	nn	12	SENT_187	[p8l851t3517r877b3544],
12	Odd	NNP	O	Odd	dep	9	SENT_187	[p8l1028t3516r1078b3538],
13	ratio	NN	O	ratio	nn	16	SENT_187	[p8l1087t3517r1145b3538],
14	ppgﬁnb	NN	O	ppgﬁnb	nn	16	SENT_187	[p8l1263t3513r1339b3546],
15	C-carrier	NN	MISC	c-carrier	nn	16	SENT_187	[p8l1460t3517r1572b3538],
16	frequency	NN	O	frequency	_	0	SENT_187	[p8l1580t3516r1706b3544],
17	(	CD	NUMBER	(	number	18	SENT_187	[p8l1714t3516r1750b3544],
18	96	CD	NUMBER	96	dep	16	SENT_187	[p8l1714t3516r1750b3544],
19	)	CD	NUMBER	)	num	21	SENT_187	[p8l1714t3516r1750b3544],
20	pc	NN	O	pc	nn	21	SENT_187	[p8l1921t3517r1946b3544],
21	ptrendd	NN	O	ptrendd	dep	18	SENT_187	[p8l6t3549r84b3579],

1	Tolerance	NN	O	tolerance	nn	4	SENT_188	[p9l372t35r495b57],
2	Severity	NN	O	severity	nn	4	SENT_188	[p9l615t35r717b62],
3	Tolerance	NN	O	tolerance	nn	4	SENT_188	[p9l1442t35r1565b57],
4	Severity	NN	O	severity	_	0	SENT_188	[p9l1684t35r1787b62],

1	Neutropenia	NN	O	neutropenia	_	0	SENT_189	[p9l32t84r190b111],
2	0.16	CD	NUMBER	0.16	num	3	SENT_189	[p9l391t85r443b106],
3	0.15	CD	NUMBER	0.15	dep	1	SENT_189	[p9l632t85r684b106],
4	0.70	CD	NUMBER	0.70	number	5	SENT_189	[p9l853t85r906b106],
5	1.11	CD	NUMBER	1.11	dep	3	SENT_189	[p9l1029t85r1077b106],
6	0.86	CD	NUMBER	0.86	num	7	SENT_189	[p9l1264t85r1317b106],
7	0.33	CD	NUMBER	0.33	dep	1	SENT_189	[p9l1460t85r1512b106],
8	0.29	CD	NUMBER	0.29	number	9	SENT_189	[p9l1702t85r1754b106],
9	0.73	CD	NUMBER	0.73	num	10	SENT_189	[p9l1923t85r1974b106],
10	Oliiemia	JJ	O	oliiemia	dep	7	SENT_189	[p9l6t122r128b179],
11	0.13	CD	NUMBER	0.13	num	12	SENT_189	[p9l391t158r442b179],
12	0.17	CD	NUMBER	0.17	dep	1	SENT_189	[p9l632t158r684b179],
13	0.28	CD	NUMBER	0.28	num	14	SENT_189	[p9l853t158r905b179],
14	0.72	CD	NUMBER	0.72	dep	12	SENT_189	[p9l1027t158r1079b179],
15	0.37	CD	NUMBER	0.37	num	16	SENT_189	[p9l1264t158r1316b179],
16	0.25	CD	NUMBER	0.25	dep	1	SENT_189	[p9l1460t158r1512b179],
17	0.33	CD	NUMBER	0.33	number	18	SENT_189	[p9l1701t158r1753b179],
18	0.55	CD	NUMBER	0.55	num	19	SENT_189	[p9l1922t158r1974b179],
19	O	NN	O	o	dep	16	SENT_189	[p9l6t194r272b255],
20	?	.	O	?	_	0	SENT_189	[p9l6t194r272b255],

1	l	NN	O	l	dep	8	SENT_190	[p9l6t194r272b255],
2	"	''	O	"	punct	1	SENT_190	[p9l6t194r272b255],
3	:1	CD	NUMBER	:1	num	4	SENT_190	[p9l6t194r272b255],
4	l‘0l	NN	O	l‘0l	dep	1	SENT_190	[p9l6t194r272b255],
5	‘	CD	NUMBER	‘	num	6	SENT_190	[p9l6t194r272b255],
6	l‘1bOCyt0p	NN	O	l‘1bocyt0p	dep	8	SENT_190	[p9l6t194r272b255],
7	€	CD	NUMBER	€	num	8	SENT_190	[p9l6t194r272b255],
8	l'lia	NN	O	l'lium	dep	12	SENT_190	[p9l6t194r272b255],
9	0.13	CD	NUMBER	0.13	num	10	SENT_190	[p9l391t229r442b250],
10	0.1	CD	NUMBER	0.1	dep	8	SENT_190	[p9l632t229r666b250],
11	6	CD	NUMBER	6	num	12	SENT_190	[p9l671t229r685b250],
12	0.51	CD	NUMBER	0.51	dep	16	SENT_190	[p9l853t229r903b250],
13	0.76	CD	NUMBER	0.76	num	14	SENT_190	[p9l1028t229r1080b250],
14	0.53	CD	NUMBER	0.53	dep	12	SENT_190	[p9l1264t229r1316b250],
15	0.25	CD	NUMBER	0.25	num	16	SENT_190	[p9l1460t229r1512b250],
16	0.31	CD	NUMBER	0.31	dep	21	SENT_190	[p9l1702t229r1751b250],
17	0.71	CD	NUMBER	0.71	num	18	SENT_190	[p9l1923t229r1972b250],
18	Oéiiesis	NNP	O	Oéiiesis	dep	16	SENT_190	[p9l6t264r119b321],
19	0.15	CD	NUMBER	0.15	num	18	SENT_190	[p9l391t300r442b321],
20	0.25	CD	NUMBER	0.25	num	21	SENT_190	[p9l632t300r684b321],
21	0.97	CD	NUMBER	0.97	dep	27	SENT_190	[p9l853t300r905b321],
22	0.98	CD	NUMBER	0.98	number	23	SENT_190	[p9l1028t300r1079b321],
23	1.00	CD	NUMBER	1.00	dep	21	SENT_190	[p9l1266t300r1317b321],
24	0.31	CD	NUMBER	0.31	num	25	SENT_190	[p9l1460t300r1509b321],
25	0.30	CD	NUMBER	0.30	dep	23	SENT_190	[p9l1702t300r1754b321],
26	1.00	CD	NUMBER	1.00	num	27	SENT_190	[p9l1924t300r1975b321],
27	Oiizephrotoxicity	NN	O	oiizephrotoxicity	dep	31	SENT_190	[p9l6t336r223b397],
28	0.17	CD	NUMBER	0.17	num	29	SENT_190	[p9l391t371r443b392],
29	0.14	CD	NUMBER	0.14	dep	27	SENT_190	[p9l632t371r685b392],
30	0.39	CD	NUMBER	0.39	num	31	SENT_190	[p9l853t371r906b392],
31	1.26	CD	NUMBER	1.26	dep	37	SENT_190	[p9l1029t371r1080b392],
32	0.38	CD	NUMBER	0.38	number	33	SENT_190	[p9l1264t371r1316b392],
33	0.33	CD	NUMBER	0.33	dep	31	SENT_190	[p9l1460t371r1512b392],
34	0.28	CD	NUMBER	0.28	num	35	SENT_190	[p9l1702t371r1754b392],
35	0.49	CD	NUMBER	0.49	dep	33	SENT_190	[p9l1923t371r1975b392],
36	0.36	CD	NUMBER	0.36	num	37	SENT_190	[p9l6t407r59b428],
37	Ototoxicity	NN	O	ototoxicity	dep	44	SENT_190	[p9l32t442r173b469],
38	0.1	CD	NUMBER	0.1	number	39	SENT_190	[p9l391t443r424b464],
39	1	CD	NUMBER	1	dep	37	SENT_190	[p9l430t443r440b463],
40	0.21	CD	NUMBER	0.21	num	41	SENT_190	[p9l632t443r682b464],
41	0.01	CD	NUMBER	0.01	dep	39	SENT_190	[p9l853t443r905b464],
42	0.47	CD	NUMBER	0.47	num	44	SENT_190	[p9l1028t443r1080b464],
43	o.	NN	O	o.	nn	44	SENT_190	[p9l1264t443r1319b464],
44	oo	NN	O	oo	dep	52	SENT_190	[p9l1264t443r1319b464],
45	0.22	CD	NUMBER	0.22	number	46	SENT_190	[p9l1460t443r1512b464],
46	0.41	CD	NUMBER	0.41	dep	44	SENT_190	[p9l1702t443r1751b464],
47	0.01	CD	NUMBER	0.01	num	50	SENT_190	[p9l1922t443r1974b464],
48	o.	NN	O	o.	nn	50	SENT_190	[p9l6t479r61b499],
49	oo	NN	O	oo	nn	50	SENT_190	[p9l6t479r61b499],
50	Neuropathy	NN	O	neuropathy	dep	46	SENT_190	[p9l32t513r182b540],
51	0.16	CD	NUMBER	0.16	num	52	SENT_190	[p9l391t514r443b535],
52	0.15	CD	NUMBER	0.15	dep	56	SENT_190	[p9l632t514r684b535],
53	0.78	CD	NUMBER	0.78	num	54	SENT_190	[p9l853t514r905b535],
54	1.08	CD	NUMBER	1.08	dep	52	SENT_190	[p9l1029t514r1079b535],
55	0.85	CD	NUMBER	0.85	num	56	SENT_190	[p9l1264t514r1316b535],
56	0.32	CD	NUMBER	0.32	dep	67	SENT_190	[p9l1460t514r1512b535],
57	0.29	CD	NUMBER	0.29	number	58	SENT_190	[p9l1701t514r1754b535],
58	0.78	CD	NUMBER	0.78	dep	56	SENT_190	[p9l1922t514r1974b535],
59	0.78	CD	NUMBER	0.78	dep	58	SENT_190	[p9l6t550r58b571],
60	The	DT	O	the	det	64	SENT_190	[p9l6t598r52b620],
61	bold	JJ	O	bold	amod	64	SENT_190	[p9l60t598r115b620],
62	and	CC	O	and	_	0	SENT_190	[p9l124t598r170b620],
63	italic	JJ	O	italic	amod	64	SENT_190	[p9l179t598r240b620],
64	values	NNS	O	value	nsubj	67	SENT_190	[p9l247t598r327b620],
65	are	VBP	O	be	cop	67	SENT_190	[p9l336t604r374b620],
66	statistically	RB	O	statistically	advmod	67	SENT_190	[p9l384t598r528b625],
67	different	JJ	O	different	_	0	SENT_190	[p9l536t598r651b620],
68	.	.	O	.	_	0	SENT_190	[p9l536t598r651b620],

1	3	CD	NUMBER	3	num	4	SENT_191	[p9l32t637r41b648],
2	‘	NN	O	‘	nn	4	SENT_191	[p9l32t637r41b648],
3	p	NN	O	p	nn	4	SENT_191	[p9l55t642r70b663],
4	value	NN	O	value	nsubj	10	SENT_191	[p9l79t636r146b658],
5	of	IN	O	of	_	0	SENT_191	[p9l155t636r181b658],
6	comparison	NN	O	comparison	prep_of	4	SENT_191	[p9l187t636r335b663],
7	of	IN	O	of	_	0	SENT_191	[p9l343t636r370b658],
8	allele	NN	O	allele	nn	9	SENT_191	[p9l375t636r441b658],
9	frequencies	NNS	O	frequency	prep_of	6	SENT_191	[p9l450t636r596b663],
10	adjusted	VBN	O	adjust	_	0	SENT_191	[p9l605t636r712b663],
11	by	IN	O	by	_	0	SENT_191	[p9l721t636r751b663],
12	Bonferroni	NNP	PERSON	Bonferroni	nn	13	SENT_191	[p9l759t636r893b658],
13	correction	NN	O	correction	prep_by	10	SENT_191	[p9l902t636r1037b658],
14	.	.	O	.	_	0	SENT_191	[p9l902t636r1037b658],

1	‘’	NN	O	‘’	nn	3	SENT_192	[p9l31t668r41b683],
2	p	NN	O	p	nn	3	SENT_192	[p9l55t677r70b698],
3	value	NN	O	value	_	0	SENT_192	[p9l79t671r146b693],
4	after	IN	O	after	_	0	SENT_192	[p9l155t671r214b693],
5	max	NN	O	max	prep_after	3	SENT_192	[p9l222t677r276b693],
6	(	CD	NUMBER	(	num	7	SENT_192	[p9l284t671r318b698],
7	T	NN	O	t	dep	3	SENT_192	[p9l284t671r318b698],
8	)	CD	NUMBER	)	num	9	SENT_192	[p9l284t671r318b698],
9	permutation	NN	O	permutation	dep	7	SENT_192	[p9l327t671r491b698],
10	.	.	O	.	_	0	SENT_192	[p9l327t671r491b698],

1	C	NN	O	c	nn	2	SENT_193	[p9l33t707r41b718],
2	p	NN	O	p	_	0	SENT_193	[p9l55t713r70b734],
3	comparing	VBG	O	compare	partmod	2	SENT_193	[p9l79t707r215b734],
4	genotype	NN	O	genotype	nn	5	SENT_193	[p9l222t710r339b734],
5	frequencies	NNS	O	frequency	dobj	3	SENT_193	[p9l348t706r494b734],
6	in	IN	O	in	_	0	SENT_193	[p9l503t707r526b728],
7	tolerant	JJ	O	tolerant	amod	10	SENT_193	[p9l534t706r635b728],
8	and	CC	O	and	_	0	SENT_193	[p9l643t706r688b728],
9	severe	JJ	O	severe	amod	10	SENT_193	[p9l698t713r778b728],
10	groups	NNS	O	group	prep_in	3	SENT_193	[p9l786t713r872b734],
11	using	VBG	O	use	partmod	10	SENT_193	[p9l881t707r949b734],
12	X2	NN	O	x2	nn	13	SENT_193	[p9l958t704r985b734],
13	test	NN	O	test	dobj	11	SENT_193	[p9l996t710r1042b728],
14	with	IN	O	with	_	0	SENT_193	[p9l1050t706r1108b728],
15	Zdf	NN	PERSON	zdf	prep_with	11	SENT_193	[p9l1116t706r1162b728],
16	.	.	O	.	_	0	SENT_193	[p9l1116t706r1162b728],

1	‘	NN	O	‘	nn	3	SENT_194	[p9l56t745r77b775],
2	'	''	O	'	_	0	SENT_194	[p9l56t745r77b775],
3	ptrend	NN	O	ptrend	_	0	SENT_194	[p9l106t764r237b806],
4	using	VBG	O	use	partmod	3	SENT_194	[p9l259t752r398b806],
5	a	DT	O	a	det	6	SENT_194	[p9l414t764r440b795],
6	Cochran	NNP	O	Cochran	dobj	4	SENT_194	[p9l458t751r940b806],
7	.	.	O	.	_	0	SENT_194	[p9l458t751r940b806],

1	—	NN	O	—	_	0	SENT_195	[p9l458t751r940b806],
2	.	.	O	.	_	0	SENT_195	[p9l458t751r940b806],

1	Armitage	NN	PERSON	armitage	nn	2	SENT_196	[p9l458t751r940b806],
2	trend	NN	O	trend	nsubj	3	SENT_196	[p9l958t751r1096b795],
3	test	NN	O	test	_	0	SENT_196	[p9l1114t758r1220b795],
4	.	.	O	.	_	0	SENT_196	[p9l1114t758r1220b795],

1	14.07	CD	DURATION	14.07	num	2	SENT_197	[p9l12t962r182b1014],
2	months	NNS	DURATION	month	_	0	SENT_197	[p9l222t959r481b1014],
3	.	.	O	.	_	0	SENT_197	[p9l222t959r481b1014],

1	For	IN	O	for	_	0	SENT_198	[p9l520t962r621b1013],
2	rs10981694	NN	O	rs10981694	prep_for	5	SENT_198	[p9l658t962r1055b1021],
3	,	,	O	,	_	0	SENT_198	[p9l658t962r1055b1021],
4	there	EX	O	there	expl	5	SENT_198	[p9l1092t959r1260b1013],
5	was	VBD	O	be	_	0	SENT_198	[p9l1296t975r1421b1013],
6	no	DT	O	no	det	8	SENT_198	[p9l1460t975r1537b1013],
7	signiﬁcant	NN	O	signiﬁcant	nn	8	SENT_198	[p9l1576t959r1910b1027],
8	difference	NN	O	difference	nsubj	5	SENT_198	[p9l1946t959r2146b1013, p9l9t1062r154b1100],
9	between	IN	O	between	_	0	SENT_198	[p9l179t1046r457b1100],
10	AA	NNP	O	AA	nn	12	SENT_198	[p9l479t1049r572b1100],
11	genotype	NN	O	genotype	nn	12	SENT_198	[p9l594t1054r892b1114],
12	patients	NNS	O	patient	nsubj	13	SENT_198	[p9l918t1047r1175b1114],
13	(	VBP	O	(	prepc_between	8	SENT_198	[p9l1202t1046r1402b1114],
14	14.00	CD	DURATION	14.00	num	15	SENT_198	[p9l1202t1046r1402b1114],
15	months	NNS	NUMBER	month	tmod	13	SENT_198	[p9l1428t1046r1697b1114],
16	)	RB	O	)	advmod	13	SENT_198	[p9l1428t1046r1697b1114],
17	and	CC	O	and	_	0	SENT_198	[p9l1723t1046r1839b1100],
18	C-carrier	NN	O	c-carrier	nn	19	SENT_198	[p9l1865t1047r2148b1100],
19	patients	NNS	O	patient	nsubj	20	SENT_198	[p9l9t1134r267b1201],
20	(	VBP	O	(	prepc_between	8	SENT_198	[p9l285t1133r485b1200],
21	13.70	CD	DURATION	13.70	num	22	SENT_198	[p9l285t1133r485b1200],
22	months	NNS	NUMBER	month	tmod	20	SENT_198	[p9l502t1133r787b1201],
23	)	RB	O	)	advmod	20	SENT_198	[p9l502t1133r787b1201],
24	.	.	O	.	_	0	SENT_198	[p9l502t1133r787b1201],

1	Results	NNS	O	result	nsubjpass	9	SENT_199	[p9l805t1133r1032b1187],
2	of	IN	O	of	_	0	SENT_199	[p9l1050t1133r1116b1187],
3	Cox	NN	O	cox	prep_of	1	SENT_199	[p9l1125t1136r1243b1187],
4	multivariate	JJ	O	multivariate	amod	7	SENT_199	[p9l1258t1133r1654b1187],
5	regression	NN	O	regression	nn	7	SENT_199	[p9l1671t1134r2003b1201],
6	survival	NN	O	survival	nn	7	SENT_199	[p9l2020t1149r2145b1187, p9l7t1220r159b1274],
7	analysis	NN	O	analysis	dep	3	SENT_199	[p9l184t1220r438b1288],
8	were	VBD	O	be	auxpass	9	SENT_199	[p9l462t1236r622b1275],
9	shown	VBN	O	show	_	0	SENT_199	[p9l649t1220r861b1275],
10	in	IN	O	in	_	0	SENT_199	[p9l886t1221r944b1274],
11	Table	NNP	O	Table	prep_in	9	SENT_199	[p9l966t1220r1138b1275],
12	3	CD	NUMBER	3	num	11	SENT_199	[p9l1163t1223r1215b1275],
13	.	.	O	.	_	0	SENT_199	[p9l1163t1223r1215b1275],

1	There	EX	O	there	expl	2	SENT_200	[p9l1238t1220r1421b1275],
2	was	VBD	O	be	_	0	SENT_200	[p9l1445t1236r1569b1275],
3	still	RB	O	still	advmod	2	SENT_200	[p9l1596t1220r1711b1275],
4	no	DT	O	no	det	6	SENT_200	[p9l1736t1236r1813b1275],
5	statistical	JJ	O	statistical	amod	6	SENT_200	[p9l1839t1220r2145b1275],
6	difference	NN	O	difference	nsubj	2	SENT_200	[p9l9t1307r331b1362],
7	among	IN	O	among	_	0	SENT_200	[p9l347t1323r567b1375],
8	different	JJ	O	different	amod	10	SENT_200	[p9l581t1307r860b1362],
9	rs10981694	NN	O	rs10981694	nn	10	SENT_200	[p9l875t1310r1258b1362],
10	genotypes	NNS	O	genotype	prep_among	6	SENT_200	[p9l1272t1316r1618b1375],
11	.	.	O	.	_	0	SENT_200	[p9l1272t1316r1618b1375],

1	From	IN	O	from	_	0	SENT_201	[p9l1635t1311r1801b1362],
2	analysis	NN	O	analysis	prep_from	9	SENT_201	[p9l1816t1308r2070b1375],
3	of	IN	O	of	_	0	SENT_201	[p9l2087t1307r2154b1362],
4	other	JJ	O	other	amod	6	SENT_201	[p9l9t1395r181b1449],
5	potential	JJ	O	potential	amod	6	SENT_201	[p9l204t1395r492b1462],
6	factors	NNS	O	factor	prep_of	2	SENT_201	[p9l519t1395r749b1457],
7	,	,	O	,	_	0	SENT_201	[p9l519t1395r749b1457],
8	we	PRP	O	we	nsubj	9	SENT_201	[p9l773t1410r868b1449],
9	found	VBD	O	find	_	0	SENT_201	[p9l894t1395r1078b1449],
10	that	IN	O	that	complm	13	SENT_201	[p9l1103t1395r1232b1449],
11	smoking	NN	O	smoking	nn	12	SENT_201	[p9l1257t1395r1531b1462],
12	status	NN	O	status	nsubj	13	SENT_201	[p9l1555t1403r1743b1449],
13	contributed	VBD	O	contribute	ccomp	9	SENT_201	[p9l1769t1395r2146b1449],
14	much	RB	O	much	advmod	13	SENT_201	[p9l9t1481r189b1535],
15	to	TO	O	to	_	0	SENT_201	[p9l209t1489r270b1535],
16	survival	NN	O	survival	nn	17	SENT_201	[p9l293t1481r545b1535],
17	rate	NN	O	rate	prep_to	14	SENT_201	[p9l566t1489r705b1536],
18	.	.	O	.	_	0	SENT_201	[p9l566t1489r705b1536],

1	Non	JJ	O	non	amod	3	SENT_202	[p9l728t1481r1166b1549],
2	—	NN	O	—	nn	3	SENT_202	[p9l728t1481r1166b1549],
3	smol	NN	O	smol	dep	49	SENT_202	[p9l728t1481r1166b1549],
4	<	JJR	O	<	dep	3	SENT_202	[p9l728t1481r1166b1549],
5	ing	CD	NUMBER	ing	num	6	SENT_202	[p9l728t1481r1166b1549],
6	group	NN	O	group	nsubj	7	SENT_202	[p9l1184t1497r1372b1549],
7	had	VBD	O	have	rcmod	4	SENT_202	[p9l1394t1481r1509b1535],
8	the	DT	O	the	det	12	SENT_202	[p9l1530t1481r1632b1535],
9	longest	JJS	O	longest	amod	12	SENT_202	[p9l1653t1481r1886b1549],
10	median	JJ	O	median	amod	12	SENT_202	[p9l1906t1481r2147b1535],
11	survival	NN	O	survival	nn	12	SENT_202	[p9l10t1568r262b1622],
12	time	NN	O	time	dobj	7	SENT_202	[p9l294t1569r440b1622],
13	(	CD	NUMBER	(	number	14	SENT_202	[p9l473t1568r672b1635],
14	18.07	CD	DURATION	18.07	num	15	SENT_202	[p9l473t1568r672b1635],
15	months	NNS	NUMBER	month	tmod	16	SENT_202	[p9l707t1568r976b1635],
16	)	RB	O	)	amod	12	SENT_202	[p9l707t1568r976b1635],
17	compared	VBN	O	compare	_	0	SENT_202	[p9l1009t1568r1329b1636],
18	with	IN	O	with	prepc_compared_with	7	SENT_202	[p9l1361t1568r1509b1622],
19	light	JJ	O	light	amod	21	SENT_202	[p9l1541t1568r1687b1636],
20	smoke	NN	O	smoke	nn	21	SENT_202	[p9l1719t1568r1926b1622],
21	group	NN	O	group	pobj	7	SENT_202	[p9l1958t1584r2146b1636],
22	(	CD	NUMBER	(	number	23	SENT_202	[p9l9t1656r209b1723],
23	12.57	CD	DURATION	12.57	num	24	SENT_202	[p9l9t1656r209b1723],
24	months	NNS	NUMBER	month	tmod	21	SENT_202	[p9l238t1655r507b1723],
25	)	CD	NUMBER	)	number	26	SENT_202	[p9l238t1655r507b1723],
26	(	CD	NUMBER	(	dep	21	SENT_202	[p9l534t1656r670b1723],
27	Log	NN	O	log	nn	29	SENT_202	[p9l534t1656r670b1723],
28	rank	NN	O	rank	nn	29	SENT_202	[p9l697t1655r840b1710],
29	p	NN	O	p	dep	26	SENT_202	[p9l861t1658r1116b1723],
30	=	JJ	O	=	amod	4	SENT_202	[p9l861t1658r1116b1723],
31	0.03	CD	NUMBER	0.03	tmod	30	SENT_202	[p9l861t1658r1116b1723],
32	,	,	O	,	_	0	SENT_202	[p9l861t1658r1116b1723],
33	hazard	NN	O	hazard	nn	34	SENT_202	[p9l1144t1655r1361b1710],
34	ratio	NN	O	ratio	conj_and	4	SENT_202	[p9l1389t1656r1536b1710],
35	0.66	CD	NUMBER	0.66	dep	34	SENT_202	[p9l1563t1658r1713b1718],
36	,	,	O	,	_	0	SENT_202	[p9l1563t1658r1713b1718],
37	95	CD	PERCENT	95	number	38	SENT_202	[p9l1741t1658r1862b1709],
38	%	NN	PERCENT	%	amod	40	SENT_202	[p9l1741t1658r1862b1709],
39	credible	JJ	O	credible	amod	40	SENT_202	[p9l1889t1655r2146b1710],
40	interval	NN	O	interval	conj_and	4	SENT_202	[p9l9t1743r256b1797],
41	0.45	CD	NUMBER	0.45	dep	40	SENT_202	[p9l278t1745r409b1797],
42	to	TO	O	to	_	0	SENT_202	[p9l432t1751r494b1797],
43	0.97	CD	NUMBER	0.97	num	44	SENT_202	[p9l516t1743r675b1810],
44	)	CD	NUMBER	)	prep_to	41	SENT_202	[p9l516t1743r675b1810],
45	and	CC	O	and	_	0	SENT_202	[p9l697t1743r813b1797],
46	heavy	JJ	O	heavy	amod	48	SENT_202	[p9l835t1743r1025b1810],
47	smoke	NN	O	smoke	nn	48	SENT_202	[p9l1045t1743r1253b1797],
48	groups	NNS	O	group	conj_and	4	SENT_202	[p9l1273t1758r1492b1810],
49	(	VBP	O	(	_	0	SENT_202	[p9l1514t1743r1990b1810],
50	13.47	CD	DURATION	13.47	num	51	SENT_202	[p9l1514t1743r1990b1810],
51	months	NNS	NUMBER	month	nn	60	SENT_202	[p9l1514t1743r1990b1810],
52	)	CD	NUMBER	)	number	53	SENT_202	[p9l1514t1743r1990b1810],
53	(	CD	NUMBER	(	dep	51	SENT_202	[p9l2011t1743r2148b1810],
54	Log	NN	O	log	nn	56	SENT_202	[p9l2011t1743r2148b1810],
55	rank	NN	O	rank	nn	56	SENT_202	[p9l9t1830r153b1884],
56	p	NN	O	p	dep	53	SENT_202	[p9l169t1845r208b1897],
57	=	JJ	O	=	amod	60	SENT_202	[p9l225t1852r258b1869],
58	0.02	CD	NUMBER	0.02	tmod	57	SENT_202	[p9l275t1832r424b1892],
59	,	,	O	,	_	0	SENT_202	[p9l275t1832r424b1892],
60	hazard	NN	O	hazard	dobj	49	SENT_202	[p9l448t1829r664b1884],
61	ratio	NN	O	ratio	nsubj	49	SENT_202	[p9l688t1830r835b1884],
62	0.52	CD	NUMBER	0.52	num	61	SENT_202	[p9l858t1832r1008b1892],
63	,	,	O	,	_	0	SENT_202	[p9l858t1832r1008b1892],
64	95	CD	PERCENT	95	number	65	SENT_202	[p9l1031t1832r1152b1884],
65	%	NN	PERCENT	%	amod	67	SENT_202	[p9l1031t1832r1152b1884],
66	credible	JJ	O	credible	amod	67	SENT_202	[p9l1174t1830r1431b1884],
67	interval	NN	O	interval	appos	61	SENT_202	[p9l1454t1830r1700b1884],
68	0.35-0	CD	NUMBER	0.35-0	num	70	SENT_202	[p9l1724t1830r2079b1897],
69	.79	CD	NUMBER	.79	num	70	SENT_202	[p9l1724t1830r2079b1897],
70	)	NN	O	)	dep	67	SENT_202	[p9l1724t1830r2079b1897],
71	.	.	O	.	_	0	SENT_202	[p9l1724t1830r2079b1897],

1	It	PRP	O	it	nsubj	2	SENT_203	[p9l2103t1833r2147b1884],
2	suggested	VBD	O	suggest	_	0	SENT_203	[p9l10t1917r328b1984],
3	that	IN	O	that	complm	9	SENT_203	[p9l347t1917r477b1971],
4	smoking	NN	O	smoking	nn	5	SENT_203	[p9l495t1917r770b1984],
5	status	NN	O	status	nsubj	9	SENT_203	[p9l789t1925r976b1971],
6	was	VBD	O	be	cop	9	SENT_203	[p9l995t1932r1120b1971],
7	the	DT	O	the	det	9	SENT_203	[p9l1140t1917r1241b1971],
8	major	JJ	O	major	amod	9	SENT_203	[p9l1262t1918r1451b1984],
9	factor	NN	O	factor	ccomp	2	SENT_203	[p9l1469t1917r1655b1971],
10	that	WDT	O	that	nsubj	11	SENT_203	[p9l1671t1917r1801b1971],
11	inﬂuences	VBZ	O	inﬂuences	rcmod	9	SENT_203	[p9l1819t1917r2145b1971],
12	overall	JJ	O	overall	amod	14	SENT_203	[p9l9t2003r227b2057],
13	survival	NN	O	survival	nn	14	SENT_203	[p9l250t2003r503b2057],
14	time	NN	O	time	dobj	11	SENT_203	[p9l525t2004r670b2057],
15	and	CC	O	and	_	0	SENT_203	[p9l693t2003r809b2057],
16	clinical	JJ	O	clinical	amod	17	SENT_203	[p9l832t2003r1058b2057],
17	outcomes	NNS	O	outcome	dobj	11	SENT_203	[p9l1082t2011r1392b2057],
18	in	IN	O	in	_	0	SENT_203	[p9l1416t2004r1475b2057],
19	NSCLC	NN	O	nsclc	nn	20	SENT_203	[p9l1498t2006r1703b2057],
20	patients	NNS	O	patient	prep_in	14	SENT_203	[p9l1725t2004r1999b2071],
21	.	.	O	.	_	0	SENT_203	[p9l1725t2004r1999b2071],

1	4	LS	NUMBER	4	_	0	SENT_204	[p9l6t2190r63b2242],
2	.	.	O	.	_	0	SENT_204	[p9l6t2190r63b2242],

1	Discussion	NN	O	discussion	_	0	SENT_205	[p9l109t2187r470b2241],

1	In	IN	O	in	_	0	SENT_206	[p9l111t2368r171b2418],
2	this	DT	O	this	det	3	SENT_206	[p9l199t2364r316b2419],
3	multi-institutions	NNS	O	multi-institution	prep_in	18	SENT_206	[p9l347t2364r919b2419],
4	based	VBN	O	base	partmod	3	SENT_206	[p9l949t2364r1132b2419],
5	epidemiologic	JJ	O	epidemiologic	amod	6	SENT_206	[p9l1163t2364r1619b2432],
6	study	NN	O	study	dobj	4	SENT_206	[p9l1649t2364r1826b2432],
7	of	IN	O	of	_	0	SENT_206	[p9l1854t2364r1920b2418],
8	NSCLC	NN	ORGANIZATION	nsclc	nn	9	SENT_206	[p9l1942t2367r2147b2419],
9	patients	NNS	O	patient	prep_of	6	SENT_206	[p9l9t2452r283b2519],
10	,	,	O	,	_	0	SENT_206	[p9l9t2452r283b2519],
11	who	WP	O	who	nsubj	13	SENT_206	[p9l328t2452r468b2506],
12	had	VBD	O	have	aux	13	SENT_206	[p9l514t2452r629b2506],
13	received	VBN	O	receive	rcmod	9	SENT_206	[p9l675t2451r945b2506],
14	cisplatin-based	JJ	O	cisplatin-based	amod	15	SENT_206	[p9l991t2452r1479b2519],
15	chemotherapy	NN	O	chemotherapy	dobj	13	SENT_206	[p9l1525t2452r2007b2519],
16	,	,	O	,	_	0	SENT_206	[p9l1525t2452r2007b2519],
17	we	PRP	O	we	nsubj	18	SENT_206	[p9l2052t2467r2146b2506],
18	investigated	VBD	O	investigate	_	0	SENT_206	[p9l9t2539r402b2606],
19	the	DT	O	the	det	20	SENT_206	[p9l434t2539r535b2593],
20	role	NN	O	role	dobj	18	SENT_206	[p9l567t2539r689b2593],
21	of	IN	O	of	_	0	SENT_206	[p9l721t2539r787b2593],
22	CTR1	NN	O	ctr1	nn	23	SENT_206	[p9l811t2542r956b2593],
23	polymorphisms	NNS	O	polymorphism	prep_of	20	SENT_206	[p9l995t2539r1500b2606],
24	in	IN	O	in	_	0	SENT_206	[p9l1533t2540r1592b2592],
25	susceptibility	NN	O	susceptibility	prep_in	18	SENT_206	[p9l1624t2539r2055b2606],
26	to	TO	O	to	_	0	SENT_206	[p9l2084t2547r2145b2593],
27	severe	JJ	O	severe	amod	29	SENT_206	[p9l10t2641r214b2679],
28	platinum	NN	O	platinum	nn	29	SENT_206	[p9l256t2625r549b2693],
29	toxicity	NN	O	toxicity	prep_to	18	SENT_206	[p9l589t2626r848b2693],
30	.	.	O	.	_	0	SENT_206	[p9l589t2626r848b2693],

1	Our	PRP$	O	we	poss	2	SENT_207	[p9l891t2628r1010b2679],
2	results	NNS	O	result	nsubj	3	SENT_207	[p9l1049t2625r1262b2679],
3	showed	VBD	O	show	_	0	SENT_207	[p9l1305t2625r1553b2679],
4	that	IN	O	that	complm	8	SENT_207	[p9l1595t2625r1724b2679],
5	rs10981694	NN	O	rs10981694	nn	6	SENT_207	[p9l1764t2628r2147b2679],
6	mutation	NN	O	mutation	nsubjpass	8	SENT_207	[p9l9t2713r306b2766],
7	was	VBD	O	be	auxpass	8	SENT_207	[p9l324t2728r448b2766],
8	associated	VBN	O	associate	ccomp	3	SENT_207	[p9l469t2712r800b2766],
9	with	IN	O	with	_	0	SENT_207	[p9l819t2712r968b2766],
10	cisplatin	NN	O	cisplatin	prep_with	8	SENT_207	[p9l988t2712r1260b2780],
11	induced	VBD	O	induce	partmod	10	SENT_207	[p9l1280t2712r1535b2766],
12	severe	JJ	O	severe	amod	13	SENT_207	[p9l1557t2728r1761b2766],
13	ototoxicity	NN	O	ototoxicity	dobj	11	SENT_207	[p9l1781t2713r2145b2780],
14	.	.	O	.	_	0	SENT_207	[p9l1781t2713r2145b2780],

1	C-carrier	JJR	O	c-carrier	amod	2	SENT_208	[p9l9t2800r293b2853],
2	people	NNS	O	people	nsubj	3	SENT_208	[p9l313t2799r527b2867],
3	seemed	VBD	O	seem	_	0	SENT_208	[p9l551t2799r795b2853],
4	to	TO	O	to	aux	5	SENT_208	[p9l817t2807r878b2853],
5	have	VB	O	have	xcomp	3	SENT_208	[p9l901t2799r1051b2853],
6	poorer	JJR	O	poorer	amod	8	SENT_208	[p9l1073t2815r1288b2867],
7	ototoxicity	NN	O	ototoxicity	nn	8	SENT_208	[p9l1308t2800r1658b2867],
8	tolerance	NN	O	tolerance	dobj	5	SENT_208	[p9l1677t2799r1976b2853],
9	after	IN	O	after	_	0	SENT_208	[p9l1998t2799r2148b2853],
10	being	VBG	O	be	auxpass	11	SENT_208	[p9l8t2886r186b2954],
11	treated	VBN	O	treat	prepc_after	5	SENT_208	[p9l207t2886r437b2941],
12	with	IN	O	with	_	0	SENT_208	[p9l460t2886r608b2940],
13	cisplatin-based	JJ	O	cisplatin-based	amod	14	SENT_208	[p9l631t2886r1120b2954],
14	chemo	NN	O	chemo	prep_with	11	SENT_208	[p9l1144t2886r1374b2941],
15	.	.	O	.	_	0	SENT_208	[p9l1144t2886r1374b2941],

1	However	RB	O	however	advmod	4	SENT_209	[p9l1399t2890r1704b2949],
2	,	,	O	,	_	0	SENT_209	[p9l1399t2890r1704b2949],
3	there	EX	O	there	expl	4	SENT_209	[p9l1729t2886r1896b2941],
4	was	VBD	O	be	_	0	SENT_209	[p9l1919t2902r2043b2941],
5	no	DT	O	no	nsubj	4	SENT_209	[p9l2069t2902r2145b2941],

1	Table	NNP	O	Table	nn	3	SENT_210	[p9l6t3092r151b3136],
2	3	CD	NUMBER	3	num	3	SENT_210	[p9l167t3094r197b3136],
3	Cox	NN	ORGANIZATION	cox	_	0	SENT_210	[p9l9t3165r103b3206],
4	multivariate	JJ	O	multivariate	amod	7	SENT_210	[p9l119t3162r436b3206],
5	regression	NN	O	regression	nn	7	SENT_210	[p9l453t3163r719b3217],
6	survival	NN	O	survival	nn	7	SENT_210	[p9l736t3162r938b3206],
7	analysis	NN	O	analysis	dep	3	SENT_210	[p9l955t3163r1159b3217],
8	of	IN	O	of	_	0	SENT_210	[p9l1177t3162r1230b3206],
9	CTR1	NN	O	ctr1	nn	11	SENT_210	[p9l1241t3165r1357b3206],
10	rs10981694	NN	O	rs10981694	nn	11	SENT_210	[p9l1380t3165r1686b3206],
11	polymorphism	NN	O	polymorphism	prep_of	7	SENT_210	[p9l1703t3162r2083b3217],
12	in	IN	O	in	_	0	SENT_210	[p9l2100t3163r2147b3206],
13	non	JJ	O	non	amod	19	SENT_210	[p9l9t3234r268b3277],
14	—	JJ	O	—	amod	19	SENT_210	[p9l9t3234r268b3277],
15	small	JJ	O	small	amod	19	SENT_210	[p9l9t3234r268b3277],
16	cell	NN	O	cell	nn	19	SENT_210	[p9l287t3234r373b3277],
17	lung	NN	O	lung	nn	19	SENT_210	[p9l392t3234r504b3288],
18	cancer	NN	O	cancer	nn	19	SENT_210	[p9l521t3246r689b3277],
19	patients	NNS	O	patient	prep_in	11	SENT_210	[p9l706t3235r925b3288],
20	.	.	O	.	_	0	SENT_210	[p9l706t3235r925b3288],

1	NSCLC	NN	ORGANIZATION	nsclc	nn	2	SENT_211	[p9l432t3373r596b3414],
2	patients	NNS	O	patient	_	0	SENT_211	[p9l613t3371r820b3425],
3	(	CD	NUMBER	(	num	4	SENT_211	[p9l838t3371r887b3425],
4	n	NN	O	n	dep	2	SENT_211	[p9l838t3371r887b3425],
5	=	JJ	O	=	amod	7	SENT_211	[p9l901t3389r928b3402],
6	204	CD	NUMBER	204	tmod	5	SENT_211	[p9l941t3371r1056b3425],
7	)	NN	O	)	dep	4	SENT_211	[p9l941t3371r1056b3425],

1	MSTa	NN	O	msta	dep	8	SENT_212	[p9l432t3510r563b3551],
2	(	CD	NUMBER	(	num	3	SENT_212	[p9l584t3508r821b3562],
3	months	NNS	NUMBER	month	dep	1	SENT_212	[p9l584t3508r821b3562],
4	)	CD	NUMBER	)	num	5	SENT_212	[p9l584t3508r821b3562],
5	Log	NN	O	log	dep	8	SENT_212	[p9l977t3511r1065b3562],
6	rank	NN	O	rank	nn	8	SENT_212	[p9l1082t3508r1197b3551],
7	p	NN	O	p	nn	8	SENT_212	[p9l1210t3520r1241b3562],
8	HR	NN	DURATION	hr	dep	11	SENT_212	[p9l1397t3511r1472b3551],
9	95	CD	PERCENT	95	num	10	SENT_212	[p9l1805t3510r1953b3551],
10	%	NN	PERCENT	%	dep	8	SENT_212	[p9l1805t3510r1953b3551],
11	CI	NN	O	ci	_	0	SENT_212	[p9l1805t3510r1953b3551],

1	Overall	JJ	O	overall	_	0	SENT_213	[p9l59t3645r242b3689],
2	1	CD	NUMBER	1	rcmod	1	SENT_213	[p9l434t3648r454b3689],
3	4.07	CD	NUMBER	4.07	dep	2	SENT_213	[p9l463t3648r570b3689],
4	—	SYM	O	—	dep	2	SENT_213	[p9l977t3671r1004b3676],
5	-	:	O	-	_	0	SENT_213	[p9l1398t3671r1425b3676],
6	—	NN	O	—	nn	7	SENT_213	[p9l1937t3671r1964b3676],
7	rs1	NN	O	rs1	dep	1	SENT_213	[p9l60t3720r130b3761],
8	0981	CD	DATE	0981	num	9	SENT_213	[p9l140t3720r261b3761],
9	694	CD	NUMBER	694	dep	7	SENT_213	[p9l271t3720r366b3761],

1	AA	NN	O	aa	nn	5	SENT_214	[p10l57t23r132b64],
2	14.00	CD	NUMBER	14.00	num	5	SENT_214	[p10l434t23r571b65],
3	—	CD	NUMBER	—	num	5	SENT_214	[p10l977t47r1004b52],
4	Reference	NNP	O	Reference	nn	5	SENT_214	[p10l1397t21r1649b65],
5	C	NNP	O	C	dep	11	SENT_214	[p10l1937t47r1964b52, p10l59t95r90b136],
6	carrier	NN	O	carrier	dep	5	SENT_214	[p10l107t93r278b136],
7	13.70	CD	NUMBER	13.70	num	6	SENT_214	[p10l434t95r571b137],
8	0.85	CD	NUMBER	0.85	number	9	SENT_214	[p10l977t95r1082b137],
9	1.01	CD	NUMBER	1.01	dep	6	SENT_214	[p10l1400t95r1497b137],
10	0.73-1	CD	NUMBER	0.73-1	dep	11	SENT_214	[p10l1825t95r2076b137],
11	.40	CD	NUMBER	.40	dep	15	SENT_214	[p10l1825t95r2076b137],
12	Age	NNP	O	Age	dep	11	SENT_214	[p10l57t166r165b218],
13	,	,	O	,	_	0	SENT_214	[p10l57t166r165b218],
14	years	NNS	DURATION	year	appos	12	SENT_214	[p10l183t177r318b218],
15	<	JJR	O	<	dep	18	SENT_214	[p10l59t238r151b279],
16	50	CD	NUMBER	50	dep	15	SENT_214	[p10l59t238r151b279],
17	1	CD	NUMBER	1	num	18	SENT_214	[p10l434t238r454b279],
18	5.47	CD	NUMBER	5.47	_	0	SENT_214	[p10l465t238r570b279],
19	-	:	O	-	_	0	SENT_214	[p10l977t261r1004b266],
20	Reference	NNP	O	Reference	dep	27	SENT_214	[p10l1397t235r1649b279],
21	50-60	CD	NUMBER	50-60	num	20	SENT_214	[p10l1937t261r1964b266, p10l60t310r218b351],
22	13.00	CD	NUMBER	13.00	num	23	SENT_214	[p10l434t310r571b352],
23	0.53	CD	NUMBER	0.53	dep	20	SENT_214	[p10l977t310r1082b352],
24	0.89	CD	NUMBER	0.89	number	25	SENT_214	[p10l1397t310r1503b352],
25	0.61	CD	NUMBER	0.61	dep	23	SENT_214	[p10l1825t310r1926b352],
26	-1.30	CD	NUMBER	-1.30	dep	27	SENT_214	[p10l1937t310r2076b352],
27	>	JJR	O	>	dep	37	SENT_214	[p10l60t382r151b424],
28	60	CD	NUMBER	60	number	29	SENT_214	[p10l60t382r151b424],
29	13.47	CD	NUMBER	13.47	num	31	SENT_214	[p10l434t382r570b424],
30	0.92	CD	NUMBER	0.92	number	31	SENT_214	[p10l977t382r1082b424],
31	0.98	CD	NUMBER	0.98	dep	27	SENT_214	[p10l1397t382r1502b424],
32	0.69-1	CD	NUMBER	0.69-1	number	33	SENT_214	[p10l1825t382r2076b424],
33	.39	CD	NUMBER	.39	num	34	SENT_214	[p10l1825t382r2076b424],
34	Sex	NN	O	sex	npadvmod	35	SENT_214	[p10l59t454r147b495],
35	Female	JJ	O	female	amod	31	SENT_214	[p10l59t524r241b568],
36	13.70	CD	NUMBER	13.70	num	37	SENT_214	[p10l434t526r571b568],
37	—	CD	NUMBER	—	dep	41	SENT_214	[p10l977t550r1004b555],
38	Reference	NNP	O	Reference	dep	37	SENT_214	[p10l1397t524r1649b568],
39	—	CD	NUMBER	—	num	38	SENT_214	[p10l1937t550r1964b555],
40	Male	JJ	O	male	amod	41	SENT_214	[p10l60t595r184b639],
41	14.30	CD	NUMBER	14.30	dep	54	SENT_214	[p10l434t598r571b639],
42	0.25	CD	NUMBER	0.25	num	43	SENT_214	[p10l977t598r1082b639],
43	0.81	CD	NUMBER	0.81	dep	41	SENT_214	[p10l1397t598r1498b639],
44	0.56-1	CD	NUMBER	0.56-1	number	45	SENT_214	[p10l1825t598r2076b639],
45	.16	CD	NUMBER	.16	num	47	SENT_214	[p10l1825t598r2076b639],
46	Smoking	NN	O	smoking	nn	47	SENT_214	[p10l59t667r284b721],
47	status	NN	O	status	dep	43	SENT_214	[p10l301t673r452b710],
48	No	DT	O	no	det	54	SENT_214	[p10l59t742r129b783],
49	1	CD	NUMBER	1	num	54	SENT_214	[p10l434t742r454b782],
50	8.07	CD	NUMBER	8.07	num	54	SENT_214	[p10l465t741r570b783],
51	—	CD	NUMBER	—	num	54	SENT_214	[p10l977t765r1004b770],
52	Reference	NNP	O	Reference	nn	54	SENT_214	[p10l1397t739r1649b783],
53	—	NNP	O	—	nn	54	SENT_214	[p10l1937t765r1964b770],
54	Light	NNP	O	Light	dep	59	SENT_214	[p10l60t810r188b864],
55	12.57	CD	NUMBER	12.57	number	56	SENT_214	[p10l434t812r570b853],
56	0.03	CD	NUMBER	0.03	dep	54	SENT_214	[p10l977t812r1081b853],
57	0.66	CD	NUMBER	0.66	num	58	SENT_214	[p10l1397t812r1504b853],
58	0.45-0	CD	NUMBER	0.45-0	dep	56	SENT_214	[p10l1825t812r2075b853],
59	.97	CD	NUMBER	.97	dep	60	SENT_214	[p10l1825t812r2075b853],
60	Heavy	JJ	O	heavy	dep	62	SENT_214	[p10l59t884r220b935],
61	13.47	CD	NUMBER	13.47	num	62	SENT_214	[p10l434t883r570b925],
62	0.02	CD	NUMBER	0.02	dep	70	SENT_214	[p10l977t883r1082b925],
63	0.52	CD	NUMBER	0.52	number	64	SENT_214	[p10l1397t883r1502b925],
64	0.35-0	CD	NUMBER	0.35-0	dep	62	SENT_214	[p10l1825t883r2075b925],
65	.79	CD	NUMBER	.79	num	68	SENT_214	[p10l1825t883r2075b925],
66	Family	NNP	O	Family	nn	68	SENT_214	[p10l60t952r232b1007],
67	cancer	NN	O	cancer	nn	68	SENT_214	[p10l248t965r417b996],
68	history	NN	O	history	dep	64	SENT_214	[p10l433t952r614b1007],
69	No	DT	O	no	det	70	SENT_214	[p10l60t1026r129b1067],
70	14.07	NN	NUMBER	14.07	dep	18	SENT_214	[p10l434t1026r570b1068],
71	-	:	O	-	_	0	SENT_214	[p10l977t1050r1004b1054],
72	Reference	NNP	O	Reference	nn	73	SENT_214	[p10l1397t1023r1649b1067],
73	Yes	NNP	O	Yes	dep	77	SENT_214	[p10l1937t1050r1964b1054, p10l57t1099r144b1140],
74	7.93	CD	NUMBER	7.93	dep	73	SENT_214	[p10l465t1098r569b1140],
75	0.96	CD	NUMBER	0.96	dep	77	SENT_214	[p10l977t1098r1084b1140],
76	0.96	CD	NUMBER	0.96	num	77	SENT_214	[p10l1397t1098r1504b1140],
77	0.23-4	CD	NUMBER	0.23-4	dep	81	SENT_214	[p10l1825t1098r2074b1140],
78	.03	CD	NUMBER	.03	num	80	SENT_214	[p10l1825t1098r2074b1140],
79	Stage	NN	O	stage	nn	80	SENT_214	[p10l59t1170r195b1222],
80	IIIA	NN	O	iium	dep	77	SENT_214	[p10l59t1241r147b1282],
81	13.70	CD	NUMBER	13.70	dep	70	SENT_214	[p10l434t1241r571b1283],
82	-	:	O	-	_	0	SENT_214	[p10l977t1265r1004b1269],
83	Reference	NNP	O	Reference	nn	84	SENT_214	[p10l1397t1239r1649b1282],
84	IIIB	NN	O	iiib	dep	91	SENT_214	[p10l1937t1265r1964b1269, p10l59t1314r141b1354],
85	14.47	CD	NUMBER	14.47	number	86	SENT_214	[p10l434t1313r570b1355],
86	0.83	CD	NUMBER	0.83	dep	84	SENT_214	[p10l977t1313r1082b1355],
87	0.96	CD	NUMBER	0.96	num	88	SENT_214	[p10l1397t1313r1504b1355],
88	0.67-1	CD	NUMBER	0.67-1	dep	86	SENT_214	[p10l1825t1313r2076b1355],
89	.39	CD	NUMBER	.39	dep	91	SENT_214	[p10l1825t1313r2076b1355],
90	IV	CD	NUMBER	iv	num	91	SENT_214	[p10l60t1385r112b1426],
91	14.07	CD	NUMBER	14.07	dep	95	SENT_214	[p10l434t1385r570b1427],
92	0.69	CD	NUMBER	0.69	num	93	SENT_214	[p10l977t1385r1083b1427],
93	0.93	CD	NUMBER	0.93	dep	91	SENT_214	[p10l1397t1385r1502b1427],
94	0.64-1	CD	NUMBER	0.64-1	num	95	SENT_214	[p10l1825t1385r2077b1427],
95	.34	CD	NUMBER	.34	dep	81	SENT_214	[p10l1825t1385r2077b1427],

1	3	CD	NUMBER	3	num	2	SENT_215	[p10l59t1522r77b1544],
2	MST	NN	O	mst	_	0	SENT_215	[p10l110t1523r236b1565],
3	:	:	O	:	_	0	SENT_215	[p10l110t1523r236b1565],
4	Median	JJ	O	median	amod	6	SENT_215	[p10l258t1520r451b1564],
5	survival	NN	O	survival	nn	6	SENT_215	[p10l469t1520r671b1564],
6	time	NN	O	time	dep	2	SENT_215	[p10l689t1521r818b1564],
7	.	.	O	.	_	0	SENT_215	[p10l689t1521r818b1564],

1	statistical	JJ	O	statistical	amod	2	SENT_216	[p10l11t1718r317b1773],
2	difference	NN	O	difference	_	0	SENT_216	[p10l339t1718r661b1773],
3	between	IN	O	between	_	0	SENT_216	[p10l683t1718r961b1773],
4	rs10981694	CD	NUMBER	rs10981694	num	5	SENT_216	[p10l983t1721r1366b1773],
5	polymorphism	NN	O	polymorphism	prep_between	2	SENT_216	[p10l1387t1718r1863b1787],
6	and	CC	O	and	_	0	SENT_216	[p10l1884t1718r2001b1773],
7	survival	NN	O	survival	nn	8	SENT_216	[p10l2024t1734r2149b1773, p10l8t1807r160b1862],
8	analysis	NN	O	analysis	prep_between	2	SENT_216	[p10l187t1807r441b1876],
9	in	IN	O	in	_	0	SENT_216	[p10l470t1808r529b1862],
10	these	DT	O	these	det	11	SENT_216	[p10l554t1807r725b1862],
11	patients	NNS	O	patient	prep_in	2	SENT_216	[p10l752t1808r1027b1876],
12	.	.	O	.	_	0	SENT_216	[p10l752t1808r1027b1876],

1	Identiﬁcation	NN	O	identiﬁcation	nsubj	8	SENT_217	[p10l1055t1807r1487b1862],
2	of	IN	O	of	_	0	SENT_217	[p10l1513t1807r1579b1862],
3	individual	JJ	O	individual	prep_of	1	SENT_217	[p10l1599t1807r1922b1862],
4	at	IN	O	at	_	0	SENT_217	[p10l1949t1815r2009b1862],
5	risk	NN	O	risk	prep_at	3	SENT_217	[p10l2034t1807r2152b1862],
6	of	IN	O	of	_	0	SENT_217	[p10l10t1896r76b1951],
7	platinum	NN	O	platinum	prep_of	5	SENT_217	[p10l87t1896r381b1965],
8	induced	VBD	O	induce	_	0	SENT_217	[p10l400t1896r655b1951],
9	severe	JJ	O	severe	amod	10	SENT_217	[p10l675t1912r880b1951],
10	toxicity	NN	O	toxicity	nsubj	12	SENT_217	[p10l898t1897r1143b1965],
11	will	MD	O	will	aux	12	SENT_217	[p10l1158t1896r1278b1951],
12	lead	VB	O	lead	ccomp	8	SENT_217	[p10l1298t1896r1429b1951],
13	to	TO	O	to	_	0	SENT_217	[p10l1448t1904r1509b1951],
14	great	JJ	O	great	amod	15	SENT_217	[p10l1527t1904r1692b1965],
15	improvement	NN	O	improvement	prep_to	12	SENT_217	[p10l1710t1897r2151b1965],
16	in	IN	O	in	_	0	SENT_217	[p10l10t1986r69b2040],
17	personal	JJ	O	personal	amod	19	SENT_217	[p10l89t1985r364b2054],
18	chemotherapeutic	JJ	O	chemotherapeutic	amod	19	SENT_217	[p10l384t1985r975b2054],
19	treatment	NN	O	treatment	prep_in	15	SENT_217	[p10l994t1993r1318b2040],
20	and	CC	O	and	_	0	SENT_217	[p10l1336t1985r1452b2040],
21	agent	NN	O	agent	nn	22	SENT_217	[p10l1473t1994r1651b2054],
22	efﬁcacy	NN	O	efﬁcacy	conj_and	19	SENT_217	[p10l1670t1985r1928b2054],
23	.	.	O	.	_	0	SENT_217	[p10l1670t1985r1928b2054],

1	To	TO	O	to	_	0	SENT_218	[p10l1946t1989r2023b2040],
2	our	PRP$	O	we	poss	3	SENT_218	[p10l2043t2001r2152b2040],
3	knowledge	NN	O	knowledge	prep_to	9	SENT_218	[p10l10t2075r379b2143],
4	,	,	O	,	_	0	SENT_218	[p10l10t2075r379b2143],
5	this	DT	O	this	nsubj	9	SENT_218	[p10l413t2075r529b2130],
6	is	VBZ	O	be	cop	9	SENT_218	[p10l564t2075r610b2130],
7	the	DT	O	the	det	9	SENT_218	[p10l644t2075r746b2130],
8	ﬁrst	JJ	O	ﬁrst	amod	9	SENT_218	[p10l780t2074r907b2130],
9	time	NN	O	time	_	0	SENT_218	[p10l938t2075r1084b2130],
10	to	TO	O	to	aux	11	SENT_218	[p10l1117t2083r1179b2130],
11	indicate	VB	O	indicate	infmod	9	SENT_218	[p10l1213t2075r1469b2130],
12	that	IN	O	that	complm	17	SENT_218	[p10l1502t2074r1631b2130],
13	CTR1	NN	O	ctr1	nn	14	SENT_218	[p10l1664t2077r1808b2130],
14	polymorphism	NN	O	polymorphism	nsubjpass	17	SENT_218	[p10l1849t2075r2149b2143, p10l10t2164r208b2232],
15	could	MD	O	could	aux	17	SENT_218	[p10l231t2164r405b2219],
16	be	VB	O	be	auxpass	17	SENT_218	[p10l428t2164r502b2219],
17	considered	VBN	O	consider	ccomp	11	SENT_218	[p10l525t2164r877b2219],
18	as	IN	O	as	mark	27	SENT_218	[p10l900t2180r962b2219],
19	a	DT	O	a	det	20	SENT_218	[p10l986t2180r1018b2219],
20	biomarker	NN	O	biomarker	nsubj	27	SENT_218	[p10l1040t2164r1377b2219],
21	for	IN	O	for	_	0	SENT_218	[p10l1399t2164r1488b2219],
22	prediction	NN	O	prediction	prep_for	20	SENT_218	[p10l1509t2164r1840b2232],
23	of	IN	O	of	_	0	SENT_218	[p10l1863t2164r1929b2219],
24	severe	JJ	O	severe	amod	26	SENT_218	[p10l1945t2180r2149b2219],
25	cisplatin	NN	O	cisplatin	nn	26	SENT_218	[p10l10t2252r572b2321],
26	—	NN	O	—	prep_of	22	SENT_218	[p10l10t2252r572b2321],
27	induced	VBD	O	induce	advcl	17	SENT_218	[p10l10t2252r572b2321],
28	toxicity	NN	O	toxicity	dobj	27	SENT_218	[p10l594t2253r839b2321],
29	in	IN	O	in	_	0	SENT_218	[p10l860t2253r919b2306],
30	cancer	NN	O	cancer	nn	31	SENT_218	[p10l942t2268r1152b2307],
31	patients	NNS	O	patient	prep_in	27	SENT_218	[p10l1173t2253r1447b2321],
32	.	.	O	.	_	0	SENT_218	[p10l1173t2253r1447b2321],

1	Cisplatin	NNP	O	Cisplatin	nsubjpass	3	SENT_219	[p10l112t2341r393b2410],
2	is	VBZ	O	be	auxpass	3	SENT_219	[p10l431t2342r477b2396],
3	considered	VBN	O	consider	_	0	SENT_219	[p10l515t2341r867b2396],
4	as	IN	O	as	_	0	SENT_219	[p10l905t2357r967b2396],
5	the	DT	O	the	det	9	SENT_219	[p10l1005t2341r1107b2396],
6	ﬁrst	JJ	O	ﬁrst	amod	9	SENT_219	[p10l1146t2341r1422b2396],
7	—	NN	O	—	nn	9	SENT_219	[p10l1146t2341r1422b2396],
8	line	NN	O	line	nn	9	SENT_219	[p10l1146t2341r1422b2396],
9	treatment	NN	O	treatment	prep_as	3	SENT_219	[p10l1459t2349r1784b2396],
10	for	IN	O	for	_	0	SENT_219	[p10l1820t2341r1910b2396],
11	NSCLC	NN	O	nsclc	nn	12	SENT_219	[p10l1946t2344r2151b2396],
12	patients	NNS	O	patient	prep_for	9	SENT_219	[p10l10t2431r285b2499],
13	,	,	O	,	_	0	SENT_219	[p10l10t2431r285b2499],
14	which	WDT	O	which	nsubjpass	18	SENT_219	[p10l320t2430r519b2485],
15	is	VBZ	O	be	auxpass	18	SENT_219	[p10l555t2431r601b2485],
16	now	RB	DATE	now	advmod	18	SENT_219	[p10l638t2446r778b2485],
17	widely	RB	O	widely	advmod	18	SENT_219	[p10l811t2430r1031b2499],
18	used	VBN	O	use	rcmod	12	SENT_219	[p10l1065t2430r1213b2485],
19	in	IN	O	in	_	0	SENT_219	[p10l1250t2431r1309b2485],
20	chemotherapeutic	JJ	O	chemotherapeutic	amod	21	SENT_219	[p10l1344t2430r1935b2499],
21	treatment	NN	O	treatment	prep_in	18	SENT_219	[p10l1970t2438r2149b2485, p10l10t2528r178b2575],
22	of	IN	O	of	_	0	SENT_219	[p10l206t2519r272b2575],
23	various	JJ	O	various	amod	24	SENT_219	[p10l291t2520r527b2575],
24	tumors	NNS	O	tumor	prep_of	21	SENT_219	[p10l556t2528r786b2575],
25	all	DT	O	all	dep	18	SENT_219	[p10l816t2519r889b2575],
26	over	IN	O	over	_	0	SENT_219	[p10l919t2535r1061b2575],
27	the	DT	O	the	det	28	SENT_219	[p10l1087t2520r1189b2575],
28	world	NN	O	world	prep_over	18	SENT_219	[p10l1216t2520r1406b2575],
29	[	CD	NUMBER	[	number	30	SENT_219	[p10l1438t2519r1578b2588],
30	20	CD	NUMBER	20	num	31	SENT_219	[p10l1438t2519r1578b2588],
31	]	NN	O	]	dep	28	SENT_219	[p10l1438t2519r1578b2588],
32	.	.	O	.	_	0	SENT_219	[p10l1438t2519r1578b2588],

1	However	RB	O	however	advmod	6	SENT_220	[p10l1609t2523r1915b2583],
2	,	,	O	,	_	0	SENT_220	[p10l1609t2523r1915b2583],
3	severe	JJ	O	severe	amod	5	SENT_220	[p10l1945t2535r2149b2575],
4	cisplatin	NN	O	cisplatin	nn	5	SENT_220	[p10l10t2608r572b2677],
5	—	NN	O	—	nsubj	6	SENT_220	[p10l10t2608r572b2677],
6	induced	VBD	O	induce	_	0	SENT_220	[p10l10t2608r572b2677],
7	toxicity	NN	O	toxicity	nsubj	11	SENT_220	[p10l619t2609r863b2677],
8	is	VBZ	O	be	cop	11	SENT_220	[p10l908t2609r955b2664],
9	the	DT	O	the	det	11	SENT_220	[p10l1002t2609r1103b2664],
10	major	JJ	O	major	amod	11	SENT_220	[p10l1151t2609r1340b2677],
11	obstacle	NN	O	obstacle	ccomp	6	SENT_220	[p10l1385t2609r1647b2664],
12	to	TO	O	to	_	0	SENT_220	[p10l1693t2617r1755b2664],
13	its	PRP$	O	its	poss	15	SENT_220	[p10l1803t2609r1876b2664],
14	clinical	JJ	O	clinical	amod	15	SENT_220	[p10l1923t2609r2149b2664],
15	efﬁcacy	NN	O	efﬁcacy	prep_to	11	SENT_220	[p10l10t2698r268b2766],
16	.	.	O	.	_	0	SENT_220	[p10l10t2698r268b2766],

1	Cisplatin	NNP	O	Cisplatin	nn	2	SENT_221	[p10l303t2698r874b2766],
2	—	NN	O	—	nsubj	3	SENT_221	[p10l303t2698r874b2766],
3	induced	VBD	O	induce	_	0	SENT_221	[p10l303t2698r874b2766],
4	ototoxicity	NN	O	ototoxicity	nsubj	12	SENT_221	[p10l908t2699r1272b2766],
5	,	,	O	,	_	0	SENT_221	[p10l908t2699r1272b2766],
6	especially	RB	O	especially	advmod	7	SENT_221	[p10l1307t2698r1624b2766],
7	hearing	VBG	O	hear	partmod	4	SENT_221	[p10l1656t2698r1900b2766],
8	loss	NN	O	loss	dobj	7	SENT_221	[p10l1933t2698r2067b2761],
9	,	,	O	,	_	0	SENT_221	[p10l1933t2698r2067b2761],
10	is	VBZ	O	be	cop	12	SENT_221	[p10l2103t2699r2149b2753],
11	usually	RB	O	usually	advmod	12	SENT_221	[p10l10t2786r241b2855],
12	irreversible	JJ	O	irreversible	ccomp	3	SENT_221	[p10l262t2786r629b2841],
13	and	CC	O	and	_	0	SENT_221	[p10l652t2786r768b2841],
14	bilateral	JJ	O	bilateral	conj_and	12	SENT_221	[p10l791t2786r1072b2842],
15	.	.	O	.	_	0	SENT_221	[p10l791t2786r1072b2842],

1	Symptoms	NNS	O	symptom	nsubj	4	SENT_222	[p10l1097t2789r1438b2855],
2	of	IN	O	of	_	0	SENT_222	[p10l1461t2786r1528b2841],
3	ototoxicity	NN	O	ototoxicity	prep_of	1	SENT_222	[p10l1543t2787r1893b2855],
4	include	VBP	O	include	_	0	SENT_222	[p10l1915t2786r2149b2841],
5	subjective	JJ	O	subjective	amod	7	SENT_222	[p10l11t2875r335b2944],
6	hearing	NN	O	hearing	nn	7	SENT_222	[p10l361t2875r605b2944],
7	loss	NN	O	loss	dobj	4	SENT_222	[p10l630t2875r764b2939],
8	,	,	O	,	_	0	SENT_222	[p10l630t2875r764b2939],
9	ear	NN	O	ear	nn	10	SENT_222	[p10l791t2891r890b2930],
10	pain	NN	O	pain	dobj	4	SENT_222	[p10l914t2876r1052b2944],
11	or	CC	O	or	_	0	SENT_222	[p10l1077t2891r1144b2930],
12	tinnitus	NN	O	tinnitus	dobj	4	SENT_222	[p10l1166t2876r1416b2930],
13	and	CC	O	and	cc	15	SENT_222	[p10l1442t2875r1558b2930],
14	so	RB	O	so	dep	15	SENT_222	[p10l1585t2891r1651b2930],
15	on	IN	O	on	advmod	4	SENT_222	[p10l1677t2891r1770b2931],
16	.	.	O	.	_	0	SENT_222	[p10l1677t2891r1770b2931],

1	It	PRP	O	it	nsubjpass	4	SENT_223	[p10l1797t2879r1841b2930],
2	has	VBZ	O	have	aux	4	SENT_223	[p10l1866t2875r1970b2930],
3	been	VBN	O	be	auxpass	4	SENT_223	[p10l1996t2875r2150b2930],
4	reported	VBN	O	report	_	0	SENT_223	[p10l10t2964r287b3033],
5	that	IN	O	that	complm	11	SENT_223	[p10l314t2964r444b3019],
6	about	IN	O	about	_	0	SENT_223	[p10l469t2964r652b3019],
7	one	CD	NUMBER	one	num	8	SENT_223	[p10l678t2964r983b3019],
8	—	CD	NUMBER	—	prep_about	11	SENT_223	[p10l678t2964r983b3019],
9	third	JJ	ORDINAL	third	amod	10	SENT_223	[p10l678t2964r983b3019],
10	patients	NNS	O	patient	nsubj	11	SENT_223	[p10l1011t2965r1269b3033],
11	suffered	VBD	O	suffer	ccomp	4	SENT_223	[p10l1298t2964r1558b3019],
12	irreversible	JJ	O	irreversible	amod	14	SENT_223	[p10l1586t2964r1953b3019],
13	hearing	NN	O	hearing	nn	14	SENT_223	[p10l1981t2964r2149b3019, p10l10t3054r109b3122],
14	loss	NN	O	loss	dobj	11	SENT_223	[p10l131t3054r248b3109],
15	after	IN	O	after	_	0	SENT_223	[p10l272t3053r422b3109],
16	Cisplatin	NN	O	cisplatin	nn	17	SENT_223	[p10l443t3054r716b3122],
17	treatment	NN	O	treatment	prep_after	11	SENT_223	[p10l738t3062r1076b3109],
18	.	.	O	.	_	0	SENT_223	[p10l738t3062r1076b3109],

1	About	RB	O	about	advmod	4	SENT_224	[p10l1098t3054r1293b3109],
2	15	CD	PERCENT	15	num	4	SENT_224	[p10l1318t3056r1436b3109],
3	%	NN	PERCENT	%	nn	4	SENT_224	[p10l1318t3056r1436b3109],
4	patients	NNS	O	patient	nsubj	6	SENT_224	[p10l1459t3054r1717b3122],
5	also	RB	O	also	advmod	6	SENT_224	[p10l1741t3054r1865b3109],
6	suffered	VBD	O	suffer	_	0	SENT_224	[p10l1889t3053r2149b3109],
7	critical	JJ	O	critical	amod	8	SENT_224	[p10l10t3143r227b3198],
8	functional	JJ	O	functional	amod	10	SENT_224	[p10l253t3143r578b3198],
9	hearing	NN	O	hearing	nn	10	SENT_224	[p10l603t3143r847b3211],
10	loss	NN	O	loss	dobj	6	SENT_224	[p10l871t3143r989b3198],
11	after	IN	O	after	_	0	SENT_224	[p10l1014t3143r1164b3198],
12	chemotherapy	NN	O	chemotherapy	prep_after	6	SENT_224	[p10l1186t3143r1656b3211],
13	[	CD	NUMBER	[	number	14	SENT_224	[p10l1681t3143r1822b3211],
14	21	CD	NUMBER	21	num	15	SENT_224	[p10l1681t3143r1822b3211],
15	]	NN	O	]	dep	6	SENT_224	[p10l1681t3143r1822b3211],
16	.	.	O	.	_	0	SENT_224	[p10l1681t3143r1822b3211],

1	There	EX	O	there	expl	2	SENT_225	[p10l1844t3143r2027b3198],
2	are	VBP	O	be	_	0	SENT_225	[p10l2052t3159r2149b3198],
3	60-68	CD	PERCENT	60-68	num	4	SENT_225	[p10l10t3235r254b3287],
4	%	NN	PERCENT	%	nsubj	2	SENT_225	[p10l10t3235r254b3287],
5	patients	NNS	O	patient	nsubj	6	SENT_225	[p10l276t3233r534b3300],
6	experimented	VBD	O	experiment	rcmod	4	SENT_225	[p10l558t3232r1010b3300],
7	hearing	NN	O	hearing	nn	9	SENT_225	[p10l1033t3232r1277b3300],
8	threshold	NN	O	threshold	nn	9	SENT_225	[p10l1298t3232r1606b3287],
9	elevation	NN	O	elevation	dobj	6	SENT_225	[p10l1629t3232r1925b3287],
10	[	CD	NUMBER	[	number	11	SENT_225	[p10l1951t3232r2091b3300],
11	22	CD	NUMBER	22	num	12	SENT_225	[p10l1951t3232r2091b3300],
12	]	NN	O	]	dep	6	SENT_225	[p10l1951t3232r2091b3300],
13	.	.	O	.	_	0	SENT_225	[p10l1951t3232r2091b3300],

1	In	IN	O	in	_	0	SENT_226	[p10l112t3323r172b3374],
2	general	JJ	O	general	prep_in	6	SENT_226	[p10l188t3320r441b3389],
3	,	,	O	,	_	0	SENT_226	[p10l188t3320r441b3389],
4	the	DT	O	the	det	5	SENT_226	[p10l459t3320r561b3375],
5	mechanisms	NNS	O	mechanism	nsubj	6	SENT_226	[p10l579t3320r981b3375],
6	result	VBP	O	result	_	0	SENT_226	[p10l1000t3320r1184b3375],
7	to	TO	O	to	_	0	SENT_226	[p10l1199t3328r1261b3375],
8	different	JJ	O	different	amod	10	SENT_226	[p10l1279t3320r1558b3375],
9	cisplatin	NN	O	cisplatin	nn	10	SENT_226	[p10l1574t3320r1846b3389],
10	response	NN	O	response	prep_to	6	SENT_226	[p10l1864t3336r2149b3389],
11	involving	VBG	O	involve	_	0	SENT_226	[p10l10t3409r310b3478],
12	four	CD	NUMBER	four	num	13	SENT_226	[p10l340t3409r472b3464],
13	pathways	NNS	O	pathway	prep_involving	10	SENT_226	[p10l501t3409r827b3478],
14	,	,	O	,	_	0	SENT_226	[p10l501t3409r827b3478],
15	altered	JJ	O	altered	amod	17	SENT_226	[p10l859t3409r1083b3464],
16	cellular	JJ	O	cellular	amod	17	SENT_226	[p10l1114t3409r1354b3464],
17	accumulation	NN	O	accumulation	prep_involving	10	SENT_226	[p10l1382t3409r1836b3473],
18	,	,	O	,	_	0	SENT_226	[p10l1382t3409r1836b3473],
19	cytosolic	JJ	O	cytosolic	amod	20	SENT_226	[p10l1868t3409r2151b3478],
20	inactivation	NN	O	inactivation	prep_involving	10	SENT_226	[p10l10t3499r393b3553],
21	of	IN	O	of	_	0	SENT_226	[p10l425t3498r491b3553],
22	platinum	NN	O	platinum	nn	23	SENT_226	[p10l517t3498r811b3567],
23	drugs	NNS	O	drug	prep_of	20	SENT_226	[p10l843t3498r1037b3567],
24	,	,	O	,	_	0	SENT_226	[p10l843t3498r1037b3567],
25	inactivation	NN	O	inactivation	prep_involving	10	SENT_226	[p10l1071t3499r1454b3553],
26	of	IN	O	of	_	0	SENT_226	[p10l1486t3498r1552b3553],
27	DNA	NN	O	dna	nn	29	SENT_226	[p10l1578t3501r1724b3553],
28	repair	NN	O	repair	nn	29	SENT_226	[p10l1755t3499r1947b3567],
29	pathway	NN	O	pathway	prep_of	25	SENT_226	[p10l1978t3498r2149b3567, p10l8t3603r142b3656],
30	and	CC	O	and	_	0	SENT_226	[p10l166t3588r283b3643],
31	altered	JJ	O	altered	amod	32	SENT_226	[p10l309t3588r533b3643],
32	apoptosis	NN	O	apoptosis	prep_of	25	SENT_226	[p10l560t3588r866b3656],
33	or	CC	O	or	_	0	SENT_226	[p10l893t3603r959b3643],
34	increased	VBN	O	increase	amod	35	SENT_226	[p10l983t3588r1289b3643],
35	tolerance	NN	O	tolerance	prep_involving	10	SENT_226	[p10l1315t3588r1614b3643],
36	to	TO	O	to	_	0	SENT_226	[p10l1640t3596r1702b3643],
37	DNA	NN	O	dna	nn	38	SENT_226	[p10l1729t3590r1875b3642],
38	damage	NN	O	damage	prep_to	35	SENT_226	[p10l1898t3587r2149b3656],

1	[	NN	O	[	_	0	SENT_227	[p11l13t17r333b85],
2	5,23	CD	NUMBER	5,23	number	3	SENT_227	[p11l13t17r333b85],
3	—	CD	NUMBER	—	dep	1	SENT_227	[p11l13t17r333b85],
4	25	CD	NUMBER	25	num	5	SENT_227	[p11l13t17r333b85],
5	]	NN	O	]	dep	3	SENT_227	[p11l13t17r333b85],
6	.	.	O	.	_	0	SENT_227	[p11l13t17r333b85],

1	Cisplatin	NNP	O	Cisplatin	nsubj	10	SENT_228	[p11l363t17r644b85],
2	could	MD	O	could	aux	4	SENT_228	[p11l672t17r846b72],
3	be	VB	O	be	auxpass	4	SENT_228	[p11l874t17r948b72],
4	accumulated	VBN	O	accumulate	_	0	SENT_228	[p11l976t17r1389b72],
5	in	IN	O	in	_	0	SENT_228	[p11l1418t18r1478b71],
6	the	DT	O	the	det	8	SENT_228	[p11l1505t17r1607b72],
7	cochlear	JJ	O	cochlear	amod	8	SENT_228	[p11l1635t17r1907b72],
8	tissues	NNS	O	tissue	prep_in	4	SENT_228	[p11l1933t18r2149b72],
9	and	CC	O	and	_	0	SENT_228	[p11l10t105r126b160],
10	induces	VBZ	O	induce	conj_and	4	SENT_228	[p11l146t105r391b160],
11	DNA	NN	O	dna	nn	13	SENT_228	[p11l411t107r558b160],
12	adduct	NN	O	adduct	nn	13	SENT_228	[p11l574t105r794b160],
13	formation	NN	O	formation	dobj	10	SENT_228	[p11l812t105r1147b161],
14	.	.	O	.	_	0	SENT_228	[p11l812t105r1147b161],

1	These	DT	O	these	det	2	SENT_229	[p11l1165t105r1350b160],
2	productions	NNS	O	production	nsubj	11	SENT_229	[p11l1370t105r1755b174],
3	could	MD	O	could	aux	4	SENT_229	[p11l1776t105r1950b160],
4	intervene	VB	O	intervene	_	0	SENT_229	[p11l1970t106r2149b160, p11l8t210r160b249],
5	the	DT	O	the	det	6	SENT_229	[p11l182t194r283b249],
6	synthesis	NN	O	synthesis	dobj	4	SENT_229	[p11l307t194r604b263],
7	of	IN	O	of	_	0	SENT_229	[p11l627t194r693b249],
8	functional	JJ	O	functional	amod	9	SENT_229	[p11l708t194r1033b249],
9	proteins	NNS	O	protein	prep_of	6	SENT_229	[p11l1056t195r1320b263],
10	and	CC	O	and	_	0	SENT_229	[p11l1343t194r1459b249],
11	decrease	VB	O	decrease	conj_and	4	SENT_229	[p11l1482t194r1761b249],
12	the	DT	O	the	det	13	SENT_229	[p11l1783t194r1885b249],
13	efﬁcacy	NN	O	efﬁcacy	dobj	11	SENT_229	[p11l1907t194r2152b263],
14	of	IN	O	of	_	0	SENT_229	[p11l10t283r76b338],
15	gene	NN	O	gene	nn	16	SENT_229	[p11l95t299r246b352],
16	translation	NN	O	translation	prep_of	13	SENT_229	[p11l274t283r624b338],
17	[	CD	NUMBER	[	num	19	SENT_229	[p11l655t283r795b352],
18	26	CD	NUMBER	26	num	19	SENT_229	[p11l655t283r795b352],
19	]	NN	O	]	dobj	4	SENT_229	[p11l655t283r795b352],
20	.	.	O	.	_	0	SENT_229	[p11l655t283r795b352],

1	Since	IN	O	since	mark	5	SENT_230	[p11l824t284r990b338],
2	the	DT	O	the	det	3	SENT_230	[p11l1018t283r1120b338],
3	cochlear	NN	O	cochlear	nsubj	10	SENT_230	[p11l1147t283r1419b338],
4	is	VBZ	O	be	auxpass	5	SENT_230	[p11l1445t284r1491b338],
5	isolated	VBN	O	isolate	advcl	18	SENT_230	[p11l1520t283r1771b338],
6	from	IN	O	from	_	0	SENT_230	[p11l1799t283r1952b338],
7	other	JJ	O	other	amod	8	SENT_230	[p11l1980t283r2152b338],
8	tissues	NNS	O	tissue	prep_from	5	SENT_230	[p11l9t373r225b427],
9	and	CC	O	and	_	0	SENT_230	[p11l250t372r366b427],
10	behaves	VBZ	O	behave	advcl	18	SENT_230	[p11l390t372r649b427],
11	as	IN	O	as	_	0	SENT_230	[p11l673t388r736b427],
12	a	DT	O	a	det	14	SENT_230	[p11l760t388r792b427],
13	closed	JJ	O	closed	amod	14	SENT_230	[p11l816t372r1016b427],
14	system	NN	O	system	prep_as	10	SENT_230	[p11l1041t380r1282b441],
15	,	,	O	,	_	0	SENT_230	[p11l1041t380r1282b441],
16	it	PRP	O	it	nsubj	18	SENT_230	[p11l1307t373r1351b427],
17	is	VBZ	O	be	cop	18	SENT_230	[p11l1373t373r1419b427],
18	insufﬁcient	JJ	O	insufﬁcient	_	0	SENT_230	[p11l1445t372r1808b427],
19	to	TO	O	to	aux	20	SENT_230	[p11l1829t380r1891b427],
20	excrete	VB	O	excrete	xcomp	18	SENT_230	[p11l1915t380r2149b427],
21	toxins	NNS	O	toxin	dobj	20	SENT_230	[p11l9t462r205b517],
22	at	IN	O	at	_	0	SENT_230	[p11l230t470r290b517],
23	a	DT	O	a	det	25	SENT_230	[p11l312t477r345b517],
24	rapid	JJ	O	rapid	amod	25	SENT_230	[p11l369t461r534b530],
25	pace	NN	O	pace	prep_at	20	SENT_230	[p11l559t477r719b530],
26	.	.	O	.	_	0	SENT_230	[p11l559t477r719b530],

1	This	DT	O	this	nsubj	2	SENT_231	[p11l742t462r873b517],
2	indicates	VBZ	O	indicate	_	0	SENT_231	[p11l899t462r1185b517],
3	that	IN	O	that	complm	14	SENT_231	[p11l1210t462r1340b517],
4	the	DT	O	the	det	6	SENT_231	[p11l1362t462r1463b517],
5	major	JJ	O	major	amod	6	SENT_231	[p11l1488t462r1678b530],
6	reason	NN	O	reason	nsubj	14	SENT_231	[p11l1700t477r1913b517],
7	of	IN	O	of	_	0	SENT_231	[p11l1937t461r2003b517],
8	oto	FW	O	oto	nn	9	SENT_231	[p11l2020t470r2149b517],
9	—	FW	O	—	prep_of	6	SENT_231	[p11l2020t470r2149b517],
10	toxicity	NN	O	toxicity	dep	9	SENT_231	[p11l9t552r254b619],
11	may	MD	O	may	aux	14	SENT_231	[p11l269t567r406b619],
12	be	VB	O	be	cop	14	SENT_231	[p11l420t551r493b606],
13	cellular	JJ	O	cellular	amod	14	SENT_231	[p11l510t551r750b606],
14	accumulation	NN	O	accumulation	ccomp	2	SENT_231	[p11l764t551r1202b606],
15	of	IN	O	of	_	0	SENT_231	[p11l1219t551r1285b606],
16	platinum	NN	O	platinum	nn	17	SENT_231	[p11l1293t551r1587b619],
17	drugs	NNS	O	drug	prep_of	14	SENT_231	[p11l1603t551r1797b619],
18	.	.	O	.	_	0	SENT_231	[p11l1603t551r1797b619],

1	It	PRP	O	it	nsubjpass	5	SENT_232	[p11l1815t554r1860b606],
2	has	VBZ	O	have	aux	5	SENT_232	[p11l1875t551r1979b606],
3	been	VBN	O	be	auxpass	5	SENT_232	[p11l1996t551r2150b606],
4	extensively	RB	O	extensively	advmod	5	SENT_232	[p11l10t639r378b708],
5	reported	VBN	O	report	_	0	SENT_232	[p11l396t639r672b708],
6	in	IN	O	in	_	0	SENT_232	[p11l693t640r752b693],
7	recent	JJ	DURATION	recent	amod	8	SENT_232	[p11l771t647r973b694],
8	years	NNS	DURATION	year	prep_in	5	SENT_232	[p11l989t655r1158b708],
9	that	WDT	O	that	dobj	13	SENT_232	[p11l1178t639r1307b694],
10	copper	NN	O	copper	nn	12	SENT_232	[p11l1325t655r1547b708],
11	transporter	NN	O	transporter	nn	12	SENT_232	[p11l1563t647r1931b708],
12	family	NN	O	family	nsubj	13	SENT_232	[p11l1949t639r2152b708],
13	plays	VBZ	O	play	rcmod	8	SENT_232	[p11l10t728r174b797],
14	an	DT	O	a	det	16	SENT_232	[p11l213t744r289b783],
15	essential	JJ	O	essential	amod	16	SENT_232	[p11l327t728r607b783],
16	role	NN	O	role	dobj	13	SENT_232	[p11l646t728r768b783],
17	in	IN	O	in	_	0	SENT_232	[p11l807t729r866b783],
18	up	RB	O	up	advmod	20	SENT_232	[p11l904t728r1219b797],
19	—	CD	NUMBER	—	pobj	18	SENT_232	[p11l904t728r1219b797],
20	taking	VBG	O	take	prepc_in	13	SENT_232	[p11l904t728r1219b797],
21	platinum	NN	O	platinum	nn	22	SENT_232	[p11l1256t728r1549b797],
22	drugs	NNS	O	drug	dobj	20	SENT_232	[p11l1588t728r1765b797],
23	and	CC	O	and	_	0	SENT_232	[p11l1804t728r1921b783],
24	transport	VB	O	transport	conj_and	20	SENT_232	[p11l1959t736r2149b783, p11l10t826r144b886],
25	them	PRP	O	they	dobj	24	SENT_232	[p11l174t817r342b872],
26	through	IN	O	through	_	0	SENT_232	[p11l373t817r631b886],
27	plasma	NN	O	plasma	nn	29	SENT_232	[p11l663t817r891b886],
28	membrane	NN	O	membrane	nn	29	SENT_232	[p11l924t817r1272b872],
29	[	NN	O	[	prep_through	24	SENT_232	[p11l1308t817r1407b886],
30	7	CD	NUMBER	7	num	31	SENT_232	[p11l1308t817r1407b886],
31	]	NN	O	]	dep	29	SENT_232	[p11l1308t817r1407b886],
32	.	.	O	.	_	0	SENT_232	[p11l1308t817r1407b886],

1	It	PRP	O	it	nsubjpass	3	SENT_233	[p11l1441t821r1485b872],
2	was	VBD	O	be	auxpass	3	SENT_233	[p11l1514t833r1638b872],
3	found	VBN	O	find	_	0	SENT_233	[p11l1672t817r1857b872],
4	that	IN	O	that	dep	3	SENT_233	[p11l1889t817r2018b872],
5	the	DT	O	the	det	7	SENT_233	[p11l2048t817r2149b872],
6	expression	NN	O	expression	nn	7	SENT_233	[p11l10t907r357b975],
7	levels	NNS	O	level	dep	13	SENT_233	[p11l375t906r555b961],
8	of	IN	O	of	_	0	SENT_233	[p11l574t906r640b961],
9	copper	NN	O	copper	nn	10	SENT_233	[p11l650t922r872b975],
10	transports	NNS	O	transport	prep_of	7	SENT_233	[p11l886t914r1216b975],
11	inﬂuenced	JJ	O	inﬂuenced	amod	12	SENT_233	[p11l1236t906r1573b961],
12	cells	NNS	O	cell	dep	13	SENT_233	[p11l1591t906r1730b961],
13	resistance	NN	O	resistance	dep	17	SENT_233	[p11l1749t907r2070b961],
14	to	TO	O	to	_	0	SENT_233	[p11l2088t914r2149b961],
15	platinum	NN	O	platinum	nn	16	SENT_233	[p11l10t996r304b1064],
16	drugs	NNS	O	drug	prep_to	13	SENT_233	[p11l327t996r504b1064],
17	including	VBG	O	include	dep	4	SENT_233	[p11l530t996r831b1064],
18	cisplatin	NN	O	cisplatin	pobj	17	SENT_233	[p11l854t996r1126b1064],
19	[	CD	NUMBER	[	num	18	SENT_233	[p11l1153t995r1350b1064],
20	5,27	CD	NUMBER	5,27	num	21	SENT_233	[p11l1153t995r1350b1064],
21	]	NN	O	]	dep	18	SENT_233	[p11l1153t995r1350b1064],
22	.	.	O	.	_	0	SENT_233	[p11l1153t995r1350b1064],

1	CTR1	NN	O	ctr1	nsubj	6	SENT_234	[p11l1376t998r1521b1051],
2	is	VBZ	O	be	cop	6	SENT_234	[p11l1552t996r1598b1051],
3	the	DT	O	the	det	6	SENT_234	[p11l1622t996r1724b1051],
4	major	JJ	O	major	amod	6	SENT_234	[p11l1749t996r1938b1064],
5	transport	NN	O	transport	nn	6	SENT_234	[p11l1959t1004r2149b1051, p11l10t1093r144b1153],
6	factor	NN	O	factor	_	0	SENT_234	[p11l169t1085r355b1140],
7	among	IN	O	among	_	0	SENT_234	[p11l378t1101r599b1153],
8	other	JJ	O	other	amod	20	SENT_234	[p11l623t1085r796b1140],
9	two	CD	NUMBER	two	num	13	SENT_234	[p11l818t1093r941b1140],
10	copper	NN	O	copper	nn	13	SENT_234	[p11l968t1101r1189b1153],
11	transporter	NN	O	transporter	nn	13	SENT_234	[p11l1212t1093r1580b1153],
12	family	NN	O	family	nn	13	SENT_234	[p11l1604t1085r1807b1153],
13	members	NNS	O	member	tmod	8	SENT_234	[p11l1832t1085r2149b1148],
14	,	,	O	,	_	0	SENT_234	[p11l1832t1085r2149b1148],
15	ATP7A	NN	O	atp7a	conj_and	13	SENT_234	[p11l7t1175r221b1227],
16	and	CC	O	and	_	0	SENT_234	[p11l240t1173r357b1228],
17	ATP7B	NN	O	atp7b	conj_and	13	SENT_234	[p11l377t1175r584b1227],
18	[	NN	O	[	nn	20	SENT_234	[p11l611t1173r710b1242],
19	7	CD	NUMBER	7	num	20	SENT_234	[p11l611t1173r710b1242],
20	]	NN	O	]	prep_among	6	SENT_234	[p11l611t1173r710b1242],
21	.	.	O	.	_	0	SENT_234	[p11l611t1173r710b1242],

1	It	PRP	O	it	nsubjpass	4	SENT_235	[p11l112t1266r157b1317],
2	has	VBZ	O	have	aux	4	SENT_235	[p11l180t1262r284b1317],
3	been	VBN	O	be	auxpass	4	SENT_235	[p11l310t1262r464b1317],
4	reported	VBN	O	report	_	0	SENT_235	[p11l488t1262r765b1331],
5	by	IN	O	by	_	0	SENT_235	[p11l790t1262r867b1331],
6	Swati	NNP	O	Swati	nn	7	SENT_235	[p11l890t1263r1066b1317],
7	S.	NNP	O	S.	agent	4	SENT_235	[p11l1092t1265r1139b1318],
8	More	RBR	O	more	dep	7	SENT_235	[p11l1165t1266r1332b1317],
9	that	IN	O	that	complm	16	SENT_235	[p11l1356t1262r1486b1317],
10	the	DT	O	the	det	12	SENT_235	[p11l1508t1262r1610b1317],
11	high	JJ	O	high	amod	12	SENT_235	[p11l1635t1262r1776b1331],
12	abundance	NN	O	abundance	nsubj	16	SENT_235	[p11l1800t1262r2149b1317],
13	of	IN	O	of	_	0	SENT_235	[p11l10t1351r76b1406],
14	CTR1	NN	O	ctr1	prep_of	12	SENT_235	[p11l90t1354r234b1406],
15	was	VBD	O	be	cop	16	SENT_235	[p11l260t1367r385b1406],
16	localized	JJ	O	localized	ccomp	4	SENT_235	[p11l407t1351r689b1406],
17	at	IN	O	at	_	0	SENT_235	[p11l710t1359r770b1406],
18	primary	JJ	O	primary	amod	19	SENT_235	[p11l789t1352r1047b1420],
19	sites	NNS	O	site	prep_at	16	SENT_235	[p11l1067t1352r1208b1406],
20	of	IN	O	of	_	0	SENT_235	[p11l1229t1351r1296b1406],
21	cisplatin	NN	O	cisplatin	nn	22	SENT_235	[p11l1308t1351r1580b1420],
22	ototoxicity	NN	O	ototoxicity	prep_of	19	SENT_235	[p11l1600t1352r1951b1420],
23	in	IN	O	in	_	0	SENT_235	[p11l1970t1352r2028b1406],
24	the	DT	O	the	det	26	SENT_235	[p11l2048t1351r2149b1406],
25	inner	JJ	O	inner	amod	26	SENT_235	[p11l10t1440r180b1494],
26	ear	NN	O	ear	prep_in	16	SENT_235	[p11l193t1455r307b1494],
27	.	.	O	.	_	0	SENT_235	[p11l193t1455r307b1494],

1	It	PRP	O	it	nsubj	2	SENT_236	[p11l324t1443r368b1494],
2	included	VBD	O	include	_	0	SENT_236	[p11l383t1439r660b1494],
3	outer	JJ	O	outer	amod	5	SENT_236	[p11l676t1448r849b1494],
4	hair	NN	O	hair	nn	5	SENT_236	[p11l863t1440r989b1494],
5	cells	NNS	O	cell	dobj	2	SENT_236	[p11l1003t1440r1158b1502],
6	,	,	O	,	_	0	SENT_236	[p11l1003t1440r1158b1502],
7	inner	JJ	O	inner	amod	9	SENT_236	[p11l1175t1440r1345b1494],
8	hair	NN	O	hair	nn	9	SENT_236	[p11l1359t1440r1486b1494],
9	cells	NNS	O	cell	appos	5	SENT_236	[p11l1499t1440r1655b1502],
10	,	,	O	,	_	0	SENT_236	[p11l1499t1440r1655b1502],
11	striavascularis	NN	O	striavasculari	appos	5	SENT_236	[p11l1672t1440r2149b1502],
12	,	,	O	,	_	0	SENT_236	[p11l1672t1440r2149b1502],
13	spiral	NN	O	spiral	nn	14	SENT_236	[p11l11t1527r186b1596],
14	ganglia	NN	O	ganglion	appos	5	SENT_236	[p11l206t1528r438b1596],
15	as	RB	O	as	_	0	SENT_236	[p11l457t1543r520b1583],
16	well	RB	O	well	_	0	SENT_236	[p11l540t1528r676b1583],
17	as	IN	O	as	_	0	SENT_236	[p11l697t1543r759b1583],
18	surrounding	JJ	O	surrounding	amod	19	SENT_236	[p11l782t1528r1179b1596],
19	nerves	NNS	O	nerve	dobj	2	SENT_236	[p11l1199t1543r1408b1583],
20	in	IN	O	in	_	0	SENT_236	[p11l1430t1528r1489b1582],
21	the	DT	O	the	det	23	SENT_236	[p11l1509t1528r1611b1583],
22	mouse	NN	O	mouse	nn	23	SENT_236	[p11l1632t1543r1843b1583],
23	cochlear	NN	O	cochlear	prep_in	19	SENT_236	[p11l1864t1528r2149b1583],
24	.	.	O	.	_	0	SENT_236	[p11l1864t1528r2149b1583],

1	Cell	NN	O	cell	nn	2	SENT_237	[p11l10t1617r126b1672],
2	lines	NNS	O	line	nsubj	8	SENT_237	[p11l154t1617r302b1672],
3	overexpressed	VBN	O	overexpress	partmod	2	SENT_237	[p11l330t1617r796b1685],
4	of	IN	O	of	_	0	SENT_237	[p11l824t1617r891b1672],
5	CTR1	NN	O	ctr1	prep_of	3	SENT_237	[p11l910t1620r1063b1672],
6	were	VBD	O	be	cop	8	SENT_237	[p11l1097t1633r1258b1672],
7	more	RBR	O	more	advmod	8	SENT_237	[p11l1286t1633r1452b1672],
8	sensitive	JJ	O	sensitive	_	0	SENT_237	[p11l1480t1618r1761b1672],
9	to	TO	O	to	_	0	SENT_237	[p11l1789t1625r1850b1672],
10	cisplatin	NN	O	cisplatin	nn	11	SENT_237	[p11l1878t1617r2150b1685],
11	treatment	NN	O	treatment	prep_to	8	SENT_237	[p11l9t1713r334b1760],
12	and	CC	O	and	_	0	SENT_237	[p11l362t1705r478b1760],
13	more	RBR	O	more	advmod	14	SENT_237	[p11l509t1721r675b1760],
14	likely	JJ	O	likely	conj_and	8	SENT_237	[p11l706t1705r880b1774],
15	to	TO	O	to	aux	16	SENT_237	[p11l908t1713r969b1760],
16	develop	VB	O	develop	xcomp	14	SENT_237	[p11l1000t1705r1253b1774],
17	ototoxicity	NN	O	ototoxicity	dobj	16	SENT_237	[p11l1283t1706r1647b1774],
18	.	.	O	.	_	0	SENT_237	[p11l1283t1706r1647b1774],

1	CTRl	NN	O	ctrl	nn	2	SENT_238	[p11l1678t1708r1831b1760],
2	inhibitor	NN	O	inhibitor	nsubj	4	SENT_238	[p11l1870t1705r2152b1760],
3	could	MD	O	could	aux	4	SENT_238	[p11l10t1794r184b1849],
4	modulate	VB	O	modulate	_	0	SENT_238	[p11l208t1794r515b1849],
5	cisplatin	NN	O	cisplatin	nn	6	SENT_238	[p11l538t1794r1100b1863],
6	—	NN	O	—	nsubj	7	SENT_238	[p11l538t1794r1100b1863],
7	induced	VBD	O	induce	ccomp	4	SENT_238	[p11l538t1794r1100b1863],
8	ototoxicity	NN	O	ototoxicity	nn	11	SENT_238	[p11l1125t1795r1475b1863],
9	and	CC	O	and	_	0	SENT_238	[p11l1497t1794r1613b1849],
10	cochlear	NN	O	cochlear	nn	11	SENT_238	[p11l1637t1794r1909b1849],
11	uptake	NN	O	uptake	dobj	7	SENT_238	[p11l1931t1794r2149b1863],
12	[	CD	NUMBER	[	number	13	SENT_238	[p11l13t1883r153b1952],
13	12	CD	NUMBER	12	num	14	SENT_238	[p11l13t1883r153b1952],
14	]	NN	O	]	dep	7	SENT_238	[p11l13t1883r153b1952],
15	.	.	O	.	_	0	SENT_238	[p11l13t1883r153b1952],

1	Thus	RB	O	thus	advmod	7	SENT_239	[p11l172t1883r341b1947],
2	,	,	O	,	_	0	SENT_239	[p11l172t1883r341b1947],
3	in	IN	O	in	_	0	SENT_239	[p11l363t1884r422b1938],
4	our	PRP$	O	we	poss	5	SENT_239	[p11l442t1899r550b1938],
5	study	NN	O	study	prep_in	7	SENT_239	[p11l569t1883r746b1952],
6	we	PRP	O	we	nsubj	7	SENT_239	[p11l763t1899r857b1938],
7	aimed	VBD	O	aim	_	0	SENT_239	[p11l877t1883r1074b1938],
8	to	TO	O	to	aux	9	SENT_239	[p11l1095t1891r1156b1938],
9	identify	VB	O	identify	xcomp	7	SENT_239	[p11l1177t1883r1427b1952],
10	whether	IN	O	whether	_	0	SENT_239	[p11l1443t1883r1718b1938],
11	CTRl	NNP	O	CTRl	nn	14	SENT_239	[p11l1736t1886r1889b1938],
12	genetic	JJ	O	genetic	amod	14	SENT_239	[p11l1917t1884r2151b1952],
13	polymorphism	NN	O	polymorphism	nn	14	SENT_239	[p11l10t1973r485b2041],
14	associates	NNS	O	associate	prep_whether	9	SENT_239	[p11l505t1973r826b2028],
15	with	IN	O	with	_	0	SENT_239	[p11l845t1973r993b2028],
16	cisplatin	NN	O	cisplatin	nn	17	SENT_239	[p11l1013t1973r1285b2041],
17	toxicity	NN	O	toxicity	prep_with	9	SENT_239	[p11l1304t1973r1548b2041],
18	in	IN	O	in	_	0	SENT_239	[p11l1567t1973r1626b2027],
19	cancer	NN	O	cancer	nn	20	SENT_239	[p11l1646t1988r1856b2028],
20	patients	NNS	O	patient	prep_in	17	SENT_239	[p11l1874t1973r2149b2041],
21	.	.	O	.	_	0	SENT_239	[p11l1874t1973r2149b2041],

1	The	DT	O	the	det	2	SENT_240	[p11l7t2062r124b2117],
2	similarity	NN	O	similarity	nsubj	11	SENT_240	[p11l149t2062r458b2130],
3	of	IN	O	of	_	0	SENT_240	[p11l480t2062r547b2117],
4	CTR1	NN	O	ctr1	nn	6	SENT_240	[p11l563t2065r716b2117],
5	gene	NN	O	gene	nn	6	SENT_240	[p11l748t2078r899b2130],
6	sequence	NN	O	sequence	prep_of	2	SENT_240	[p11l924t2078r1222b2130],
7	between	IN	O	between	_	0	SENT_240	[p11l1246t2062r1524b2117],
8	human	JJ	O	human	prep_between	6	SENT_240	[p11l1548t2062r1773b2117],
9	and	CC	O	and	_	0	SENT_240	[p11l1797t2062r1913b2117],
10	mouse	NN	O	mouse	prep_between	6	SENT_240	[p11l1939t2078r2149b2117],
11	is	VBZ	O	be	_	0	SENT_240	[p11l10t2151r56b2205],
12	about	IN	O	about	_	0	SENT_240	[p11l75t2150r259b2205],
13	92	CD	PERCENT	92	num	14	SENT_240	[p11l275t2153r412b2214],
14	%	NN	PERCENT	%	prep_about	11	SENT_240	[p11l275t2153r412b2214],
15	,	,	O	,	_	0	SENT_240	[p11l275t2153r412b2214],
16	indicating	VBG	O	indicate	xcomp	11	SENT_240	[p11l432t2150r754b2219],
17	that	IN	O	that	complm	26	SENT_240	[p11l770t2150r900b2205],
18	CTR1	NN	O	ctr1	nsubj	26	SENT_240	[p11l917t2153r1069b2205],
19	is	VBZ	O	be	cop	26	SENT_240	[p11l1097t2151r1143b2205],
20	a	DT	O	a	det	26	SENT_240	[p11l1162t2166r1194b2205],
21	highly	RB	O	highly	amod	26	SENT_240	[p11l1212t2150r1414b2219],
22	conserved	VBN	O	conserve	dep	21	SENT_240	[p11l1430t2150r1756b2205],
23	gene	NN	O	gene	nn	24	SENT_240	[p11l1774t2166r1925b2219],
24	[	NN	O	[	dobj	22	SENT_240	[p11l1947t2150r2088b2219],
25	28	CD	NUMBER	28	num	26	SENT_240	[p11l1947t2150r2088b2219],
26	]	NN	O	]	ccomp	16	SENT_240	[p11l1947t2150r2088b2219],
27	.	.	O	.	_	0	SENT_240	[p11l1947t2150r2088b2219],

1	It	PRP	O	it	nsubjpass	4	SENT_241	[p11l2107t2153r2151b2205],
2	has	VBZ	O	have	aux	4	SENT_241	[p11l10t2239r115b2294],
3	been	VBN	O	be	auxpass	4	SENT_241	[p11l135t2239r289b2294],
4	reported	VBN	O	report	_	0	SENT_241	[p11l309t2239r586b2308],
5	that	IN	O	that	complm	9	SENT_241	[p11l605t2239r735b2294],
6	CTR1	NN	O	ctr1	nsubj	9	SENT_241	[p11l753t2242r906b2294],
7	has	VBZ	O	have	aux	9	SENT_241	[p11l934t2239r1039b2294],
8	a	DT	O	a	advmod	9	SENT_241	[p11l1059t2255r1091b2294],
9	glycosylated	VBN	O	glycosylate	ccomp	4	SENT_241	[p11l1109t2239r1511b2308],
10	N	NN	O	n	nn	11	SENT_241	[p11l1532t2239r1886b2294],
11	—	NN	O	—	nsubj	14	SENT_241	[p11l1532t2239r1886b2294],
12	terminal	JJ	O	terminal	dep	13	SENT_241	[p11l1532t2239r1886b2294],
13	domain	NN	O	domain	dep	14	SENT_241	[p11l1907t2239r2150b2294],
14	exposed	VBN	O	expose	xcomp	9	SENT_241	[p11l10t2328r274b2397],
15	to	TO	O	to	_	0	SENT_241	[p11l289t2336r351b2383],
16	the	DT	O	the	det	18	SENT_241	[p11l367t2328r468b2383],
17	outside	JJ	O	outside	amod	18	SENT_241	[p11l485t2328r720b2383],
18	milieu	NN	O	milieu	prep_to	14	SENT_241	[p11l737t2328r956b2384],
19	.	.	O	.	_	0	SENT_241	[p11l737t2328r956b2384],

1	There	EX	O	there	expl	2	SENT_242	[p11l970t2328r1152b2383],
2	are	VBP	O	be	_	0	SENT_242	[p11l1168t2344r1266b2383],
3	three	CD	NUMBER	three	num	6	SENT_242	[p11l1282t2328r1449b2383],
4	transmembrane	JJ	O	transmembrane	amod	6	SENT_242	[p11l1465t2328r1981b2383],
5	(	NN	O	(	nn	6	SENT_242	[p11l1997t2328r2149b2397],
6	TM	NN	MISC	tm	iobj	2	SENT_242	[p11l1997t2328r2149b2397],
7	)	CD	NUMBER	)	nsubj	2	SENT_242	[p11l1997t2328r2149b2397],

1	442	CD	NUMBER	442	num	3	SENT_243	[p11l402t2473r448b2494],
2	X.	NNP	O	X.	nn	3	SENT_243	[p11l1216t2473r1238b2494],
3	Xu	NNP	O	Xu	_	0	SENT_243	[p11l1246t2473r1279b2494],
4	et	FW	O	et	nn	5	SENT_243	[p11l1288t2475r1311b2494],
5	al.	FW	O	al.	dep	3	SENT_243	[p11l1318t2472r1343b2494],
6	/	:	O	/	punct	3	SENT_243	[p11l1350t2472r1362b2499],
7	Lung	NN	O	lung	nn	8	SENT_243	[p11l1368t2473r1428b2499],
8	Cancer	NN	O	cancer	dep	3	SENT_243	[p11l1435t2473r1518b2494],
9	77	CD	NUMBER	77	number	10	SENT_243	[p11l1527t2473r1555b2494],
10	(	CD	NUMBER	(	num	11	SENT_243	[p11l1562t2472r1643b2499],
11	2012	CD	DATE	2012	dep	8	SENT_243	[p11l1562t2472r1643b2499],
12	)	CD	NUMBER	)	number	13	SENT_243	[p11l1562t2472r1643b2499],
13	438-442	CD	NUMBER	438-442	num	11	SENT_243	[p11l1650t2473r1757b2494],

1	segments	NNS	O	segment	_	0	SENT_244	[p11l10t2620r313b2679],
2	and	CC	O	and	_	0	SENT_244	[p11l337t2612r453b2666],
3	a	DT	O	a	det	5	SENT_244	[p11l476t2627r508b2666],
4	cytosolic	JJ	O	cytosolic	amod	5	SENT_244	[p11l531t2612r813b2679],
5	loop	NN	O	loop	conj_and	1	SENT_244	[p11l836t2612r973b2679],
6	connecting	VBG	O	connect	partmod	1	SENT_244	[p11l996t2612r1352b2679],
7	TM1	NN	O	tm1	dobj	6	SENT_244	[p11l1370t2615r1506b2665],
8	and	CC	O	and	_	0	SENT_244	[p11l1537t2612r1653b2666],
9	TM2	NN	O	tm2	dobj	6	SENT_244	[p11l1673t2614r1815b2665],
10	as	RB	O	as	_	0	SENT_244	[p11l1839t2627r1902b2666],
11	well	RB	O	well	_	0	SENT_244	[p11l1924t2611r2060b2666],
12	as	IN	O	as	_	0	SENT_244	[p11l2083t2627r2145b2666],
13	the	DT	O	the	det	17	SENT_244	[p11l9t2699r110b2753],
14	cytosolic	JJ	O	cytosolic	amod	17	SENT_244	[p11l126t2699r409b2766],
15	C	NN	O	c	nn	17	SENT_244	[p11l424t2700r801b2753],
16	—	NN	O	—	nn	17	SENT_244	[p11l424t2700r801b2753],
17	terminus	NN	O	terminus	conj_and	7	SENT_244	[p11l424t2700r801b2753],
18	.	.	O	.	_	0	SENT_244	[p11l424t2700r801b2753],

1	Three	CD	NUMBER	three	num	2	SENT_245	[p11l815t2699r998b2753],
2	monomers	NNS	O	monomer	nsubj	3	SENT_245	[p11l1014t2714r1359b2753],
3	form	VBP	O	form	_	0	SENT_245	[p11l1376t2699r1529b2753],
4	a	DT	O	a	det	14	SENT_245	[p11l1544t2715r1576b2753],
5	stable	JJ	O	stable	amod	14	SENT_245	[p11l1592t2699r1779b2753],
6	complex	NN	O	complex	dep	5	SENT_245	[p11l1796t2699r2071b2766],
7	to	TO	O	to	aux	11	SENT_245	[p11l2084t2707r2146b2753],
8	be	VB	O	be	cop	11	SENT_245	[p11l9t2785r82b2839],
9	the	DT	O	the	det	11	SENT_245	[p11l101t2785r202b2839],
10	functioning	VBG	O	function	amod	11	SENT_245	[p11l222t2785r593b2853],
11	CTRl	NN	O	ctrl	infmod	6	SENT_245	[p11l611t2788r763b2839],
12	[	CD	NUMBER	[	number	13	SENT_245	[p11l794t2785r991b2853],
13	9,29	CD	NUMBER	9,29	num	14	SENT_245	[p11l794t2785r991b2853],
14	]	NN	O	]	dobj	3	SENT_245	[p11l794t2785r991b2853],
15	.	.	O	.	_	0	SENT_245	[p11l794t2785r991b2853],

1	Up	IN	O	up	prep	10	SENT_246	[p11l1010t2788r1098b2853],
2	to	TO	O	to	pcomp	1	SENT_246	[p11l1117t2793r1178b2839],
3	now	RB	DATE	now	pobj	2	SENT_246	[p11l1198t2801r1352b2847],
4	,	,	O	,	_	0	SENT_246	[p11l1198t2801r1352b2847],
5	few	JJ	O	few	amod	7	SENT_246	[p11l1372t2785r1490b2839],
6	missense	NN	O	missense	nn	7	SENT_246	[p11l1507t2786r1800b2839],
7	mutations	NNS	O	mutation	nsubjpass	10	SENT_246	[p11l1819t2786r2145b2839],
8	have	VBP	O	have	aux	10	SENT_246	[p11l10t2872r159b2926],
9	been	VBN	O	be	auxpass	10	SENT_246	[p11l181t2872r335b2926],
10	found	VBN	O	find	_	0	SENT_246	[p11l358t2872r543b2926],
11	along	IN	O	along	_	0	SENT_246	[p11l566t2872r741b2940],
12	the	DT	O	the	det	18	SENT_246	[p11l761t2872r863b2926],
13	CTR1	NN	O	ctr1	nn	18	SENT_246	[p11l886t2875r1039b2926],
14	exon	NN	O	exon	nn	18	SENT_246	[p11l1070t2888r1224b2926],
15	sequence	NN	O	sequence	nn	18	SENT_246	[p11l1247t2888r1544b2940],
16	[	NN	O	[	nn	18	SENT_246	[p11l1571t2872r1711b2940],
17	30	CD	NUMBER	30	num	18	SENT_246	[p11l1571t2872r1711b2940],
18	]	NN	O	]	prep_along	10	SENT_246	[p11l1571t2872r1711b2940],
19	.	.	O	.	_	0	SENT_246	[p11l1571t2872r1711b2940],

1	Any	DT	O	any	det	3	SENT_247	[p11l108t2962r236b3027],
2	genotypic	JJ	O	genotypic	amod	3	SENT_247	[p11l267t2960r585b3027],
3	polymorphism	NN	O	polymorphism	nsubj	15	SENT_247	[p11l618t2959r1093b3027],
4	may	MD	O	may	aux	5	SENT_247	[p11l1127t2975r1264b3027],
5	cause	VB	O	cause	ccomp	30	SENT_247	[p11l1296t2975r1472b3013],
6	a	DT	O	a	det	8	SENT_247	[p11l1506t2975r1538b3013],
7	certain	JJ	O	certain	amod	8	SENT_247	[p11l1572t2960r1794b3013],
8	change	NN	O	change	dobj	5	SENT_247	[p11l1828t2959r2054b3027],
9	of	IN	O	of	_	0	SENT_247	[p11l2088t2959r2154b3013],
10	CTR1	NN	O	ctr1	nn	12	SENT_247	[p11l10t3049r162b3101],
11	protein	NN	O	protein	nn	12	SENT_247	[p11l191t3047r425b3114],
12	structure	NN	O	structure	prep_of	8	SENT_247	[p11l445t3054r737b3101],
13	and	CC	O	and	_	0	SENT_247	[p11l757t3046r874b3101],
14	thus	RB	O	thus	advmod	5	SENT_247	[p11l894t3046r1031b3101],
15	affect	VB	O	affect	conj_and	5	SENT_247	[p11l1052t3046r1229b3101],
16	its	PRP$	O	its	poss	17	SENT_247	[p11l1249t3047r1321b3101],
17	function	NN	O	function	dobj	15	SENT_247	[p11l1343t3046r1611b3101],
18	as	IN	O	as	_	0	SENT_247	[p11l1630t3062r1692b3101],
19	a	DT	O	a	det	20	SENT_247	[p11l1713t3062r1746b3101],
20	transporter	NN	O	transporter	prep_as	15	SENT_247	[p11l1765t3054r2146b3114],
21	,	,	O	,	_	0	SENT_247	[p11l1765t3054r2146b3114],
22	at	IN	O	at	_	0	SENT_247	[p11l9t3142r69b3188],
23	the	DT	O	the	det	24	SENT_247	[p11l95t3134r197b3188],
24	meantime	NN	O	meantime	prep_at	15	SENT_247	[p11l226t3134r568b3196],
25	,	,	O	,	_	0	SENT_247	[p11l226t3134r568b3196],
26	genetic	JJ	O	genetic	amod	27	SENT_247	[p11l597t3134r830b3201],
27	mutations	NNS	O	mutation	nsubj	30	SENT_247	[p11l859t3134r1185b3188],
28	may	MD	O	may	aux	30	SENT_247	[p11l1215t3149r1352b3201],
29	also	RB	O	also	advmod	30	SENT_247	[p11l1379t3134r1502b3188],
30	contribute	VB	O	contribute	_	0	SENT_247	[p11l1532t3133r1866b3188],
31	to	TO	O	to	_	0	SENT_247	[p11l1894t3142r1956b3188],
32	CTRl	NN	O	ctrl	nn	34	SENT_247	[p11l1985t3136r2138b3188],
33	expression	NN	O	expression	nn	34	SENT_247	[p11l9t3222r357b3288],
34	regulation	NN	O	regulation	prep_to	30	SENT_247	[p11l390t3221r735b3288],
35	.	.	O	.	_	0	SENT_247	[p11l390t3221r735b3288],

1	All	PDT	O	all	predet	3	SENT_248	[p11l767t3221r853b3274],
2	these	DT	O	these	det	3	SENT_248	[p11l887t3221r1057b3275],
3	mechanism	NN	O	mechanism	nsubj	5	SENT_248	[p11l1092t3221r1463b3275],
4	could	MD	O	could	aux	5	SENT_248	[p11l1497t3221r1671b3275],
5	lead	VB	O	lead	_	0	SENT_248	[p11l1705t3221r1837b3275],
6	to	TO	O	to	_	0	SENT_248	[p11l1870t3229r1932b3275],
7	interindividual	JJ	O	interindividual	amod	8	SENT_248	[p11l1967t3222r2146b3275, p11l10t3307r332b3361],
8	variances	NNS	O	variance	prep_to	5	SENT_248	[p11l359t3308r662b3361],
9	of	IN	O	of	_	0	SENT_248	[p11l691t3307r757b3361],
10	cisplatin	NN	O	cisplatin	nn	11	SENT_248	[p11l778t3307r1339b3375],
11	—	NN	O	—	prep_of	8	SENT_248	[p11l778t3307r1339b3375],
12	induced	VBD	O	induce	partmod	11	SENT_248	[p11l778t3307r1339b3375],
13	ototoxicity	NN	O	ototoxicity	dobj	12	SENT_248	[p11l1368t3308r1732b3375],
14	.	.	O	.	_	0	SENT_248	[p11l1368t3308r1732b3375],

1	Because	IN	O	because	mark	10	SENT_249	[p11l1761t3310r2016b3361],
2	the	DT	O	the	det	4	SENT_249	[p11l2045t3307r2146b3361],
3	signiﬁcant	JJ	O	signiﬁcant	amod	4	SENT_249	[p11l10t3394r344b3462],
4	SNP	NN	ORGANIZATION	snp	nsubj	10	SENT_249	[p11l371t3397r496b3448],
5	in	IN	O	in	_	0	SENT_249	[p11l523t3395r582b3448],
6	our	PRP$	O	we	poss	7	SENT_249	[p11l610t3410r719b3448],
7	study	NN	O	study	prep_in	4	SENT_249	[p11l746t3394r923b3462],
8	is	VBZ	O	be	cop	10	SENT_249	[p11l949t3395r995b3448],
9	tagger	NN	O	tagger	nn	10	SENT_249	[p11l1024t3402r1227b3462],
10	SNP	NN	O	snp	advcl	18	SENT_249	[p11l1253t3397r1379b3448],
11	of	IN	O	of	_	0	SENT_249	[p11l1405t3394r1472b3448],
12	CTR1	NN	O	ctr1	nn	13	SENT_249	[p11l1493t3397r1637b3448],
13	gene	NN	O	gene	prep_of	10	SENT_249	[p11l1671t3410r1838b3462],
14	,	,	O	,	_	0	SENT_249	[p11l1671t3410r1838b3462],
15	it	PRP	O	it	nsubj	18	SENT_249	[p11l1868t3395r1912b3448],
16	is	VBZ	O	be	cop	18	SENT_249	[p11l1939t3395r1985b3448],
17	representative	JJ	O	representative	amod	18	SENT_249	[p11l2015t3410r2146b3462, p11l10t3482r367b3536],
18	SNP	NN	ORGANIZATION	snp	_	0	SENT_249	[p11l396t3484r521b3536],
19	along	IN	O	along	_	0	SENT_249	[p11l548t3481r724b3549],
20	region	NN	O	region	prep_along	18	SENT_249	[p11l752t3482r955b3549],
21	with	IN	O	with	_	0	SENT_249	[p11l981t3481r1129b3536],
22	high	JJ	O	high	amod	24	SENT_249	[p11l1157t3481r1298b3549],
23	linkage	NN	O	linkage	nn	24	SENT_249	[p11l1326t3481r1556b3549],
24	disequilibrium	NN	O	disequilibrium	prep_with	20	SENT_249	[p11l1586t3481r2074b3549],
25	.	.	O	.	_	0	SENT_249	[p11l1586t3481r2074b3549],

1	It	PRP	O	it	nsubjpass	4	SENT_250	[p11l2104t3485r2148b3535],
2	may	MD	O	may	aux	4	SENT_250	[p11l10t3584r147b3636],
3	be	VB	O	be	auxpass	4	SENT_250	[p11l171t3568r245b3622],
4	related	VBN	O	relate	_	0	SENT_250	[p11l273t3568r496b3623],
5	to	TO	O	to	_	0	SENT_250	[p11l523t3576r585b3623],
6	several	JJ	O	several	amod	7	SENT_250	[p11l613t3568r837b3623],
7	mutations	NNS	O	mutation	prep_to	4	SENT_250	[p11l866t3569r1192b3623],
8	or	CC	O	or	_	0	SENT_250	[p11l1220t3584r1286b3622],
9	polymorphisms	NNS	O	polymorphism	prep_to	4	SENT_250	[p11l1312t3568r1816b3636],
10	along	IN	O	along	_	0	SENT_250	[p11l1844t3568r2020b3636],
11	the	DT	O	the	det	13	SENT_250	[p11l2045t3568r2146b3623],
12	gene	NN	O	gene	nn	13	SENT_250	[p11l8t3671r159b3723],
13	sequence	NN	O	sequence	prep_along	4	SENT_250	[p11l190t3671r503b3723],
14	.	.	O	.	_	0	SENT_250	[p11l190t3671r503b3723],

1	This	DT	O	this	det	2	SENT_251	[p11l530t3656r662b3710],
2	genotype	NN	O	genotype	nsubj	4	SENT_251	[p11l691t3664r989b3723],
3	may	MD	O	may	aux	4	SENT_251	[p11l1019t3671r1157b3723],
4	cause	VB	O	cause	_	0	SENT_251	[p11l1184t3671r1360b3710],
5	a	DT	O	a	det	7	SENT_251	[p11l1389t3671r1422b3710],
6	signiﬁcant	JJ	O	signiﬁcant	amod	7	SENT_251	[p11l1451t3655r1785b3723],
7	change	NN	O	change	dobj	4	SENT_251	[p11l1813t3656r2039b3723],
8	on	IN	O	on	_	0	SENT_251	[p11l2069t3671r2147b3710],
9	CTR	NN	MISC	ctr	nn	11	SENT_251	[p11l10t3746r155b3797],
10	]	CD	NUMBER	]	num	11	SENT_251	[p11l10t3746r155b3797],
11	structure	NN	O	structure	prep_on	7	SENT_251	[p11l182t3751r474b3797],
12	or	CC	O	or	_	0	SENT_251	[p11l493t3758r560b3797],
13	CTR1	NN	O	ctr1	nn	15	SENT_251	[p11l577t3746r722b3797],
14	expression	NN	O	expression	nn	15	SENT_251	[p11l749t3744r1096b3810],
15	level	NN	O	level	prep_on	7	SENT_251	[p11l1115t3743r1264b3797],
16	in	IN	O	in	_	0	SENT_251	[p11l1284t3744r1343b3796],
17	inner	JJ	O	inner	amod	18	SENT_251	[p11l1362t3744r1532b3797],
18	ear	NN	O	ear	prep_in	4	SENT_251	[p11l1549t3758r1662b3797],
19	.	.	O	.	_	0	SENT_251	[p11l1549t3758r1662b3797],

1	Thus	RB	O	thus	advmod	7	SENT_252	[p11l1680t3743r1849b3805],
2	,	,	O	,	_	0	SENT_252	[p11l1680t3743r1849b3805],
3	different	JJ	O	different	amod	4	SENT_252	[p11l1869t3743r2148b3797],
4	genotypes	NNS	O	genotype	nsubjpass	7	SENT_252	[p12l8t24r337b84],
5	may	MD	O	may	aux	7	SENT_252	[p12l360t32r498b84],
6	be	VB	O	be	auxpass	7	SENT_252	[p12l517t16r590b70],
7	related	VBN	O	relate	_	0	SENT_252	[p12l613t16r836b70],
8	to	TO	O	to	_	0	SENT_252	[p12l857t24r919b70],
9	different	JJ	O	different	amod	11	SENT_252	[p12l941t16r1220b70],
10	drug	NN	O	drug	nn	11	SENT_252	[p12l1240t16r1388b84],
11	accumulation	NN	O	accumulation	prep_to	7	SENT_252	[p12l1408t16r1847b70],
12	in	IN	O	in	_	0	SENT_252	[p12l1868t17r1927b70],
13	tumor	NN	O	tumor	nn	14	SENT_252	[p12l1947t24r2149b70],
14	tissues	NNS	O	tissue	prep_in	7	SENT_252	[p12l9t104r225b157],
15	as	RB	O	as	_	0	SENT_252	[p12l251t119r314b157],
16	well	RB	O	well	_	0	SENT_252	[p12l339t103r475b157],
17	as	IN	O	as	_	0	SENT_252	[p12l501t119r563b157],
18	other	JJ	O	other	amod	19	SENT_252	[p12l590t103r762b157],
19	tissues	NNS	O	tissue	prep_in	7	SENT_252	[p12l785t104r1018b166],
20	,	,	O	,	_	0	SENT_252	[p12l785t104r1018b166],
21	contributing	VBG	O	contribute	xcomp	7	SENT_252	[p12l1044t103r1446b171],
22	to	TO	O	to	_	0	SENT_252	[p12l1469t111r1531b157],
23	different	JJ	O	different	amod	24	SENT_252	[p12l1557t103r1836b157],
24	response	NN	O	response	prep_to	21	SENT_252	[p12l1861t119r2146b171],
25	to	TO	O	to	_	0	SENT_252	[p12l9t198r70b245],
26	cisplatin	NN	O	cisplatin	nn	27	SENT_252	[p12l93t190r366b258],
27	chemotherapy	NN	O	chemotherapy	prep_to	21	SENT_252	[p12l388t190r870b258],
28	.	.	O	.	_	0	SENT_252	[p12l388t190r870b258],

1	This	DT	O	this	det	2	SENT_253	[p12l108t278r240b332],
2	study	NN	O	study	nsubj	4	SENT_253	[p12l287t277r464b345],
3	also	RB	O	also	advmod	4	SENT_253	[p12l507t278r631b332],
4	has	VBZ	O	have	_	0	SENT_253	[p12l677t278r782b332],
5	several	JJ	O	several	amod	6	SENT_253	[p12l829t278r1053b332],
6	strengths	NNS	O	strength	dobj	4	SENT_253	[p12l1100t278r1398b345],
7	and	CC	O	and	_	0	SENT_253	[p12l1445t278r1560b332],
8	limitations	NNS	O	limitation	dobj	4	SENT_253	[p12l1607t278r1970b332],
9	.	.	O	.	_	0	SENT_253	[p12l1607t278r1970b332],

1	This	DT	O	this	nsubj	3	SENT_254	[p12l2014t278r2145b332],
2	is	VBZ	O	be	cop	3	SENT_254	[p12l10t366r56b419],
3	prospective	JJ	O	prospective	_	0	SENT_254	[p12l123t366r512b432],
4	,	,	O	,	_	0	SENT_254	[p12l123t366r512b432],
5	multi-institution	JJ	O	multi-institution	appos	3	SENT_254	[p12l579t365r1122b419],
6	based	VBN	O	base	partmod	5	SENT_254	[p12l1186t365r1370b419],
7	association	NN	O	association	nn	8	SENT_254	[p12l1436t366r1793b419],
8	research	NN	O	research	dobj	6	SENT_254	[p12l1859t365r2145b419],
9	.	.	O	.	_	0	SENT_254	[p12l1859t365r2145b419],

1	We	PRP	O	we	nsubj	2	SENT_255	[p12l7t455r115b506],
2	studied	VBD	O	study	_	0	SENT_255	[p12l185t452r422b506],
3	association	NN	O	association	dobj	2	SENT_255	[p12l491t453r848b506],
4	between	IN	O	between	_	0	SENT_255	[p12l917t452r1195b506],
5	CTR1	NN	O	ctr1	nn	6	SENT_255	[p12l1265t455r1409b506],
6	polymorphism	NN	O	polymorphism	prep_between	3	SENT_255	[p12l1486t452r1961b519],
7	and	CC	O	and	_	0	SENT_255	[p12l2030t452r2146b506],
8	severe	JJ	O	severe	amod	10	SENT_255	[p12l10t554r214b592],
9	cisplatin	NN	O	cisplatin	nn	10	SENT_255	[p12l249t538r521b606],
10	toxicity	NN	O	toxicity	prep_between	3	SENT_255	[p12l555t539r813b606],
11	.	.	O	.	_	0	SENT_255	[p12l555t539r813b606],

1	These	DT	O	these	det	2	SENT_256	[p12l847t538r1032b592],
2	results	NNS	O	result	nsubj	3	SENT_256	[p12l1067t538r1280b592],
3	provided	VBD	O	provide	_	0	SENT_256	[p12l1316t538r1602b606],
4	more	RBR	O	more	advmod	5	SENT_256	[p12l1638t554r1804b592],
5	statistical	JJ	O	statistical	amod	6	SENT_256	[p12l1840t538r2146b592],
6	power	NN	O	power	dobj	3	SENT_256	[p12l10t641r216b693],
7	and	CC	O	and	_	0	SENT_256	[p12l237t625r353b679],
8	less	JJR	O	less	dep	9	SENT_256	[p12l378t625r492b679],
9	false	JJ	O	false	amod	11	SENT_256	[p12l517t625r661b679],
10	positive	JJ	O	positive	amod	11	SENT_256	[p12l685t626r938b693],
11	probability	NN	O	probability	dobj	3	SENT_256	[p12l962t625r1330b693],
12	.	.	O	.	_	0	SENT_256	[p12l962t625r1330b693],

1	However	RB	O	however	advmod	8	SENT_257	[p12l1355t629r1660b688],
2	,	,	O	,	_	0	SENT_257	[p12l1355t629r1660b688],
3	molecular	JJ	O	molecular	nsubj	6	SENT_257	[p12l1686t625r2009b679],
4	and	CC	O	and	_	0	SENT_257	[p12l2030t625r2146b679],
5	cellular	JJ	O	cellular	conj_and	3	SENT_257	[p12l9t712r249b767],
6	researches	VBZ	O	research	parataxis	8	SENT_257	[p12l285t712r623b767],
7	are	VBP	O	be	auxpass	8	SENT_257	[p12l662t728r759b767],
8	needed	VBN	O	need	_	0	SENT_257	[p12l797t712r1029b767],
9	to	TO	O	to	aux	10	SENT_257	[p12l1067t720r1128b766],
10	explore	VB	O	explore	xcomp	8	SENT_257	[p12l1166t712r1406b780],
11	how	WRB	O	how	advmod	14	SENT_257	[p12l1445t712r1584b767],
12	CTR1	NN	O	ctr1	nn	13	SENT_257	[p12l1620t715r1773b767],
13	mutations	NNS	O	mutation	nsubj	14	SENT_257	[p12l1819t713r2145b767],
14	affect	VBP	O	affect	ccomp	10	SENT_257	[p12l9t799r187b854],
15	the	DT	O	the	det	16	SENT_257	[p12l208t800r310b854],
16	uptake	NN	O	uptake	dobj	14	SENT_257	[p12l335t800r569b867],
17	,	,	O	,	_	0	SENT_257	[p12l335t800r569b867],
18	accumulation	NN	O	accumulation	conj_and	16	SENT_257	[p12l594t800r1047b862],
19	,	,	O	,	_	0	SENT_257	[p12l594t800r1047b862],
20	efﬁcacy	NN	O	efﬁcacy	dobj	14	SENT_257	[p12l1072t799r1316b867],
21	and	CC	O	and	_	0	SENT_257	[p12l1338t800r1455b854],
22	response	NN	O	response	dobj	14	SENT_257	[p12l1479t815r1765b867],
23	to	TO	O	to	_	0	SENT_257	[p12l1789t808r1850b854],
24	cisplatin	NN	O	cisplatin	nn	25	SENT_257	[p12l1875t799r2147b867],
25	treatment	NN	O	treatment	prep_to	14	SENT_257	[p12l9t895r347b941],
26	.	.	O	.	_	0	SENT_257	[p12l9t895r347b941],

1	Furthermore	RB	O	furthermore	advmod	9	SENT_258	[p12l375t887r799b949],
2	,	,	O	,	_	0	SENT_258	[p12l375t887r799b949],
3	multi-cohort	JJ	O	multi-cohort	nsubjpass	9	SENT_258	[p12l826t887r1240b941],
4	based	VBN	O	base	partmod	3	SENT_258	[p12l1264t887r1447b941],
5	epidemic	JJ	O	epidemic	amod	6	SENT_258	[p12l1474t887r1770b954],
6	studies	NNS	O	study	dobj	4	SENT_258	[p12l1796t887r2021b941],
7	are	VBP	O	be	auxpass	9	SENT_258	[p12l2049t902r2146b941],
8	still	RB	O	still	advmod	9	SENT_258	[p12l10t973r125b1027],
9	needed	VBN	O	need	_	0	SENT_258	[p12l149t973r381b1027],
10	to	TO	O	to	aux	11	SENT_258	[p12l403t981r465b1027],
11	provide	VB	O	provide	xcomp	9	SENT_258	[p12l488t973r733b1041],
12	further	JJ	O	further	amod	13	SENT_258	[p12l756t973r983b1027],
13	validation	NN	O	validation	dobj	11	SENT_258	[p12l1001t973r1324b1027],
14	of	IN	O	of	_	0	SENT_258	[p12l1347t973r1413b1027],
15	our	PRP$	O	we	poss	16	SENT_258	[p12l1428t989r1536b1027],
16	ﬁndings	NNS	O	ﬁndings	prep_of	13	SENT_258	[p12l1557t973r1830b1041],
17	.	.	O	.	_	0	SENT_258	[p12l1557t973r1830b1041],

1	In	IN	O	in	_	0	SENT_259	[p12l111t1063r171b1114],
2	conclusion	NN	O	conclusion	prep_in	6	SENT_259	[p12l198t1060r558b1123],
3	,	,	O	,	_	0	SENT_259	[p12l198t1060r558b1123],
4	this	DT	O	this	det	5	SENT_259	[p12l586t1060r702b1114],
5	study	NN	O	study	nsubj	6	SENT_259	[p12l732t1060r909b1128],
6	demonstrates	VBZ	O	demonstrate	_	0	SENT_259	[p12l935t1060r1374b1114],
7	that	IN	O	that	complm	25	SENT_259	[p12l1402t1060r1545b1122],
8	,	,	O	,	_	0	SENT_259	[p12l1402t1060r1545b1122],
9	within	IN	O	within	_	0	SENT_259	[p12l1572t1060r1784b1114],
10	study	NN	O	study	nn	11	SENT_259	[p12l1812t1060r1989b1128],
11	limitations	NNS	O	limitation	prep_within	25	SENT_259	[p12l2015t1060r2146b1114, p12l10t1148r249b1201],
12	of	IN	O	of	_	0	SENT_259	[p12l291t1147r357b1201],
13	single	JJ	O	single	amod	14	SENT_259	[p12l390t1147r576b1215],
14	ethnicity	NN	O	ethnicity	prep_of	11	SENT_259	[p12l617t1147r917b1215],
15	,	,	O	,	_	0	SENT_259	[p12l617t1147r917b1215],
16	the	DT	O	the	det	18	SENT_259	[p12l957t1147r1059b1201],
17	genetic	JJ	O	genetic	amod	18	SENT_259	[p12l1098t1148r1332b1215],
18	polymorphism	NN	O	polymorphism	nsubj	25	SENT_259	[p12l1372t1147r1847b1215],
19	of	IN	O	of	_	0	SENT_259	[p12l1886t1147r1953b1201],
20	CTR1	NN	O	ctr1	prep_of	18	SENT_259	[p12l1985t1150r2138b1201],
21	is	VBZ	O	be	auxpass	22	SENT_259	[p12l10t1235r56b1289],
22	associated	VBN	O	associate	rcmod	20	SENT_259	[p12l90t1234r422b1289],
23	with	IN	O	with	_	0	SENT_259	[p12l454t1234r602b1288],
24	cisplatin	NN	O	cisplatin	prep_with	22	SENT_259	[p12l635t1234r907b1302],
25	induced	VBD	O	induce	ccomp	6	SENT_259	[p12l941t1234r1196b1289],
26	severe	JJ	O	severe	amod	27	SENT_259	[p12l1230t1250r1434b1289],
27	ototoxicity	NN	O	ototoxicity	dobj	25	SENT_259	[p12l1468t1235r1818b1302],
28	in	IN	O	in	_	0	SENT_259	[p12l1850t1235r1909b1288],
29	NSCLC	NN	O	nsclc	nn	30	SENT_259	[p12l1942t1237r2148b1289],
30	patients	NNS	O	patient	prep_in	25	SENT_259	[p12l10t1322r284b1389],
31	.	.	O	.	_	0	SENT_259	[p12l10t1322r284b1389],

1	Our	PRP$	O	we	poss	2	SENT_260	[p12l315t1324r434b1376],
2	study	NN	O	study	nsubj	3	SENT_260	[p12l463t1322r640b1389],
3	suggested	VBD	O	suggest	_	0	SENT_260	[p12l668t1322r986b1389],
4	that	IN	O	that	complm	9	SENT_260	[p12l1016t1322r1146b1376],
5	CTR1	NN	O	ctr1	nn	6	SENT_260	[p12l1174t1324r1327b1376],
6	polymorphism	NN	O	polymorphism	nsubjpass	9	SENT_260	[p12l1365t1322r1840b1389],
7	could	MD	O	could	aux	9	SENT_260	[p12l1869t1322r2043b1376],
8	be	VB	O	be	auxpass	9	SENT_260	[p12l2073t1322r2146b1376],
9	used	VBN	O	use	ccomp	3	SENT_260	[p12l9t1409r157b1463],
10	as	IN	O	as	_	0	SENT_260	[p12l173t1424r236b1463],
11	a	DT	O	a	det	13	SENT_260	[p12l253t1424r285b1463],
12	predictive	JJ	O	predictive	amod	13	SENT_260	[p12l301t1409r623b1476],
13	biomarker	NN	O	biomarker	prep_as	9	SENT_260	[p12l639t1409r975b1463],
14	for	IN	O	for	_	0	SENT_260	[p12l990t1409r1079b1463],
15	identifying	VBG	O	identify	prepc_for	9	SENT_260	[p12l1093t1409r1444b1476],
16	platinum	NN	O	platinum	nn	18	SENT_260	[p12l1459t1409r1753b1476],
17	chemotherapeutic	JJ	O	chemotherapeutic	amod	18	SENT_260	[p12l1768t1409r2146b1463, p12l9t1496r245b1563],
18	response	NN	O	response	dobj	15	SENT_260	[p12l267t1511r553b1563],
19	in	IN	O	in	_	0	SENT_260	[p12l576t1496r635b1549],
20	cancer	NN	O	cancer	nn	21	SENT_260	[p12l657t1511r867b1549],
21	patients	NNS	O	patient	prep_in	18	SENT_260	[p12l888t1496r1146b1563],
22	in	IN	O	in	_	0	SENT_260	[p12l1170t1496r1229b1549],
23	the	DT	DATE	the	det	24	SENT_260	[p12l1250t1495r1352b1549],
24	future	NN	DATE	future	prep_in	15	SENT_260	[p12l1375t1495r1586b1550],
25	.	.	O	.	_	0	SENT_260	[p12l1375t1495r1586b1550],

1	Conﬂict	NN	O	conﬂict	_	0	SENT_261	[p12l8t1676r271b1731],
2	of	IN	O	of	_	0	SENT_261	[p12l290t1676r362b1731],
3	interest	NN	O	interest	nn	4	SENT_261	[p12l377t1676r641b1731],
4	statement	NN	O	statement	prep_of	1	SENT_261	[p12l661t1684r1006b1731],

1	The	DT	O	the	det	2	SENT_262	[p12l108t1854r225b1908],
2	authors	NNS	O	author	nsubj	3	SENT_262	[p12l248t1854r491b1908],
3	declared	VBD	O	declare	_	0	SENT_262	[p12l515t1854r788b1908],
4	no	DT	O	no	det	5	SENT_262	[p12l811t1870r888b1908],
5	conﬂict	NN	O	conﬂict	dobj	3	SENT_262	[p12l911t1854r1149b1908],
6	of	IN	O	of	_	0	SENT_262	[p12l1170t1854r1237b1908],
7	interest	NN	O	interest	prep_of	5	SENT_262	[p12l1252t1855r1513b1909],
8	.	.	O	.	_	0	SENT_262	[p12l1252t1855r1513b1909],

1	Acknowledgment	NN	O	acknowledgment	_	0	SENT_263	[p12l6t2035r609b2103],

1	This	DT	O	this	det	2	SENT_264	[p12l108t2213r240b2267],
2	work	NN	O	work	nsubjpass	4	SENT_264	[p12l287t2212r455b2267],
3	was	VBD	O	be	auxpass	4	SENT_264	[p12l499t2228r624b2267],
4	supported	VBN	O	support	_	0	SENT_264	[p12l674t2213r1000b2280],
5	by	IN	O	by	_	0	SENT_264	[p12l1048t2213r1125b2280],
6	the	DT	O	the	det	8	SENT_264	[p12l1171t2213r1272b2267],
7	National	NNP	O	National	nn	8	SENT_264	[p12l1322t2213r1592b2267],
8	High	NNP	O	High	agent	4	SENT_264	[p12l1642t2213r1960b2280],
9	—	CD	NUMBER	—	num	10	SENT_264	[p12l1642t2213r1960b2280],
10	tech	NN	O	tech	dep	19	SENT_264	[p12l1642t2213r1960b2280],
11	R&D	NNP	O	R&D	nn	12	SENT_264	[p12l2009t2215r2146b2267],
12	Program	NNP	O	Program	dep	10	SENT_264	[p12l10t2303r283b2367],
13	of	IN	O	of	_	0	SENT_264	[p12l318t2300r384b2354],
14	China	NNP	LOCATION	China	prep_of	12	SENT_264	[p12l411t2300r593b2354],
15	(	CD	NUMBER	(	num	14	SENT_264	[p12l627t2300r768b2367],
16	863	CD	NUMBER	863	num	17	SENT_264	[p12l627t2300r768b2367],
17	Program	NN	O	program	dep	19	SENT_264	[p12l806t2300r1105b2367],
18	)	CD	NUMBER	)	number	19	SENT_264	[p12l806t2300r1105b2367],
19	(	CD	NUMBER	(	dep	31	SENT_264	[p12l1140t2300r1688b2367],
20	2009AAO22704	NN	O	2009aao22704	nn	21	SENT_264	[p12l1140t2300r1688b2367],
21	)	NN	O	)	dep	19	SENT_264	[p12l1140t2300r1688b2367],
22	and	CC	O	and	_	0	SENT_264	[p12l1723t2300r1839b2354],
23	National	NNP	ORGANIZATION	National	nn	26	SENT_264	[p12l1875t2300r2146b2354],
24	Natural	NNP	ORGANIZATION	Natural	nn	26	SENT_264	[p12l10t2387r248b2441],
25	Science	NNP	ORGANIZATION	Science	nn	26	SENT_264	[p12l271t2388r509b2441],
26	Foundation	NNP	ORGANIZATION	Foundation	dep	31	SENT_264	[p12l532t2387r897b2441],
27	of	IN	O	of	_	0	SENT_264	[p12l919t2387r986b2441],
28	China	NNP	LOCATION	China	prep_of	26	SENT_264	[p12l1000t2387r1181b2441],
29	(	CD	NUMBER	(	num	28	SENT_264	[p12l1204t2387r1593b2454],
30	30873089	CD	NUMBER	30873089	num	31	SENT_264	[p12l1204t2387r1593b2454],
31	)	NN	O	)	dep	8	SENT_264	[p12l1204t2387r1593b2454],
32	.	.	O	.	_	0	SENT_264	[p12l1204t2387r1593b2454],

1	References	NNS	O	reference	_	0	SENT_265	[p12l8t2568r376b2623],

1	[	NN	O	[	_	0	SENT_266	[p12l38t2734r102b2789],
2	1	CD	NUMBER	1	number	3	SENT_266	[p12l38t2734r102b2789],
3	]	CD	NUMBER	]	num	4	SENT_266	[p12l38t2734r102b2789],
4	Program	NN	O	program	dep	1	SENT_266	[p12l138t2737r368b2789],
5	,	,	O	,	_	0	SENT_266	[p12l138t2737r368b2789],
6	NT	NN	O	nt	appos	1	SENT_266	[p12l387t2737r468b2785],
7	,	,	O	,	_	0	SENT_266	[p12l387t2737r468b2785],
8	Cisplatin	NNP	O	Cisplatin	appos	6	SENT_266	[p12l487t2735r724b2789],
9	.	.	O	.	_	0	SENT_266	[p12l487t2735r724b2789],

1	Rep	NNP	O	Rep	nn	2	SENT_267	[p12l743t2737r837b2789],
2	Carcinog	NNP	DATE	Carcinog	_	0	SENT_267	[p12l855t2735r1091b2789],
3	,	,	DATE	,	_	0	SENT_267	[p12l855t2735r1091b2789],
4	2011	CD	DATE	2011	appos	2	SENT_267	[p12l1110t2735r1359b2789],
5	(	CD	NUMBER	(	number	6	SENT_267	[p12l1110t2735r1359b2789],
6	12	CD	NUMBER	12	num	7	SENT_267	[p12l1110t2735r1359b2789],
7	)	NN	O	)	dep	4	SENT_267	[p12l1110t2735r1359b2789],
8	:	:	O	:	_	0	SENT_267	[p12l1110t2735r1359b2789],
9	110-111	CD	NUMBER	110-111	dep	2	SENT_267	[p12l1384t2737r1619b2779],
10	.	.	O	.	_	0	SENT_267	[p12l1384t2737r1619b2779],

1	[	NN	O	[	_	0	SENT_268	[p12l38t2801r102b2855],
2	2	CD	NUMBER	2	num	1	SENT_268	[p12l38t2801r102b2855],
3	]	CD	NUMBER	]	num	5	SENT_268	[p12l38t2801r102b2855],
4	jemal	NN	O	jemal	nn	5	SENT_268	[p12l130t2801r279b2855],
5	A	NN	O	a	dep	1	SENT_268	[p12l308t2803r357b2851],
6	,	,	O	,	_	0	SENT_268	[p12l308t2803r357b2851],
7	Siegel	NNP	PERSON	Siegel	nn	8	SENT_268	[p12l389t2801r539b2855],
8	R	NNP	PERSON	R	appos	5	SENT_268	[p12l571t2804r614b2851],
9	,	,	O	,	_	0	SENT_268	[p12l571t2804r614b2851],
10	Xu	NNP	PERSON	Xu	nn	11	SENT_268	[p12l645t2804r715b2845],
11	J	NNP	PERSON	J	appos	5	SENT_268	[p12l740t2804r773b2855],
12	,	,	O	,	_	0	SENT_268	[p12l740t2804r773b2855],
13	Ward	NNP	PERSON	Ward	nn	16	SENT_268	[p12l803t2801r946b2845],
14	E.	NNP	O	E.	nn	16	SENT_268	[p12l979t2804r1019b2845],
15	Cancer	NNP	O	Cancer	nn	16	SENT_268	[p12l1051t2803r1226b2845],
16	statistics	NNS	O	statistics	appos	5	SENT_268	[p12l1258t2802r1494b2851],
17	,	,	O	,	_	0	SENT_268	[p12l1258t2802r1494b2851],
18	2010	CD	DATE	2010	appos	5	SENT_268	[p12l1527t2803r1666b2845],
19	.	.	O	.	_	0	SENT_268	[p12l1527t2803r1666b2845],

1	CA	NNP	O	CA	nn	2	SENT_269	[p12l1699t2803r1768b2845],
2	Cancer	NNP	O	Cancer	nsubj	3	SENT_269	[p12l1798t2803r2017b2855],
3	]	VBD	O	]	_	0	SENT_269	[p12l1798t2803r2017b2855],
4	Clin	NN	O	clin	dobj	3	SENT_269	[p12l2049t2801r2147b2845],

1	[	NN	O	[	nn	3	SENT_270	[p12l38t2933r102b2987],
2	3	CD	NUMBER	3	num	3	SENT_270	[p12l38t2933r102b2987],
3	]	NN	O	]	_	0	SENT_270	[p12l38t2933r102b2987],
4	Hoffman	NNP	ORGANIZATION	Hoffman	nn	5	SENT_270	[p12l137t2933r361b2977],
5	PC	NNP	ORGANIZATION	PC	dep	3	SENT_270	[p12l455t2935r529b2983],
6	,	,	O	,	_	0	SENT_270	[p12l455t2935r529b2983],
7	Mauer	NNP	ORGANIZATION	Mauer	nn	8	SENT_270	[p12l625t2936r791b2977],
8	AM	NNP	ORGANIZATION	AM	appos	5	SENT_270	[p12l881t2935r982b2983],
9	,	,	O	,	_	0	SENT_270	[p12l881t2935r982b2983],
10	Vokes	NNP	PERSON	Vokes	nn	11	SENT_270	[p12l1075t2933r1228b2977],
11	EE	NNP	O	EE	appos	5	SENT_270	[p12l1323t2936r1395b2977],
12	.	.	O	.	_	0	SENT_270	[p12l1323t2936r1395b2977],

1	Lung	NN	O	lung	_	0	SENT_271	[p12l1491t2936r1615b2987],
2	cancer	NN	O	cancer	dep	1	SENT_271	[p12l1707t2946r1886b2977],
3	.	.	O	.	_	0	SENT_271	[p12l1707t2946r1886b2977],

1	Lancet	NNP	O	Lancet	_	0	SENT_272	[p12l1982t2936r2148b2977],

1	[	NN	O	[	nn	5	SENT_273	[p12l38t3065r102b3119],
2	4	CD	NUMBER	4	num	5	SENT_273	[p12l38t3065r102b3119],
3	]	CD	NUMBER	]	num	5	SENT_273	[p12l38t3065r102b3119],
4	Spira	NNP	PERSON	Spira	nn	5	SENT_273	[p12l137t3066r266b3119],
5	A	NNP	O	A	_	0	SENT_273	[p12l288t3067r336b3115],
6	,	,	O	,	_	0	SENT_273	[p12l288t3067r336b3115],
7	Ettinger	NNP	O	Ettinger	nn	8	SENT_273	[p12l362t3066r568b3119],
8	DS	NN	O	d	appos	5	SENT_273	[p12l591t3067r669b3109],
9	.	.	O	.	_	0	SENT_273	[p12l591t3067r669b3109],

1	Multidisciplinary	JJ	O	multidisciplinary	amod	2	SENT_274	[p12l695t3065r1139b3119],
2	management	NN	O	management	_	0	SENT_274	[p12l1162t3071r1502b3119],
3	of	IN	O	of	_	0	SENT_274	[p12l1525t3065r1578b3108],
4	lung	NN	O	lung	nn	5	SENT_274	[p12l1597t3065r1710b3119],
5	cancer	NN	O	cancer	prep_of	2	SENT_274	[p12l1733t3077r1912b3109],
6	.	.	O	.	_	0	SENT_274	[p12l1733t3077r1912b3109],

1	N	NN	O	n	nn	2	SENT_275	[p12l1937t3067r1974b3108],
2	Englj	NN	O	englj	_	0	SENT_275	[p12l1999t3065r2147b3119],

1	Med	VBN	O	med	_	0	SENT_276	[p12l137t3131r249b3175],
2	2004	CD	DATE	2004	dobj	1	SENT_276	[p12l267t3131r815b3185],
3	;	:	O	;	_	0	SENT_276	[p12l267t3131r815b3185],
4	350	CD	NUMBER	350	number	5	SENT_276	[p12l267t3131r815b3185],
5	(	CD	NUMBER	(	dep	2	SENT_276	[p12l267t3131r815b3185],
6	4	CD	NUMBER	4	num	7	SENT_276	[p12l267t3131r815b3185],
7	)	NN	O	)	dep	5	SENT_276	[p12l267t3131r815b3185],
8	:379	CD	NUMBER	:379	number	9	SENT_276	[p12l267t3131r815b3185],
9	—	CD	NUMBER	—	dep	5	SENT_276	[p12l267t3131r815b3185],
10	92	CD	NUMBER	92	dep	9	SENT_276	[p12l267t3131r815b3185],
11	.	.	O	.	_	0	SENT_276	[p12l267t3131r815b3185],

1	[	NN	O	[	nn	5	SENT_277	[p12l38t3196r102b3251],
2	5	CD	NUMBER	5	num	5	SENT_277	[p12l38t3196r102b3251],
3	]	CD	NUMBER	]	num	5	SENT_277	[p12l38t3196r102b3251],
4	Rabik	NNP	O	Rabik	nn	5	SENT_277	[p12l138t3197r280b3240],
5	CA	NNP	O	CA	_	0	SENT_277	[p12l298t3199r378b3247],
6	,	,	O	,	_	0	SENT_277	[p12l298t3199r378b3247],
7	Dolan	NNP	PERSON	Dolan	nn	8	SENT_277	[p12l399t3197r548b3240],
8	ME	NNP	O	ME	appos	5	SENT_277	[p12l568t3199r661b3241],
9	.	.	O	.	_	0	SENT_277	[p12l568t3199r661b3241],

1	Molecular	JJ	O	molecular	amod	2	SENT_278	[p12l682t3197r941b3240],
2	mechanisms	NNS	O	mechanism	_	0	SENT_278	[p12l959t3197r1280b3240],
3	of	IN	O	of	_	0	SENT_278	[p12l1302t3196r1355b3240],
4	resistance	NN	O	resistance	prep_of	2	SENT_278	[p12l1369t3197r1626b3240],
5	and	CC	O	and	_	0	SENT_278	[p12l1645t3197r1738b3240],
6	toxicity	NN	O	toxicity	conj_and	4	SENT_278	[p12l1758t3197r1954b3251],
7	associated	VBN	O	associate	partmod	4	SENT_278	[p12l1972t3197r2147b3240, p12l137t3263r246b3307],

1	with	IN	O	with	_	0	SENT_279	[p12l263t3263r382b3307],
2	platinating	JJ	O	platinating	amod	3	SENT_279	[p12l400t3263r681b3317],
3	agents	NNS	O	agent	pobj	1	SENT_279	[p12l698t3269r877b3317],
4	.	.	O	.	_	0	SENT_279	[p12l698t3269r877b3317],

1	Cancer	NNP	O	Cancer	nn	3	SENT_280	[p12l896t3265r1071b3307],
2	Treat	NNP	O	Treat	nn	3	SENT_280	[p12l1085t3266r1219b3307],
3	Rev	NN	O	rev	_	0	SENT_280	[p12l1236t3266r1328b3307],
4	2007	CD	DATE	2007	num	3	SENT_280	[p12l1345t3263r1794b3317],
5	;	:	O	;	_	0	SENT_280	[p12l1345t3263r1794b3317],
6	33	CD	NUMBER	33	num	7	SENT_280	[p12l1345t3263r1794b3317],
7	(	NN	O	(	dep	3	SENT_280	[p12l1345t3263r1794b3317],
8	1	CD	NUMBER	1	number	9	SENT_280	[p12l1345t3263r1794b3317],
9	)	CD	NUMBER	)	dep	7	SENT_280	[p12l1345t3263r1794b3317],
10	:9	CD	NUMBER	:9	num	11	SENT_280	[p12l1345t3263r1794b3317],
11	—	NN	O	—	dep	9	SENT_280	[p12l1345t3263r1794b3317],
12	23	CD	NUMBER	23	dep	9	SENT_280	[p12l1345t3263r1794b3317],
13	.	.	O	.	_	0	SENT_280	[p12l1345t3263r1794b3317],

1	[	NN	O	[	nn	5	SENT_281	[p12l38t3328r102b3383],
2	6	CD	NUMBER	6	num	5	SENT_281	[p12l38t3328r102b3383],
3	]	CD	NUMBER	]	num	5	SENT_281	[p12l38t3328r102b3383],
4	Clegg	NNP	MISC	Clegg	nn	5	SENT_281	[p12l137t3328r276b3383],
5	A	NNP	MISC	A	dep	21	SENT_281	[p12l286t3330r333b3379],
6	,	,	O	,	_	0	SENT_281	[p12l286t3330r333b3379],
7	Scott	NNP	PERSON	Scott	nn	8	SENT_281	[p12l347t3331r476b3372],
8	DA	NNP	PERSON	DA	appos	5	SENT_281	[p12l488t3330r573b3379],
9	,	,	O	,	_	0	SENT_281	[p12l488t3330r573b3379],
10	Hewitson	NNP	PERSON	Hewitson	nn	11	SENT_281	[p12l588t3329r834b3372],
11	P	NN	O	p	appos	5	SENT_281	[p12l847t3331r886b3379],
12	,	,	O	,	_	0	SENT_281	[p12l847t3331r886b3379],
13	Sidhu	NNP	PERSON	Sidhu	nn	14	SENT_281	[p12l900t3328r1045b3372],
14	M	NNP	O	M	appos	5	SENT_281	[p12l1058t3331r1119b3379],
15	,	,	O	,	_	0	SENT_281	[p12l1058t3331r1119b3379],
16	Waugh	NNP	PERSON	Waugh	appos	5	SENT_281	[p12l1131t3328r1316b3383],
17	N.	NNP	PERSON	N.	dep	21	SENT_281	[p12l1329t3331r1379b3372],
18	Clinical	JJ	PERSON	clinical	amod	21	SENT_281	[p12l1393t3328r1580b3372],
19	and	CC	O	and	_	0	SENT_281	[p12l1594t3328r1687b3372],
20	cost	NN	O	cost	conj_and	18	SENT_281	[p12l1700t3335r1803b3372],
21	effectiveness	NN	O	effectiveness	dep	41	SENT_281	[p12l1814t3328r2146b3372],
22	of	IN	O	of	_	0	SENT_281	[p12l137t3395r190b3438],
23	paclitaxel	NN	O	paclitaxel	prep_of	21	SENT_281	[p12l208t3395r469b3449],
24	,	,	O	,	_	0	SENT_281	[p12l208t3395r469b3449],
25	docetaxel	NN	O	docetaxel	prep_of	21	SENT_281	[p12l494t3395r753b3445],
26	,	,	O	,	_	0	SENT_281	[p12l494t3395r753b3445],
27	gemcitabine	NN	O	gemcitabine	prep_of	21	SENT_281	[p12l777t3395r1108b3449],
28	,	,	O	,	_	0	SENT_281	[p12l777t3395r1108b3449],
29	and	CC	O	and	_	0	SENT_281	[p12l1133t3395r1225b3438],
30	vinorelbine	NN	O	vinorelbine	prep_of	21	SENT_281	[p12l1249t3395r1543b3438],
31	in	IN	O	in	_	0	SENT_281	[p12l1568t3396r1616b3438],
32	non	JJ	O	non	amod	37	SENT_281	[p12l1640t3395r1899b3438],
33	—	JJ	O	—	amod	37	SENT_281	[p12l1640t3395r1899b3438],
34	small	JJ	O	small	amod	37	SENT_281	[p12l1640t3395r1899b3438],
35	cell	NN	O	cell	nn	37	SENT_281	[p12l1924t3395r2010b3438],
36	lung	NN	O	lung	nn	37	SENT_281	[p12l2035t3395r2148b3449],
37	cancer	NN	O	cancer	prep_in	23	SENT_281	[p12l137t3474r319b3505],
38	:	:	O	:	_	0	SENT_281	[p12l137t3474r319b3505],
39	a	DT	O	a	det	41	SENT_281	[p12l341t3474r367b3505],
40	systematic	JJ	O	systematic	amod	41	SENT_281	[p12l385t3462r660b3516],
41	review	NN	O	review	_	0	SENT_281	[p12l678t3462r865b3505],
42	.	.	O	.	_	0	SENT_281	[p12l678t3462r865b3505],

1	Thorax	NNP	O	Thorax	_	0	SENT_282	[p12l881t3461r1063b3505],
2	2002	CD	DATE	2002	num	1	SENT_282	[p12l1079t3461r1529b3515],
3	;	:	O	;	_	0	SENT_282	[p12l1079t3461r1529b3515],
4	57	CD	NUMBER	57	num	5	SENT_282	[p12l1079t3461r1529b3515],
5	(	NN	O	(	dep	1	SENT_282	[p12l1079t3461r1529b3515],
6	1	CD	NUMBER	1	number	7	SENT_282	[p12l1079t3461r1529b3515],
7	)	CD	NUMBER	)	dep	5	SENT_282	[p12l1079t3461r1529b3515],
8	:20	CD	NUMBER	:20	num	9	SENT_282	[p12l1079t3461r1529b3515],
9	—	NN	O	—	dep	7	SENT_282	[p12l1079t3461r1529b3515],
10	8	CD	NUMBER	8	dep	7	SENT_282	[p12l1079t3461r1529b3515],
11	.	.	O	.	_	0	SENT_282	[p12l1079t3461r1529b3515],

1	[	NN	O	[	_	0	SENT_283	[p12l39t3527r103b3581],
2	7	CD	NUMBER	7	num	1	SENT_283	[p12l39t3527r103b3581],
3	]	CD	NUMBER	]	num	5	SENT_283	[p12l39t3527r103b3581],
4	Ishida	NNP	PERSON	Ishida	nn	5	SENT_283	[p12l138t3527r291b3571],
5	S	NN	PERSON	s	dep	1	SENT_283	[p12l310t3529r348b3577],
6	,	,	O	,	_	0	SENT_283	[p12l310t3529r348b3577],
7	Lee	NNP	PERSON	Lee	nn	8	SENT_283	[p12l369t3530r497b3581],
8	]	NNP	O	]	appos	1	SENT_283	[p12l369t3530r497b3581],
9	,	,	O	,	_	0	SENT_283	[p12l369t3530r497b3581],
10	Thiele	NNP	PERSON	Thiele	nn	12	SENT_283	[p12l515t3527r672b3571],
11	D	NNP	O	D	nn	12	SENT_283	[p12l692t3530r758b3581],
12	]	NN	O	]	appos	8	SENT_283	[p12l692t3530r758b3581],
13	,	,	O	,	_	0	SENT_283	[p12l692t3530r758b3581],
14	Herskowitz	NNP	PERSON	Herskowitz	nn	16	SENT_283	[p12l779t3527r1073b3571],
15	I.	NNP	PERSON	I.	nn	16	SENT_283	[p12l1093t3530r1118b3571],
16	Uptake	NNP	PERSON	Uptake	appos	8	SENT_283	[p12l1138t3527r1320b3581],
17	of	IN	O	of	_	0	SENT_283	[p12l1340t3527r1393b3571],
18	the	DT	O	the	det	21	SENT_283	[p12l1405t3527r1487b3571],
19	anticancer	JJ	O	anticancer	amod	21	SENT_283	[p12l1506t3528r1776b3571],
20	drug	NN	O	drug	nn	21	SENT_283	[p12l1793t3527r1912b3581],
21	cisplatin	NN	O	cisplatin	prep_of	16	SENT_283	[p12l1930t3527r2148b3581],
22	mediated	VBN	O	mediate	partmod	21	SENT_283	[p12l138t3592r380b3636],
23	by	IN	O	by	_	0	SENT_283	[p12l394t3593r456b3647],
24	the	DT	O	the	det	27	SENT_283	[p12l469t3593r550b3636],
25	copper	NN	O	copper	nn	27	SENT_283	[p12l565t3605r742b3647],
26	transporter	NN	O	transporter	nn	27	SENT_283	[p12l754t3599r1048b3647],
27	Ctr1	NN	O	ctr1	agent	22	SENT_283	[p12l1061t3595r1161b3636],
28	in	IN	O	in	_	0	SENT_283	[p12l1183t3593r1230b3636],
29	yeast	NN	O	yeast	prep_in	27	SENT_283	[p12l1242t3599r1378b3647],
30	and	CC	O	and	_	0	SENT_283	[p12l1391t3592r1484b3636],
31	mammals	NNS	O	mammal	prep_in	27	SENT_283	[p12l1499t3592r1765b3636],
32	.	.	O	.	_	0	SENT_283	[p12l1499t3592r1765b3636],

1	Proc	NNP	O	Proc	nn	5	SENT_284	[p12l1781t3595r1891b3636],
2	Natl	NNP	O	Natl	nn	5	SENT_284	[p12l1905t3592r2009b3636],
3	Acad	NNP	O	Acad	nn	5	SENT_284	[p12l2022t3592r2147b3636],
4	Sci	NNP	O	Sci	nn	5	SENT_284	[p12l138t3660r207b3702],
5	USA	NNP	O	USA	_	0	SENT_284	[p12l225t3661r331b3702],
6	2002	CD	DATE	2002	num	5	SENT_284	[p12l347t3659r992b3713],
7	;	:	O	;	_	0	SENT_284	[p12l347t3659r992b3713],
8	99	CD	NUMBER	99	number	9	SENT_284	[p12l347t3659r992b3713],
9	(	CD	NUMBER	(	dep	5	SENT_284	[p12l347t3659r992b3713],
10	22	CD	NUMBER	22	num	11	SENT_284	[p12l347t3659r992b3713],
11	)	NN	O	)	dep	9	SENT_284	[p12l347t3659r992b3713],
12	:14298	CD	NUMBER	:14298	num	13	SENT_284	[p12l347t3659r992b3713],
13	—	NN	O	—	dep	9	SENT_284	[p12l347t3659r992b3713],
14	302	CD	NUMBER	302	dep	13	SENT_284	[p12l347t3659r992b3713],
15	.	.	O	.	_	0	SENT_284	[p12l347t3659r992b3713],

1	[	NN	O	[	nsubj	8	SENT_285	[p12l39t3725r103b3780],
2	8	CD	NUMBER	8	num	1	SENT_285	[p12l39t3725r103b3780],
3	]	CD	NUMBER	]	num	4	SENT_285	[p12l39t3725r103b3780],
4	Song	NN	O	song	dep	1	SENT_285	[p12l138t3727r262b3780],
5	IS	VBZ	O	be	cop	8	SENT_285	[p12l292t3727r347b3776],
6	,	,	O	,	_	0	SENT_285	[p12l292t3727r347b3776],
7	Savaraj	NNP	PERSON	Savaraj	nn	8	SENT_285	[p12l380t3726r562b3780],
8	N	NNP	PERSON	N	_	0	SENT_285	[p12l596t3728r646b3775],
9	,	,	O	,	_	0	SENT_285	[p12l596t3728r646b3775],
10	Siddik	NNP	O	Siddik	nn	11	SENT_285	[p12l678t3725r838b3769],
11	ZH	NNP	O	ZH	appos	8	SENT_285	[p12l867t3728r950b3776],
12	,	,	O	,	_	0	SENT_285	[p12l867t3728r950b3776],
13	Liu	NNP	PERSON	Liu	nn	14	SENT_285	[p12l983t3726r1058b3769],
14	P	NN	PERSON	p	appos	8	SENT_285	[p12l1090t3728r1130b3776],
15	,	,	O	,	_	0	SENT_285	[p12l1090t3728r1130b3776],
16	Wei	NNP	LOCATION	Wei	nn	17	SENT_285	[p12l1160t3726r1263b3769],
17	Y	NN	LOCATION	y	appos	8	SENT_285	[p12l1293t3728r1338b3775],
18	,	,	O	,	_	0	SENT_285	[p12l1293t3728r1338b3775],
19	Wu	NNP	O	Wu	nn	21	SENT_285	[p12l1368t3728r1459b3769],
20	C	NNP	O	C	nn	21	SENT_285	[p12l1491t3727r1551b3780],
21	]	NN	O	]	appos	8	SENT_285	[p12l1491t3727r1551b3780],
22	,	,	O	,	_	0	SENT_285	[p12l1491t3727r1551b3780],
23	et	FW	O	et	nn	24	SENT_285	[p12l1583t3732r1631b3769],
24	al.	FW	O	al.	appos	8	SENT_285	[p12l1661t3725r1716b3769],
25	.	.	O	.	_	0	SENT_285	[p12l1661t3725r1716b3769],

1	Role	NN	O	role	_	0	SENT_286	[p12l1749t3725r1858b3769],
2	of	IN	O	of	_	0	SENT_286	[p12l1889t3725r1943b3769],
3	human	JJ	O	human	amod	6	SENT_286	[p12l1968t3725r2148b3769],
4	copper	NN	O	copper	nn	6	SENT_286	[p13l138t25r315b67],
5	transporter	NN	O	transporter	nn	6	SENT_286	[p13l357t19r651b67],
6	Ctr1	NN	O	ctr1	prep_of	1	SENT_286	[p13l694t15r794b56],
7	in	IN	O	in	_	0	SENT_286	[p13l845t13r892b56],
8	the	DT	O	the	det	9	SENT_286	[p13l936t13r1017b56],
9	transport	NN	O	transport	prep_in	1	SENT_286	[p13l1061t19r1301b67],
10	of	IN	O	of	_	0	SENT_286	[p13l1344t12r1398b56],
11	platinum-based	JJ	O	platinum-based	amod	13	SENT_286	[p13l1435t13r1843b67],
12	antitumor	NN	O	antitumor	nn	13	SENT_286	[p13l1887t13r2150b56],
13	agents	NNS	O	agent	prep_of	9	SENT_286	[p13l138t85r303b133],
14	in	IN	O	in	_	0	SENT_286	[p13l336t80r383b122],
15	cisplatin-sensitive	JJ	O	cisplatin-sensitive	amod	18	SENT_286	[p13l415t79r885b133],
16	and	CC	O	and	_	0	SENT_286	[p13l917t79r1010b123],
17	cisplatin-resistant	JJ	O	cisplatin-resistant	conj_and	15	SENT_286	[p13l1042t79r1510b133],
18	cells	NNS	O	cell	prep_in	1	SENT_286	[p13l1541t79r1665b123],
19	.	.	O	.	_	0	SENT_286	[p13l1541t79r1665b123],

1	Mol	NNP	O	Mol	nn	3	SENT_287	[p13l1698t79r1795b123],
2	Cancer	NNP	O	Cancer	nn	3	SENT_287	[p13l1828t81r2003b123],
3	Ther	NNP	O	Ther	_	0	SENT_287	[p13l2031t79r2150b123],
4	2004	CD	DATE	2004	num	3	SENT_287	[p13l138t144r652b199],
5	;	:	O	;	_	0	SENT_287	[p13l138t144r652b199],
6	3	CD	NUMBER	3	num	7	SENT_287	[p13l138t144r652b199],
7	(	NN	O	(	dep	3	SENT_287	[p13l138t144r652b199],
8	12	CD	NUMBER	12	number	9	SENT_287	[p13l138t144r652b199],
9	)	CD	NUMBER	)	num	10	SENT_287	[p13l138t144r652b199],
10	:1543	CD	NUMBER	:1543	dep	7	SENT_287	[p13l138t144r652b199],
11	—	CD	NUMBER	—	number	12	SENT_287	[p13l138t144r652b199],
12	9	CD	NUMBER	9	num	10	SENT_287	[p13l138t144r652b199],
13	.	.	O	.	_	0	SENT_287	[p13l138t144r652b199],

1	[	NN	O	[	nn	3	SENT_288	[p13l39t211r103b265],
2	9	CD	NUMBER	9	num	3	SENT_288	[p13l39t211r103b265],
3	]	NN	O	]	_	0	SENT_288	[p13l39t211r103b265],
4	Jiang	NNP	PERSON	Jiang	nn	5	SENT_288	[p13l131t212r264b265],
5	J	NNP	PERSON	J	dep	3	SENT_288	[p13l283t214r315b265],
6	,	,	O	,	_	0	SENT_288	[p13l283t214r315b265],
7	Nadas	NNP	PERSON	Nadas	nn	8	SENT_288	[p13l343t211r497b255],
8	IA	NNP	O	IA	appos	5	SENT_288	[p13l525t213r588b261],
9	,	,	O	,	_	0	SENT_288	[p13l525t213r588b261],
10	Kim	NNP	PERSON	Kim	nn	11	SENT_288	[p13l615t212r717b254],
11	MA	NNP	PERSON	MA	appos	5	SENT_288	[p13l744t213r842b261],
12	,	,	O	,	_	0	SENT_288	[p13l744t213r842b261],
13	Franz	NNP	PERSON	Franz	nn	14	SENT_288	[p13l870t214r1009b255],
14	KJ	NNP	PERSON	KJ	appos	5	SENT_288	[p13l1036t214r1099b265],
15	.	.	O	.	_	0	SENT_288	[p13l1036t214r1099b265],

1	A	DT	O	a	det	4	SENT_289	[p13l1124t213r1162b254],
2	Mets	NNPS	ORGANIZATION	Mets	nn	4	SENT_289	[p13l1186t214r1310b255],
3	motif	NN	O	motif	nn	4	SENT_289	[p13l1338t211r1481b255],
4	peptide	NN	O	peptide	nsubj	11	SENT_289	[p13l1502t211r1696b265],
5	found	VBN	O	find	partmod	4	SENT_289	[p13l1723t211r1871b255],
6	in	IN	O	in	_	0	SENT_289	[p13l1898t212r1946b254],
7	copper	NN	O	copper	nn	9	SENT_289	[p13l1972t224r2150b265],
8	transport	NN	O	transport	nn	9	SENT_289	[p13l138t283r378b331],
9	proteins	NNS	O	protein	prep_in	5	SENT_289	[p13l396t277r607b331],
10	selectively	RB	O	selectively	advmod	11	SENT_289	[p13l627t276r899b331],
11	binds	VBZ	O	bind	_	0	SENT_289	[p13l916t276r1055b320],
12	Cu	NN	O	cu	dobj	11	SENT_289	[p13l1075t277r1197b330],
13	(	CD	NUMBER	(	num	12	SENT_289	[p13l1075t277r1197b330],
14	I	PRP	O	I	nsubj	15	SENT_289	[p13l1075t277r1197b330],
15	)	VBP	O	)	rcmod	12	SENT_289	[p13l1075t277r1197b330],
16	with	IN	O	with	_	0	SENT_289	[p13l1215t276r1334b320],
17	methionine-only	JJ	O	methionine-only	amod	18	SENT_289	[p13l1353t276r1788b331],
18	coordination	NN	O	coordination	prep_with	15	SENT_289	[p13l1806t276r2147b320],
19	.	.	O	.	_	0	SENT_289	[p13l1806t276r2147b320],

1	Inorg	NNP	ORGANIZATION	Inorg	nn	2	SENT_290	[p13l138t346r273b397],
2	Chem	NNP	ORGANIZATION	Chem	_	0	SENT_290	[p13l290t343r436b386],
3	2005	CD	DATE	2005	dep	2	SENT_290	[p13l453t343r1034b397],
4	;	:	O	;	_	0	SENT_290	[p13l453t343r1034b397],
5	44	CD	NUMBER	44	number	6	SENT_290	[p13l453t343r1034b397],
6	(	CD	NUMBER	(	dep	3	SENT_290	[p13l453t343r1034b397],
7	26	CD	NUMBER	26	num	8	SENT_290	[p13l453t343r1034b397],
8	)	NN	O	)	dep	6	SENT_290	[p13l453t343r1034b397],
9	:9787	CD	NUMBER	:9787	number	10	SENT_290	[p13l453t343r1034b397],
10	—	CD	NUMBER	—	dep	2	SENT_290	[p13l453t343r1034b397],
11	94	CD	NUMBER	94	dep	10	SENT_290	[p13l453t343r1034b397],
12	.	.	O	.	_	0	SENT_290	[p13l453t343r1034b397],

1	[	NN	O	[	nn	5	SENT_291	[p13l7t409r103b464],
2	10	CD	NUMBER	10	num	5	SENT_291	[p13l7t409r103b464],
3	]	CD	NUMBER	]	num	5	SENT_291	[p13l7t409r103b464],
4	Lee	NNP	PERSON	Lee	nn	5	SENT_291	[p13l138t412r221b453],
5	J	NNP	PERSON	J	_	0	SENT_291	[p13l241t412r274b464],
6	,	,	O	,	_	0	SENT_291	[p13l241t412r274b464],
7	Prohaska	NNP	PERSON	Prohaska	nn	8	SENT_291	[p13l300t409r533b453],
8	JR	NNP	O	JR	appos	5	SENT_291	[p13l552t412r619b464],
9	,	,	O	,	_	0	SENT_291	[p13l552t412r619b464],
10	Dagenais	NNP	PERSON	Dagenais	nn	11	SENT_291	[p13l646t410r877b464],
11	SL	NNP	O	SL	appos	5	SENT_291	[p13l904t411r970b459],
12	,	,	O	,	_	0	SENT_291	[p13l904t411r970b459],
13	Glover	NNP	ORGANIZATION	Glover	nn	14	SENT_291	[p13l997t409r1167b453],
14	TW	NNP	ORGANIZATION	TW	appos	5	SENT_291	[p13l1188t412r1290b459],
15	,	,	O	,	_	0	SENT_291	[p13l1188t412r1290b459],
16	Thiele	NNP	O	Thiele	nn	17	SENT_291	[p13l1314t409r1471b453],
17	DJ	NNP	O	DJ	appos	5	SENT_291	[p13l1497t412r1564b464],
18	.	.	O	.	_	0	SENT_291	[p13l1497t412r1564b464],

1	Isolation	NN	O	isolation	_	0	SENT_292	[p13l1591t409r1812b453],
2	of	IN	O	of	_	0	SENT_292	[p13l1837t409r1891b453],
3	a	DT	O	a	det	7	SENT_292	[p13l1910t422r1936b453],
4	murine	JJ	O	murine	amod	7	SENT_292	[p13l1962t410r2147b453],
5	copper	NN	O	copper	nn	7	SENT_292	[p13l138t487r315b529],
6	transporter	NN	O	transporter	nn	7	SENT_292	[p13l327t481r621b529],
7	gene	NN	O	gene	prep_of	1	SENT_292	[p13l632t487r766b529],
8	,	,	O	,	_	0	SENT_292	[p13l632t487r766b529],
9	tissue	NN	O	tissue	nn	11	SENT_292	[p13l780t475r928b518],
10	speciﬁc	NN	O	speciﬁc	nn	11	SENT_292	[p13l943t474r1134b529],
11	expression	NN	O	expression	prep_of	1	SENT_292	[p13l1147t475r1425b529],
12	and	CC	O	and	_	0	SENT_292	[p13l1439t475r1532b518],
13	functional	JJ	O	functional	amod	14	SENT_292	[p13l1546t474r1806b518],
14	complementation	NN	O	complementation	conj_and	7	SENT_292	[p13l1821t475r2147b529, p13l137t542r289b585],
15	of	IN	O	of	_	0	SENT_292	[p13l306t541r360b585],
16	a	DT	O	a	det	20	SENT_292	[p13l371t554r397b585],
17	yeast	NN	O	yeast	nn	20	SENT_292	[p13l413t547r548b595],
18	copper	NN	O	copper	nn	20	SENT_292	[p13l565t554r742b595],
19	transport	NN	O	transport	nn	20	SENT_292	[p13l758t547r999b595],
20	mutant	NN	O	mutant	prep_of	1	SENT_292	[p13l1016t547r1216b585],
21	.	.	O	.	_	0	SENT_292	[p13l1016t547r1216b585],

1	Gene	NNP	O	Gene	_	0	SENT_293	[p13l1235t543r1364b585],
2	2000	CD	DATE	2000	num	1	SENT_293	[p13l1382t541r1962b595],
3	;	:	O	;	_	0	SENT_293	[p13l1382t541r1962b595],
4	254	CD	NUMBER	254	num	5	SENT_293	[p13l1382t541r1962b595],
5	(	NN	O	(	dep	1	SENT_293	[p13l1382t541r1962b595],
6	1	CD	NUMBER	1	num	7	SENT_293	[p13l1382t541r1962b595],
7	—	NN	O	—	dep	5	SENT_293	[p13l1382t541r1962b595],
8	2	CD	NUMBER	2	number	9	SENT_293	[p13l1382t541r1962b595],
9	)	CD	NUMBER	)	dep	5	SENT_293	[p13l1382t541r1962b595],
10	:87	CD	NUMBER	:87	num	11	SENT_293	[p13l1382t541r1962b595],
11	—	NN	O	—	dep	9	SENT_293	[p13l1382t541r1962b595],
12	96	CD	NUMBER	96	dep	9	SENT_293	[p13l1382t541r1962b595],
13	.	.	O	.	_	0	SENT_293	[p13l1382t541r1962b595],

1	[	NN	O	[	nn	5	SENT_294	[p13l6t606r103b661],
2	11	CD	NUMBER	11	num	5	SENT_294	[p13l6t606r103b661],
3	]	CD	NUMBER	]	num	5	SENT_294	[p13l6t606r103b661],
4	Holzer	NNP	PERSON	Holzer	nn	5	SENT_294	[p13l138t607r308b650],
5	AK	NNP	O	AK	_	0	SENT_294	[p13l324t608r409b657],
6	,	,	O	,	_	0	SENT_294	[p13l324t608r409b657],
7	Katano	NNP	PERSON	Katano	nn	8	SENT_294	[p13l430t609r608b650],
8	K	NNP	PERSON	K	appos	5	SENT_294	[p13l629t609r673b657],
9	,	,	O	,	_	0	SENT_294	[p13l629t609r673b657],
10	Klomp	NNP	PERSON	Klomp	nn	11	SENT_294	[p13l695t607r862b661],
11	LW	NNP	O	LW	appos	5	SENT_294	[p13l883t609r978b657],
12	,	,	O	,	_	0	SENT_294	[p13l883t609r978b657],
13	Howell	NNP	PERSON	Howell	nn	14	SENT_294	[p13l999t606r1181b650],
14	SB	NN	O	sb	appos	5	SENT_294	[p13l1202t609r1274b650],
15	.	.	O	.	_	0	SENT_294	[p13l1202t609r1274b650],

1	Cisplatin	NNP	O	Cisplatin	nsubj	3	SENT_295	[p13l1295t606r1520b661],
2	rapidly	RB	O	rapidly	advmod	3	SENT_295	[p13l1540t606r1722b661],
3	down-regulates	VBZ	O	down-regulate	_	0	SENT_295	[p13l1741t606r2147b661],
4	its	PRP$	O	its	poss	8	SENT_295	[p13l138t673r196b716],
5	own	JJ	O	own	amod	8	SENT_295	[p13l218t685r329b716],
6	inﬂux	NN	O	inﬂux	nn	8	SENT_295	[p13l350t673r499b716],
7	transporter	NN	O	transporter	nn	8	SENT_295	[p13l518t679r812b727],
8	hCTR1	NN	O	hctr1	dobj	3	SENT_295	[p13l832t673r988b716],
9	in	IN	O	in	_	0	SENT_295	[p13l1016t674r1064b716],
10	cultured	VBN	O	culture	prepc_in	3	SENT_295	[p13l1084t673r1299b716],
11	human	JJ	O	human	amod	14	SENT_295	[p13l1321t673r1501b716],
12	ovarian	JJ	O	ovarian	amod	14	SENT_295	[p13l1522t673r1714b716],
13	carcinoma	NN	O	carcinoma	nn	14	SENT_295	[p13l1734t674r2002b716],
14	cells	NNS	O	cell	dobj	10	SENT_295	[p13l2023t673r2147b717],
15	.	.	O	.	_	0	SENT_295	[p13l2023t673r2147b717],

1	Clin	NNP	O	Clin	nn	3	SENT_296	[p13l138t739r236b783],
2	Cancer	NNP	O	Cancer	nn	3	SENT_296	[p13l254t741r429b783],
3	Res	NNP	O	Res	_	0	SENT_296	[p13l445t742r530b783],
4	2004	CD	DATE	2004	num	3	SENT_296	[p13l549t739r1097b793],
5	;	:	O	;	_	0	SENT_296	[p13l549t739r1097b793],
6	10	CD	NUMBER	10	number	7	SENT_296	[p13l549t739r1097b793],
7	(	CD	NUMBER	(	dep	3	SENT_296	[p13l549t739r1097b793],
8	19	CD	NUMBER	19	num	9	SENT_296	[p13l549t739r1097b793],
9	)	NN	O	)	dep	7	SENT_296	[p13l549t739r1097b793],
10	:6744	CD	NUMBER	:6744	number	11	SENT_296	[p13l549t739r1097b793],
11	—	CD	NUMBER	—	dep	7	SENT_296	[p13l549t739r1097b793],
12	9	CD	NUMBER	9	dep	11	SENT_296	[p13l549t739r1097b793],
13	.	.	O	.	_	0	SENT_296	[p13l549t739r1097b793],

1	[	NN	O	[	_	0	SENT_297	[p13l6t804r103b859],
2	12	CD	NUMBER	12	num	1	SENT_297	[p13l6t804r103b859],
3	]	CD	NUMBER	]	num	5	SENT_297	[p13l6t804r103b859],
4	More	JJR	O	more	amod	5	SENT_297	[p13l138t807r271b848],
5	SS	NN	O	ss	dep	1	SENT_297	[p13l304t807r372b855],
6	,	,	O	,	_	0	SENT_297	[p13l304t807r372b855],
7	Akil	NNP	PERSON	Akil	nn	8	SENT_297	[p13l403t805r504b848],
8	O	NNP	PERSON	O	appos	5	SENT_297	[p13l537t807r586b855],
9	,	,	O	,	_	0	SENT_297	[p13l537t807r586b855],
10	lanculescu	NNP	O	lanculescu	nn	11	SENT_297	[p13l619t805r890b848],
11	AG	NNP	ORGANIZATION	AG	appos	5	SENT_297	[p13l920t807r1008b855],
12	,	,	O	,	_	0	SENT_297	[p13l920t807r1008b855],
13	Geier	NNP	ORGANIZATION	Geier	nn	14	SENT_297	[p13l1042t805r1178b848],
14	EG	NNP	ORGANIZATION	EG	appos	5	SENT_297	[p13l1210t807r1290b855],
15	,	,	O	,	_	0	SENT_297	[p13l1210t807r1290b855],
16	Lustig	NNP	ORGANIZATION	Lustig	nn	17	SENT_297	[p13l1323t805r1476b859],
17	LR	NNP	ORGANIZATION	LR	appos	5	SENT_297	[p13l1508t807r1579b855],
18	,	,	O	,	_	0	SENT_297	[p13l1508t807r1579b855],
19	Giacomini	NNP	PERSON	Giacomini	nn	20	SENT_297	[p13l1613t805r1874b848],
20	KM	NNP	O	KM	appos	5	SENT_297	[p13l1907t807r2005b849],
21	.	.	O	.	_	0	SENT_297	[p13l1907t807r2005b849],

1	Role	NN	O	role	_	0	SENT_298	[p13l2038t805r2147b848],
2	of	IN	O	of	_	0	SENT_298	[p13l138t871r191b915],
3	the	DT	O	the	det	5	SENT_298	[p13l208t871r289b915],
4	copper	NN	O	copper	nn	5	SENT_298	[p13l313t884r491b925],
5	transporter	NN	O	transporter	prep_of	1	SENT_298	[p13l512t877r817b925],
6	.	.	O	.	_	0	SENT_298	[p13l512t877r817b925],

1	CTR1	NN	O	ctr1	_	0	SENT_299	[p13l842t873r983b921],
2	,	,	O	,	_	0	SENT_299	[p13l842t873r983b921],
3	in	IN	O	in	dep	1	SENT_299	[p13l1008t872r1055b914],
4	platinum-induced	JJ	O	platinum-induced	amod	5	SENT_299	[p13l1079t871r1545b925],
5	ototoxicity	NN	O	ototoxicity	pobj	3	SENT_299	[p13l1569t872r1899b925],
6	.	.	O	.	_	0	SENT_299	[p13l1569t872r1899b925],

1	J	NNP	O	J	nn	2	SENT_300	[p13l1569t872r1899b925],
2	Neurosci	NNP	O	Neurosci	_	0	SENT_300	[p13l1922t872r2147b915],
3	2010	CD	DATE	2010	num	5	SENT_300	[p13l138t937r685b991],
4	;	:	O	;	_	0	SENT_300	[p13l138t937r685b991],
5	30	CD	NUMBER	30	dep	2	SENT_300	[p13l138t937r685b991],
6	(	CD	NUMBER	(	number	7	SENT_300	[p13l138t937r685b991],
7	28	CD	NUMBER	28	num	8	SENT_300	[p13l138t937r685b991],
8	)	NN	O	)	dep	5	SENT_300	[p13l138t937r685b991],
9	:9500	CD	NUMBER	:9500	number	10	SENT_300	[p13l138t937r685b991],
10	—	CD	NUMBER	—	dep	2	SENT_300	[p13l138t937r685b991],
11	9	CD	NUMBER	9	dep	10	SENT_300	[p13l138t937r685b991],
12	.	.	O	.	_	0	SENT_300	[p13l138t937r685b991],

1	[	RB	O	[	dep	5	SENT_301	[p13l6t1003r103b1057],
2	13	CD	NUMBER	13	num	5	SENT_301	[p13l6t1003r103b1057],
3	]	CD	NUMBER	]	num	5	SENT_301	[p13l6t1003r103b1057],
4	Kalikaki	NNP	MISC	Kalikaki	nn	5	SENT_301	[p13l138t1003r342b1047],
5	A	NNP	O	A	_	0	SENT_301	[p13l371t1005r419b1053],
6	,	,	O	,	_	0	SENT_301	[p13l371t1005r419b1053],
7	Kanaki	NNP	O	Kanaki	nn	8	SENT_301	[p13l450t1003r623b1047],
8	M	NNP	O	M	appos	5	SENT_301	[p13l655t1006r716b1053],
9	,	,	O	,	_	0	SENT_301	[p13l655t1006r716b1053],
10	Vassalou	NNP	PERSON	Vassalou	nn	11	SENT_301	[p13l745t1003r973b1047],
11	H	NNP	PERSON	H	appos	5	SENT_301	[p13l1004t1006r1054b1053],
12	,	,	O	,	_	0	SENT_301	[p13l1004t1006r1054b1053],
13	Souglakos	NNP	PERSON	Souglakos	nn	14	SENT_301	[p13l1086t1003r1342b1057],
14	J	NNP	PERSON	J	appos	11	SENT_301	[p13l1366t1006r1399b1057],
15	,	,	O	,	_	0	SENT_301	[p13l1366t1006r1399b1057],
16	Voutsina	NNP	O	Voutsina	nn	17	SENT_301	[p13l1428t1004r1657b1047],
17	A	NNP	O	A	appos	11	SENT_301	[p13l1685t1005r1733b1053],
18	,	,	O	,	_	0	SENT_301	[p13l1685t1005r1733b1053],
19	Georgoulias	NNP	O	Georgoulias	nn	20	SENT_301	[p13l1765t1003r2069b1057],
20	V	NNP	O	V	appos	11	SENT_301	[p13l2099t1006r2147b1053],
21	,	,	O	,	_	0	SENT_301	[p13l2099t1006r2147b1053],
22	et	FW	O	et	nn	23	SENT_301	[p13l138t1075r186b1112],
23	al.	FW	O	al.	appos	11	SENT_301	[p13l209t1068r264b1112],
24	.	.	O	.	_	0	SENT_301	[p13l209t1068r264b1112],

1	DNA	NN	O	dna	nn	4	SENT_302	[p13l289t1070r406b1112],
2	repair	NN	O	repair	nn	4	SENT_302	[p13l429t1069r582b1123],
3	gene	NN	O	gene	nn	4	SENT_302	[p13l604t1081r725b1123],
4	polymorphisms	NNS	O	polymorphism	nsubj	5	SENT_302	[p13l750t1068r1153b1123],
5	predict	VBP	O	predict	_	0	SENT_302	[p13l1179t1069r1361b1123],
6	favorable	JJ	O	favorable	amod	8	SENT_302	[p13l1384t1068r1622b1112],
7	clinical	JJ	O	clinical	amod	8	SENT_302	[p13l1646t1068r1827b1112],
8	outcome	NN	O	outcome	dobj	5	SENT_302	[p13l1852t1075r2076b1112],
9	in	IN	O	in	_	0	SENT_302	[p13l2101t1069r2148b1112],
10	advanced	JJ	O	advanced	amod	12	SENT_302	[p13l138t1135r381b1178],
11	non	JJ	O	non	amod	12	SENT_302	[p13l399t1135r773b1178],
12	—	NN	O	—	prep_in	8	SENT_302	[p13l399t1135r773b1178],
13	small	JJ	O	small	amod	17	SENT_302	[p13l399t1135r773b1178],
14	—	NN	O	—	nn	17	SENT_302	[p13l399t1135r773b1178],
15	cell	NN	O	cell	nn	17	SENT_302	[p13l399t1135r773b1178],
16	lung	NN	O	lung	nn	17	SENT_302	[p13l792t1135r904b1189],
17	cancer	NN	O	cancer	dep	12	SENT_302	[p13l921t1147r1100b1179],
18	.	.	O	.	_	0	SENT_302	[p13l921t1147r1100b1179],

1	Clin	NNP	O	Clin	nn	3	SENT_303	[p13l1119t1135r1217b1178],
2	Lung	NN	O	lung	nn	3	SENT_303	[p13l1235t1138r1359b1189],
3	Cancer	NN	O	cancer	_	0	SENT_303	[p13l1376t1137r1551b1178],
4	2009	CD	DATE	2009	dep	3	SENT_303	[p13l1567t1135r2082b1189],
5	;	:	O	;	_	0	SENT_303	[p13l1567t1135r2082b1189],
6	10	CD	NUMBER	10	num	7	SENT_303	[p13l1567t1135r2082b1189],
7	(	NN	O	(	dep	3	SENT_303	[p13l1567t1135r2082b1189],
8	2	CD	NUMBER	2	number	9	SENT_303	[p13l1567t1135r2082b1189],
9	)	CD	NUMBER	)	dep	7	SENT_303	[p13l1567t1135r2082b1189],
10	:118	CD	NUMBER	:118	num	11	SENT_303	[p13l1567t1135r2082b1189],
11	—	NN	O	—	dep	9	SENT_303	[p13l1567t1135r2082b1189],
12	23	CD	NUMBER	23	dep	9	SENT_303	[p13l1567t1135r2082b1189],
13	.	.	O	.	_	0	SENT_303	[p13l1567t1135r2082b1189],

1	[	NN	O	[	nn	4	SENT_304	[p13l6t1201r103b1256],
2	14	CD	NUMBER	14	num	4	SENT_304	[p13l6t1201r103b1256],
3	]	NN	O	]	nn	4	SENT_304	[p13l6t1201r103b1256],
4	Booton	NN	PERSON	booton	_	0	SENT_304	[p13l138t1204r320b1245],
5	R	NN	PERSON	r	dep	4	SENT_304	[p13l339t1204r382b1252],
6	,	,	O	,	_	0	SENT_304	[p13l339t1204r382b1252],
7	Ward	NNP	ORGANIZATION	Ward	nn	8	SENT_304	[p13l401t1201r544b1245],
8	T	NN	ORGANIZATION	t	appos	5	SENT_304	[p13l561t1204r604b1251],
9	,	,	O	,	_	0	SENT_304	[p13l561t1204r604b1251],
10	Heighway	NN	ORGANIZATION	heighway	nn	11	SENT_304	[p13l624t1201r884b1256],
11	J	NN	ORGANIZATION	j	appos	5	SENT_304	[p13l895t1204r928b1256],
12	,	,	O	,	_	0	SENT_304	[p13l895t1204r928b1256],
13	Taylor	NNP	PERSON	Taylor	nn	14	SENT_304	[p13l946t1201r1110b1256],
14	P	NN	O	p	appos	5	SENT_304	[p13l1128t1204r1168b1251],
15	,	,	O	,	_	0	SENT_304	[p13l1128t1204r1168b1251],
16	Power	NNP	O	Power	nn	17	SENT_304	[p13l1189t1204r1352b1245],
17	F	NN	O	f	appos	5	SENT_304	[p13l1370t1204r1407b1252],
18	,	,	O	,	_	0	SENT_304	[p13l1370t1204r1407b1252],
19	Ashcroft	NNP	PERSON	Ashcroft	nn	20	SENT_304	[p13l1425t1201r1644b1245],
20	L	NNP	PERSON	L	appos	5	SENT_304	[p13l1662t1204r1699b1252],
21	,	,	O	,	_	0	SENT_304	[p13l1662t1204r1699b1252],
22	et	FW	O	et	nn	23	SENT_304	[p13l1719t1208r1768b1245],
23	al.	FW	O	al.	appos	5	SENT_304	[p13l1786t1201r1840b1245],
24	.	.	O	.	_	0	SENT_304	[p13l1786t1201r1840b1245],

1	Xeroderma	NN	ORGANIZATION	xeroderma	nn	2	SENT_305	[p13l1859t1201r2148b1245],
2	pigmentosum	NN	O	pigmentosum	nsubj	6	SENT_305	[p13l138t1267r496b1321],
3	group	NN	O	group	nn	5	SENT_305	[p13l516t1279r666b1321],
4	D	NN	O	d	nn	5	SENT_305	[p13l687t1269r723b1310],
5	haplotype	NN	O	haplotype	dep	2	SENT_305	[p13l745t1267r1002b1321],
6	predicts	VBZ	O	predict	_	0	SENT_305	[p13l1023t1267r1228b1321],
7	for	IN	O	for	_	0	SENT_305	[p13l1250t1266r1322b1310],
8	response	NN	O	response	prep_for	6	SENT_305	[p13l1341t1279r1582b1321],
9	,	,	O	,	_	0	SENT_305	[p13l1341t1279r1582b1321],
10	survival	NN	O	survival	conj_and	8	SENT_305	[p13l1604t1267r1819b1317],
11	,	,	O	,	_	0	SENT_305	[p13l1604t1267r1819b1317],
12	and	CC	O	and	_	0	SENT_305	[p13l1840t1267r1933b1310],
13	toxicity	NN	O	toxicity	prep_for	6	SENT_305	[p13l1954t1267r2149b1321],
14	after	IN	O	after	_	0	SENT_305	[p13l138t1333r258b1377],
15	platinum-based	JJ	O	platinum-based	amod	16	SENT_305	[p13l282t1333r689b1387],
16	chemotherapy	NN	O	chemotherapy	prep_after	8	SENT_305	[p13l715t1333r1090b1387],
17	in	IN	O	in	_	0	SENT_305	[p13l1115t1334r1162b1376],
18	advanced	JJ	O	advanced	amod	22	SENT_305	[p13l1187t1333r1430b1377],
19	nonsmall	JJ	O	nonsmall	amod	22	SENT_305	[p13l1456t1333r1693b1377],
20	cell	NN	O	cell	nn	22	SENT_305	[p13l1719t1333r1805b1377],
21	lung	NN	O	lung	nn	22	SENT_305	[p13l1831t1333r1944b1387],
22	cancer	NN	O	cancer	prep_in	16	SENT_305	[p13l1968t1346r2147b1377],
23	.	.	O	.	_	0	SENT_305	[p13l1968t1346r2147b1377],

1	Cancer	NN	O	cancer	_	0	SENT_306	[p13l138t1401r313b1442],
2	2006	CD	DATE	2006	num	1	SENT_306	[p13l329t1399r909b1453],
3	;	:	O	;	_	0	SENT_306	[p13l329t1399r909b1453],
4	106	CD	NUMBER	106	number	5	SENT_306	[p13l329t1399r909b1453],
5	(	CD	NUMBER	(	dep	1	SENT_306	[p13l329t1399r909b1453],
6	11	CD	NUMBER	11	num	7	SENT_306	[p13l329t1399r909b1453],
7	)	NN	O	)	dep	5	SENT_306	[p13l329t1399r909b1453],
8	:2421	CD	NUMBER	:2421	num	9	SENT_306	[p13l329t1399r909b1453],
9	—	NN	O	—	dep	5	SENT_306	[p13l329t1399r909b1453],
10	7	CD	NUMBER	7	dep	9	SENT_306	[p13l329t1399r909b1453],
11	.	.	O	.	_	0	SENT_306	[p13l329t1399r909b1453],

1	[	RB	O	[	advmod	2	SENT_307	[p13l6t1465r103b1519],
2	15	CD	NUMBER	15	_	0	SENT_307	[p13l6t1465r103b1519],
3	]	CD	NUMBER	]	num	5	SENT_307	[p13l6t1465r103b1519],
4	Yu	NN	PERSON	yu	nn	5	SENT_307	[p13l136t1468r203b1508],
5	D	NN	PERSON	d	dep	2	SENT_307	[p13l220t1468r269b1515],
6	,	,	O	,	_	0	SENT_307	[p13l220t1468r269b1515],
7	Zhang	NNP	PERSON	Zhang	nn	8	SENT_307	[p13l287t1465r445b1519],
8	X	NNP	PERSON	X	appos	5	SENT_307	[p13l459t1468r508b1515],
9	,	,	O	,	_	0	SENT_307	[p13l459t1468r508b1515],
10	Liu	NNP	PERSON	Liu	nn	11	SENT_307	[p13l526t1465r601b1508],
11	J	NNP	PERSON	J	appos	5	SENT_307	[p13l612t1468r645b1519],
12	,	,	O	,	_	0	SENT_307	[p13l612t1468r645b1519],
13	Yuan	NNP	O	Yuan	nn	14	SENT_307	[p13l661t1468r792b1508],
14	P	NN	O	p	appos	5	SENT_307	[p13l809t1468r849b1515],
15	,	,	O	,	_	0	SENT_307	[p13l809t1468r849b1515],
16	Tan	NNP	O	Tan	nn	17	SENT_307	[p13l865t1468r959b1508],
17	W	NNP	O	W	appos	5	SENT_307	[p13l973t1468r1043b1515],
18	,	,	O	,	_	0	SENT_307	[p13l973t1468r1043b1515],
19	Guo	NNP	O	Guo	nn	20	SENT_307	[p13l1062t1467r1163b1508],
20	Y	NN	O	y	appos	5	SENT_307	[p13l1179t1468r1224b1515],
21	,	,	O	,	_	0	SENT_307	[p13l1179t1468r1224b1515],
22	et	FW	O	et	nn	23	SENT_307	[p13l1242t1471r1291b1508],
23	al.	FW	O	al.	appos	5	SENT_307	[p13l1307t1465r1362b1509],
24	.	.	O	.	_	0	SENT_307	[p13l1307t1465r1362b1509],

1	Characterization	NN	O	characterization	_	0	SENT_308	[p13l1380t1465r1806b1508],
2	of	IN	O	of	_	0	SENT_308	[p13l1823t1465r1876b1508],
3	functional	JJ	O	functional	amod	9	SENT_308	[p13l1888t1465r2147b1508],
4	excision	NN	O	excision	nn	9	SENT_308	[p13l138t1532r348b1575],
5	repair	NN	O	repair	nn	9	SENT_308	[p13l366t1532r520b1586],
6	cross-complementation	NN	O	cross-complementation	nn	9	SENT_308	[p13l537t1531r1152b1586],
7	group	NN	O	group	nn	9	SENT_308	[p13l1169t1544r1319b1586],
8	1	CD	NUMBER	1	num	9	SENT_308	[p13l1341t1534r1361b1574],
9	variants	NNS	O	variant	prep_of	1	SENT_308	[p13l1384t1532r1591b1575],
10	and	CC	O	and	_	0	SENT_308	[p13l1610t1531r1703b1575],
11	their	PRP$	O	they	poss	12	SENT_308	[p13l1722t1531r1845b1575],
12	association	NN	O	association	prep_of	1	SENT_308	[p13l1862t1532r2148b1575],
13	with	IN	O	with	_	0	SENT_308	[p13l137t1597r255b1640],
14	lung	NN	O	lung	nn	16	SENT_308	[p13l273t1597r385b1651],
15	cancer	NN	O	cancer	nn	16	SENT_308	[p13l402t1609r571b1640],
16	risk	NN	O	risk	prep_with	1	SENT_308	[p13l587t1597r681b1640],
17	and	CC	O	and	_	0	SENT_308	[p13l698t1597r790b1640],
18	prognosis	NN	O	prognosis	prep_with	1	SENT_308	[p13l809t1597r1070b1651],
19	.	.	O	.	_	0	SENT_308	[p13l809t1597r1070b1651],

1	Clin	NNP	ORGANIZATION	Clin	nn	3	SENT_309	[p13l1089t1597r1188b1640],
2	Cancer	NNP	ORGANIZATION	Cancer	nn	3	SENT_309	[p13l1206t1599r1381b1640],
3	Res	NNP	ORGANIZATION	Res	_	0	SENT_309	[p13l1397t1599r1482b1640],
4	2008	CD	DATE	2008	num	3	SENT_309	[p13l1501t1597r2048b1651],
5	;	:	O	;	_	0	SENT_309	[p13l1501t1597r2048b1651],
6	14	CD	NUMBER	14	number	7	SENT_309	[p13l1501t1597r2048b1651],
7	(	CD	NUMBER	(	dep	3	SENT_309	[p13l1501t1597r2048b1651],
8	9	CD	NUMBER	9	num	9	SENT_309	[p13l1501t1597r2048b1651],
9	)	NN	O	)	dep	7	SENT_309	[p13l1501t1597r2048b1651],
10	:2878	CD	NUMBER	:2878	number	11	SENT_309	[p13l1501t1597r2048b1651],
11	—	CD	NUMBER	—	dep	7	SENT_309	[p13l1501t1597r2048b1651],
12	86	CD	NUMBER	86	dep	11	SENT_309	[p13l1501t1597r2048b1651],
13	.	.	O	.	_	0	SENT_309	[p13l1501t1597r2048b1651],

1	[	RB	O	[	dep	5	SENT_310	[p13l6t1663r103b1718],
2	16	CD	NUMBER	16	num	5	SENT_310	[p13l6t1663r103b1718],
3	]	CD	NUMBER	]	num	5	SENT_310	[p13l6t1663r103b1718],
4	Lee	NNP	PERSON	Lee	nn	5	SENT_310	[p13l138t1666r221b1707],
5	W	NNP	PERSON	W	_	0	SENT_310	[p13l251t1666r321b1713],
6	,	,	O	,	_	0	SENT_310	[p13l251t1666r321b1713],
7	Lockhart	NNP	ORGANIZATION	Lockhart	nn	8	SENT_310	[p13l354t1663r577b1707],
8	AC	NN	ORGANIZATION	ac	appos	5	SENT_310	[p13l606t1665r688b1713],
9	,	,	O	,	_	0	SENT_310	[p13l606t1665r688b1713],
10	Kim	NNP	PERSON	Kim	nn	11	SENT_310	[p13l721t1664r823b1706],
11	RB	NN	O	rb	appos	5	SENT_310	[p13l855t1666r932b1713],
12	,	,	O	,	_	0	SENT_310	[p13l855t1666r932b1713],
13	Rothenberg	NNP	PERSON	Rothenberg	nn	14	SENT_310	[p13l965t1663r1264b1718],
14	ML	NNP	O	ML	appos	11	SENT_310	[p13l1295t1666r1385b1707],
15	.	.	O	.	_	0	SENT_310	[p13l1295t1666r1385b1707],

1	Cancer	NN	O	cancer	nn	2	SENT_311	[p13l1417t1665r1592b1707],
2	pharmacogenomics	NNS	O	pharmacogenomic	_	0	SENT_311	[p13l1623t1663r2144b1718],
3	:	:	O	:	_	0	SENT_311	[p13l1623t1663r2144b1718],
4	powerful	JJ	O	powerful	amod	5	SENT_311	[p13l138t1729r370b1783],
5	tools	NNS	O	tool	dep	2	SENT_311	[p13l399t1729r522b1772],
6	in	IN	O	in	_	0	SENT_311	[p13l552t1729r599b1772],
7	cancer	NN	O	cancer	nn	8	SENT_311	[p13l628t1741r796b1772],
8	chemotherapy	NN	O	chemotherapy	prep_in	5	SENT_311	[p13l823t1729r1198b1783],
9	and	CC	O	and	_	0	SENT_311	[p13l1225t1729r1318b1772],
10	drug	NN	O	drug	nn	11	SENT_311	[p13l1347t1729r1466b1783],
11	development	NN	O	development	conj_and	8	SENT_311	[p13l1493t1729r1846b1783],
12	.	.	O	.	_	0	SENT_311	[p13l1493t1729r1846b1783],

1	Oncologist	NN	O	oncologist	_	0	SENT_312	[p13l1875t1729r2149b1783],
2	2005	CD	DATE	2005	num	1	SENT_312	[p13l138t1795r652b1849],
3	;	:	O	;	_	0	SENT_312	[p13l138t1795r652b1849],
4	10	CD	NUMBER	10	num	5	SENT_312	[p13l138t1795r652b1849],
5	(	NN	O	(	dep	1	SENT_312	[p13l138t1795r652b1849],
6	2	CD	NUMBER	2	number	7	SENT_312	[p13l138t1795r652b1849],
7	)	CD	NUMBER	)	dep	5	SENT_312	[p13l138t1795r652b1849],
8	:104	CD	NUMBER	:104	num	9	SENT_312	[p13l138t1795r652b1849],
9	—	NN	O	—	dep	7	SENT_312	[p13l138t1795r652b1849],
10	11	CD	NUMBER	11	dep	7	SENT_312	[p13l138t1795r652b1849],
11	.	.	O	.	_	0	SENT_312	[p13l138t1795r652b1849],

1	[	NN	O	[	_	0	SENT_313	[p13l6t1860r103b1915],
2	17	CD	NUMBER	17	num	1	SENT_313	[p13l6t1860r103b1915],
3	]	CD	NUMBER	]	num	5	SENT_313	[p13l6t1860r103b1915],
4	Therasse	NN	O	therasse	nn	5	SENT_313	[p13l136t1860r362b1904],
5	P	NN	O	p	dep	1	SENT_313	[p13l377t1863r417b1911],
6	,	,	O	,	_	0	SENT_313	[p13l377t1863r417b1911],
7	Arbuck	NNP	ORGANIZATION	Arbuck	nn	8	SENT_313	[p13l431t1860r617b1904],
8	SG	NNP	ORGANIZATION	SG	appos	5	SENT_313	[p13l631t1863r708b1911],
9	,	,	O	,	_	0	SENT_313	[p13l631t1863r708b1911],
10	Eisenhauer	NNP	PERSON	Eisenhauer	nn	11	SENT_313	[p13l725t1861r1011b1904],
11	EA	NN	PERSON	ea	appos	5	SENT_313	[p13l1025t1862r1102b1911],
12	,	,	O	,	_	0	SENT_313	[p13l1025t1862r1102b1911],
13	Wanders	NNP	O	Wanders	nn	14	SENT_313	[p13l1116t1860r1347b1904],
14	J	NNP	O	J	appos	5	SENT_313	[p13l1357t1863r1389b1915],
15	,	,	O	,	_	0	SENT_313	[p13l1357t1863r1389b1915],
16	Kaplan	NNP	PERSON	Kaplan	nn	17	SENT_313	[p13l1406t1860r1582b1915],
17	RS	NN	O	r	appos	5	SENT_313	[p13l1597t1863r1670b1911],
18	,	,	O	,	_	0	SENT_313	[p13l1597t1863r1670b1911],
19	Rubinstein	NN	PERSON	rubinstein	nn	20	SENT_313	[p13l1687t1860r1962b1904],
20	L	NN	O	l	appos	5	SENT_313	[p13l1978t1863r2014b1911],
21	,	,	O	,	_	0	SENT_313	[p13l1978t1863r2014b1911],
22	et	FW	O	et	nn	23	SENT_313	[p13l2030t1867r2078b1904],
23	al.	FW	O	al.	appos	5	SENT_313	[p13l2092t1861r2147b1904],
24	.	.	O	.	_	0	SENT_313	[p13l2092t1861r2147b1904],

1	New	NNP	O	New	nn	2	SENT_314	[p13l138t1930r255b1970],
2	guidelines	NNS	O	guideline	nsubj	4	SENT_314	[p13l265t1927r529b1981],
3	to	TO	O	to	aux	4	SENT_314	[p13l542t1933r592b1970],
4	evaluate	VB	O	evaluate	_	0	SENT_314	[p13l605t1927r821b1970],
5	the	DT	O	the	det	6	SENT_314	[p13l833t1927r915b1970],
6	response	NN	O	response	dobj	4	SENT_314	[p13l928t1939r1156b1981],
7	to	TO	O	to	_	0	SENT_314	[p13l1169t1933r1218b1970],
8	treatment	NN	O	treatment	prep_to	4	SENT_314	[p13l1230t1933r1490b1970],
9	in	IN	O	in	_	0	SENT_314	[p13l1501t1928r1548b1970],
10	solid	JJ	O	solid	amod	11	SENT_314	[p13l1561t1927r1681b1970],
11	tumors	NNS	O	tumor	prep_in	8	SENT_314	[p13l1693t1933r1890b1971],
12	.	.	O	.	_	0	SENT_314	[p13l1693t1933r1890b1971],

1	European	JJ	ORGANIZATION	european	amod	2	SENT_315	[p13l1904t1930r2148b1981],
2	Organization	NNP	ORGANIZATION	Organization	_	0	SENT_315	[p13l138t1994r471b2048],
3	for	IN	ORGANIZATION	for	_	0	SENT_315	[p13l490t1993r561b2037],
4	Research	NNP	ORGANIZATION	Research	prep_for	2	SENT_315	[p13l580t1993r809b2037],
5	and	CC	ORGANIZATION	and	_	0	SENT_315	[p13l828t1993r921b2037],
6	Treatment	NN	ORGANIZATION	treatment	conj_and	4	SENT_315	[p13l939t1996r1210b2037],
7	of	IN	ORGANIZATION	of	_	0	SENT_315	[p13l1228t1993r1282b2037],
8	Cancer	NN	ORGANIZATION	cancer	prep_of	6	SENT_315	[p13l1295t1995r1481b2043],
9	,	,	O	,	_	0	SENT_315	[p13l1295t1995r1481b2043],
10	National	NNP	ORGANIZATION	National	nn	12	SENT_315	[p13l1501t1993r1718b2037],
11	Cancer	NNP	ORGANIZATION	Cancer	nn	12	SENT_315	[p13l1738t1996r1913b2037],
12	Institute	NNP	ORGANIZATION	Institute	appos	2	SENT_315	[p13l1931t1994r2147b2037],
13	of	IN	O	of	_	0	SENT_315	[p13l138t2058r191b2102],
14	the	DT	O	the	det	16	SENT_315	[p13l210t2059r291b2102],
15	United	NNP	LOCATION	United	nn	16	SENT_315	[p13l316t2059r488b2102],
16	States	NNPS	LOCATION	States	prep_of	12	SENT_315	[p13l514t2061r679b2109],
17	,	,	O	,	_	0	SENT_315	[p13l514t2061r679b2109],
18	National	NNP	ORGANIZATION	National	nn	20	SENT_315	[p13l705t2059r922b2102],
19	Cancer	NNP	ORGANIZATION	Cancer	nn	20	SENT_315	[p13l948t2061r1123b2102],
20	Institute	NNP	ORGANIZATION	Institute	appos	2	SENT_315	[p13l1147t2059r1363b2102],
21	of	IN	ORGANIZATION	of	_	0	SENT_315	[p13l1389t2059r1442b2102],
22	Canada	NNP	ORGANIZATION	Canada	prep_of	20	SENT_315	[p13l1461t2059r1699b2113],
23	.	.	O	.	_	0	SENT_315	[p13l1461t2059r1699b2113],

1	J	NNP	O	J	nn	4	SENT_316	[p13l1461t2059r1699b2113],
2	Natl	NNP	O	Natl	nn	4	SENT_316	[p13l1725t2059r1829b2102],
3	Cancer	NNP	O	Cancer	nn	4	SENT_316	[p13l1855t2061r2030b2102],
4	Inst	NNP	O	Inst	_	0	SENT_316	[p13l2054t2061r2149b2102],
5	2000	CD	DATE	2000	num	4	SENT_316	[p13l138t2125r652b2179],
6	;	:	O	;	_	0	SENT_316	[p13l138t2125r652b2179],
7	92	CD	NUMBER	92	number	8	SENT_316	[p13l138t2125r652b2179],
8	(	CD	NUMBER	(	dep	4	SENT_316	[p13l138t2125r652b2179],
9	3	CD	NUMBER	3	num	10	SENT_316	[p13l138t2125r652b2179],
10	)	NN	O	)	dep	8	SENT_316	[p13l138t2125r652b2179],
11	:205	CD	NUMBER	:205	number	12	SENT_316	[p13l138t2125r652b2179],
12	—	CD	NUMBER	—	dep	8	SENT_316	[p13l138t2125r652b2179],
13	16	CD	NUMBER	16	dep	12	SENT_316	[p13l138t2125r652b2179],
14	.	.	O	.	_	0	SENT_316	[p13l138t2125r652b2179],

1	[	NN	O	[	_	0	SENT_317	[p13l6t2190r103b2245],
2	18	CD	NUMBER	18	num	1	SENT_317	[p13l6t2190r103b2245],
3	]	CD	NUMBER	]	num	5	SENT_317	[p13l6t2190r103b2245],
4	Stephens	NNP	PERSON	Stephens	nn	5	SENT_317	[p13l138t2190r371b2245],
5	M	NN	PERSON	m	dep	1	SENT_317	[p13l408t2193r469b2241],
6	,	,	O	,	_	0	SENT_317	[p13l408t2193r469b2241],
7	Smith	NNP	ORGANIZATION	Smith	nn	8	SENT_317	[p13l507t2191r657b2234],
8	NJ	NNP	ORGANIZATION	NJ	appos	5	SENT_317	[p13l693t2193r761b2245],
9	,	,	O	,	_	0	SENT_317	[p13l693t2193r761b2245],
10	Donnelly	NNP	PERSON	Donnelly	nn	12	SENT_317	[p13l798t2190r1031b2245],
11	P.	NNP	O	P.	nn	12	SENT_317	[p13l1066t2193r1106b2234],
12	A	NNP	O	A	appos	5	SENT_317	[p13l1141t2192r1179b2234],
13	new	JJ	O	new	amod	15	SENT_317	[p13l1214t2203r1323b2234],
14	statistical	JJ	O	statistical	amod	15	SENT_317	[p13l1359t2190r1603b2234],
15	method	NN	O	method	dep	1	SENT_317	[p13l1641t2190r1839b2234],
16	for	IN	O	for	_	0	SENT_317	[p13l1876t2190r1948b2234],
17	haplotype	NN	O	haplotype	nn	18	SENT_317	[p13l1983t2190r2147b2245, p13l137t2263r249b2311],
18	reconstruction	NN	O	reconstruction	prep_for	15	SENT_317	[p13l285t2258r662b2300],
19	from	IN	O	from	_	0	SENT_317	[p13l697t2257r819b2300],
20	population	NN	O	population	nn	21	SENT_317	[p13l854t2257r1134b2311],
21	data	NNS	O	datum	prep_from	18	SENT_317	[p13l1169t2257r1291b2301],
22	.	.	O	.	_	0	SENT_317	[p13l1169t2257r1291b2301],

1	Am	VBP	O	be	dep	4	SENT_318	[p13l1324t2259r1413b2300],
2	J	NN	O	j	nn	4	SENT_318	[p13l1441t2260r1461b2311],
3	Hum	NNP	O	Hum	nn	4	SENT_318	[p13l1497t2260r1621b2300],
4	Genet	NNP	O	Genet	_	0	SENT_318	[p13l1656t2259r1808b2300],
5	2001	CD	DATE	2001	num	4	SENT_318	[p13l1841t2259r1962b2300],
6	;	:	O	;	_	0	SENT_318	[p13l1976t2257r2144b2311],
7	68	CD	NUMBER	68	num	8	SENT_318	[p13l1976t2257r2144b2311],
8	(	CD	NUMBER	(	dep	4	SENT_318	[p13l1976t2257r2144b2311],
9	4	CD	NUMBER	4	num	10	SENT_318	[p13l1976t2257r2144b2311],
10	)	NN	O	)	dep	8	SENT_318	[p13l1976t2257r2144b2311],
11	:	:	O	:	_	0	SENT_318	[p13l1976t2257r2144b2311],
12	978-89	CD	NUMBER	978-89	dep	8	SENT_318	[p13l138t2326r342b2368],
13	.	.	O	.	_	0	SENT_318	[p13l138t2326r342b2368],

1	[	NN	O	[	_	0	SENT_319	[p13l6t2389r103b2444],
2	19	CD	NUMBER	19	num	1	SENT_319	[p13l6t2389r103b2444],
3	]	CD	NUMBER	]	num	5	SENT_319	[p13l6t2389r103b2444],
4	Stephens	NNP	PERSON	Stephens	nn	5	SENT_319	[p13l138t2390r371b2444],
5	M	NN	O	m	dep	1	SENT_319	[p13l415t2392r476b2440],
6	,	,	O	,	_	0	SENT_319	[p13l415t2392r476b2440],
7	Scheet	NNP	O	Scheet	nn	9	SENT_319	[p13l520t2390r689b2433],
8	P.	NNP	O	P.	nn	9	SENT_319	[p13l731t2392r771b2434],
9	Accounting	NNP	O	Accounting	dep	1	SENT_319	[p13l812t2390r1107b2444],
10	for	IN	O	for	_	0	SENT_319	[p13l1148t2389r1220b2433],
11	decay	NN	O	decay	prep_for	9	SENT_319	[p13l1262t2390r1409b2444],
12	of	IN	O	of	_	0	SENT_319	[p13l1451t2389r1504b2433],
13	linkage	NN	O	linkage	nn	14	SENT_319	[p13l1542t2390r1726b2444],
14	disequilibrium	NN	O	disequilibrium	prep_of	11	SENT_319	[p13l1770t2390r2148b2444],
15	in	IN	O	in	_	0	SENT_319	[p13l138t2457r185b2499],
16	haplotype	NN	O	haplotype	nn	17	SENT_319	[p13l226t2456r483b2511],
17	inference	NN	O	inference	prep_in	14	SENT_319	[p13l524t2456r762b2500],
18	and	CC	O	and	_	0	SENT_319	[p13l803t2456r896b2500],
19	missing-data	JJ	O	missing-data	amod	20	SENT_319	[p13l937t2456r1271b2511],
20	imputation	NN	O	imputation	conj_and	5	SENT_319	[p13l1311t2457r1611b2511],
21	.	.	O	.	_	0	SENT_319	[p13l1311t2457r1611b2511],

1	Am	VBP	O	be	dep	2	SENT_320	[p13l1650t2458r1738b2499],
2	J	NN	O	j	_	0	SENT_320	[p13l1772t2459r1792b2511],
3	Hum	NNP	O	Hum	nn	4	SENT_320	[p13l1833t2459r1957b2500],
4	Genet	NNP	O	Genet	dep	2	SENT_320	[p13l1997t2458r2149b2500],
5	2005	CD	DATE	2005	dep	4	SENT_320	[p13l138t2522r652b2576],
6	;	:	O	;	_	0	SENT_320	[p13l138t2522r652b2576],
7	76	CD	NUMBER	76	number	8	SENT_320	[p13l138t2522r652b2576],
8	(	CD	NUMBER	(	dep	5	SENT_320	[p13l138t2522r652b2576],
9	3	CD	NUMBER	3	num	10	SENT_320	[p13l138t2522r652b2576],
10	)	NN	O	)	dep	12	SENT_320	[p13l138t2522r652b2576],
11	:449	CD	NUMBER	:449	dep	10	SENT_320	[p13l138t2522r652b2576],
12	—	CD	NUMBER	—	dep	5	SENT_320	[p13l138t2522r652b2576],
13	62	CD	NUMBER	62	dep	12	SENT_320	[p13l138t2522r652b2576],
14	.	.	O	.	_	0	SENT_320	[p13l138t2522r652b2576],

1	[	RB	O	[	advmod	6	SENT_321	[p13l6t2588r103b2642],
2	20	CD	NUMBER	20	num	6	SENT_321	[p13l6t2588r103b2642],
3	]	CD	NUMBER	]	num	6	SENT_321	[p13l6t2588r103b2642],
4	Carpenter	NNP	MISC	Carpenter	nn	6	SENT_321	[p13l138t2590r394b2642],
5	D.	NNP	MISC	D.	nn	6	SENT_321	[p13l408t2591r457b2632],
6	Reputation	NNP	MISC	Reputation	_	0	SENT_321	[p13l474t2589r757b2642],
7	and	CC	O	and	_	0	SENT_321	[p13l773t2588r866b2632],
8	power	NN	O	power	conj_and	6	SENT_321	[p13l882t2601r1061b2642],
9	:	:	O	:	_	0	SENT_321	[p13l882t2601r1061b2642],
10	organizational	JJ	O	organizational	amod	11	SENT_321	[p13l1081t2588r1451b2642],
11	image	NN	O	image	dep	6	SENT_321	[p13l1468t2589r1622b2642],
12	and	CC	O	and	_	0	SENT_321	[p13l1639t2588r1731b2632],
13	pharmaceutical	JJ	O	pharmaceutical	amod	14	SENT_321	[p13l1748t2588r2147b2642],
14	regulation	NN	O	regulation	conj_and	11	SENT_321	[p13l138t2654r402b2708],
15	at	IN	O	at	_	0	SENT_321	[p13l420t2660r467b2697],
16	the	DT	O	the	det	17	SENT_321	[p13l484t2653r565b2697],
17	FDA	NNP	ORGANIZATION	FDA	prep_at	11	SENT_321	[p13l583t2655r698b2697],
18	.	.	O	.	_	0	SENT_321	[p13l583t2655r698b2697],

1	Princeton	NNP	LOCATION	Princeton	_	0	SENT_322	[p13l717t2654r979b2697],
2	:	:	O	:	_	0	SENT_322	[p13l717t2654r979b2697],
3	Princeton	NNP	ORGANIZATION	Princeton	nn	5	SENT_322	[p13l1001t2654r1248b2697],
4	University	NNP	ORGANIZATION	University	nn	5	SENT_322	[p13l1265t2654r1532b2708],
5	Press	NNP	ORGANIZATION	Press	dep	1	SENT_322	[p13l1549t2656r1696b2704],
6	;	:	O	;	_	0	SENT_322	[p13l1549t2656r1696b2704],
7	2010	CD	DATE	2010	dep	5	SENT_322	[p13l1718t2656r1857b2697],
8	.	.	O	.	_	0	SENT_322	[p13l1718t2656r1857b2697],

1	[	NN	O	[	_	0	SENT_323	[p13l6t2720r103b2774],
2	21	CD	NUMBER	21	num	1	SENT_323	[p13l6t2720r103b2774],
3	]	CD	NUMBER	]	num	5	SENT_323	[p13l6t2720r103b2774],
4	Li	NNP	PERSON	Li	nn	5	SENT_323	[p13l138t2721r178b2763],
5	Y	NN	PERSON	y	dep	1	SENT_323	[p13l192t2723r238b2770],
6	,	,	O	,	_	0	SENT_323	[p13l192t2723r238b2770],
7	Womer	NNP	PERSON	Womer	nn	8	SENT_323	[p13l251t2723r448b2763],
8	RB	NN	O	rb	appos	5	SENT_323	[p13l462t2723r539b2770],
9	,	,	O	,	_	0	SENT_323	[p13l462t2723r539b2770],
10	SilberJH	NN	O	silberjh	appos	5	SENT_323	[p13l555t2720r784b2774],
11	.	.	O	.	_	0	SENT_323	[p13l555t2720r784b2774],

1	Predicting	VBG	O	predict	_	0	SENT_324	[p13l800t2720r1062b2774],
2	cisplatin	NN	O	cisplatin	nn	3	SENT_324	[p13l1076t2720r1294b2774],
3	ototoxicity	NN	O	ototoxicity	dobj	1	SENT_324	[p13l1309t2721r1589b2774],
4	in	IN	O	in	_	0	SENT_324	[p13l1603t2721r1650b2763],
5	children	NNS	O	child	prep_in	1	SENT_324	[p13l1665t2720r1893b2764],
6	:	:	O	:	_	0	SENT_324	[p13l1665t2720r1893b2764],
7	the	DT	O	the	det	8	SENT_324	[p13l1912t2720r1993b2763],
8	inﬂuence	NN	O	inﬂuence	dep	5	SENT_324	[p13l2009t2720r2147b2763, p13l138t2799r254b2830],

1	of	IN	O	of	_	0	SENT_325	[p13l273t2786r326b2830],
2	age	NN	O	age	pobj	1	SENT_325	[p13l337t2799r423b2841],
3	and	CC	O	and	_	0	SENT_325	[p13l441t2786r534b2830],
4	the	DT	O	the	det	6	SENT_325	[p13l552t2786r633b2830],
5	cumulative	JJ	O	cumulative	amod	6	SENT_325	[p13l652t2786r939b2830],
6	dose	NN	O	dose	conj_and	2	SENT_325	[p13l957t2786r1086b2830],
7	.	.	O	.	_	0	SENT_325	[p13l957t2786r1086b2830],

1	EurJ	NN	O	eurj	nn	2	SENT_326	[p13l1105t2789r1222b2841],
2	Cancer	NN	O	cancer	_	0	SENT_326	[p13l1240t2788r1415b2830],
3	2004	CD	DATE	2004	dep	2	SENT_326	[p13l1431t2786r2011b2840],
4	;	:	O	;	_	0	SENT_326	[p13l1431t2786r2011b2840],
5	40	CD	NUMBER	40	number	6	SENT_326	[p13l1431t2786r2011b2840],
6	(	CD	NUMBER	(	dep	3	SENT_326	[p13l1431t2786r2011b2840],
7	16	CD	NUMBER	16	num	8	SENT_326	[p13l1431t2786r2011b2840],
8	)	NN	O	)	dep	6	SENT_326	[p13l1431t2786r2011b2840],
9	:2445	CD	NUMBER	:2445	number	10	SENT_326	[p13l1431t2786r2011b2840],
10	—	CD	NUMBER	—	dep	2	SENT_326	[p13l1431t2786r2011b2840],
11	51	CD	NUMBER	51	dep	10	SENT_326	[p13l1431t2786r2011b2840],
12	.	.	O	.	_	0	SENT_326	[p13l1431t2786r2011b2840],

1	[	NN	O	[	_	0	SENT_327	[p13l6t2851r103b2906],
2	22	CD	NUMBER	22	number	3	SENT_327	[p13l6t2851r103b2906],
3	]	CD	NUMBER	]	dep	1	SENT_327	[p13l6t2851r103b2906],
4	McKeage	NNP	O	McKeage	nn	5	SENT_327	[p13l138t2854r369b2906],
5	MJ	NNP	O	MJ	dep	3	SENT_327	[p13l390t2854r469b2906],
6	.	.	O	.	_	0	SENT_327	[p13l390t2854r469b2906],

1	Comparative	JJ	O	comparative	amod	4	SENT_328	[p13l490t2852r818b2906],
2	adverse	JJ	O	adverse	amod	4	SENT_328	[p13l839t2852r1036b2895],
3	effect	NN	O	effect	nn	4	SENT_328	[p13l1057t2851r1199b2895],
4	proﬁles	NNS	O	proﬁles	_	0	SENT_328	[p13l1218t2851r1409b2906],
5	of	IN	O	of	_	0	SENT_328	[p13l1430t2852r1484b2895],
6	platinum	NN	O	platinum	nn	7	SENT_328	[p13l1498t2852r1733b2906],
7	drugs	NNS	O	drug	prep_of	4	SENT_328	[p13l1753t2852r1908b2906],
8	.	.	O	.	_	0	SENT_328	[p13l1753t2852r1908b2906],

1	Drug	NN	O	drug	nn	2	SENT_329	[p13l1930t2854r2055b2906],
2	Saf	NN	O	saf	_	0	SENT_329	[p13l2074t2851r2154b2895],

1	[	NN	O	[	nn	6	SENT_330	[p13l6t2983r103b3038],
2	23	CD	NUMBER	23	num	6	SENT_330	[p13l6t2983r103b3038],
3	]	CD	NUMBER	]	num	6	SENT_330	[p13l6t2983r103b3038],
4	Kelland	NNP	PERSON	Kelland	nn	6	SENT_330	[p13l138t2983r331b3027],
5	L.	NNP	O	L.	nn	6	SENT_330	[p13l355t2986r392b3027],
6	The	NNP	O	The	_	0	SENT_330	[p13l415t2983r508b3027],
7	resurgence	NN	O	resurgence	dep	6	SENT_330	[p13l533t2996r815b3038],
8	of	IN	O	of	_	0	SENT_330	[p13l839t2983r892b3027],
9	platinum-based	JJ	O	platinum-based	amod	11	SENT_330	[p13l910t2983r1318b3038],
10	cancer	NN	O	cancer	nn	11	SENT_330	[p13l1343t2996r1511b3027],
11	chemotherapy	NN	O	chemotherapy	prep_of	7	SENT_330	[p13l1534t2983r1919b3038],
12	.	.	O	.	_	0	SENT_330	[p13l1534t2983r1919b3038],

1	Nat	NNP	PERSON	Nat	_	0	SENT_331	[p13l1944t2986r2034b3027],
2	Rev	NN	PERSON	rev	dep	1	SENT_331	[p13l2057t2986r2149b3027],

1	Cancer	NN	O	cancer	_	0	SENT_332	[p13l138t3052r313b3093],
2	2007	CD	DATE	2007	num	1	SENT_332	[p13l329t3050r811b3104],
3	;	:	O	;	_	0	SENT_332	[p13l329t3050r811b3104],
4	7	CD	NUMBER	7	number	5	SENT_332	[p13l329t3050r811b3104],
5	(	CD	NUMBER	(	dep	1	SENT_332	[p13l329t3050r811b3104],
6	8	CD	NUMBER	8	num	7	SENT_332	[p13l329t3050r811b3104],
7	)	NN	O	)	dep	5	SENT_332	[p13l329t3050r811b3104],
8	:573	CD	NUMBER	:573	number	9	SENT_332	[p13l329t3050r811b3104],
9	—	CD	NUMBER	—	dep	5	SENT_332	[p13l329t3050r811b3104],
10	84	CD	NUMBER	84	dep	9	SENT_332	[p13l329t3050r811b3104],
11	.	.	O	.	_	0	SENT_332	[p13l329t3050r811b3104],

1	[	NN	O	[	_	0	SENT_333	[p13l6t3116r103b3171],
2	24	CD	NUMBER	24	num	1	SENT_333	[p13l6t3116r103b3171],
3	]	CD	NUMBER	]	num	5	SENT_333	[p13l6t3116r103b3171],
4	Garmann	NN	PERSON	garmann	nn	5	SENT_333	[p13l138t3118r376b3160],
5	D	NN	PERSON	d	dep	1	SENT_333	[p13l393t3119r442b3166],
6	,	,	O	,	_	0	SENT_333	[p13l393t3119r442b3166],
7	Warnecke	NNP	PERSON	Warnecke	nn	8	SENT_333	[p13l458t3116r719b3160],
8	A	NNP	O	A	conj_and	5	SENT_333	[p13l734t3118r783b3166],
9	,	,	O	,	_	0	SENT_333	[p13l734t3118r783b3166],
10	Kalayda	NNP	O	Kalayda	nn	11	SENT_333	[p13l801t3116r1003b3171],
11	GV	NNP	O	GV	conj_and	5	SENT_333	[p13l1020t3118r1105b3166],
12	,	,	O	,	_	0	SENT_333	[p13l1020t3118r1105b3166],
13	Kratz	NNP	PERSON	Kratz	nn	14	SENT_333	[p13l1123t3119r1257b3160],
14	F	NN	O	f	conj_and	5	SENT_333	[p13l1275t3119r1312b3166],
15	,	,	O	,	_	0	SENT_333	[p13l1275t3119r1312b3166],
16	Jaehde	NNP	O	Jaehde	nn	19	SENT_333	[p13l1323t3116r1499b3171],
17	U.	NNP	O	U.	nn	19	SENT_333	[p13l1516t3119r1566b3160],
18	Cellular	NNP	O	Cellular	nn	19	SENT_333	[p13l1584t3116r1782b3160],
19	accumulation	NN	O	accumulation	dep	1	SENT_333	[p13l1797t3116r2148b3160],
20	and	CC	O	and	_	0	SENT_333	[p13l138t3182r231b3225],
21	cytotoxicity	NN	O	cytotoxicity	dep	1	SENT_333	[p13l248t3183r555b3236],
22	of	IN	O	of	_	0	SENT_333	[p13l570t3182r624b3225],
23	macromolecular	JJ	O	macromolecular	amod	25	SENT_333	[p13l635t3182r1058b3225],
24	platinum	NN	O	platinum	nn	25	SENT_333	[p13l1074t3182r1308b3236],
25	complexes	NNS	O	complex	prep_of	1	SENT_333	[p13l1325t3182r1598b3236],
26	in	IN	O	in	_	0	SENT_333	[p13l1617t3183r1664b3225],
27	cisplatin-resistant	JJ	O	cisplatin-resistant	amod	29	SENT_333	[p13l1682t3182r2149b3236],
28	tumor	NN	O	tumor	nn	29	SENT_333	[p13l138t3255r298b3292],
29	cells	NNS	O	cell	prep_in	25	SENT_333	[p13l314t3248r471b3303],
30	.	.	O	.	_	0	SENT_333	[p13l314t3248r471b3303],

1	J	NNP	O	J	nn	3	SENT_334	[p13l314t3248r471b3303],
2	Control	NNP	O	Control	nn	3	SENT_334	[p13l489t3248r678b3292],
3	Release	NNP	O	Release	_	0	SENT_334	[p13l697t3248r888b3292],
4	2008	CD	DATE	2008	num	3	SENT_334	[p13l906t3248r1421b3302],
5	;	:	O	;	_	0	SENT_334	[p13l906t3248r1421b3302],
6	131	CD	NUMBER	131	num	7	SENT_334	[p13l906t3248r1421b3302],
7	(	NN	O	(	dep	3	SENT_334	[p13l906t3248r1421b3302],
8	2	CD	NUMBER	2	number	9	SENT_334	[p13l906t3248r1421b3302],
9	)	CD	NUMBER	)	dep	7	SENT_334	[p13l906t3248r1421b3302],
10	:100	CD	NUMBER	:100	num	11	SENT_334	[p13l906t3248r1421b3302],
11	—	NN	O	—	dep	9	SENT_334	[p13l906t3248r1421b3302],
12	6	CD	NUMBER	6	dep	9	SENT_334	[p13l906t3248r1421b3302],
13	.	.	O	.	_	0	SENT_334	[p13l906t3248r1421b3302],

1	[	NN	O	[	_	0	SENT_335	[p13l6t3313r103b3368],
2	25	CD	NUMBER	25	number	3	SENT_335	[p13l6t3313r103b3368],
3	]	CD	NUMBER	]	dep	1	SENT_335	[p13l6t3313r103b3368],
4	Stewart	NNP	O	Stewart	nn	5	SENT_335	[p13l138t3316r337b3357],
5	DJ	NNP	O	DJ	dep	3	SENT_335	[p13l363t3316r430b3368],
6	.	.	O	.	_	0	SENT_335	[p13l363t3316r430b3368],

1	Mechanisms	NNS	O	mechanism	_	0	SENT_336	[p13l458t3314r780b3357],
2	of	IN	O	of	_	0	SENT_336	[p13l807t3313r860b3357],
3	resistance	NN	O	resistance	prep_of	1	SENT_336	[p13l881t3314r1138b3357],
4	to	TO	O	to	_	0	SENT_336	[p13l1165t3320r1214b3357],
5	cisplatin	NN	O	cisplatin	prep_to	1	SENT_336	[p13l1241t3314r1459b3368],
6	and	CC	O	and	_	0	SENT_336	[p13l1486t3314r1579b3357],
7	carboplatin	NN	O	carboplatin	prep_to	1	SENT_336	[p13l1606t3314r1911b3368],
8	.	.	O	.	_	0	SENT_336	[p13l1606t3314r1911b3368],

1	Crit	NNP	O	Crit	_	0	SENT_337	[p13l1938t3314r2031b3357],
2	Rev	NN	O	rev	dep	1	SENT_337	[p13l2057t3316r2149b3357],

1	Oncol	NNP	O	Oncol	nn	2	SENT_338	[p13l138t3380r284b3424],
2	Hematol	NNP	O	Hematol	_	0	SENT_338	[p13l303t3380r522b3424],
3	2007	CD	DATE	2007	num	2	SENT_338	[p13l540t3380r1022b3434],
4	;	:	O	;	_	0	SENT_338	[p13l540t3380r1022b3434],
5	63	CD	NUMBER	63	num	6	SENT_338	[p13l540t3380r1022b3434],
6	(	NN	O	(	dep	2	SENT_338	[p13l540t3380r1022b3434],
7	1	CD	NUMBER	1	number	8	SENT_338	[p13l540t3380r1022b3434],
8	)	CD	NUMBER	)	dep	6	SENT_338	[p13l540t3380r1022b3434],
9	:12	CD	NUMBER	:12	num	10	SENT_338	[p13l540t3380r1022b3434],
10	—	NN	O	—	dep	8	SENT_338	[p13l540t3380r1022b3434],
11	31	CD	NUMBER	31	dep	8	SENT_338	[p13l540t3380r1022b3434],
12	.	.	O	.	_	0	SENT_338	[p13l540t3380r1022b3434],

1	[	NN	O	[	_	0	SENT_339	[p13l6t3445r103b3500],
2	26	CD	NUMBER	26	num	1	SENT_339	[p13l6t3445r103b3500],
3	]	CD	NUMBER	]	num	5	SENT_339	[p13l6t3445r103b3500],
4	Rybak	NNP	ORGANIZATION	Rybak	nn	5	SENT_339	[p13l138t3445r295b3500],
5	LP	NN	ORGANIZATION	lp	dep	1	SENT_339	[p13l307t3448r375b3496],
6	,	,	O	,	_	0	SENT_339	[p13l307t3448r375b3496],
7	Husain	NNP	PERSON	Husain	nn	8	SENT_339	[p13l389t3446r567b3489],
8	K	NNP	PERSON	K	appos	5	SENT_339	[p13l580t3448r625b3496],
9	,	,	O	,	_	0	SENT_339	[p13l580t3448r625b3496],
10	Morris	NNP	ORGANIZATION	Morris	nn	11	SENT_339	[p13l639t3446r808b3489],
11	C	NNP	ORGANIZATION	C	appos	5	SENT_339	[p13l822t3448r864b3496],
12	,	,	O	,	_	0	SENT_339	[p13l822t3448r864b3496],
13	Whitworth	NNP	PERSON	Whitworth	nn	14	SENT_339	[p13l876t3445r1165b3489],
14	C	NNP	O	C	appos	5	SENT_339	[p13l1178t3448r1220b3496],
15	,	,	O	,	_	0	SENT_339	[p13l1178t3448r1220b3496],
16	Somani	NNP	PERSON	Somani	nn	18	SENT_339	[p13l1234t3446r1424b3489],
17	S.	NNP	O	S.	nn	18	SENT_339	[p13l1438t3448r1476b3489],
18	Effect	NN	O	effect	appos	5	SENT_339	[p13l1491t3445r1635b3489],
19	of	IN	O	of	_	0	SENT_339	[p13l1647t3445r1700b3489],
20	protective	JJ	O	protective	amod	21	SENT_339	[p13l1707t3446r1968b3500],
21	agents	NNS	O	agent	prep_of	18	SENT_339	[p13l1981t3452r2147b3500],
22	against	IN	O	against	_	0	SENT_339	[p13l138t3512r322b3566],
23	cisplatin	NN	O	cisplatin	nn	24	SENT_339	[p13l338t3512r556b3566],
24	ototoxicity	NN	O	ototoxicity	prep_against	5	SENT_339	[p13l574t3513r865b3566],
25	.	.	O	.	_	0	SENT_339	[p13l574t3513r865b3566],

1	Am	VBP	O	be	dep	2	SENT_340	[p13l882t3514r1001b3566],
2	]	CD	NUMBER	]	_	0	SENT_340	[p13l882t3514r1001b3566],
3	Otol	JJ	O	otol	dep	2	SENT_340	[p13l1019t3512r1125b3555],
4	2000	CD	DATE	2000	dep	3	SENT_340	[p13l1143t3512r1658b3566],
5	;	:	O	;	_	0	SENT_340	[p13l1143t3512r1658b3566],
6	21	CD	NUMBER	21	number	7	SENT_340	[p13l1143t3512r1658b3566],
7	(	CD	NUMBER	(	dep	4	SENT_340	[p13l1143t3512r1658b3566],
8	4	CD	NUMBER	4	num	9	SENT_340	[p13l1143t3512r1658b3566],
9	)	NN	O	)	dep	11	SENT_340	[p13l1143t3512r1658b3566],
10	:513	CD	NUMBER	:513	dep	9	SENT_340	[p13l1143t3512r1658b3566],
11	—	CD	NUMBER	—	dep	4	SENT_340	[p13l1143t3512r1658b3566],
12	20	CD	NUMBER	20	dep	11	SENT_340	[p13l1143t3512r1658b3566],
13	.	.	O	.	_	0	SENT_340	[p13l1143t3512r1658b3566],

1	[	NN	O	[	nn	5	SENT_341	[p13l6t3578r103b3633],
2	27	CD	NUMBER	27	num	5	SENT_341	[p13l6t3578r103b3633],
3	]	CD	NUMBER	]	num	5	SENT_341	[p13l6t3578r103b3633],
4	Katano	NNP	PERSON	Katano	nn	5	SENT_341	[p13l138t3581r316b3622],
5	K	NNP	PERSON	K	_	0	SENT_341	[p13l330t3581r375b3628],
6	,	,	O	,	_	0	SENT_341	[p13l330t3581r375b3628],
7	Kondo	NNP	PERSON	Kondo	nn	8	SENT_341	[p13l389t3578r553b3622],
8	A	NNP	O	A	appos	5	SENT_341	[p13l564t3580r612b3628],
9	,	,	O	,	_	0	SENT_341	[p13l564t3580r612b3628],
10	Safaei	NNP	PERSON	Safaei	nn	11	SENT_341	[p13l626t3578r775b3622],
11	R	NNP	PERSON	R	appos	8	SENT_341	[p13l789t3581r832b3628],
12	,	,	O	,	_	0	SENT_341	[p13l789t3581r832b3628],
13	Holzer	NNP	PERSON	Holzer	nn	14	SENT_341	[p13l847t3578r1016b3622],
14	A	NNP	O	A	appos	8	SENT_341	[p13l1025t3580r1073b3629],
15	,	,	O	,	_	0	SENT_341	[p13l1025t3580r1073b3629],
16	Samimi	NNP	PERSON	Samimi	nn	17	SENT_341	[p13l1087t3579r1280b3622],
17	G	NNP	PERSON	G	appos	8	SENT_341	[p13l1294t3580r1342b3628],
18	,	,	O	,	_	0	SENT_341	[p13l1294t3580r1342b3628],
19	Mishima	NNP	LOCATION	Mishima	nn	20	SENT_341	[p13l1357t3578r1580b3622],
20	M	NNP	O	M	appos	8	SENT_341	[p13l1593t3581r1654b3628],
21	,	,	O	,	_	0	SENT_341	[p13l1593t3581r1654b3628],
22	et	FW	O	et	nn	23	SENT_341	[p13l1668t3585r1716b3622],
23	al.	FW	O	al.	appos	8	SENT_341	[p13l1728t3578r1783b3622],
24	.	.	O	.	_	0	SENT_341	[p13l1728t3578r1783b3622],

1	Acquisition	NN	O	acquisition	nsubjpass	7	SENT_342	[p13l1795t3579r2088b3633],
2	of	IN	O	of	_	0	SENT_342	[p13l2101t3578r2154b3622],
3	resistance	NN	O	resistance	prep_of	1	SENT_342	[p13l138t3644r395b3687],
4	to	TO	O	to	_	0	SENT_342	[p13l410t3650r460b3687],
5	cisplatin	NN	O	cisplatin	prep_to	3	SENT_342	[p13l475t3644r693b3698],
6	is	VBZ	O	be	auxpass	7	SENT_342	[p13l709t3644r746b3687],
7	accompanied	VBN	O	accompany	_	0	SENT_342	[p13l762t3644r1103b3698],
8	by	IN	O	by	_	0	SENT_342	[p13l1118t3644r1180b3698],
9	changes	NNS	O	change	agent	7	SENT_342	[p13l1194t3644r1399b3698],
10	in	IN	O	in	_	0	SENT_342	[p13l1416t3644r1463b3687],
11	the	DT	O	the	det	13	SENT_342	[p13l1478t3644r1559b3687],
12	cellular	JJ	O	cellular	amod	13	SENT_342	[p13l1575t3644r1767b3687],
13	pharmacology	NN	O	pharmacology	prep_in	9	SENT_342	[p13l1780t3644r2149b3698],
14	of	IN	O	of	_	0	SENT_342	[p13l138t3710r191b3754],
15	copper	NN	O	copper	prep_of	13	SENT_342	[p13l203t3723r391b3764],
16	.	.	O	.	_	0	SENT_342	[p13l203t3723r391b3764],

1	Cancer	NNP	O	Cancer	nn	2	SENT_343	[p13l410t3712r585b3754],
2	Res	NNP	O	Res	_	0	SENT_343	[p13l601t3713r686b3754],
3	2002	CD	DATE	2002	dep	2	SENT_343	[p13l705t3710r1285b3764],
4	;	:	O	;	_	0	SENT_343	[p13l705t3710r1285b3764],
5	62	CD	NUMBER	62	number	6	SENT_343	[p13l705t3710r1285b3764],
6	(	CD	NUMBER	(	dep	3	SENT_343	[p13l705t3710r1285b3764],
7	22	CD	NUMBER	22	num	8	SENT_343	[p13l705t3710r1285b3764],
8	)	NN	O	)	dep	6	SENT_343	[p13l705t3710r1285b3764],
9	:6559	CD	NUMBER	:6559	number	10	SENT_343	[p13l705t3710r1285b3764],
10	—	CD	NUMBER	—	dep	2	SENT_343	[p13l705t3710r1285b3764],
11	65	CD	NUMBER	65	dep	10	SENT_343	[p13l705t3710r1285b3764],
12	.	.	O	.	_	0	SENT_343	[p13l705t3710r1285b3764],

1	[	NN	O	[	nn	5	SENT_344	[p13l6t3775r103b3830],
2	28	CD	NUMBER	28	num	5	SENT_344	[p13l6t3775r103b3830],
3	]	CD	NUMBER	]	num	5	SENT_344	[p13l6t3775r103b3830],
4	Lee	NNP	PERSON	Lee	nn	5	SENT_344	[p13l138t3778r221b3819],
5	J	NNP	PERSON	J	_	0	SENT_344	[p13l234t3778r267b3830],
6	,	,	O	,	_	0	SENT_344	[p13l234t3778r267b3830],
7	Prohaska	NNP	PERSON	Prohaska	nn	8	SENT_344	[p13l287t3775r520b3819],
8	JR	NNP	O	JR	appos	5	SENT_344	[p13l532t3778r600b3830],
9	,	,	O	,	_	0	SENT_344	[p13l532t3778r600b3830],
10	Thiele	NNP	O	Thiele	nn	11	SENT_344	[p13l618t3775r775b3819],
11	DJ	NNP	O	DJ	appos	8	SENT_344	[p13l794t3778r861b3830],
12	.	.	O	.	_	0	SENT_344	[p13l794t3778r861b3830],

1	Essential	JJ	O	essential	amod	2	SENT_345	[p13l881t3775r1107b3819],
2	role	NN	O	role	_	0	SENT_345	[p13l1127t3776r1224b3819],
3	for	IN	O	for	_	0	SENT_345	[p13l1244t3775r1315b3819],
4	mammalian	JJ	O	mammalian	amod	6	SENT_345	[p13l1333t3776r1642b3819],
5	copper	NN	O	copper	nn	6	SENT_345	[p13l1661t3788r1838b3830],
6	transporter	NN	O	transporter	prep_for	2	SENT_345	[p13l1855t3782r2150b3830],

1	Ctrl	NNP	O	Ctrl	_	0	SENT_346	[p14l138t19r238b60],
2	in	IN	O	in	_	0	SENT_346	[p14l268t18r316b60],
3	copper	NN	O	copper	nn	4	SENT_346	[p14l338t29r516b71],
4	homeostasis	NN	O	homeostasis	prep_in	1	SENT_346	[p14l537t17r855b60],
5	and	CC	O	and	_	0	SENT_346	[p14l879t17r972b60],
6	embryonic	JJ	O	embryonic	amod	7	SENT_346	[p14l996t17r1271b71],
7	development	NN	O	development	prep_in	1	SENT_346	[p14l1294t17r1646b71],
8	.	.	O	.	_	0	SENT_346	[p14l1294t17r1646b71],

1	Proc	NNP	ORGANIZATION	Proc	nn	5	SENT_347	[p14l1670t20r1781b60],
2	Natl	NNP	ORGANIZATION	Natl	nn	5	SENT_347	[p14l1804t17r1908b60],
3	Acad	NNP	ORGANIZATION	Acad	nn	5	SENT_347	[p14l1929t17r2054b60],
4	Sci	NNP	ORGANIZATION	Sci	nn	5	SENT_347	[p14l2078t18r2147b60],
5	USA	NNP	ORGANIZATION	USA	_	0	SENT_347	[p14l137t84r243b126],
6	2001	CD	DATE	2001	num	5	SENT_347	[p14l259t85r379b126],
7	;	:	O	;	_	0	SENT_347	[p14l394t83r807b137],
8	98	CD	NUMBER	98	number	9	SENT_347	[p14l394t83r807b137],
9	(	CD	NUMBER	(	dep	5	SENT_347	[p14l394t83r807b137],
10	12	CD	NUMBER	12	num	11	SENT_347	[p14l394t83r807b137],
11	)	NN	O	)	dep	9	SENT_347	[p14l394t83r807b137],
12	:6842	CD	NUMBER	:6842	num	13	SENT_347	[p14l394t83r807b137],
13	—	NN	O	—	dep	9	SENT_347	[p14l394t83r807b137],
14	7	CD	NUMBER	7	dep	13	SENT_347	[p14l394t83r807b137],
15	.	.	O	.	_	0	SENT_347	[p14l394t83r807b137],

1	[	NN	O	[	nn	6	SENT_348	[p14l6t149r103b203],
2	29	CD	NUMBER	29	num	6	SENT_348	[p14l6t149r103b203],
3	]	CD	NUMBER	]	num	6	SENT_348	[p14l6t149r103b203],
4	De	NNP	PERSON	De	nn	6	SENT_348	[p14l138t152r204b192],
5	Feo	NNP	PERSON	Feo	nn	6	SENT_348	[p14l230t152r316b192],
6	C	NNP	O	C	_	0	SENT_348	[p14l341t151r402b203],
7	]	NN	O	]	dep	6	SENT_348	[p14l341t151r402b203],
8	,	,	O	,	_	0	SENT_348	[p14l341t151r402b203],
9	Aller	NNP	PERSON	Aller	nn	10	SENT_348	[p14l425t149r549b192],
10	SG	NNP	O	SG	appos	7	SENT_348	[p14l573t151r651b199],
11	,	,	O	,	_	0	SENT_348	[p14l573t151r651b199],
12	Siluvai	NNP	ORGANIZATION	Siluvai	nn	13	SENT_348	[p14l677t149r847b192],
13	GS	NN	ORGANIZATION	g	appos	7	SENT_348	[p14l873t151r950b199],
14	,	,	O	,	_	0	SENT_348	[p14l873t151r950b199],
15	Blackburn	NNP	ORGANIZATION	Blackburn	nn	17	SENT_348	[p14l977t149r1236b192],
16	N	NNP	ORGANIZATION	N	nn	17	SENT_348	[p14l1261t152r1328b203],
17	]	NN	O	]	appos	7	SENT_348	[p14l1261t152r1328b203],
18	,	,	O	,	_	0	SENT_348	[p14l1261t152r1328b203],
19	Unger	NNP	PERSON	Unger	nn	20	SENT_348	[p14l1354t152r1510b203],
20	VM	NNP	O	VM	appos	7	SENT_348	[p14l1532t152r1633b193],
21	.	.	O	.	_	0	SENT_348	[p14l1532t152r1633b193],

1	Three	CD	NUMBER	three	num	2	SENT_349	[p14l1656t149r2147b192],
2	—	CD	NUMBER	—	_	0	SENT_349	[p14l1656t149r2147b192],
3	dimensional	JJ	O	dimensional	amod	4	SENT_349	[p14l1656t149r2147b192],
4	structure	NN	O	structure	dep	2	SENT_349	[p14l139t222r372b259],
5	of	IN	O	of	_	0	SENT_349	[p14l400t215r454b259],
6	the	DT	O	the	det	10	SENT_349	[p14l475t215r557b259],
7	human	JJ	O	human	amod	10	SENT_349	[p14l585t215r765b259],
8	copper	NN	O	copper	nn	10	SENT_349	[p14l794t228r971b270],
9	transporter	NN	O	transporter	nn	10	SENT_349	[p14l997t222r1291b270],
10	hCTR1	NN	O	hctr1	prep_of	4	SENT_349	[p14l1318t215r1493b259],
11	.	.	O	.	_	0	SENT_349	[p14l1318t215r1493b259],

1	Proc	NNP	ORGANIZATION	Proc	nn	5	SENT_350	[p14l1523t218r1633b259],
2	Natl	NNP	ORGANIZATION	Natl	nn	5	SENT_350	[p14l1661t215r1766b259],
3	Acad	NNP	ORGANIZATION	Acad	nn	5	SENT_350	[p14l1792t215r1917b259],
4	Sci	NNP	ORGANIZATION	Sci	nn	5	SENT_350	[p14l1946t216r2015b259],
5	USA	NNP	ORGANIZATION	USA	_	0	SENT_350	[p14l2043t217r2150b259],
6	2009	CD	DATE	2009	num	5	SENT_350	[p14l138t281r751b335],
7	;	:	O	;	_	0	SENT_350	[p14l138t281r751b335],
8	106	CD	NUMBER	106	number	9	SENT_350	[p14l138t281r751b335],
9	(	CD	NUMBER	(	dep	5	SENT_350	[p14l138t281r751b335],
10	11	CD	NUMBER	11	num	11	SENT_350	[p14l138t281r751b335],
11	)	NN	O	)	dep	9	SENT_350	[p14l138t281r751b335],
12	:4237	CD	NUMBER	:4237	number	13	SENT_350	[p14l138t281r751b335],
13	—	CD	NUMBER	—	dep	9	SENT_350	[p14l138t281r751b335],
14	42	CD	NUMBER	42	dep	13	SENT_350	[p14l138t281r751b335],
15	.	.	O	.	_	0	SENT_350	[p14l138t281r751b335],

1	[	RB	O	[	advmod	5	SENT_351	[p14l6t347r103b401],
2	30	CD	NUMBER	30	num	5	SENT_351	[p14l6t347r103b401],
3	]	CD	NUMBER	]	num	5	SENT_351	[p14l6t347r103b401],
4	Eisses	NNP	O	Eisses	nn	5	SENT_351	[p14l138t348r287b391],
5	JF	NNP	O	JF	_	0	SENT_351	[p14l303t350r365b401],
6	,	,	O	,	_	0	SENT_351	[p14l303t350r365b401],
7	Kaplan	NNP	PERSON	Kaplan	nn	8	SENT_351	[p14l388t347r565b401],
8	JH	NNP	O	JH	appos	5	SENT_351	[p14l580t350r655b401],
9	.	.	O	.	_	0	SENT_351	[p14l580t350r655b401],

1	Molecular	JJ	O	molecular	amod	2	SENT_352	[p14l678t347r937b391],
2	characterization	NN	O	characterization	_	0	SENT_352	[p14l958t347r1377b391],
3	of	IN	O	of	_	0	SENT_352	[p14l1399t347r1452b391],
4	hCTR1	NN	O	hctr1	prep_of	2	SENT_352	[p14l1468t347r1643b397],
5	,	,	O	,	_	0	SENT_352	[p14l1468t347r1643b397],
6	the	DT	O	the	det	10	SENT_352	[p14l1666t347r1747b391],
7	human	JJ	O	human	amod	10	SENT_352	[p14l1770t347r1951b391],
8	copper	NN	O	copper	nn	10	SENT_352	[p14l1972t360r2150b401],
9	uptake	NN	O	uptake	nn	10	SENT_352	[p14l138t413r313b467],
10	protein	NN	O	protein	appos	4	SENT_352	[p14l331t413r563b467],
11	]	CD	NUMBER	]	num	13	SENT_352	[p14l331t413r563b467],
12	Biol	NNP	O	Biol	nn	13	SENT_352	[p14l581t412r677b456],
13	Chem	NNP	O	Chem	dep	10	SENT_352	[p14l695t412r842b456],
14	2002	CD	DATE	2002	num	13	SENT_352	[p14l859t413r1505b467],
15	;	:	O	;	_	0	SENT_352	[p14l859t413r1505b467],
16	277	CD	NUMBER	277	number	17	SENT_352	[p14l859t413r1505b467],
17	(	CD	NUMBER	(	dep	2	SENT_352	[p14l859t413r1505b467],
18	32	CD	NUMBER	32	num	19	SENT_352	[p14l859t413r1505b467],
19	)	NN	O	)	dep	17	SENT_352	[p14l859t413r1505b467],
20	:29	CD	NUMBER	:29	num	21	SENT_352	[p14l859t413r1505b467],
21	l62	NN	O	l62	dep	17	SENT_352	[p14l859t413r1505b467],
22	—	CD	NUMBER	—	num	23	SENT_352	[p14l859t413r1505b467],
23	7l	NN	O	7l	dep	21	SENT_352	[p14l859t413r1505b467],
24	.	.	O	.	_	0	SENT_352	[p14l859t413r1505b467],

